0000950123-11-067205.txt : 20110721 0000950123-11-067205.hdr.sgml : 20110721 20110721164922 ACCESSION NUMBER: 0000950123-11-067205 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20110721 DATE AS OF CHANGE: 20110721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVIV REIT, INC. CENTRAL INDEX KEY: 0001499686 IRS NUMBER: 273200673 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-103 FILM NUMBER: 11980359 BUSINESS ADDRESS: STREET 1: 630 FIFTH AVENUE STREET 2: 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10111 BUSINESS PHONE: 212-651-1123 MAIL ADDRESS: STREET 1: 630 FIFTH AVENUE STREET 2: 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alamogordo Aviv, L.L.C. CENTRAL INDEX KEY: 0001519042 IRS NUMBER: 270123540 STATE OF INCORPORATION: NM FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-115 FILM NUMBER: 11980372 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arkansas Aviv, L.L.C. CENTRAL INDEX KEY: 0001519043 IRS NUMBER: 300509615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-117 FILM NUMBER: 11980371 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arma Yates, L.L.C. CENTRAL INDEX KEY: 0001519044 IRS NUMBER: 273971035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-114 FILM NUMBER: 11980370 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Asset Management, L.L.C. CENTRAL INDEX KEY: 0001519045 IRS NUMBER: 300305067 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-113 FILM NUMBER: 11980369 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Financing I, L.L.C. CENTRAL INDEX KEY: 0001519046 IRS NUMBER: 113747125 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-112 FILM NUMBER: 11980368 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Financing II, L.L.C. CENTRAL INDEX KEY: 0001519047 IRS NUMBER: 364597042 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-111 FILM NUMBER: 11980367 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Financing III, L.L.C. CENTRAL INDEX KEY: 0001519048 IRS NUMBER: 364641210 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-110 FILM NUMBER: 11980366 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Financing IV, L.L.C. CENTRAL INDEX KEY: 0001519050 IRS NUMBER: 270836481 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-109 FILM NUMBER: 11980365 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Financing V, L.L.C. CENTRAL INDEX KEY: 0001519051 IRS NUMBER: 270836548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-108 FILM NUMBER: 11980364 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Foothills, L.L.C. CENTRAL INDEX KEY: 0001519052 IRS NUMBER: 364572035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-107 FILM NUMBER: 11980375 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Liberty, L.L.C. CENTRAL INDEX KEY: 0001519054 IRS NUMBER: 364572034 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-105 FILM NUMBER: 11980361 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv OP Ltd Partner, L.L.C. CENTRAL INDEX KEY: 0001519055 IRS NUMBER: 273474432 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-104 FILM NUMBER: 11980360 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avon Ohio, L.L.C. CENTRAL INDEX KEY: 0001519056 IRS NUMBER: 364601433 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-102 FILM NUMBER: 11980358 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Healthcare Properties Operating Partnership I, L.P. CENTRAL INDEX KEY: 0001519057 IRS NUMBER: 113747120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-106 FILM NUMBER: 11980362 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Benton Harbor, L.L.C. CENTRAL INDEX KEY: 0001519062 IRS NUMBER: 364204807 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-98 FILM NUMBER: 11980355 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BHG Aviv, L.L.C. CENTRAL INDEX KEY: 0001519063 IRS NUMBER: 364601432 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-97 FILM NUMBER: 11980354 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bonham Texas, L.L.C. CENTRAL INDEX KEY: 0001519065 IRS NUMBER: 300358809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-96 FILM NUMBER: 11980353 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Burton NH Property, L.L.C. CENTRAL INDEX KEY: 0001519066 IRS NUMBER: 113714506 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-95 FILM NUMBER: 11980352 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: California Aviv Two, L.L.C. CENTRAL INDEX KEY: 0001519067 IRS NUMBER: 264117080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-93 FILM NUMBER: 11980350 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: California Aviv, L.L.C. CENTRAL INDEX KEY: 0001519068 IRS NUMBER: 383786697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-94 FILM NUMBER: 11980351 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Camas Associates, L.L.C. CENTRAL INDEX KEY: 0001519069 IRS NUMBER: 364340182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-92 FILM NUMBER: 11980349 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Casa/Sierra California Associates, L.L.C. CENTRAL INDEX KEY: 0001519070 IRS NUMBER: 364572017 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-91 FILM NUMBER: 11980348 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chatham Aviv, L.L.C. CENTRAL INDEX KEY: 0001519071 IRS NUMBER: 270354315 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-90 FILM NUMBER: 11980347 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chenal Arkansas, L.L.C. CENTRAL INDEX KEY: 0001519072 IRS NUMBER: 043835270 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-89 FILM NUMBER: 11980346 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chippewa Valley, L.L.C. CENTRAL INDEX KEY: 0001519073 IRS NUMBER: 364065826 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-88 FILM NUMBER: 11980363 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Clarkston Care, L.L.C. CENTRAL INDEX KEY: 0001519074 IRS NUMBER: 760802028 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-87 FILM NUMBER: 11980344 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Clayton Associates, L.L.C. CENTRAL INDEX KEY: 0001519075 IRS NUMBER: 364572014 STATE OF INCORPORATION: NM FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-86 FILM NUMBER: 11980343 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Colonial Madison Associates, L.L.C. CENTRAL INDEX KEY: 0001519076 IRS NUMBER: 383741678 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-85 FILM NUMBER: 11980342 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Columbia View Associates, L.L.C. CENTRAL INDEX KEY: 0001519077 IRS NUMBER: 364204809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-84 FILM NUMBER: 11980341 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Columbus Texas Aviv, L.L.C. CENTRAL INDEX KEY: 0001519078 IRS NUMBER: 383735473 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-83 FILM NUMBER: 11980340 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Columbus Western Avenue, L.L.C. CENTRAL INDEX KEY: 0001519079 IRS NUMBER: 710960205 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-82 FILM NUMBER: 11980339 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Commerce Nursing Homes, L.L.C. CENTRAL INDEX KEY: 0001519080 IRS NUMBER: 364122632 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-81 FILM NUMBER: 11980338 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CR Aviv, L.L.C. CENTRAL INDEX KEY: 0001519081 IRS NUMBER: 205354773 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-80 FILM NUMBER: 11980337 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Denison Texas, L.L.C. CENTRAL INDEX KEY: 0001519082 IRS NUMBER: 320173170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-79 FILM NUMBER: 11980336 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Effingham Associates, L.L.C. CENTRAL INDEX KEY: 0001519083 IRS NUMBER: 364150491 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-78 FILM NUMBER: 11980335 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elite Mattoon, L.L.C. CENTRAL INDEX KEY: 0001519084 IRS NUMBER: 364454111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-77 FILM NUMBER: 11980334 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elite Yorkville, L.L.C. CENTRAL INDEX KEY: 0001519085 IRS NUMBER: 364454114 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-76 FILM NUMBER: 11980333 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Falfurrias Texas, L.L.C. CENTRAL INDEX KEY: 0001519086 IRS NUMBER: 611501714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-75 FILM NUMBER: 11980332 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Florence Heights Associates, L.L.C. CENTRAL INDEX KEY: 0001519087 IRS NUMBER: 113747131 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-74 FILM NUMBER: 11980331 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fountain Associates, L.L.C. CENTRAL INDEX KEY: 0001519088 IRS NUMBER: 364572016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-73 FILM NUMBER: 11980330 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Four Fountains Aviv, L.L.C. CENTRAL INDEX KEY: 0001519089 IRS NUMBER: 364601434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-72 FILM NUMBER: 11980329 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Freewater Oregon, L.L.C. CENTRAL INDEX KEY: 0001519090 IRS NUMBER: 362280966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-71 FILM NUMBER: 11980328 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fullerton California, L.L.C. CENTRAL INDEX KEY: 0001519091 IRS NUMBER: 364480527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-19 FILM NUMBER: 11980345 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Giltex Care, L.L.C. CENTRAL INDEX KEY: 0001519094 IRS NUMBER: 364572036 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-18 FILM NUMBER: 11980327 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Great Bend Property, L.L.C. CENTRAL INDEX KEY: 0001519095 IRS NUMBER: 273971138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-17 FILM NUMBER: 11980326 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Heritage Monterey Associates, L.L.C. CENTRAL INDEX KEY: 0001519096 IRS NUMBER: 364056688 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-70 FILM NUMBER: 11980325 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HHM Aviv, L.L.C. CENTRAL INDEX KEY: 0001519097 IRS NUMBER: 320205746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-69 FILM NUMBER: 11980324 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hidden Acres Property, L.L.C. CENTRAL INDEX KEY: 0001519098 IRS NUMBER: 272457250 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-68 FILM NUMBER: 11980323 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Highland Leasehold, L.L.C. CENTRAL INDEX KEY: 0001519099 IRS NUMBER: 202873499 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-67 FILM NUMBER: 11980322 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hobbs Associates, L.L.C. CENTRAL INDEX KEY: 0001519100 IRS NUMBER: 364177337 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-66 FILM NUMBER: 11980321 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hot Springs Aviv, L.L.C. CENTRAL INDEX KEY: 0001519101 IRS NUMBER: 300470700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-65 FILM NUMBER: 11980320 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Houston Texas Aviv, L.L.C. CENTRAL INDEX KEY: 0001519102 IRS NUMBER: 364587739 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-64 FILM NUMBER: 11980319 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hutchinson Kansas, L.L.C. CENTRAL INDEX KEY: 0001519103 IRS NUMBER: 510559326 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-63 FILM NUMBER: 11980318 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Idaho Associates, L.L.C. CENTRAL INDEX KEY: 0001519104 IRS NUMBER: 364114446 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-62 FILM NUMBER: 11980317 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Karan Associates Two, L.L.C. CENTRAL INDEX KEY: 0001519105 IRS NUMBER: 611514965 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-60 FILM NUMBER: 11980315 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Karan Associates, L.L.C. CENTRAL INDEX KEY: 0001519106 IRS NUMBER: 113747208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-61 FILM NUMBER: 11980316 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KB Northwest Associates, L.L.C. CENTRAL INDEX KEY: 0001519107 IRS NUMBER: 364572025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-59 FILM NUMBER: 11980314 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kingsville Texas, L.L.C. CENTRAL INDEX KEY: 0001519108 IRS NUMBER: 371522939 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-58 FILM NUMBER: 11980313 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Manor Associates, L.L.C. CENTRAL INDEX KEY: 0001519109 IRS NUMBER: 364572020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-57 FILM NUMBER: 11980312 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Healthcare Capital Corp CENTRAL INDEX KEY: 0001519119 IRS NUMBER: 274536064 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-116 FILM NUMBER: 11980373 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aviv Healthcare Properties L.P. CENTRAL INDEX KEY: 0001519120 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 352249166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824 FILM NUMBER: 11980258 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mansfield Aviv, L.L.C. CENTRAL INDEX KEY: 0001519121 IRS NUMBER: 320183852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-56 FILM NUMBER: 11980311 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Massachusetts Nursing Homes, L.L.C. CENTRAL INDEX KEY: 0001519122 IRS NUMBER: 202873416 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-55 FILM NUMBER: 11980310 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Minnesota Associates, L.L.C. CENTRAL INDEX KEY: 0001519123 IRS NUMBER: 364469552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-54 FILM NUMBER: 11980308 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Missouri Associates, L.L.C. CENTRAL INDEX KEY: 0001519124 IRS NUMBER: 364572033 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-53 FILM NUMBER: 11980307 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Missouri Regency Associates, L.L.C. CENTRAL INDEX KEY: 0001519125 IRS NUMBER: 364572031 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-52 FILM NUMBER: 11980306 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Montana Associates, L.L.C. CENTRAL INDEX KEY: 0001519126 IRS NUMBER: 364149849 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-51 FILM NUMBER: 11980305 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Monterey Park Leasehold Mortgage, L.L.C. CENTRAL INDEX KEY: 0001519127 IRS NUMBER: 320267202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-50 FILM NUMBER: 11980304 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mt. Vernon Texas, L.L.C. CENTRAL INDEX KEY: 0001519128 IRS NUMBER: 352270167 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-16 FILM NUMBER: 11980303 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: N.M. Bloomfield Three Plus One Ltd Co CENTRAL INDEX KEY: 0001519129 IRS NUMBER: 742748292 STATE OF INCORPORATION: NM FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-14 FILM NUMBER: 11980301 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: N.M. Espanola Three Plus One Ltd Co CENTRAL INDEX KEY: 0001519130 IRS NUMBER: 742748289 STATE OF INCORPORATION: NM FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-13 FILM NUMBER: 11980300 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: N.M. Lordsburg Three Plus One Ltd Co CENTRAL INDEX KEY: 0001519131 IRS NUMBER: 742748286 STATE OF INCORPORATION: NM FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-12 FILM NUMBER: 11980299 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: N.M. Silver City Three Plus One Ltd Co CENTRAL INDEX KEY: 0001519132 IRS NUMBER: 742748283 STATE OF INCORPORATION: NM FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-11 FILM NUMBER: 11980298 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Newtown ALF Property, L.L.C. CENTRAL INDEX KEY: 0001519133 IRS NUMBER: 274083571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-15 FILM NUMBER: 11980302 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Northridge Arkansas, L.L.C. CENTRAL INDEX KEY: 0001519134 IRS NUMBER: 043835262 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-10 FILM NUMBER: 11980297 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Norwalk ALF Property, L.L.C. CENTRAL INDEX KEY: 0001519135 IRS NUMBER: 274083805 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-09 FILM NUMBER: 11980296 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oakland Nursing Homes, L.L.C. CENTRAL INDEX KEY: 0001519136 IRS NUMBER: 364572018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-08 FILM NUMBER: 11980295 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: October Associates, L.L.C. CENTRAL INDEX KEY: 0001519137 IRS NUMBER: 364572030 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-07 FILM NUMBER: 11980294 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ogden Associates, L.L.C. CENTRAL INDEX KEY: 0001519138 IRS NUMBER: 364412291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-06 FILM NUMBER: 11980293 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ohio Aviv, L.L.C. CENTRAL INDEX KEY: 0001519139 IRS NUMBER: 364597043 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-05 FILM NUMBER: 11980292 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Omaha Associates, L.L.C. CENTRAL INDEX KEY: 0001519140 IRS NUMBER: 364572019 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-04 FILM NUMBER: 11980291 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orange ALF Property, L.L.C. CENTRAL INDEX KEY: 0001519141 IRS NUMBER: 274083471 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-03 FILM NUMBER: 11980290 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orange, L.L.C. CENTRAL INDEX KEY: 0001519142 IRS NUMBER: 364095365 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-02 FILM NUMBER: 11980289 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oregon Associates, L.L.C. CENTRAL INDEX KEY: 0001519143 IRS NUMBER: 364572024 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-01 FILM NUMBER: 11980288 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Peabody Associates, L.L.C. CENTRAL INDEX KEY: 0001519144 IRS NUMBER: 364572029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-49 FILM NUMBER: 11980287 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Prescott Arkansas, L.L.C. CENTRAL INDEX KEY: 0001519146 IRS NUMBER: 043835264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-47 FILM NUMBER: 11980285 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Raton Property Ltd Co CENTRAL INDEX KEY: 0001519147 IRS NUMBER: 364111094 STATE OF INCORPORATION: NM FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-46 FILM NUMBER: 11980284 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Red Rocks, L.L.C. CENTRAL INDEX KEY: 0001519148 IRS NUMBER: 364192351 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-45 FILM NUMBER: 11980283 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Richland Washington, L.L.C. CENTRAL INDEX KEY: 0001519149 IRS NUMBER: 260081509 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-44 FILM NUMBER: 11980282 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Riverside Nursing Home Associates, L.L.C. CENTRAL INDEX KEY: 0001519150 IRS NUMBER: 364340184 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-43 FILM NUMBER: 11980281 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rose Baldwin Park Property L.L.C. CENTRAL INDEX KEY: 0001519151 IRS NUMBER: 364111092 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-42 FILM NUMBER: 11980280 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Salem Associates, L.L.C. CENTRAL INDEX KEY: 0001519152 IRS NUMBER: 364572028 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-41 FILM NUMBER: 11980279 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: San Juan NH Property, L.L.C. CENTRAL INDEX KEY: 0001519153 IRS NUMBER: 113714511 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-40 FILM NUMBER: 11980278 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Santa Ana-Bartlett, L.L.C. CENTRAL INDEX KEY: 0001519154 IRS NUMBER: 364212739 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-39 FILM NUMBER: 11980277 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Santa Fe Missouri Associates, L.L.C. CENTRAL INDEX KEY: 0001519155 IRS NUMBER: 364165126 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-38 FILM NUMBER: 11980276 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Searcy Aviv, L.L.C. CENTRAL INDEX KEY: 0001519157 IRS NUMBER: 383779442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-36 FILM NUMBER: 11980274 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pomona Vista L.L.C. CENTRAL INDEX KEY: 0001519158 IRS NUMBER: 364111095 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-48 FILM NUMBER: 11980286 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Skagit Aviv, L.L.C. CENTRAL INDEX KEY: 0001519159 IRS NUMBER: 364641209 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-35 FILM NUMBER: 11980273 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Skyview Associates, L.L.C. CENTRAL INDEX KEY: 0001519160 IRS NUMBER: 364572023 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-34 FILM NUMBER: 11980272 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Southeast Missouri Property, L.L.C. CENTRAL INDEX KEY: 0001519161 IRS NUMBER: 273502072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-33 FILM NUMBER: 11980271 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Star City Arkansas, L.L.C. CENTRAL INDEX KEY: 0001519162 IRS NUMBER: 432089308 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-32 FILM NUMBER: 11980270 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sun-Mesa Properties, L.L.C. CENTRAL INDEX KEY: 0001519163 IRS NUMBER: 364047650 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-31 FILM NUMBER: 11980269 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tujunga, L.L.C. CENTRAL INDEX KEY: 0001519164 IRS NUMBER: 364389732 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-30 FILM NUMBER: 11980267 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Savoy/Bonham Venture, L.L.C. CENTRAL INDEX KEY: 0001519165 IRS NUMBER: 364572026 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-37 FILM NUMBER: 11980275 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VRB Aviv, L.L.C. CENTRAL INDEX KEY: 0001519166 IRS NUMBER: 760802032 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-29 FILM NUMBER: 11980266 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Washington-Oregon Associates, L.L.C. CENTRAL INDEX KEY: 0001519167 IRS NUMBER: 364192347 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-28 FILM NUMBER: 11980265 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Watauga Associates, L.L.C. CENTRAL INDEX KEY: 0001519168 IRS NUMBER: 364163268 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-27 FILM NUMBER: 11980264 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Wellington Leasehold, L.L.C. CENTRAL INDEX KEY: 0001519169 IRS NUMBER: 273971187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-26 FILM NUMBER: 11980263 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: West Pearl Street, L.L.C. CENTRAL INDEX KEY: 0001519170 IRS NUMBER: 810637081 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-25 FILM NUMBER: 11980262 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Wheeler Healthcare Associates, L.L.C. CENTRAL INDEX KEY: 0001519171 IRS NUMBER: 742752353 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-24 FILM NUMBER: 11980261 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Willis Texas Aviv, L.L.C. CENTRAL INDEX KEY: 0001519172 IRS NUMBER: 371522942 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-23 FILM NUMBER: 11980309 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Woodland Arkansas, L.L.C. CENTRAL INDEX KEY: 0001519173 IRS NUMBER: 043835266 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-22 FILM NUMBER: 11980260 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xion, L.L.C. CENTRAL INDEX KEY: 0001519174 IRS NUMBER: 364062845 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-21 FILM NUMBER: 11980259 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Yuba Aviv, L.L.C. CENTRAL INDEX KEY: 0001519175 IRS NUMBER: 113750228 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-20 FILM NUMBER: 11980374 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Belleville Illinois, L.L.C. CENTRAL INDEX KEY: 0001519251 IRS NUMBER: 320188341 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-101 FILM NUMBER: 11980357 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bellingham II Associates, L.L.C. CENTRAL INDEX KEY: 0001519252 IRS NUMBER: 113747130 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-173824-100 FILM NUMBER: 11980356 BUSINESS ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: (312) 855-0930 MAIL ADDRESS: STREET 1: 303 WEST MADISON STREET, SUITE 2400 CITY: CHICAGO STATE: IL ZIP: 60606 424B3 1 c64208b3e424b3.htm 424B3 e424b3
Table of Contents

 
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-173824
PROSPECTUS
$300,000,000
 
(AVIV HEALTHCARE LOGO)
Aviv Healthcare Properties Limited Partnership
Aviv Healthcare Capital Corporation
 
Exchange Offer for
7  3/4% Senior Notes Due 2019
 
 
On February 4, 2011, Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation (the “Issuers”) issued $200.0 million in aggregate principal amount of unregistered 7 3/4% Senior Notes due 2019. On April 5, 2011, the Issuers issued $100.0 million in aggregate principal amount of unregistered 7 3/4% Senior Notes due 2019 that, other than the issuance date and the aggregate principal amount, are substantially identical to the notes issued on February 4, 2011. The notes issued on February 4, 2011 and April 5, 2011 are collectively referred to as the “Old Notes.” We are conducting the exchange offer in order to provide you with an opportunity to exchange your Old Notes for freely tradable 7 3/4% Senior Notes due 2019 that have been registered under the Securities Act of 1933, as amended (the “Securities Act”) (which we refer to as the “Exchange Notes” and, together with the Old Notes, the “Notes”).
 
Terms of the Exchange Offer:
•     Expires 5:00 p.m., New York City time, August 22, 2011, unless extended.
•     You may withdraw tendered outstanding Old Notes any time before the expiration or termination of the exchange offer.
•     The exchange offer is subject to customary conditions that may be waived by us.
•     We will not receive any proceeds from the exchange offer.
•     The exchange of Old Notes for Exchange Notes should not be a taxable exchange for United States federal income tax purposes. See “Material U.S. Federal Income Tax Considerations.”
•     All Old Notes that are validly tendered and not validly withdrawn prior to the expiration of the exchange offer will be exchanged for Exchange Notes.
 
Terms of the Exchange Notes:
•     The Exchange Notes will mature on February 15, 2019. The Exchange Notes will pay interest semi-annually in cash in arrears on February 15 and August 15 of each year, beginning on August 15, 2011.
•     The Exchange Notes will be fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Aviv REIT, Inc. (“Aviv REIT”) and, with certain exceptions, all of its existing and future restricted subsidiaries, other than the Issuers.
•     The Exchange Notes and the senior guarantees will be our general unsecured senior obligations and will be subordinated to all of our and the guarantors’ existing and future secured indebtedness to the extent of the assets securing such secured indebtedness, pari passu with all existing and future senior unsecured indebtedness and senior to all existing and future senior subordinated indebtedness. The subordinated guarantees provided by the borrowers under our existing credit facilities will be general unsecured senior obligations and will be subordinated to all of the obligations of those borrowers under our existing credit facilities or any permitted refinancing of those facilities, pari passu with all existing and future senior unsecured indebtedness and senior to all existing and future senior subordinated indebtedness.
•     We may redeem the Exchange Notes in whole or in part from time to time. See “Description of Exchange Notes.”
•     Upon a change of control, we must give holders the opportunity to sell their Exchange Notes to us at 101% of their principal amount plus accrued and unpaid interest, if any.
•     The terms of the Exchange Notes are identical to those of the outstanding Old Notes, except the transfer restrictions, registration rights and additional interest provisions relating to the Old Notes do not apply to the Exchange Notes.
 
For a discussion of the specific risks that you should consider before tendering your outstanding Old Notes in the exchange offer, see the “Risk Factors” section beginning on page 13 of this prospectus.
 
 
No public market exists for the outstanding Old Notes. We do not intend to list the Exchange Notes on any securities exchange and, therefore, no active public market is anticipated for the Exchange Notes.
 
 
Neither the Securities and Exchange Commission nor any state or other domestic or foreign securities commission or regulatory authority has approved or disapproved of the Notes or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
 
 
 
The date of this prospectus is July 21, 2011.


 

 
Each broker-dealer that receives Exchange Notes for its own account pursuant to the exchange offer must acknowledge that it will deliver a prospectus in connection with any resale of such Exchange Notes. By so acknowledging and by delivering a prospectus, a broker-dealer will not be deemed to admit that it is an “underwriter” within the meaning of the Securities Act. A broker dealer who acquired Old Notes as a result of market making or other trading activities may use this prospectus, as supplemented or amended from time to time, in connection with any resales of the Exchange Notes. We have agreed that, for a period of up to 180 days after the closing of the exchange offer, we will make this prospectus available for use in connection with any such resale. See “Plan of Distribution.”
 
You should rely only on the information contained in this prospectus. We have not authorized anyone to provide you with information different from that contained in this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy securities other than those specifically offered hereby or an offer to sell any securities offered hereby in any jurisdiction where, or to any person whom, it is unlawful to make such offer or solicitation. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of the Exchange Notes.
 
 
 
 
TABLE OF CONTENTS
 
         
    1  
    13  
    30  
    39  
    40  
    41  
    43  
    63  
    73  
    76  
    83  
    84  
    87  
    90  
    92  
    146  
    152  
    153  
    153  
    153  
    F-1  
 
 
 
 
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
This prospectus includes forward-looking statements. Forward-looking statements provide our current expectations or forecasts of future events. Forward-looking statements include statements about our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events, performance and underlying assumptions and other statements that are not historical facts. Examples of forward-looking statements include all statements regarding our expected future financial position, results of operations, cash flows, liquidity, financing plans, business strategy, projected growth opportunities and potential acquisitions, plans and


Table of Contents

objectives of management for future operations, and compliance with and changes in governmental regulations. You can identify forward-looking statements by their use of forward-looking words, such as “may,” “will,” “anticipates,” “expect,” “believe,” “estimate,” “intend,” “plan,” “should,” “seek” or comparable terms, or the negative use of those words, but the absence of these words does not necessarily mean that a statement is not forward-looking.
 
These forward-looking statements are made based on our current expectations and beliefs concerning future events affecting us and are subject to uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control, that could cause our actual results to differ materially from those matters expressed in or implied by these forward-looking statements. Important factors that could cause actual results to differ materially from our expectations include those disclosed under “Risk Factors” and elsewhere in this prospectus. There may be additional risks of which we are presently unaware or that we currently deem immaterial. Forward-looking statements are not guarantees of future performance. We do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of this prospectus or to update you on the occurrence of any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this prospectus.
 
PRESENTATION OF NON-GAAP FINANCIAL INFORMATION AND PORTFOLIO STATISTICS
 
In this prospectus, we use financial measures that are derived on the basis of methodologies other than in accordance with generally accepted accounting principles (“GAAP”). The “non-GAAP” financial measures used in this prospectus include FFO, Adjusted FFO, EBITDA and Adjusted EBITDA. We derive these measures as follows:
 
  •     The National Association of Real Estate Investment Trusts, or NAREIT, defines FFO as net income (computed in accordance with GAAP), excluding gains from sales of property, plus real estate depreciation and amortization (excluding amortization of deferred financing costs) and after adjustments for unconsolidated partnerships and joint ventures. Applying the NAREIT definition to our financial statements results in FFO representing net income before depreciation and gain on sale of assets.
 
  •     Adjusted FFO represents FFO before deferred rental income, stock-based compensation, amortization of intangible income, amortization of deferred financing costs, offering costs, indemnity payments, loss on impairment of assets, loss on extinguishment of debt and change in fair value of derivatives.
 
  •     EBITDA represents net income before interest expense (net), taxes, depreciation and amortization of deferred financing costs.
 
  •     Adjusted EBITDA represents EBITDA before stock-based compensation, amortization of intangible income, offering costs, indemnity payments, loss on impairment of assets, loss on extinguishment of debt, change in fair value of derivatives and gain on sale of assets.
 
The indenture governing the Notes uses the terms Adjusted FFO and Adjusted EBITDA. For further discussion of the terms used in the indenture governing the Notes, see “Description of Exchange Notes—Certain Definitions.” For a further description of how FFO, Adjusted FFO, EBITDA and Adjusted EBITDA are calculated from, and a reconciliation of those measures to, our net income, see “Summary—Summary Financial Data.”
 
Our management uses FFO, Adjusted FFO, EBITDA and Adjusted EBITDA as important supplemental measures of our operating performance and liquidity. FFO is intended to exclude GAAP historical cost depreciation and amortization of real estate and related assets, which assumes that the value of


ii


Table of Contents

real estate assets diminishes ratably over time. Historically, however, real estate values have risen or fallen with market conditions. The term FFO was designed by the real estate industry to address this issue and as an indicator of our ability to incur and service debt. Because FFO and Adjusted FFO exclude depreciation and amortization unique to real estate, gains and losses from property dispositions and extraordinary items and because EBITDA and Adjusted EBITDA exclude certain non-cash charges and adjustments and amounts spent on interest and taxes, they provide our management with performance measures that, when compared year over year or with other real estate investment trusts, or REITs, reflect the impact to operations from trends in occupancy rates, rental rates, operating costs, development activities and, with respect to FFO and Adjusted FFO, interest costs, in each case providing perspective not immediately apparent from net income. In addition, we believe that FFO, Adjusted FFO, EBITDA and Adjusted EBITDA are frequently used by securities analysts, investors and other interested parties in the evaluation of REITs.
 
We offer these measures to assist the users of our financial statements in assessing our financial performance and liquidity under GAAP, but these measures are non-GAAP measures and should not be considered measures of liquidity, alternatives to net income or indicators of any other performance measure determined in accordance with GAAP, nor are they indicative of funds available to fund our cash needs, including our ability to make payments on our indebtedness. In addition, our calculations of these measures are not necessarily comparable to similar measures as calculated by other companies that do not use the same definition or implementation guidelines or interpret the standards differently from us. Investors should not rely on these measures as a substitute for any GAAP measure, including net income or revenues.
 
In addition to these non-GAAP financial measures, we present certain statistics in this prospectus regarding our portfolio of properties. These statistics include EBITDAR coverage, EBITDARM coverage, Portfolio Occupancy and Quality Mix, which are derived as follows:
 
  •     EBITDAR coverage represents EBITDAR, which we define as earnings before interest, taxes, depreciation, amortization and rent expense, of our operators for the applicable period, divided by the rent paid to us by our operators during such period.
 
  •     EBITDARM coverage represents EBITDARM, which we define as earnings before interest, taxes, depreciation, amortization, rent expense and management fees charged by the operator, of our operators for the applicable period, divided by the rent paid to us by our operators during such period.
 
  •     Portfolio Occupancy represents the average daily number of beds at our properties that are occupied during the applicable period divided by the total number of beds at our properties that are available for use during the applicable period.
 
  •     Quality Mix represents total revenues from all payor sources, excluding Medicaid revenues, at our properties divided by the total revenue at our properties for the applicable period.
 
In order to determine EBITDAR and EBITDARM coverage for the period presented, EBITDAR and EBITDARM coverage is stated only with respect to properties owned by us and operated by the same operator for the entire period. Accordingly, EBITDAR and EBITDARM coverage for the year ended December 31, 2010 included 150 of the 185 properties in our portfolio as of December 31, 2010.


iii


Table of Contents

INDUSTRY AND MARKET DATA
 
This prospectus includes information with respect to market share and industry conditions from third-party sources or based upon our estimates using such sources when available. While we believe that such information and estimates are reasonable and reliable, we have not independently verified any of the data from third-party sources. Similarly, our internal research is based upon our understanding of industry conditions, and such information has not been independently verified.
 
TRADEMARKS
 
As used in this prospectus, “Aviv REIT,” “Aviv Healthcare” and “Aviv Financing” are trademarks of our company. This prospectus also refers to brand names, trademarks or service marks of other companies. All brand names and other trademarks or service marks cited in this prospectus are the property of their respective holders.


iv


Table of Contents

 
SUMMARY
 
This summary highlights selected information appearing in this prospectus and may not contain all of the information that is important to you. This prospectus includes information about the Exchange Notes and the exchange offer as well as information regarding our business and detailed financial data. You should read this prospectus in its entirety, including “Risk Factors” and the financial statements and related notes appearing elsewhere in this prospectus, before deciding to participate in the exchange offer.
 
Unless the context requires otherwise or except as otherwise noted, as used in this prospectus the words “Aviv REIT,” “we,” “company,” “us” and “our” refer to Aviv REIT, Inc. and its subsidiaries, including the Issuers. Throughout this prospectus, we refer to operators and tenants by their commonly-known trade names; however, each operator or tenant may operate through a variety of legal entities, some or all of which may not be under common ownership. In addition, we use the words “operator” and “tenant” interchangeably when referring to these unaffiliated third parties.
 
Our Company
 
We operate as a self-administered, self-managed real estate investment trust, or REIT, that focuses on the ownership of healthcare properties, principally skilled nursing facilities (“SNFs”). We generate our revenues through long-term triple-net leases with a diversified group of high quality operators throughout the United States. Through our predecessor entities, we have been in the business of financing SNF operators through triple-net leases for over 30 years. We believe that we have one of the largest SNF portfolios in the United States which consisted of 187 properties, of which 168 were SNFs, with 18,300 licensed beds in 25 states leased to 32 operators, as of March 31, 2011. For the twelve months ended March 31, 2011, our revenues and Adjusted EBITDA were $95.1 million and $76.4 million, respectively. See “Presentation of Non-GAAP Financial Information and Portfolio Statistics” and “Summary Financial Data.”
 
We believe we are well positioned to benefit from our diversified portfolio of properties and extensive network of operator relationships. We focus on cultivating close relationships with our operators by working closely with them to help them achieve their business objectives. As a result of these efforts, we are in a position to effectively manage our portfolio, make additional investments and continue to expand our business. From April 2005 through March 2011, we completed $507.1 million of acquisitions. In 2010, we completed $79.2 million of acquisitions and investments. In addition, from January 1, 2011 through the date of this prospectus, we completed $71.5 million in investments. We target EBITDAR and EBITDARM coverages that we believe allow us to balance our rental income with appropriate operating and financial performance for our operators. Our EBITDAR and EBITDARM coverages for the year ended December 31, 2010 were 1.4x and 1.8x, respectively, and we have collected 99.5% of the rents owed to us over the last three years.
 
The structure of our triple-net leases has significantly contributed to our consistent and stable performance and positions us to benefit from a long-term stream of rental income. Our leases typically have initial terms of 10 years or more, annual rent escalation provisions of 2% to 3% and typically do not have operator purchase options. We also seek additional support for the rental income generated by the leases through guarantees, master leases, cross-default provisions and security deposits. As of March 31, 2011, the leases for 185 of our 187 properties were supported by personal and/or corporate guarantees.
 
Corporate Information
 
Aviv REIT was incorporated as a Maryland corporation on July 30, 2010 and operates in a manner intended to allow it to qualify as a REIT for federal income tax purposes. Aviv REIT intends to make its election to be taxed as a REIT effective as of its taxable year ending December 31, 2010.
 
Aviv REIT is the sole general partner of Aviv Healthcare Properties Limited Partnership. Our headquarters are located at 303 West Madison Street, Suite 2400, Chicago, Illinois 60606. Our telephone


1


Table of Contents

number is (312) 855-0930. Our internet website is http://www.avivreit.com. The information contained on, or accessible through, our website is not incorporated by reference into this prospectus and should not be considered a part of this prospectus.
 
The Exchange Offer
 
On February 4, 2011 and April 5, 2011, the Issuers sold, through private placements exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), $300,000,000 in aggregate principal amount of 7 3/4% Senior Notes due 2019 (the “Old Notes”), all of which are eligible to be exchanged for notes which have been registered under the Securities Act (the “Exchange Notes”). The Old Notes and the Exchange Notes are referred to together as the “Notes.”
 
Simultaneously with the private placements, we entered into registration rights agreements with the initial purchasers of the Old Notes (collectively, the “registration rights agreements”). Under the registration rights agreements, we are required to cause a registration statement for substantially identical notes, which will be issued in exchange for the Old Notes, to be filed with the Securities and Exchange Commission (the “SEC”) and to use our reasonable best efforts to complete the exchange offer by October 3, 2011. You may exchange your Old Notes for Exchange Notes in the exchange offer. You should read the discussion under the headings “The Exchange Offer” and “Description of Exchange Notes” for further information regarding the Exchange Notes.
 
Securities to be Exchanged Up to $300,000,000 principal amount of 7 3/4% Senior Notes due 2019.
 
The Exchange Offer; Securities Act Registration We are offering to exchange the Old Notes for an equal principal amount of the Exchange Notes. Old Notes may be exchanged only in denominations of $2,000 of principal amount and any integral multiple of $1,000 in excess thereof.
 
The exchange offer is being made pursuant to the registration rights agreements, which grant the initial purchasers and any subsequent holders of the Old Notes certain exchange and registration rights. The exchange offer is intended to satisfy those exchange and registration rights with respect to the Old Notes. After the exchange offer is complete and except for our obligations to file a shelf registration statement under the circumstances described below, you will no longer be entitled to any exchange or registration rights with respect to Old Notes.
 
You may tender your outstanding Old Notes for Exchange Notes by following the procedures described under the heading “The Exchange Offer.”
 
Expiration Date The exchange offer will expire at 5:00 p.m., New York City time, on August 22, 2011, or a later date and time to which the Issuers may extend it.
 
Withdrawal Rights You may withdraw your tender of the Old Notes at any time prior to the expiration date of the exchange offer. Any Old Notes not accepted by us for exchange for any reason will be returned to you at our expense promptly after the expiration or termination of the exchange offer.


2


Table of Contents

 
Conditions to the Exchange Offer The exchange offer is subject to customary conditions, some of which we may waive. We intend to conduct the exchange offer in accordance with the provisions of the registration rights agreements and the applicable requirements of the Securities Act, the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the SEC.
 
For more information, see “The Exchange Offer—Conditions to the Exchange Offer.”
 
Procedures for Tendering Old Notes Through Brokers and Banks Because the Old Notes are represented by global book-entry notes, the Depository Trust Company (“DTC”), as depositary, or its nominee is treated as the registered holder of the Old Notes and will be the only entity that can tender your Old Notes for Exchange Notes.
 
To tender your outstanding Old Notes, you must instruct the institution where you keep your Old Notes to tender your Old Notes on your behalf so that they are received on or prior to the expiration of the exchange offer. By tendering your Old Notes you will be deemed to have acknowledged and agreed to be bound by the terms set forth under “The Exchange Offer.” Your outstanding Old Notes must be tendered in denominations of $2,000 of principal amount and any integral multiple of $1,000 in excess thereof. In order for your tender to be considered valid, the exchange agent must receive a confirmation of book-entry transfer of your outstanding Old Notes into the exchange agent’s account at DTC, under the procedure described in this prospectus under the heading “The Exchange Offer,” on or before 5:00 p.m., New York City time, on the expiration date of the exchange offer.
 
See “The Exchange Offer” for more information regarding the procedures for tendering Old Notes.
 
Effect of Not Tendering Old Notes If you do not tender your Old Notes or if you do tender them but they are not accepted by us, your Old Notes will continue to be subject to the existing restrictions on transfer. Except for our obligation to file a shelf registration statement under the circumstances described below, we will have no further obligation to provide for the registration of the Old Notes under the Securities Act. If your outstanding Old Notes are not tendered and accepted in the exchange offer, it may become more difficult for you to sell or transfer your outstanding Old Notes.
 
Resale of the Exchange Notes Under existing interpretations by the staff of the SEC as set forth in no-action letters issued to unrelated third parties and referenced below, we believe that the Exchange Notes issued in the exchange offer in exchange for Old Notes may be offered for resale, resold and otherwise transferred by you without compliance with the registration and prospectus delivery provisions of the Securities Act, if you:


3


Table of Contents

 
•    are not an “affiliate” of ours within the meaning of Rule 405 of the Securities Act;
 
•    are acquiring the Exchange Notes in the ordinary course of business; and
 
•    have no arrangement or understanding with any person to participate in a distribution of the Exchange Notes.
 
In addition, each participating broker-dealer that receives Exchange Notes for its own account pursuant to the exchange offer in exchange for Old Notes that were acquired as a result of market-making or other trading activity must also acknowledge that it will deliver a prospectus in connection with any resale of the Exchange Notes. For more information, see “Plan of Distribution.”
 
Any holder of Old Notes, including any broker-dealer, who:
 
•    is our affiliate,
 
•    does not acquire the Exchange Notes in the ordinary course of its business, or
 
•    tenders in the exchange offer with the intention to participate, or for the purpose of participating, in a distribution of Exchange Notes,
 
cannot rely on the position of the staff of the SEC expressed in Exxon Capital Holdings Corporation, Morgan Stanley & Co., Incorporated or similar no-action letters and, in the absence of an applicable exemption, must comply with the registration and prospectus delivery requirements of the Securities Act in connection with the resale of the Exchange Notes or it may incur liability under the Securities Act. We will not be responsible for, or indemnify against, any such liability.
 
Minimum Condition The exchange offer is not conditioned on any minimum aggregate principal amount of Old Notes being tendered for exchange.
 
Appraisal or Dissenters’ Rights Holders of the Old Notes do not have any appraisal or dissenters’ rights in connection with the exchange offer.
 
Material United States Federal Income Tax Considerations Your exchange of Old Notes for Exchange Notes to be issued in the exchange offer will not be a taxable event for U.S. federal income tax purposes. See “Material U.S. Federal Income Tax Considerations” for a summary of U.S. federal tax consequences associated with the exchange of Old Notes for Exchange Notes and the ownership and disposition of those Exchange Notes.
 
Use of Proceeds We will not receive any proceeds from the issuance of Exchange Notes pursuant to the exchange offer.


4


Table of Contents

 
Exchange Agent The Bank of New York Mellon Trust Company, N.A. is serving as the exchange agent in connection with the exchange offer. The address and telephone number of the exchange agent are set forth under the heading “The Exchange Offer—Exchange Agent.”
 
Shelf Registration Statement The registration rights agreements require that we file a shelf registration statement, in addition to or in lieu of conducting the exchange offer, in the event that:
 
(1) we are not required to file the exchange offer registration statement or to consummate the exchange offer because the exchange offer is not permitted by law or SEC policy; or
 
(2) for any reason, we do not consummate the exchange offer by October 3, 2011; or
 
(3) any holder notifies us that:
 
    •    it is not permitted under law or SEC policy to participate in the exchange offer;
 
    •    it cannot publicly resell new notes that it acquires in the exchange offer without delivering a prospectus, and the prospectus contained in the exchange offer registration statement is not appropriate or available for resales by that holder;
 
    •    it is a broker-dealer and holds Old Notes that it has not exchanged and that it acquired directly from us or one of our affiliates; or
 
    •    an initial purchaser so requests (with respect to Old Notes that have not been resold and that it acquired directly from us or one of our affiliates).
 
You should refer to the section titled “Risk Factors” on page 13 of this prospectus for a description of some of the risks you should consider before participating in the exchange offer.


5


Table of Contents

The Exchange Notes
 
The summary below describes the principal terms of the Exchange Notes. Certain of the terms and conditions described below are subject to important limitations and exceptions. The terms of the Exchange Notes are identical to the terms of the Old Notes, except that the transfer restrictions, registration rights and provisions for additional interest relating to the Old Notes do not apply to the Exchange Notes. The “Description of Exchange Notes” section of this prospectus contains a more detailed description of the terms and conditions of the Exchange Notes.
 
 
Issuers Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation.
 
Securities Offered $300,000,000 principal amount of 7 3/4% Senior Notes due 2019.
 
Maturity February 15, 2019.
 
Interest Rate Interest on the Exchange Notes will accrue at a rate of 7.750% per annum from February 4, 2011 or from the date of the last payment of interest on the Old Notes, whichever is later. Interest will be computed on the basis of a 360-day year comprised of twelve 30-day months. We will not pay interest on Old Notes tendered and accepted for exchange.
 
Interest Payment Dates Each February 15 and August 15, beginning on August 15, 2011.
 
Ranking The Exchange Notes and the senior guarantees thereof will be the Issuers’ and such guarantors’ senior unsecured obligations and will rank:
 
•    senior to all existing and future indebtedness that by its terms is expressly subordinated to the Exchange Notes, including the subordinated guarantees provided by the Issuers and such guarantors of the obligations under our existing mortgage term loan and acquisition credit line;
 
•    pari passu with all existing and future senior unsecured indebtedness, including a limited unsecured guarantee of the obligations under our existing mortgage term loan and acquisition credit line provided by Aviv Healthcare Properties Limited Partnership;
 
•    effectively junior to all secured indebtedness to the extent of the value of the collateral securing such debt, including our revolving credit facility; and
 
•    structurally subordinate to all of the existing and future liabilities of our subsidiaries that do not guarantee the Exchange Notes.


6


Table of Contents

 
The subordinated guarantees of the Exchange Notes will be such guarantors’ subordinated unsecured obligations and will rank:
 
•    senior to all existing and future indebtedness of such guarantors that by its terms is expressly subordinated to subordinated guarantees of such guarantors;
 
•    pari passu with all existing and future senior unsecured indebtedness of such guarantors; and
 
•    contractually junior to such guarantors’ obligations under our existing mortgage term loan and acquisition credit line.
 
Guarantees The Exchange Notes will be guaranteed by Aviv REIT and the existing subsidiaries and (subject to certain exceptions) future subsidiaries of the Issuers (other than the subsidiaries that hold properties subject to mortgages whose terms prohibit such subsidiaries from entering into guarantees of other indebtedness). In each instance, the Exchange Notes will be fully and unconditionally guaranteed, jointly and severally, on an unsecured basis by the applicable guarantors. If we do not make payments required by the Exchange Notes, the guarantors must make them. The subsidiary guarantees may be released under certain circumstances.
 
Optional Redemption We may redeem some or all of the Exchange Notes at any time on or after February 15, 2015, at the redemption prices specified under the section “Description of Exchange Notes—Optional Redemption” plus accrued and unpaid interest, if any, to the redemption date. We may also redeem some or all of the Exchange Notes before February 15, 2015 at a redemption price of 100% of the principal amount thereof plus accrued and unpaid interest, if any, to the redemption date, plus a “make-whole” premium.
 
Optional Redemption after Equity Offering At any time prior to February 15, 2014, we may also redeem up to 35% of the original aggregate principal amount of the Exchange Notes with the proceeds from specific kinds of equity offerings at a redemption price equal to 107.750% of the aggregate principal amount of the Exchange Notes to be redeemed, plus accrued and unpaid interest, if any, to the redemption date. See “Description of Exchange Notes—Optional Redemption.”
 
Change of Control Offer If a change in control of our company occurs, we must give holders the opportunity to sell their Exchange Notes to us at 101% of their principal amount plus accrued and unpaid interest, if any. We, however, may not be able to pay the required price for the Exchange Notes presented to us at the time of a change of control event because we may have insufficient funds.


7


Table of Contents

 
Restrictive Covenants The indenture governing the Notes (including the Exchange Notes) contains covenants that, among other things, limit our ability and the ability of our restricted subsidiaries to:
 
•    incur or guarantee additional indebtedness;
 
•    incur or guarantee secured indebtedness;
 
•    pay dividends or distributions on, or redeem or repurchase, our capital stock;
 
•    make certain investments or other restricted payments;
 
•    sell assets;
 
•    enter into transactions with affiliates;
 
•    merge or consolidate or sell all or substantially all of our assets; and
 
•    create restrictions on the ability of our restricted subsidiaries to pay dividends or other amounts to us.
 
In addition, we are required to maintain Total Unencumbered Assets (as defined in “Description of Exchange Notes”) of at least 150% of our unsecured indebtedness. These covenants are subject to a number of important limitations and exceptions. See “Description of Exchange Notes—Covenants.”
 
Absence of a Public Market for the Exchange Notes The Exchange Notes are a new issue of securities with no established public market. We do not intend to apply for listing of the Exchange Notes on any securities exchange.
 
You should refer to the section titled “Risk Factors” on page 13 of this prospectus for a description of some of the risks you should consider before investing in the Exchange Notes.


8


Table of Contents

Summary Financial Data
 
You should read the following summary historical consolidated financial and other data in connection with “Selected Financial Data,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the historical consolidated financial statements and related notes thereto appearing elsewhere in this prospectus.
 
The summary historical consolidated financial data as of December 31, 2010 and 2009 and for the years ended December 31, 2010, 2009 and 2008 have been derived from the audited historical consolidated financial statements of Aviv Healthcare Properties Limited Partnership appearing elsewhere in this prospectus. The summary historical consolidated balance sheet data as of December 31, 2008 have been derived from the audited historical consolidated financial statements of Aviv Healthcare Properties Limited Partnership, which are not included in this prospectus. The summary historical consolidated financial data as of March 31, 2011 and 2010 and for the three months ended March 31, 2011 and 2010 have been derived from the unaudited historical consolidated financial statements of Aviv Healthcare Properties Limited Partnership appearing elsewhere in this prospectus. The unaudited historical financial statements include all adjustments, consisting of normal recurring adjustments, that we consider necessary for a fair presentation of our financial condition and results of operations as of such dates and for such periods under accounting principles generally accepted in the United States. The historical results are not necessarily indicative of the results to be expected in the future.
 
                                         
   
Year Ended December 31,
   
Three Months Ended March 31,
 
Operating Information
 
2008
   
2009
   
2010
   
2010
   
2011
 
    (in thousands)  
 
Revenues
                                       
Rental income
    $72,143       $82,775       $84,490       $21,150       $19,690  
Tenant recoveries
    4,831       6,056       6,442       1,529       1,689  
Interest on loans to lessees
    1,859       3,493       5,226       1,131       1,332  
                                         
Total revenues
    78,833       92,324       96,158       23,810       22,711  
Expenses
                                       
Rent and other operating expenses
    1,088       612       575       169       202  
General and administrative
    6,809       7,741       10,725       1,424       3,468  
Offering costs
          6,864                    
Real estate taxes
    5,116       6,232       6,475       1,605       1,689  
Depreciation
    14,616       17,528       17,854       4,362       4,799  
Loss on impairment
    932             96              
                                         
Total expenses
    28,561       38,977       35,725       7,560       10,158  
                                         
Operating income
    50,272       53,347       60,433       16,250       12,553  
Other income and expenses
                                       
Interest and other income
    2,012       466       133       63       6  
Interest expense
    (26,272 )     (26,570 )     (22,723 )     (5,865 )     (7,556 )
Change in fair value of derivatives
    (8,674 )     6,988       2,931       1,321        
Amortization of deferred financing costs
    (537 )     (550 )     (1,008 )     (139 )     (679 )
Gain on sale of assets, net
                512              
Loss on extinguishment of debt
                (2,295 )           (3,143 )
                                         
Total other income and expenses
    (33,471 )     (19,666 )     (22,450 )     (4,620 )     (11,372 )
                                         
Income from continuing operations
    16,801       33,681       37,983       11,630       1,181  
Discontinued operations
    73                          
                                         
Net income
    $16,874       $33,681       $37,983       $11,630       $1,181  
                                         


9


Table of Contents

                                         
   
As of December 31,
 
As of March 31,
Balance Sheet Information
 
2008
 
2009
 
2010
 
2010
 
2011
    (in thousands)
 
Cash and cash equivalents
    $9,361       $15,543       $13,028       $8,162       $10,504  
Loan receivables
    20,361       28,970       36,611       34,575       30,727  
Rental properties, net of accumulated depreciation
    564,600       577,736       627,101       583,646       650,378  
Total assets
    634,368       665,130       731,400       668,243       746,990  
Mortgage and other notes payable
    463,546       480,105       440,576       477,542       454,624  
Total liabilities
    519,096       527,598       486,244       530,054       499,969  
Total equity
    77,871       74,562       245,156       73,068       247,021  
 
                                         
   
Year Ended December 31,
 
Three Months Ended March 31,
Other Information
 
2008
 
2009
 
2010
 
2010
 
2011
    (in thousands)
 
Cash flows provided by operating activities
    $32,048       $40,042       $54,680       $14,014       $13,670  
Cash flows used in investing activities
    (89,075 )     (38,493 )     (75,117 )     (7,756 )     (22,350 )
Cash flows provided by (used in) financing activities
    50,010       4,632       17,922       (13,638 )     6,156  
Purchase of rental properties
    (94,392 )     (16,376 )     (54,884 )           (24,826 )
Capital improvements and other
    (1,833 )     (13,508 )     (7,883 )     (2,152 )     (3,250 )
Funds from operations (FFO) (1)
    31,536       51,209       55,325       15,992       5,979  
Adjusted FFO (1)
    34,036       43,554       52,278       13,229       11,191  
EBITDA (2)
    56,429       77,863       79,434       21,933       14,210  
Adjusted EBITDA (2)
    63,923       76,047       77,923       19,126       17,577  
 
                                                         
   
Year Ended December 31,
   
Three Months Ended March 31,
 
Other Information
 
2006
   
2007
   
2008
   
2009
   
2010
   
2010
   
2011
 
    (In thousands)  
 
Ratio of earnings to fixed charges (3)
    1.70 x     1.66 x     1.63 x     2.23 x     2.60x       2.94 x     1.14 x
 
 
(1) FFO represents net income before depreciation and gain on sale of assets. Adjusted FFO represents FFO before deferred rental income, stock-based compensation, amortization of intangible income, amortization of deferred financing costs, offering costs, indemnity payments, loss on impairment of assets, loss on extinguishment of debt and change in fair value of derivatives. For a discussion of FFO and Adjusted FFO, including their limits as financial measures, see “Presentation of Non-GAAP Financial Information and Portfolio Statistics.” The following table is a reconciliation of FFO and Adjusted FFO to net income, the most directly comparable measure calculated in accordance with GAAP:
 


10


Table of Contents

                                         
   
Year Ended December 31,
   
Three Months Ended March 31,
 
Funds from Operations
 
2008
   
2009
   
2010
   
2010
   
2011
 
    (in thousands)  
 
Net income
    $16,874       $33,681       $37,983       $11,630       $1,181  
Depreciation
    14,662       17,528       17,854       4,362       4,798  
Gain on sale of assets, net
                (512 )            
                                         
FFO
    31,536       51,209       55,325       15,992       5,979  
Deferred rental income
    (5,531 )     (6,389 )     (3,056 )     (95 )     1,166  
Stock-based compensation
    406       406       2,219       102       586  
Amortization of intangible income
    (2,518 )     (2,098 )     (3,681 )     (1,771 )     (362 )
Amortization of deferred financing costs
    537       550       1,008       139       679  
Offering costs(a)
          6,864                    
Indemnity payments(b)
                1,003       183        
Loss on impairment of assets
    932             96              
Change in fair value of derivatives
    8,674       (6,988 )     (2,931 )     (1,321 )      
Non-cash loss on extinguishment of debt
                2,295             3,143  
                                         
Adjusted FFO
    $34,036       $43,554       $52,278       $13,229       $11,191  
                                         
 
  (a)  Represents costs associated with a planned initial public offering of our company in 2008 and 2009 that was abandoned.
 
  (b)  Represents payments made to one of our operators to indemnify the operator for certain government obligations owed by the prior operator from whom we are seeking reimbursement. The total possible remaining liability for these obligations is $0.7 million.
 
(2) EBITDA represents net income before interest expense (net), taxes, depreciation and amortization of deferred financing costs. Adjusted EBITDA represents EBITDA before stock-based compensation, amortization of intangible income, offering costs, indemnity payments, loss on impairment of assets, loss on extinguishment of debt, change in fair value of derivatives and gain on sale of assets. For a discussion of EBITDA and Adjusted EBITDA, including their limits as financial measures, see “Presentation of Non-GAAP Financial Information and Portfolio Statistics.” The following table is a reconciliation of EBITDA and Adjusted EBITDA to net income, the most directly comparable measure calculated in accordance with GAAP:
 
                                         
   
Year Ended December 31,
   
Three Months Ended March 31,
 
EBITDA
 
2008
   
2009
   
2010
   
2010
   
2011
 
    (in thousands)  
 
Net income
    $16,874       $33,681       $37,983       $11,630       $1,181  
Interest expense, net
    24,356       26,104       22,589       5,802       7,551  
Depreciation
    14,662       17,528       17,854       4,362       4,799  
Amortization of deferred financing costs
    537       550       1,008       139       679  
                                         

11


Table of Contents

                                         
   
Year Ended December 31,
   
Three Months Ended March 31,
 
EBITDA
 
2008
   
2009
   
2010
   
2010
   
2011
 
    (in thousands)  
 
EBITDA
    56,429       77,863       79,434       21,933       14,210  
Stock-based compensation
    406       406       2,219       102       586  
Amortization of intangible income
    (2,518 )     (2,098 )     (3,681 )     (1,771 )     (362 )
Offering costs (a)
          6,864                    
Indemnity payments (b)
                1,003       183        
Loss on impairment of assets
    932             96              
Loss on extinguishment of debt
                2,295             3,143  
Change in fair value of derivatives
    8,674       (6,988 )     (2,931 )     (1,321 )      
Gain on sale of assets, net
                (512 )            
                                         
Adjusted EBITDA
    $63,923       $76,047       $77,923       $19,126       $17,577  
                                         
 
  (a)  Represents costs associated with a planned initial public offering of our company in 2008 and 2009 that was abandoned.
 
  (b)  Represents payments made to one of our operators to indemnify the operator for certain government obligations owed by the prior operator from whom we are seeking reimbursement. The total possible remaining liability for these obligations is $0.7 million.
 
(3) For purposes of the ratio of earnings to fixed charges, earnings consists of net income before fixed charges. Fixed charges consist of interest expensed and capitalized and amortized premiums, preferred dividends, discounts and capitalized expenses related to indebtedness.

12


Table of Contents

 
RISK FACTORS
 
An investment in the Exchange Notes involves significant risks. You should consider the following risks in addition to information set forth elsewhere in this prospectus before deciding to participate in the exchange offer. If any of the matters highlighted by the risks discussed in this prospectus occur, our business, financial condition, liquidity and results of operations could be materially and adversely affected, and you could lose all or a part of your investment.
 
Risks Relating to Our Business and Operations
 
Our business is dependent upon our tenants successfully operating their businesses and their failure to do so could have a material adverse effect on our ability to successfully and profitably operate our business.
 
We depend on our tenants to operate the properties we own in a manner which generates revenues sufficient to allow them to meet their obligations to us, including their obligations to pay rent, maintain certain insurance coverage, pay real estate taxes and maintain the properties in a manner so as not to jeopardize their operating licenses or regulatory status. The ability of our tenants to fulfill their obligations under our leases may depend, in part, upon the overall profitability of their operations, including any other SNFs or other properties or businesses they may acquire or operate. Cash flow generated by certain individual properties have not in the past been, and currently are not, sufficient for a tenant to meet its obligations to us. Our financial position could be weakened and our ability to fulfill our obligations under our indebtedness could be limited if any of our major tenants were unable to meet their obligations to us or failed to renew or extend their relationship with us as their lease terms expire, or if we were unable to lease or re-lease our properties on economically favorable terms. While we have generally been successful in the past in transitioning properties from one tenant to another where properties are underperforming, there can be no assurance that we will be able to continue to identify and successfully transition underperforming properties going forward. In addition, from time to time we may recognize deferred rent write-offs in connection with transitioning properties. These adverse developments could arise due to a number of factors, including those described in the risk factors below, including those under the heading “—Risks Relating to Our Tenants and the Skilled Nursing Facility Industry.”
 
We are subject to risks associated with debt financing, which could negatively impact our business and our ability to repay maturing debt.
 
Financing for future investments and our maturing commitments may be provided by borrowings under our credit facilities, private or public offerings of debt, the assumption of secured indebtedness, mortgage financing on a portion of our owned portfolio or through joint ventures. We are subject to risks normally associated with debt financing, including the risks that our cash flow will be insufficient to make timely payments of interest, that we will be unable to refinance existing indebtedness or support collateral obligations and that the terms of refinancing will not be as favorable as the terms of existing indebtedness. If we are unable to refinance or extend principal payments due at maturity or pay them with proceeds from other capital transactions, our cash flow may not be sufficient in all years to repay all maturing debt and to pay distributions to our stockholders. Furthermore, if prevailing interest rates, changes in our debt ratings or other factors at the time of refinancing result in higher interest rates upon refinancing, the interest expense relating to that refinanced indebtedness would increase, which could reduce our profitability. Moreover, additional debt financing increases the amount of our leverage, which could negatively affect our ability to obtain additional financing in the future or make us more vulnerable to a downturn in our results of operations or the economy generally. See “—Risks Relating to the Notes and Our Other Indebtedness.”


13


Table of Contents

Certain tenants account for a significant percentage of our rental income, and the failure of any of these tenants to meet their obligations to us could materially reduce our rental income and net income.
 
For the twelve months ended March 31, 2011, approximately 13.3% of our total rent under existing leases was from Evergreen, which operates 17 of our properties in California, Montana, Nevada, Oregon and Washington, approximately 10.6% of our total rent under existing leases was from Daybreak, which operates 28 of our properties in Texas, and approximately 9.4% of our total rent under existing leases was from SunMar, which operates 13 of our properties in California. No other tenant generated more than 9.1% of our total rent under existing leases for the twelve months ended March 31, 2011.
 
The failure or inability of any of these tenants, or of other tenants that account for a significant percentage of our rental income, to meet their obligations to us could materially reduce our rental income and net income, which could in turn materially adversely affect our results of operations and our ability to make payments on our indebtedness, including the Notes.
 
The geographic concentration of our properties could leave us vulnerable to an economic downturn, regulatory or reimbursement changes or acts of nature in those areas, resulting in a decrease in our revenues or otherwise negatively impacting our results of operations.
 
For the twelve months ended March 31, 2011, the three states from which we derived the largest amount of rent under existing leases were California (17.6%), Texas (14.9%) and Arkansas (9.5%). As a result of these concentrations, the conditions of local economies and real estate markets, changes in governmental rules and regulations, particularly with respect to Medicaid, acts of nature and other factors that may result in a decrease in demand for long-term care services in these states could have an adverse impact on our tenants’ revenues, costs and results of operations, which may affect their ability to meet their obligations to us.
 
Our portfolio currently consists predominantly of SNFs; any significant cost increases, reductions in reimbursement rates or other regulatory changes could negatively affect our tenants’ businesses and their ability to meet their obligations to us.
 
Our portfolio is predominately comprised of SNFs. As a result of our focus on SNFs, any changes in governmental rules and regulations, particularly with respect to Medicare and Medicaid reimbursement, or any other changes negatively affecting SNFs, could have an adverse impact on our tenants’ revenues, costs and results of operations, which may affect their ability to meet their obligations to us.
 
We may not be successful in identifying and consummating suitable acquisitions or investment opportunities, which may impede our growth and negatively affect our results of operations and may result in the use of a significant amount of management resources.
 
Our ability to expand through acquisitions is integral to our business strategy and requires us to identify suitable acquisition or investment opportunities that meet our criteria and are compatible with our growth strategy. Accordingly, we may often be engaged in evaluating potential transactions and other strategic alternatives. Although there is uncertainty that any of these discussions will result in definitive agreements or the completion of any transaction, we may devote a significant amount of our management resources to such a transaction, which could negatively impact our operations. In addition, we may incur significant costs in connection with seeking acquisitions or other strategic opportunities, regardless of whether the contemplated transactions are completed, and in combining our operations in the event that any such transactions are completed.
 
Our ability to acquire properties successfully may be constrained by the following significant risks:
 
  •     competition from other real estate investors with significant capital, including publicly-traded REITs and institutional investment funds;


14


Table of Contents

  •     competition from other potential acquirers may significantly increase the purchase price for a property we acquire, which could reduce our growth prospects;
 
  •     unsatisfactory results of our due diligence investigations or failure to meet other customary closing conditions; and
 
  •     failure to finance an acquisition on favorable terms or at all.
 
If any of these risks are realized, our business, financial condition and results of operations and our ability to make payments on our indebtedness, including the Notes, may be materially and adversely affected.
 
The fact that we must distribute 90% of our REIT taxable income annually in order to maintain our qualification as a REIT may limit our ability to rely upon rental payments from our leased properties or subsequently acquired properties in order to finance acquisitions. As a result, if debt or equity financing is not available on acceptable terms, further acquisitions might be limited or curtailed.
 
If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements could be impaired, which could adversely affect our operating results, our ability to operate our business and our ability to make payments on our indebtedness.
 
Beginning with the fiscal year ending December 31, 2012, we will be required to perform system and process evaluation and testing of our internal control over financial reporting to allow management to begin reporting on the effectiveness of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act. We cannot be certain that we will be able to successfully complete the procedures, certification and attestation requirements of Section 404 or that we will not identify material weaknesses in our internal control over financial reporting. If we fail to comply with the requirements of Section 404 or if we identify and report a material weakness, it may affect the reliability of our internal control over financial reporting, which could adversely affect the trading price of the Notes, and we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources.
 
Because real estate investments are relatively illiquid, our ability to promptly sell properties in our portfolio is limited.
 
Because real estate investments are relatively illiquid, our ability to promptly sell one or more properties in our portfolio is limited. The real estate market is affected by many factors, such as general economic conditions, availability of financing, interest rates and other factors, including supply and demand, that are beyond our control. In addition, our properties are special purpose properties that could not be readily converted to general residential, retail or office use. Transfers of operations of SNFs and other healthcare properties are subject to regulatory approvals not required for transfers of other types of commercial operations and other types of real estate. We cannot predict whether we will be able to sell any property for the price or on the terms set by us or whether any price or other terms offered by a prospective purchaser would be acceptable to us. We also cannot predict the length of time needed to find a willing purchaser and to close the sale of a property. To the extent we are unable to sell any properties for our book value, we may be required to take a non-cash impairment charge or loss on the sale, either of which would reduce our net income.
 
We may be required to expend funds to correct defects or to make improvements before a property can be sold. We may not have funds available to correct those defects or to make those improvements. We may agree to transfer restrictions that materially restrict us from selling that property for a period of time or impose other restrictions, such as a limitation on the amount of debt that can be placed or repaid on that property. These transfer restrictions would impede our ability to sell a property even if we deem it necessary or appropriate. These facts and any others that would impede our ability to respond to adverse changes in the


15


Table of Contents

performance of our properties may have a material adverse effect on our business, financial condition and results of operations.
 
Uninsured losses or losses in excess of our tenants’ insurance coverage could adversely affect our financial position and our cash flow.
 
Under the terms of our leases, our tenants are required to maintain comprehensive general liability, fire, flood, earthquake, boiler and machinery, nursing home or long-term care professional liability and extended coverage insurance with respect to our properties with policy specifications, limits and deductibles set forth in the leases or other written agreements between us and the tenant. However, our properties may be adversely affected by casualty losses which exceed insurance coverages and reserves. Should an uninsured loss occur, we could lose both our investment in, and anticipated profits and cash flows from, the property. Even if it were practicable to restore the property to its condition prior to the damage caused by a major casualty, the operations of the affected property would likely be suspended for a considerable period of time. In the event of any substantial loss affecting a property, disputes over insurance claims could arise.
 
As an owner of real property, we may be exposed to environmental liabilities.
 
Under various federal, state and local environmental laws, ordinances and regulations, a current or previous owner of real property, such as us, may be liable in certain circumstances for the costs of investigation, removal, remediation or release of hazardous or toxic substances (including materials containing asbestos) at, under or disposed of in connection with such property, as well as certain other potential costs relating to hazardous or toxic substances, including government fines and damages for injuries to persons or adjacent property. Such laws often impose liability without regard to whether the owner knew of, or was responsible for, the presence or disposal of such substances, and liability may be imposed on the owner in connection with the activities of a tenant at the property. The cost of any required investigation, remediation, removal, fines or personal or property damages and the owner’s liability therefore could exceed the value of the property and/or the assets of the owner. In addition, the presence of such substances, or the failure to properly dispose of or remediate such substances, may adversely affect our tenants’ ability to attract additional residents, our ability to sell or rent such property or to borrow using such property as collateral which, in turn, could reduce our revenues.
 
Although our leases require the tenant to indemnify us for certain environmental liabilities, the scope of such obligations may be limited. For instance, some of our leases do not require the tenant to indemnify us for environmental liabilities arising before the tenant took possession of the premises. Further, we cannot assure you that any such tenant would be able to fulfill its indemnification obligations. If we were to be liable for any such environmental liabilities and were unable to seek recovery against our tenants, our business, financial condition and results of operations could be materially and adversely affected.
 
We depend upon our key employees and our failure to retain or attract sufficient numbers of qualified personnel could have a material adverse effect on our business.
 
Our future performance depends to a significant degree upon the continued contributions of our management team and other employees. As of March 31, 2011, we had 22 full-time employees and two part-time employees and, as a result, the loss of even a small number of our employees may have an adverse effect on our business. Accordingly, our future success depends on our ability to retain, attract, hire and train skilled management and other qualified personnel. Competition for qualified employees is intense, and we compete for qualified employees with companies that may have greater financial resources than we have. Consequently, we may not be successful in retaining, attracting, hiring and training the people we need, which would seriously impede our ability to implement our business strategy.


16


Table of Contents

Craig M. Bernfield has significant influence over our board of directors.
 
Pursuant to a Stockholders Agreement entered into by Aviv REIT, Inc., an affiliate of Lindsay Goldberg, LLC (“Lindsay Goldberg”), a representative of certain limited partners related to the family of Zev Karkomi and an entity formed by Craig Bernfield, our Chairman, President and Chief Executive Officer, a total of eleven votes are to be cast at all meetings of Aviv REIT’s board of directors. Subject to certain exceptions, Class B directors, who are designated by Mr. Bernfield, are entitled to cast a total of six such votes. As a result, subject to certain exceptions, Mr. Bernfield has the ability to effectively control many of our decisions and substantially influence our business, policies, affairs and matters requiring the approval of our board of directors, including the determination of the outcome of many significant corporate transactions.
 
Risks Relating to Our Tenants and the Skilled Nursing Facility Industry
 
Our tenants’ failure to comply with the requirements of governmental reimbursement programs such as Medicare or Medicaid, licensing and certification requirements, fraud and abuse regulations or new legislative developments may affect their ability to meet their obligations to us.
 
Our tenants are subject to numerous federal, state and local laws and regulations that are subject to frequent and substantial changes (sometimes applied retroactively) resulting from legislation, adoption of rules and regulations, and administrative and judicial interpretations of existing laws. The ultimate timing or effect of any changes in these laws and regulations cannot be predicted. We have no direct control over our tenants’ ability to meet the numerous federal, state and local regulatory requirements. The failure of any of our tenants to comply with these laws, requirements and regulations may affect their ability to meet their obligations to us. In particular:
 
  •     Licensing and Certification.  Our tenants and facilities are subject to regulatory and licensing requirements of federal, state and local authorities and are periodically surveyed by them to confirm compliance. Failure to obtain licensure or loss or suspension of licensure or certification may prevent a facility from operating or result in a suspension of reimbursement payments until all licensure or certification issues have been resolved and the necessary licenses or certification are obtained or reinstated. In addition, some states require that SNFs obtain governmental approval, in the form of a Certificate of Need, or CON, or similar certification, that generally varies by state and is subject to change, prior to the addition or construction of new beds, the addition of services or certain capital expenditures. The CON laws and regulations may restrict our ability to add new facilities or expand an existing facility’s size or services. In addition, CON laws may constrain our ability to lease a particular property to a new tenant.
 
  •     Medicare and Medicaid Certification.  A significant portion of the revenues of our tenants that operate SNFs is derived from participation in government-funded reimbursement programs, primarily Medicare and Medicaid, and failure to maintain certification to participate in these programs could result in a loss of funding from such programs. Loss of certification could cause the revenues of our tenants to decline, potentially jeopardizing their ability to meet their obligations to us.
 
  •     Fraud and Abuse Laws and Regulations.  There are various highly complex federal and state laws governing a wide array of referrals, financial relationships and arrangements and prohibiting fraud by healthcare providers, including criminal provisions that prohibit financial inducements for referrals, filing false claims or making false statements to receive payment or certification under Medicare and Medicaid, or failing to refund overpayments or improper payments. Violations of these laws subject persons and entities to termination from participation in Medicare, Medicaid and other federally funded healthcare programs or result in the imposition of treble damages and fines or other penalties, which may affect that tenant’s ability to meet its obligations to us or to continue operating the facility.


17


Table of Contents

  •     Other Laws.  Other laws that impact how our tenants conduct their operations include: federal and state laws designed to protect the confidentiality and security of patient health information; state and local licensure laws; laws protecting consumers against deceptive practices; laws generally affecting our tenants’ management of property and equipment and how our tenants generally conduct their operations, such as fire, health and safety, and environmental laws; federal and state laws affecting assisted living facilities mandating quality of services and care, and quality of food service; resident rights (including abuse and neglect laws); and health standards set by the federal Occupational Safety and Health Administration. We cannot predict the effect additional costs to comply with these laws may have on the expenses of our tenants and their ability to meet their obligations to us.
 
  •     Legislative and Regulatory Developments.  Because all of our properties are used as healthcare properties, we will be impacted by the risks associated with the healthcare industry, including healthcare reform. While the expansion of healthcare coverage may result in some additional demand for services provided by tenants, reimbursement levels may be lower than the costs required to provide such services, which could materially adversely affect the ability of tenants to generate profits and pay rent under their lease agreements with us and thereby could materially adversely affect our business, financial position or results of operations. Regulatory proposals and rules are released on an ongoing basis that may have an impact on the healthcare system in general and the skilled nursing and long-term care industries in particular. We cannot predict whether any legislative or regulatory proposals will be adopted or, if adopted, what effect, if any, these proposals would have on our tenants and their ability to meet their obligations to us.
 
Our tenants depend on reimbursement from government and other third-party payors; reimbursement rates from such payors may be reduced, which could cause our tenants’ revenues to decline and affect their ability to meet their obligations to us.
 
The ability of our tenants to generate revenue and profit influences the underlying value of our properties. Revenues of our tenants are generally derived from payments for patient care. Sources of such payments for SNFs include Medicare, state Medicaid programs, private insurance carriers, healthcare service plans, health maintenance organizations, preferred provider arrangements, self-insured employers and the patients themselves. Medicare and Medicaid programs, as well as numerous private insurance and managed care plans, generally require participating providers to accept government-determined reimbursement levels as payment in full for services rendered, without regard to a facility’s charges. Changes in the reimbursement rate or methods of payment from third-party payors, including Medicare and Medicaid, or the implementation of other measures to reduce reimbursements for services provided by our tenants, have in the past and could in the future result in a substantial reduction in our tenants’ revenues. Additionally, revenue realizable under third-party payor agreements can change after examination and retroactive adjustment by payors during the claims settlement processes or as a result of post-payment audits. Payors may disallow requests for reimbursement based on determinations that certain costs are not reimbursable or reasonable or because additional documentation is necessary or because certain services were not covered or were not medically necessary. There also continue to be new legislative and regulatory proposals that could impose further limitations on government and private payments to healthcare providers. In some cases, states have enacted or are considering enacting measures designed to reduce their Medicaid expenditures and to make changes to private healthcare insurance. Moreover, healthcare facilities continue to experience pressures from private payors attempting to control healthcare costs, and reimbursement from private payors has in many cases effectively been reduced to levels approaching those of government payors. We cannot assure you that adequate reimbursement levels will continue to be available for the services provided by our tenants. Further limits on the scope of services reimbursed and on reimbursement rates could have a material adverse effect on our tenants’ liquidity, financial condition and results of operations, which could cause the revenues of our tenants to decline and which may affect their ability to meet their obligations to us.


18


Table of Contents

Government budget deficits could lead to a reduction in Medicaid and Medicare reimbursement.
 
A number of states are currently managing budget deficits, which may put pressure on states to decrease reimbursement rates for our tenants with the goal of decreasing state expenditures under their state Medicaid programs. The need to control Medicaid expenditures may be exacerbated by the potential for increased enrollment in Medicaid due to unemployment and declines in family incomes. These potential reductions could be compounded by the potential for federal cost-cutting efforts that could lead to reductions in reimbursement to our tenants under both the Medicaid and Medicare programs. Potential reductions in Medicaid and Medicare reimbursement to our tenants could reduce the cash flow of our tenants and their ability to meet their obligations to us.
 
Our tenants may be subject to significant legal actions that could subject them to increased operating costs and substantial uninsured liabilities, which may affect their ability to meet their obligations to us.
 
Our tenants may be subject to claims that their services have resulted in resident injury or other adverse effects. The insurance coverage maintained by our tenants, whether through commercial insurance or self-insurance, may not cover all claims made against them or continue to be available at a reasonable cost, if at all. In some states, insurance coverage for the risk of punitive damages arising from professional liability and general liability claims and/or litigation may not, in certain cases, be available to our tenants due to state law prohibitions or limitations of availability. As a result, our tenants operating in these states may be liable for punitive damage awards that are either not covered or are in excess of their insurance policy limits. From time to time, there may also be increases in government investigations of long-term care providers, particularly in the area of Medicare/Medicaid false claims, as well as increases in enforcement actions resulting from these investigations. Insurance is not available to cover such losses. Any adverse determination in a legal proceeding or government investigation, whether currently asserted or arising in the future, could lead to potential termination from government programs, large penalties and fines and otherwise have a material adverse effect on a tenant’s financial condition. If a tenant is unable to obtain or maintain insurance coverage, if judgments are obtained in excess of the insurance coverage, if a tenant is required to pay uninsured punitive damages, or if a tenant is subject to an uninsurable government enforcement action, the tenant could be exposed to substantial additional liabilities, which could result in its bankruptcy or insolvency or have a material adverse effect on the tenant’s business and its ability to meet its obligations to us.
 
Moreover, advocacy groups that monitor the quality of care at healthcare facilities have sued healthcare facility operators and called upon state and federal legislators to enhance their oversight of trends in healthcare facility ownership and quality of care. Patients have also sued healthcare facility operators and have, in certain cases, succeeded in winning very large damage awards for alleged abuses. This litigation and potential litigation in the future has materially increased the costs incurred by our tenants for monitoring and reporting quality of care compliance. In addition, the cost of medical malpractice and liability insurance has increased and may continue to increase so long as the present litigation environment affecting the operations of healthcare facilities continues. Increased costs could limit our tenants’ ability to meet their obligations to us, potentially decreasing our revenue and increasing our collection and litigation costs. To the extent we are required to remove or replace a tenant, our revenue from the affected property could be reduced or eliminated for an extended period of time.
 
The bankruptcy, insolvency or financial deterioration of our tenants could delay or prevent our ability to collect unpaid rents or require us to find new tenants.
 
We receive substantially all of our income as rent payments under leases of our properties. We have very limited control over the success or failure of our tenants’ businesses and, at any time, any of our tenants may experience a downturn in its business that may weaken its financial condition. As a result, our tenants may fail to make rent payments when due or declare bankruptcy. Any tenant failures to make rent payments when due or tenant bankruptcies could result in the termination of the tenant’s lease and could have a material


19


Table of Contents

adverse effect on our business, financial condition and results of operations, our ability to make distributions to our stockholders and our ability to make payments on our indebtedness, including the Notes.
 
If tenants are unable to comply with the terms of the leases, we may be forced to modify the leases in ways that are unfavorable to us. Alternatively, the failure of a tenant to perform under a lease could require us to declare a default, repossess the property, find a suitable replacement tenant, operate the property or sell the property. There is no assurance that we would be able to lease a property on substantially equivalent or better terms than the prior lease, or at all, find another tenant, successfully reposition the property for other uses or sell the property on terms that are favorable to us.
 
If any lease expires or is terminated, we could be responsible for all of the operating expenses for that property until it is re-leased or sold. If we experience a significant number of un-leased properties, our operating expenses could increase significantly. Any significant increase in our operating costs may have a material adverse effect on our business, financial condition and results of operations, our ability to make distributions to our stockholders and our ability to make payments on our indebtedness, including the Notes.
 
Any bankruptcy filing by or relating to one of our tenants could bar all efforts by us to collect pre-bankruptcy debts from that tenant or seize its property. A tenant bankruptcy could also delay our efforts to collect past due balances under the leases and could ultimately preclude collection of all or a portion of these sums. It is possible that we may recover substantially less than the full value of any unsecured claims we hold, if any, which may have a material adverse effect on our business, financial condition and results of operations, our ability to make distributions to our stockholders and our ability to make payments on our indebtedness, including the Notes. Furthermore, dealing with a tenant’s bankruptcy or other default may divert management’s attention and cause us to incur substantial legal and other costs.
 
If one or more of our tenants files for bankruptcy relief, the U.S. federal Bankruptcy Code provides that a debtor has the option to assume or reject the unexpired lease within a certain period of time. However, our leases with tenants that lease more than one of our properties are generally made pursuant to a single master lease covering all of that tenant’s properties leased from us, or are cross-defaulted with other leases, and consequently there is uncertainty about how such arrangements may be treated in a bankruptcy. It is possible that in bankruptcy the debtor-tenant may be required to assume or reject the master lease or cross-defaulted leases as a whole, rather than making the decision on a property-by-property basis, thereby preventing the debtor-tenant from assuming the better performing properties and terminating the master lease or cross-defaulted leases with respect to the poorer performing properties. The U.S. federal Bankruptcy Code generally requires that a debtor must assume or reject a contract in its entirety. Thus, under this scenario, a debtor could not choose to keep the beneficial provisions of a contract while rejecting the burdensome ones; the contract must be assumed or rejected as a whole. However, where under applicable state law a contract (even though it is contained in a single document) is determined to be divisible or severable into different agreements, or similarly, where a collection of documents is determined to constitute separate agreements instead of a single, integrated contract, then in those circumstances a debtor/trustee may be allowed to assume some of the divisible or separate agreements while rejecting the others.
 
Risks Relating to the Notes and Our Other Indebtedness
 
We have substantial indebtedness and have the ability to incur significant additional indebtedness.
 
We have substantial indebtedness and we may increase our indebtedness in the future. As of March 31, 2011, we had total indebtedness of $454.6 million outstanding. After giving pro forma effect to the sale of the Old Notes and the application of the proceeds therefrom to repay certain outstanding indebtedness, we anticipate that we would have had total indebtedness of approximately $508.4 million as of March 31,


20


Table of Contents

2011, including $300.0 million of indebtedness with respect to the Old Notes. Our level of indebtedness could have important consequences to investors. For example, it could:
 
  •     limit our ability to satisfy our obligations with respect to the Notes and our other debt;
 
  •     increase our vulnerability to general adverse economic and industry conditions;
 
  •     limit our ability to obtain additional financing to fund future working capital, capital expenditures and other general corporate requirements, or to carry out other aspects of our business;
 
  •     increase our cost of borrowing;
 
  •     require us to dedicate a substantial portion of our cash flow from operations to payments on indebtedness, thereby reducing the availability of such cash flow to fund working capital, capital expenditures and other general corporate requirements, or to carry out other aspects of our business;
 
  •     require us to pledge as collateral substantially all of our assets;
 
  •     require us to maintain certain debt coverage and financial ratios at specified levels, thereby reducing our financial flexibility;
 
  •     limit our ability to make material acquisitions or take advantage of business opportunities that may arise;
 
  •     limit our ability to make distributions to our stockholders, which may cause us to become subject to federal corporate income tax on any income that we do not distribute;
 
  •     expose us to fluctuations in interest rates, to the extent our borrowings bear variable rates of interests;
 
  •     limit our flexibility in planning for, or reacting to, changes in our business and industry; and
 
  •     place us at a potential competitive disadvantage compared to our competitors that have less debt.
 
In addition, the indenture governing the Notes permits us to incur substantial additional debt, including secured debt (to which the Notes will be effectively subordinated). If we incur additional debt, the related risks described above could intensify.
 
We may be unable to service our indebtedness, including the Notes.
 
Our ability to make scheduled payments on and to refinance our indebtedness, including the Notes, depends on and is subject to our future financial and operating performance, which in turn is affected by general and regional economic, financial, competitive, business and other factors beyond our control, including the availability of financing in the banking and capital markets. Our business may fail to generate sufficient cash flow from operations or future borrowings may be unavailable to us under our existing credit facility, our revolving credit facility or from other sources in an amount sufficient to enable us to make payments on our debt, including the Notes, to refinance our debt or to fund our other liquidity needs, including making distributions and dividends to maintain our REIT status. If we are unable to meet our debt obligations or to fund our other liquidity needs, we will need to restructure or refinance all or a portion of our debt, including the Notes. We may be unable to refinance any of our debt, including our existing credit facility, our revolving credit facility and the Notes, on commercially reasonable terms or at all. In particular, our existing credit


21


Table of Contents

facility and our revolving credit facility will mature prior to the maturity of the Notes. If we were unable to make payments or refinance our debt or obtain new financing under these circumstances, we would have to consider other options, such as asset sales, equity issuances and/or negotiations with our lenders to restructure the applicable debt. Our existing credit facility, our revolving credit facility and the indenture governing the Notes restrict, and market or business conditions may limit, our ability to take some or all of these actions. Any restructuring or refinancing of our indebtedness could be at higher interest rates and may require us to comply with more onerous covenants that could further restrict our business operations. In addition, although the indenture governing the Notes limits our ability to incur additional indebtedness, this limitation is subject to a number of significant exceptions and the amount of additional indebtedness incurred could nevertheless be substantial. Furthermore, the indenture governing the Notes does not impose any limitation on our ability to incur liabilities that are not considered indebtedness under the indenture governing the Notes.
 
The Notes and the guarantees are unsecured and are effectively subordinated to our secured indebtedness to the extent of the value of the collateral securing such indebtedness.
 
The Notes and the guarantees are the Issuers’ and the guarantors’ unsecured obligations. The indenture governing the Notes generally permits us to incur secured indebtedness so long as we maintain a specified ratio of unencumbered assets to unsecured debt. The Notes and the guarantees are effectively subordinated to all of our existing and future secured debt and that of the guarantors to the extent of the value of the assets securing such obligations, including our existing credit facility and our revolving credit facility. Our obligations under our existing credit facility and our revolving credit facility are secured by first lien mortgages on certain of our properties, a pledge of the capital stock of subsidiaries owning such properties and other customary collateral, including an assignment of leases and rents with respect to such mortgaged properties. After giving pro forma effect to the sale of the Old Notes and the application of the proceeds therefrom to repay certain outstanding indebtedness, we anticipate that we would have had an aggregate of approximately $199.3 million of secured mortgage indebtedness and $9.1 million of other secured indebtedness as of March 31, 2011. In addition, we have $100.0 million available for borrowing under our acquisition credit line and $14.8 million available for borrowing under our revolving credit facility (which, subject to certain conditions precedent, can be increased by an additional $75.0 million). Because the Notes are unsecured obligations, your right of repayment may be compromised in the following situations:
 
  •     We enter into bankruptcy, liquidation, reorganization or other winding-up;
 
  •     There is a default in payment under any of our secured debt; or
 
  •     There is an acceleration of any of our secured debt.
 
If any of these events occurs, the secured lenders could foreclose on our assets in which they have been granted a security interest, in each case to your exclusion, even if an event of default exists under the indenture governing the Notes at such time. As a result, upon the occurrence of any of these events, it is possible that there would be no assets remaining from which your claims could be satisfied or, if any assets remained, they might be insufficient to fully satisfy your claims. You may therefore not be fully repaid if we or the subsidiary guarantors become insolvent or otherwise fail to make payment on the Notes.
 
Certain guarantees of the Notes are subordinated to the borrowings of the applicable Note guarantors under our existing credit facilities.
 
The guarantees of the subordinated guarantee subsidiaries rank behind all of the subordinated guarantee subsidiaries’ indebtedness under our mortgage term loan and acquisition credit line or any permitted refinancing thereof. Our revenues attributable to the properties held by the subordinated guarantee subsidiaries were $41.7 million for the twelve months ended March 31, 2011, and, as of March 31, 2011, these properties accounted for 44.8% of our total real estate investments, net of accumulated depreciation. After giving pro forma effect to the sale of the Old Notes and the use of proceeds therefrom, as of March 31, 2011, the


22


Table of Contents

subordinated guarantee subsidiaries would have had aggregate secured indebtedness to third parties of approximately $199.3 million.
 
As a result of this subordination, upon any distribution to the creditors of the subordinated guarantee subsidiaries in a bankruptcy, liquidation or reorganization or similar proceeding relating to the subordinated guarantee subsidiaries or their property, the holders of the indebtedness under the mortgage term loan and acquisition credit line of the subordinated guarantee subsidiaries will be entitled to be paid in full before any payment may be made with respect to the guarantees of the Notes of such subordinated guarantee subsidiaries. In addition, all payments on the guarantees of the Notes by the subordinated guarantee subsidiaries will be blocked until payment in full of the mortgage term loan and acquisition credit line (or any permitted refinancing thereof).
 
Because amounts otherwise payable to the holders of the Notes by the subordinated guarantee subsidiaries in a bankruptcy or similar proceeding are required to be paid to the lenders under the mortgage term loan and acquisition credit line instead, the holders of the Notes may receive less, ratably, than the holders of trade payables or other unsecured, unsubordinated creditors in any such proceeding. Holders of the Notes may not be fully repaid if we or the subordinated guarantee subsidiaries become insolvent or otherwise fail to make payment on the Notes. See “Description of Exchange Notes—Subordination of Guaranties of Subordinated Guaranty Subsidiaries” for a full description of the subordination provisions.
 
The Notes are structurally subordinated to all liabilities of our non-guarantor subsidiaries.
 
The Notes are structurally subordinated to the indebtedness and other liabilities of our subsidiaries that are not guaranteeing the Notes or in the future do not guarantee the Notes. These non-guarantor subsidiaries are separate and distinct legal entities and have no obligation, contingent or otherwise, to pay any amounts due pursuant to the Notes, or to make any funds available therefor, whether by dividends, loans, distributions or other payments. Any right that we or the subsidiary guarantors have to receive any assets of any of the non-guarantor subsidiaries upon the bankruptcy, liquidation or reorganization of those subsidiaries, and the consequent rights of holders of Notes to realize proceeds from the sale of any of those subsidiaries’ assets, will be effectively subordinated to the claims of those subsidiaries’ creditors, including creditors (including mortgage holders) and holders of preferred equity interests of those subsidiaries. Accordingly, in the event of a bankruptcy, liquidation or reorganization of any of our non-guarantor subsidiaries, these non-guarantor subsidiaries will pay the holders of their debts, holders of preferred equity interests and their trade creditors before distributing any of their assets to us. Our revenues attributable to the properties held by the non-guarantor subsidiaries was $0.5 million for the twelve months ended March 31, 2011, and, as of March 31, 2011, these properties accounted for 2.7% of Aviv REIT’s total real estate investments, net of accumulated depreciation.
 
We rely on our subsidiaries for our operating funds, and our non-guarantor subsidiaries have no obligation to supply us with any funds.
 
We conduct our operations through subsidiaries and depend on our subsidiaries for the funds necessary to operate and repay our debt obligations. We depend on the transfer of funds from our subsidiaries to make the payments due under the Notes. Under certain circumstances, one or more of our subsidiaries may be released from its, or may not be required to provide a, guarantee of the Notes, and in such circumstances, will not be required to fund any of our obligations with respect to the Notes. Each of our subsidiaries is a distinct legal entity and has no obligation, contingent or otherwise, to transfer funds to us. In addition, our ability to make payments under the Notes, and the ability of our subsidiaries to transfer funds to us, could be restricted by the terms of subsequent financings.


23


Table of Contents

Covenants in our debt agreements will restrict our activities and could adversely affect our business.
 
Our debt agreements, including the indenture governing the Notes, our existing credit facility and our revolving credit facility, contain various covenants that limit our ability and the ability of our restricted subsidiaries to engage in various transactions including:
 
  •     Incurring additional secured and unsecured debt;
 
  •     Paying dividends or making other distributions on, redeeming or repurchasing the capital stock of Aviv REIT;
 
  •     Making investments or other restricted payments;
 
  •     Entering into transactions with affiliates;
 
  •     Issuing stock of or interests in restricted subsidiaries;
 
  •     Engaging in non-healthcare related business activities;
 
  •     Creating restrictions on the ability of our restricted subsidiaries to pay dividends or other amounts to us;
 
  •     Selling assets; or
 
  •     Effecting a consolidation or merger or selling all or substantially all of our assets.
 
These covenants limit our operational flexibility and could prevent us from taking advantage of business opportunities as they arise, growing our business or competing effectively. In addition, our existing credit facility and our revolving credit facility require us to maintain specified financial covenants, which include a maximum leverage ratio and a minimum fixed charge coverage ratio, as well as satisfy other financial condition tests. The indenture governing the Notes requires us to maintain Total Unencumbered Assets (as defined in “Description of Exchange Notes”) of at least 150% of our unsecured indebtedness. Our ability to meet these requirements may be affected by events beyond our control, and we may not meet these requirements.
 
A breach of any of the covenants or other provisions in our debt agreements could result in an event of default, which if not cured or waived, could result in such debt becoming immediately due and payable. This, in turn, could cause our other debt to become due and payable as a result of cross-acceleration provisions contained in the agreements governing such other debt. We may be unable to maintain compliance with these covenants and, if we fail to do so, we may be unable to obtain waivers from the lenders and/or amend the covenants. In the event that some or all of our debt is accelerated and becomes immediately due and payable, we may not have the funds to repay, or the ability to refinance, such debt.
 
A rise in interest rates may impact our future debt costs.
 
We have availability to borrow $100.0 million under our acquisition credit line and $25.0 million available for borrowing under our revolving credit facility (which, subject to certain conditions precedent, can be increased by an additional $75.0 million), and any amounts borrowed under the facilities would accrue interest at variable rates. Because we may incur a significant amount of indebtedness that bears interest at a variable rate, we may be exposed to market risks relating to changes in interest rates. A significant increase in interest rates could impact the ability of our subsidiaries to make distributions to us, which would reduce or available cash and impact our ability to finance future investments and meet maturing commitments. Rising


24


Table of Contents

interest rates could limit our ability to refinance existing debt when it matures or cause us to pay higher interest rates upon refinancing.
 
Federal and state statutes allow courts, under specific circumstances, to void guarantees and require noteholders to return payments received from subsidiary guarantors.
 
Under the federal bankruptcy law and comparable provisions of state fraudulent transfer laws, a guarantee of the Notes could be voided, or claims in respect of a guarantee could be subordinated to all other debts of that subsidiary guarantor if, among other things, the subsidiary guarantor, at the time it incurred the debt evidenced by its guarantee, received less than reasonably equivalent value or fair consideration for the incurrence of such guarantee and (i) was insolvent or rendered insolvent by reason of such incurrence, (ii) was engaged in a business or transaction for which the subsidiary guarantor’s remaining assets constituted unreasonably small capital, or (iii) intended to incur, or believed that it would incur, debts beyond its ability to pay such debts as they mature.
 
In addition, any payment by that subsidiary guarantor pursuant to its guarantee could be voided and required to be returned to the subsidiary guarantor, or to a fund for the benefit of our creditors or the creditors of the subsidiary guarantor.
 
The measures of insolvency for purposes of these fraudulent transfer laws will vary depending upon the law applied in any proceeding to determine whether a fraudulent transfer has occurred. Generally, however, a subsidiary guarantor would be considered insolvent if:
 
  •     The sum of its debts, including contingent liabilities, was greater than the fair saleable value of all of its assets;
 
  •     The present fair saleable value of its assets was less than the amount that would be required to pay its probable liability on its existing debts, including contingent liabilities, as they become absolute and mature; or
 
  •     It could not pay its debts as they become due.
 
On the basis of historical financial information, recent operating history and other factors, we believe that each subsidiary guarantor, after giving effect to its guarantee of the Notes, will not be insolvent, will have a fair market value of its assets greater than the total amount of its liabilities (including contingent liabilities), will have a present fair salable value of its assets greater than the amount that will be required to pay its probable liabilities on its debts as they become absolute and matured, will be able to realize upon its assets and pay its debts and other liabilities, including contingent liabilities, as they mature, and will not have unreasonably small capital. We cannot assure you, however, as to what standard a court would apply in making these determinations or that a court would agree with our conclusions in this regard. In addition, each guarantee will contain a provision intended to limit the subsidiary guarantor’s liability to the maximum amount that it could incur without causing the incurrence of obligations under its guarantee to be a fraudulent transfer. This provision may not be effective to protect the guarantees from being voided under fraudulent transfer laws, or may eliminate the subsidiary guarantor’s obligations or reduce the subsidiary guarantor’s obligations to an amount that effectively makes the guarantee worthless.
 
We may not have the funds necessary to finance the repurchase of the Notes in connection with a change of control offer required by the indenture governing the Notes.
 
Upon the occurrence of specific kinds of change of control events, the indenture governing the Notes requires us to make an offer to repurchase all outstanding Notes at 101% of the principal amount thereof, plus accrued and unpaid interest (and additional interest, if any) to the date of repurchase. However, it is possible that we will not have sufficient funds, or the ability to raise sufficient funds, at the time of the change of control to


25


Table of Contents

make the required repurchase of the Notes. In addition, restrictions under our existing credit facility, our revolving credit facility or other future debt, may not allow us to repurchase the Notes upon a change of control. If we could not refinance such senior debt or otherwise obtain a waiver from the holders of such debt, we would be prohibited from repurchasing the Notes, which would constitute an event of default under the indenture governing the Notes, which in turn would constitute a default under our existing credit facility and our revolving credit facility. In addition, certain important corporate events, such as leveraged recapitalizations that would increase the level of our indebtedness, would not constitute a “Change of Control” under the indenture governing the Notes although these types of transactions could affect our capital structure or credit ratings and the holders of the Notes. See “Description of Exchange Notes—Repurchase of Notes upon a Change of Control.”
 
Courts interpreting change of control provisions under New York law (which is the governing law of the indenture governing the Notes) have not provided clear and consistent meanings of such change of control provisions which leads to subjective judicial interpretation. In addition, a court case in Delaware has questioned whether an indenture change of control provision, similar to the one contained in the indenture governing the Notes, related to a change of control as a result of a change in the composition of a board of directors could be unenforceable on public policy grounds. Accordingly, the ability of a holder of Notes to require us to repurchase Notes as a result of a change in the composition of our board of directors is uncertain. Another court may not enforce the change of control provisions in the indenture governing the Notes as written for the benefit of the holders, and the change of control provisions could be impacted if we become a debtor in a bankruptcy case.
 
An active trading market may not develop for the Notes, which may hinder your ability to liquidate your investment.
 
We do not intend to list the Notes on any national securities exchange or seek the admission of the Notes for quotation through any automated inter-dealer quotation system. As a result, an active trading market for the Notes may not develop or be sustained. If an active trading market for the Notes fails to develop or be sustained, the trading price of the Notes could be adversely affected.
 
The liquidity of the trading market for the Notes and the trading price quoted for the Notes may be adversely affected by many factors, some of which are beyond our control, including:
 
  •     Prevailing interest rates;
 
  •     Demand for high yield debt securities generally;
 
  •     General economic conditions;
 
  •     Our financial condition, performance and future prospects;
 
  •     Our credit rating; and
 
  •     Prospects for companies in our industry generally.
 
Historically, the market of non-investment grade debt like the Notes has been subject to disruptions that have caused substantial market price fluctuations in the price of securities that are similar to the Notes. Therefore, even if a trading market for the Notes develops, it may be subject to disruptions and price volatility.
 
A downgrade, suspension or withdrawal of the rating assigned by a rating agency to the Notes, if any, could cause the liquidity or market value of the Notes to decline.
 
The Notes have been rated by rating agencies. A rating is not a recommendation to purchase, sell or hold the Notes. We cannot assure you that any rating assigned will remain for any given period of time or that a rating will not be lowered or withdrawn entirely by a rating agency if, in that rating agency’s judgment,


26


Table of Contents

circumstances relating to the basis of the rating, such as adverse changes in our business, so warrant. Any lowering or withdrawal of a rating by a rating agency could reduce the liquidity or market value of the Notes.
 
Risks Relating to Our Tax Status and Other Tax Related Matters
 
Our failure to remain qualified as a REIT would have significant adverse consequences to us and our ability to make payments on our indebtedness, including the Notes.
 
Aviv REIT intends to operate in a manner that will allow it to be taxed as a REIT for U.S. federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”). Aviv REIT intends to make the election to be taxed as a REIT effective as of its taxable year ending December 31, 2010. We have not requested and do not plan to request a ruling from the Internal Revenue Service, or IRS, that we qualify as a REIT, and the statements in this prospectus are not binding on the IRS or any court. If we fail to qualify or lose our qualification as a REIT, we will face serious tax consequences that would substantially reduce the funds available for satisfying our obligations for each of the years involved because:
 
  •     we would not be allowed a deduction for distributions to stockholders in computing our taxable income and we would be subject to U.S. federal income tax at regular corporate rates;
 
  •     we also could be subject to the U.S. federal alternative minimum tax and possibly increased state and local taxes; and
 
  •     unless we are entitled to relief under applicable statutory provisions, we could not elect to be taxed as a REIT for four taxable years following a year during which we were disqualified.
 
Qualification as a REIT involves the application of highly technical and complex Code provisions and regulations promulgated thereunder for which there are only limited judicial and administrative interpretations. Even a technical or inadvertent violation could jeopardize our ability to remain qualified as a REIT. The complexity of these provisions and of the applicable U.S. Treasury Department regulations that have been promulgated under the Code is greater in the case of a REIT that, like us, holds its assets through a partnership. The determination of various factual matters and circumstances not entirely within our control may affect our ability to remain qualified as a REIT. In order to remain qualified as a REIT, we must satisfy a number of requirements on a continuing basis, including requirements regarding the composition of our assets, sources of our gross income and stockholder ownership. Also, we must make distributions to stockholders aggregating annually at least 90% of our net taxable income, excluding capital gains.
 
As a result of these factors, our failure to qualify as a REIT also could impair our ability to expand our business, raise capital and make payments on our indebtedness, including the Notes.
 
Even if we remain qualified as a REIT, we may face other tax liabilities that reduce our cash flow.
 
Even if we remain qualified for taxation as a REIT, we may be subject to certain federal, state and local taxes on our income and assets, including taxes on any undistributed income, tax on income from some activities conducted as a result of a foreclosure, and state or local income, property and transfer taxes. Any of these taxes would decrease cash available for the payment of our debt obligations. In addition, we may use taxable REIT subsidiaries to undertake indirectly activities that the REIT rules might otherwise preclude it from doing directly or through pass-through subsidiaries. Such taxable REIT subsidiaries will be subject to corporate level income tax at regular rates.
 
To maintain our REIT qualification, we may be forced to borrow funds during unfavorable market conditions.
 
To qualify as a REIT, we generally must distribute to our stockholders at least 90% of our net taxable income each year, excluding net capital gains, and we will be subject to regular corporate income taxes to the


27


Table of Contents

extent that we distribute less than 100% of our net taxable income each year. In addition, we will be subject to a 4% nondeductible excise tax on the amount, if any, by which distributions paid by us in any calendar year are less than the sum of 85% of our ordinary income, 95% of our capital gain net income and 100% of our undistributed income from prior years. In order to qualify as a REIT and avoid the payment of income and excise taxes, we may need to borrow funds on a short-term basis, or possibly on a long-term basis, to meet the REIT distribution requirements even if the then prevailing market conditions are not favorable for these borrowings. These borrowing needs could result from, among other things, a difference in timing between the actual receipt of cash and inclusion of income for U.S. federal income tax purposes, the effect of non-deductible capital expenditures, the creation of reserves or required debt amortization payments. The terms of the indenture governing the Notes, our existing credit facility and our revolving credit facility restrict our ability to incur additional indebtedness.
 
Complying with REIT requirements may limit our ability to hedge effectively.
 
The REIT provisions of the Code substantially limit our ability to hedge our liabilities. Any income from a hedging transaction we enter into to manage risk of interest rate changes with respect to borrowings made or to be made to acquire or carry real estate assets generally does not constitute “gross income” for purposes of the 75% gross income test or the 95% gross income test, if certain requirements are met. To the extent that we enter into other types of hedging transactions, the income from those transactions is likely to be treated as non-qualifying income for purposes of both of the gross income tests. As a result, we might have to limit our use of advantageous hedging techniques or implement those hedges through a taxable REIT subsidiary, or TRS. This could increase the cost of our hedging activities because a domestic TRS would be subject to tax on gains or expose us to greater risks associated with changes in interest rates than we would otherwise want to bear.
 
New legislation or administrative or judicial action, in each instance potentially with retroactive effect, could make it more difficult or impossible for us to qualify as a REIT.
 
The present U.S. federal income tax treatment of REITs may be modified, possibly with retroactive effect, by legislative, judicial or administrative action at any time, which could affect the U.S. federal income tax treatment of an investment in our common stock and impair our ability to raise capital through the sale of equity. The U.S. federal income tax rules that affect REITs constantly are under review by persons involved in the legislative process, the IRS and the U.S. Treasury Department, which results in statutory changes as well as frequent revisions to regulations and interpretations. Revisions in U.S. federal tax laws and interpretations thereof could cause us to change our investments and commitments, which could also affect the tax considerations of an investment in our common stock and impair our ability to raise capital through the sale of equity.
 
We have limited experience operating as a REIT and therefore may have difficulty in successfully and profitably operating our business in compliance with the regulatory requirements applicable to REITs.
 
Aviv REIT was formed on July 30, 2010, and we have limited experience operating as a REIT and complying with the numerous technical restrictions and limitations set forth in the Code, as applicable to REITs. As a result, we cannot assure you that we will be able to successfully operate as a REIT or comply with regulatory requirements applicable to REITs, and you should be especially cautious in drawing conclusions about the ability of our management team to operate our business.
 
Risks Relating to the Exchange Offer
 
You may not be able to sell your Old Notes if you do not exchange them for Exchange Notes in the exchange offer.
 
If you do not exchange your Old Notes for Exchange Notes in the exchange offer, your Old Notes will continue to be subject to restrictions on transfer. In general, you may not offer, sell or otherwise transfer the Old Notes in the United States unless they are:
 
  •     registered under the Securities Act;


28


Table of Contents

  •     offered or sold pursuant to an exemption from the Securities Act and applicable state securities laws; or
 
  •     offered or sold in a transaction not subject to the Securities Act and applicable state securities laws.
 
The Issuers and the guarantors do not currently anticipate that they will register the Old Notes under the Securities Act and, except for the limited instances involving the initial purchasers or holders of the Old Notes who are not eligible to participate in the exchange offer or who do not receive freely transferable Exchange Notes in the exchange offer, they will not be under any obligation to do so under the registration rights agreements or otherwise.
 
Your ability to sell your Old Notes may be significantly more limited and the price at which you may be able to sell your Old Notes may be significantly lower if you do not exchange them for Exchange Notes in the exchange offer.
 
To the extent that the Old Notes are tendered and accepted for exchange in the exchange offer, the trading market for the Old Notes that remain outstanding may be significantly more limited. As a result, the liquidity of the Old Notes not tendered and accepted for exchange could be adversely affected. The extent of the market for Old Notes and the availability of price quotations would depend on a number of factors, including the number of holders of Old Notes remaining outstanding and the interest of securities firms in maintaining a market in the Old Notes. An issue of securities with a similar outstanding market value available for trading, which is called the “float,” may command a lower price than would be comparable to an issue of securities with a greater float. As a result, the market price for the Old Notes that are not exchanged in the exchange offer may be affected adversely to the extent that the Old Notes exchanged in the exchange offer reduce the float. The reduced float also may make the trading price of the Old Notes that are not exchanged more volatile.
 
You must comply with the exchange offer procedures in order to receive new, freely tradable Exchange Notes.
 
Delivery of Exchange Notes in exchange for Old Notes tendered and accepted for exchange pursuant to the exchange offer will be made only after timely receipt by the exchange agent of book-entry transfer of Old Notes into the exchange agent’s account at DTC, as depositary, including an Agent’s Message (as defined in “The Exchange Offer—Procedures for Tendering Old Notes Through Brokers and Banks”). We are not required to notify you of defects or irregularities in tenders of Old Notes for exchange. Old Notes that are not tendered or that are tendered but we do not accept for exchange will, following consummation of the exchange offer, continue to be subject to the existing transfer restrictions under the Securities Act and, upon consummation of the exchange offer, certain registration and other rights under the registration rights agreement will terminate. See “The Exchange Offer—Procedures for Tendering Old Notes Through Brokers and Banks” and “The Exchange Offer—Consequences of Failure to Exchange.”
 
Some holders who exchange their Old Notes may be deemed to be underwriters, and these holders will be required to comply with the registration and prospectus delivery requirements in connection with any resale transaction.
 
If you exchange your Old Notes in the exchange offer for the purpose of participating in a distribution of the Exchange Notes, you may be deemed to have received restricted securities and, if so, will be required to comply with the registration and prospectus delivery requirements of the Securities Act in connection with any resale transaction.


29


Table of Contents

 
THE EXCHANGE OFFER
 
Purpose of the Exchange Offer
 
In connection with the sale of the Old Notes, we entered into registration rights agreements pursuant to which we agreed, for the benefit of the holders of the Old Notes, at our cost, to use our reasonable best efforts:
 
  (1)  to file with the SEC an exchange offer registration statement pursuant to which we and the guarantors will offer, in exchange for the Old Notes, new notes identical in all material respects to, and evidencing the same indebtedness as, the Old Notes (but will not contain terms with respect to transfer restrictions or provide for the additional interest described below);
 
  (2)  to cause the exchange offer registration statement to be declared effective under the Securities Act prior to September 2, 2011; and
 
  (3)  to cause the exchange offer to be consummated by October 3, 2011 (the “Consummation Deadline”).
 
Under existing interpretations by the staff of the SEC as set forth in no-action letters issued to unrelated third parties and referenced below, we believe that the Exchange Notes issued in the exchange offer in exchange for the Old Notes may be offered for resale, resold and otherwise transferred by any exchange noteholder without compliance with the registration and prospectus delivery provisions of the Securities Act, if:
 
  (1)  such holder is not an “affiliate” of ours within the meaning of Rule 405 of the Securities Act;
 
  (2)  such Exchange Notes are acquired in the ordinary course of the holder’s business; and
 
  (3)  such holder has no arrangement or understanding with any person to participate in a distribution (within the meaning of the Securities Act) of the Exchange Notes.
 
Any holder who tenders in the exchange offer with the intention of participating in any manner in a distribution of the Exchange Notes:
 
  (1)  cannot rely on the position of the staff of the SEC set forth in Exxon Capital Holdings Corporation, Morgan Stanley & Co., Incorporated or similar no-action letters; and
 
  (2)  in the absence of an applicable exemption, must comply with the registration and prospectus delivery requirements of the Securities Act in connection with a resale of the Exchange Notes or it may incur liability under the Securities Act. We will not be responsible for, or indemnify against, any such liability.
 
If, as stated above, a holder cannot rely on the position of the staff of the SEC set forth in Exxon Capital Holdings Corporation, Morgan Stanley & Co., Incorporated or similar no-action letters, any effective registration statement used in connection with a secondary resale transaction must contain the selling security holder information required by Item 507 of Regulation S-K under the Securities Act.
 
We do not intend to seek our own interpretation regarding the exchange offer, and we cannot assure you that the staff of the SEC would make a similar determination with respect to the Exchange Notes as it has in other interpretations to third parties.


30


Table of Contents

 
This prospectus may be used for an offer to resell, for the resale or for other retransfer of Exchange Notes only as specifically set forth in this prospectus. With regard to broker-dealers, only broker-dealers that acquired the Old Notes for its own account as a result of market-making activities or other trading activities may participate in the exchange offer. Each broker-dealer that receives Exchange Notes for its own account in exchange for Old Notes, where such Old Notes were acquired by such broker-dealer as a result of market-making activities or other trading activities, must acknowledge that it will deliver a prospectus in connection with any resale of the Exchange Notes. Please read the section entitled “Plan of Distribution” for more details regarding these procedures for the transfer of Exchange Notes. We have agreed, for a period of 180 days after the exchange offer is consummated, to make this prospectus available to any broker-dealer for use in connection with any resale of the Exchange Notes.
 
In order to participate in the exchange offer, each holder of Old Notes that wishes to exchange Old Notes for Exchange Notes in the exchange offer will be required to make the representations described below under “—Representations.”
 
Shelf Registration Statement
 
In the event that:
 
  (1)  we are not required to file the exchange offer registration statement or to consummate the exchange offer because the exchange offer is not permitted by law or SEC policy; or
 
  (2)  for any reason, we do not consummate the exchange offer by October 3, 2011; or
 
  (3)  any holder notifies us that:
 
  •     it is not permitted under law or SEC policy to participate in the exchange offer;
 
  •     it cannot publicly resell new notes that it acquires in the exchange offer without delivering a prospectus, and the prospectus contained in the exchange offer registration statement is not appropriate or available for resales by that holder;
 
  •     it is a broker-dealer and holds Old Notes that it has not exchanged and that it acquired directly from us or one of our affiliates; or
 
  •     an initial purchaser so requests (with respect to Old Notes that have not been resold and that it acquired directly from us or one of our affiliates);
 
then in addition to or in lieu of conducting the exchange offer, we will be required to file a shelf registration statement with the SEC to cover resales of the Old Notes or the Exchange Notes, as the case may be. In that case, we will use our reasonable best efforts to (a) cause the registration statement to become effective (i) in the case of clause (1) above, by the 90th day after we determine we are not permitted to file the exchange offer registration statement or to consummate the exchange offer due to a change in law or policy but in any event not earlier than September 2, 2011, (ii) in the case of clause (2) above, by the 90th day after the Consummation Deadline, and (iii) in the case of clause (3) above, by the 90th day after receipt of such notice but in any event not later than September 2, 2011, and (b) maintain the effectiveness of the registration statement for two years or such lesser period after which all the notes registered therein have been sold under the Securities Act.
 
Additional Interest
 
If (1) we have not filed the exchange offer registration statement or the shelf registration statement by the dates described above as required by the registration rights agreements, (2) the exchange offer registration


31


Table of Contents

statement or the shelf registration statement is not declared effective by the dates described above as required by the registration rights agreements, (3) we do not consummate the exchange offer described in this prospectus by the Consummation Deadline, or (4) the shelf registration statement is declared effective, but thereafter, subject to certain exceptions, ceases to be effective or usable in connection with resales of any Notes registered under the shelf registration statement during the periods specified in the registration rights agreements, then we will be in default under the registration rights agreements. If one or more of the registration defaults occurs, the annual interest rate on the Old Notes will increase by 0.25% per annum during the 90-day period immediately following such default. The amount of additional interest will increase by an additional 0.25% per annum at the end of each subsequent 90-day period until all registration defaults are cured, up to a maximum additional interest rate of 1.00% per annum. When we have cured all of the registration defaults, the interest rate on the Old Notes will revert immediately to the original level.
 
The exchange offer is intended to satisfy our exchange offer obligations under the registration rights agreements. The Notes will not have rights to additional interest as set forth above upon the consummation of the exchange offer.
 
Terms of the Exchange Offer
 
We are offering to exchange up to $300.0 million aggregate principal amount of the Exchange Notes, the issuance of which has been registered under the Securities Act, for an equal principal amount of the Old Notes. Upon the terms and subject to the conditions set forth in this prospectus, we will accept any and all Old Notes validly tendered and not withdrawn prior to 5:00 p.m., New York City time, on the expiration date of the exchange offer. We will issue $1,000 principal amount of Exchange Notes in exchange for each $1,000 principal amount of Old Notes accepted in the exchange offer. Holders may tender some or all of their Old Notes pursuant to the exchange offer. However, Old Notes may be tendered only in denominations of $2,000 of principal amount and any integral multiple of $1,000 in excess thereof.
 
The form and terms of the Exchange Notes are the same as the form and terms of the Old Notes except that the Old Notes have been registered under the Securities Act and will not have transfer restrictions or contain the additional interest provisions of the Old Notes. The Exchange Notes will evidence the same debt as the Old Notes and will be issued under and entitled to the benefits of the indenture governing the Notes. Consequently, the Old Notes and the Exchange Notes will be treated as a single class of debt securities under the indenture governing the Notes.
 
As of the date of this prospectus, Old Notes representing $300.0 million in aggregate principal amount were outstanding, and there was one registered holder, Cede & Co., as nominee of DTC. This prospectus is being sent to all registered holders of the Old Notes.
 
The exchange offer is not conditioned on any minimum aggregate principal amount of Old Notes being tendered for exchange.
 
We intend to conduct the exchange offer in accordance with the applicable requirements of the Exchange Act and the rules and regulations of the SEC. We will be deemed to have accepted for exchange properly tendered Old Notes when we have given oral or written notice of the acceptance to the exchange agent. The exchange agent will act as agent for the tendering holders for the purposes of receiving the Exchange Notes from us and delivering the Exchange Notes to such holders.
 
Old Notes that are not tendered for exchange in the exchange offer or that are tendered but we do not accept for exchange will remain outstanding and continue to accrue interest and will continue to be entitled to the rights and benefits such holders have under the indenture relating to the Old Notes. The Old Notes that are not exchanged will continue to be subject to the existing transfer restrictions under the Securities Act and, upon consummation of the exchange offer, certain registration and other rights under the registration rights


32


Table of Contents

agreements will terminate. Holders of the Old Notes do not have any appraisal or dissenters’ rights in connection with the exchange offer.
 
Holders who tender Old Notes in the exchange offer will not be required to pay brokerage commissions or fees or transfer taxes with respect to the exchange of Old Notes pursuant to the exchange offer. We will pay all charges and expenses, other than transfer taxes in certain circumstances, in connection with the exchange offer. See “—Fees and Expenses” and “—Transfer Taxes” below.
 
Expiration Date; Extensions; Amendments
 
The exchange offer will remain open for at least 30 days, and in all events will remain open for at least 20 full business days. The term “expiration date” will mean 5:00 p.m., New York City time, on August 22, 2011, unless we, in our sole discretion, extend the exchange offer, in which case the term “expiration date” will mean the latest date and time to which the exchange offer is extended.
 
In order to extend the exchange offer, we will notify the exchange agent in writing of any extension. We will notify in writing by press release or other public announcement the registered holders of Old Notes of the extension no later than 9:00 a.m., New York City time, on the business day after the previously scheduled expiration date.
 
We reserve the right, in our sole discretion:
 
  (1)  to delay accepting any Old Notes, to extend the exchange offer or, if any of the conditions to the exchange offer set forth below under “—Conditions to the Exchange Offer” have not been satisfied, to terminate the exchange offer, by giving oral (promptly confirmed in writing) or written notice of such delay, extension or termination to the exchange agent; or
 
  (2)  to amend the terms of the exchange offer in any manner.
 
Any delay in acceptance, extension, termination or amendment will be followed as promptly as practicable by written notice to the registered holders by a press release or other public announcement. If we amend the exchange offer in a manner that we determine to constitute a material change in the exchange offer, or if we waive a condition to the exchange offer, we will promptly disclose such amendment or waiver in a manner reasonably calculated to inform the holders of Old Notes of such amendment or waiver, and we will extend the exchange offer period, if necessary, so that at least five business days remain in the exchange offer following notice of the material change. If we terminate the exchange offer as provided in this prospectus before accepting any Old Notes for exchange or if we amend the terms of the exchange offer in a manner that constitutes a fundamental change in the information set forth in the registration statement of which this prospectus forms a part, we will promptly file a post-effective amendment to the registration statement of which this prospectus forms a part. In addition, we will in all events comply with our obligation to, promptly after expiration or termination of the exchange offer, as applicable, exchange all Old Notes properly tendered and accepted for exchange in the exchange offer and return all Old Notes not accepted for exchange.
 
Procedures for Tendering Old Notes Through Brokers and Banks
 
Since the Old Notes are represented by global book-entry notes, DTC, as depositary, or its nominee is treated as the registered holder of the Old Notes and will be the only entity that can tender your Old Notes for Exchange Notes. Therefore, to tender Old Notes subject to the exchange offer and to obtain Exchange Notes, you must instruct the institution where you keep your Old Notes to tender your Old Notes on your behalf so that they are received on or prior to the expiration of the exchange offer.


33


Table of Contents

 
To tender your Old Notes in the exchange offer, you must:
 
  (1)  comply with DTC’s Automated Tender Offer Program (“ATOP”) procedures described below; and
 
  (2)  the exchange agent must receive a timely confirmation of a book-entry transfer of the Old Notes into its account at DTC through ATOP pursuant to the procedure for book-entry transfer described below, along with a properly transmitted Agent’s Message (defined below), before the expiration date.
 
IF YOU WISH TO ACCEPT THE EXCHANGE OFFER, PLEASE INSTRUCT YOUR BROKER OR ACCOUNT REPRESENTATIVE IN TIME FOR YOUR OLD NOTES TO BE TENDERED BEFORE THE 5:00 PM (NEW YORK CITY TIME) DEADLINE ON AUGUST 22, 2011.
 
In order to accept the exchange offer on behalf of a holder of Old Notes you must submit or cause your DTC participant to submit an Agent’s Message as described below.
 
The exchange agent, on our behalf, will seek to establish an ATOP account with respect to the outstanding Old Notes at DTC promptly after the delivery of this prospectus. Any financial institution that is a DTC participant, including your broker or bank, may make book-entry tender of outstanding Old Notes by causing the book-entry transfer of such Old Notes into our ATOP account in accordance with DTC’s procedures for such transfers. Concurrently with the delivery of Old Notes, an Agent’s Message in connection with such book-entry transfer must be transmitted by DTC to, and received by, the exchange agent on or prior to 5:00 pm, New York City Time on the expiration date. The confirmation of a book entry transfer into the ATOP account as described above is referred to herein as a “Book-Entry Confirmation.”
 
The term “Agent’s Message” means a message transmitted by the DTC participants to DTC, and thereafter transmitted by DTC to the exchange agent, forming a part of the Book-Entry Confirmation which states that DTC has received an express acknowledgment from the participant in DTC described in such Agent’s Message stating that such participant and beneficial holder agree to be bound by the terms of the exchange offer, including the letter of transmittal, and that the agreement may be enforced against such participant.
 
Each Agent’s Message must include the following information:
 
  (1)  Name of the beneficial owner tendering such Old Notes;
 
  (2)  Account number of the beneficial owner tendering such Old Notes;
 
  (3)  Principal amount of Old Notes tendered by such beneficial owner; and
 
  (4)  A confirmation that the beneficial holder of the Old Notes tendered has made the representations for our benefit set forth under “—Representations” below.
 
BY SENDING AN AGENT’S MESSAGE THE DTC PARTICIPANT IS DEEMED TO HAVE CERTIFIED THAT THE BENEFICIAL HOLDER FOR WHOM NOTES ARE BEING TENDERED HAS BEEN PROVIDED WITH A COPY OF THIS PROSPECTUS AND AGREES TO BE BOUND BY THE TERMS OF THE EXCHANGE OFFER, INCLUDING THE LETTER OF TRANSMITTAL.
 
The delivery of Old Notes through DTC, and any transmission of an Agent’s Message through ATOP, is at the election and risk of the person tendering Old Notes. We will ask the exchange agent to instruct DTC to promptly return those Old Notes, if any, that were tendered through ATOP but were not accepted by us, to the DTC participant that tendered such Old Notes on behalf of holders of the Old Notes.


34


Table of Contents

 
When you tender your outstanding Old Notes and we accept them, the tender will be a binding agreement between you and us as described in this prospectus. By using the ATOP procedures to exchange Old Notes, you will not be required to deliver a letter of transmittal to the exchange agent. However, you will be bound by its terms, and you will be deemed to have made the acknowledgements and the representations and warranties it contains, just as if you had signed it.
 
We will decide all questions about the validity, form, eligibility, time of receipt, acceptance and withdrawal of tendered Old Notes, and our reasonable determination will be final and binding on you. We reserve the absolute right to: (1) reject any and all tenders of any particular Old Note not properly tendered; (2) refuse to accept any Old Note if, in our reasonable judgment or the judgment of our counsel, the acceptance would be unlawful; and (3) waive any defects or irregularities or conditions of the exchange offer as to any particular Old Notes before the expiration of the offer. Our interpretation of the terms and conditions of the exchange offer will be final and binding on all parties. You must cure any defects or irregularities in connection with tenders of Old Notes as we will reasonably determine. Neither us, the exchange agent nor any other person will incur any liability for failure to notify you of any defect or irregularity with respect to your tender of Old Notes. If we waive any terms or conditions pursuant to (3) above with respect to a noteholder, we will extend the same waiver to all noteholders with respect to that term or condition being waived.
 
Representations
 
To participate in the exchange offer, each holder of Old Notes that wishes to exchange Old Notes for Exchange Notes in the exchange offer will be required to make the following representations:
 
  (1)  it has full corporate (or similar) power and authority to tender, exchange, assign and transfer the Old Notes and to acquire the Exchange Notes;
 
  (2)  when the Old Notes are accepted for exchange, the Issuers will acquire good and unencumbered title to the tendered Old Notes, free and clear of all liens, restrictions, charges and encumbrances and not subject to any adverse claim; and
 
  (3)  if such holder is a broker dealer that will receive Exchange Notes for its own account in exchange for Old Notes that were acquired as a result of market-making or other trading activities, then such holder will comply with the applicable provisions of the Securities Act with respect to any resale of the Exchange Notes. See “Plan of Distribution.”
 
Broker-dealers who cannot make the representations in item (3) of the paragraph above cannot use this prospectus in connection with resales of the Exchange Notes issued in the exchange offer.
 
Each holder of Old Notes that wishes to exchange Old Notes for Exchange Notes in the exchange offer and any beneficial owner of those Old Notes also will be required to make the following representations:
 
  (1)  neither the holder nor any beneficial owner of the Old Notes is an “affiliate” (as defined in Rule 405 under the Securities Act) of the Issuers;
 
  (2)  neither the holder nor any beneficial owner of the Old Notes is engaged in or intends to engage in, and has no arrangement or understanding with any person to participate in, a distribution (within the meaning of the Securities Act) of the Exchange Notes;
 
  (3)  any Exchange Notes to be acquired by the holder and any beneficial owner of the Old Notes pursuant to the exchange offer will be acquired in the ordinary course of business of the person receiving such Exchange Notes; and


35


Table of Contents

 
  (4)  the holder is not acting on behalf of any person who could not truthfully make the foregoing representations.
 
BY TENDERING YOUR OLD NOTES YOU ARE DEEMED TO HAVE MADE THESE REPRESENTATIONS.
 
If you are our “affiliate,” as defined under Rule 405 of the Securities Act, if you are a broker-dealer who acquired your Old Notes in the initial offering and not as a result of market-making or trading activities, or if you are engaged in or intend to engage in or have an arrangement or understanding with any person to participate in a distribution of Exchange Notes acquired in the exchange offer, you or that person:
 
  (1)  cannot rely on the position of the staff of the SEC set forth in Exxon Capital Holdings Corporation, Morgan Stanley & Co., Incorporated or similar no-action letters; and
 
  (2)  in the absence of an applicable exemption, must comply with the registration and prospectus delivery requirements of the Securities Act in connection with a resale of the Exchange Notes.
 
Acceptance of Outstanding Old Notes for Exchange; Delivery of Exchange Notes
 
We will accept validly tendered Old Notes when the conditions to the exchange offer have been satisfied or we have waived them. We will have accepted your validly tendered Old Notes when we have given oral or written notice to the exchange agent. The exchange agent will act as agent for the tendering holders for the purpose of receiving the Exchange Notes from us. If we do not accept any tendered Old Notes for exchange by book-entry transfer because of an invalid tender or other valid reason, we will credit the Old Notes to an account maintained with DTC promptly after the exchange offer terminates or expires.
 
THE AGENT’S MESSAGE MUST BE TRANSMITTED TO THE EXCHANGE AGENT ON OR BEFORE 5:00 PM, NEW YORK CITY TIME, ON THE EXPIRATION DATE.
 
No Guaranteed Delivery
 
There are no guaranteed delivery procedures provided for by us in conjunction with the exchange offer. Holders of Old Notes must timely tender their Old Notes in accordance with the procedures set forth herein.
 
Withdrawal Rights
 
You may withdraw your tender of outstanding notes at any time before 5:00 p.m., New York City time, on the expiration date.
 
For a withdrawal to be effective, you should contact your bank or broker where your Old Notes are held and have them send an ATOP notice of withdrawal so that it is received by the exchange agent before 5:00 p.m., New York City time, on the expiration date. Such notice of withdrawal must:
 
  (1)  specify the name of the person that tendered the Old Notes to be withdrawn;
 
  (2)  identify the Old Notes to be withdrawn, including the CUSIP number and principal amount at maturity of the Old Notes; and
 
  (3)  specify the name and number of an account at the DTC to which your withdrawn Old Notes can be credited.
 
We will decide all questions as to the validity, form and eligibility of the notices and our determination will be final and binding on all parties. Any tendered Old Notes that you withdraw will not be


36


Table of Contents

considered to have been validly tendered. We will promptly return any outstanding Old Notes that have been tendered but not exchanged, or credit them to the DTC account. You may re-tender properly withdrawn Old Notes by following one of the procedures described above before the expiration date.
 
Conditions to the Exchange Offer
 
Notwithstanding any other provision of the exchange offer, we are not required to accept for exchange, or to issue Exchange Notes in exchange for, any Old Notes and may terminate or amend the exchange offer if, at any time before the expiration of the exchange offer, (1) we determine that the exchange offer violates applicable law, any applicable interpretation of the staff of the SEC or any order of any governmental agency or court of competent jurisdiction or (2) any action or proceeding has been instituted or threatened in any court or before any governmental agency with respect to the exchange offer which, in our reasonable judgment, could reasonably be expected to impair our ability to proceed with the exchange offer or have a material adverse effect on us.
 
The foregoing conditions are for our sole benefit and may be asserted by us regardless of the circumstances giving rise to any such condition or may be waived by us in whole or in part at any time before the expiration of the exchange offer in our sole discretion. Our failure to exercise any of the foregoing rights at any time will not be deemed a waiver of any such right and each such right will be deemed an ongoing right which may be asserted at any time before the expiration of the exchange offer. If we waive any conditions of the exchange offer, we will promptly disclose such waiver in a manner reasonably calculated to inform the holders of Old Notes of such waiver.
 
In addition, we will not accept for exchange any Old Notes tendered, and no Exchange Notes will be issued in exchange for any Old Notes, if at such time any stop order will be threatened or in effect with respect to the registration statement of which this prospectus constitutes a part or the qualification of the indenture under the Trust Indenture Act of 1939, as amended. In any such event we are required to use our reasonable best efforts to promptly obtain the withdrawal of any stop order.
 
Exchange Agent
 
We have appointed The Bank of New York Mellon Trust Company, N.A. as the exchange agent for the exchange offer. You should direct questions, requests for assistance, and requests for additional copies of this prospectus and the letter of transmittal to the exchange agent addressed as follows:
 
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., EXCHANGE AGENT
 
By registered or certified mail, overnight delivery:
 
c/o The Bank of New York Mellon Corporation
Corporate Trust Operations—Reorganization Unit
480 Washington Boulevard, 27th Floor
Jersey City, New Jersey 07310
Attn: Ms. Diane Amoroso
 
For information call:
 
(212) 815-2742
 
Delivery to an address other than set forth above will not constitute a valid delivery.
 
Fees and Expenses
 
The principal solicitation is being made through DTC by The Bank of New York Mellon Trust Company, N.A., as exchange agent. We will pay the exchange agent customary fees for its services,


37


Table of Contents

reimburse the exchange agent for its reasonable out-of-pocket expenses incurred in connection with the provision of these services and pay other registration expenses, including registration and filing fees and expenses, fees and expenses of compliance with federal securities and state securities or blue sky securities laws, printing expenses, messenger and delivery services and telephone, fees and disbursements to our counsel, application and filing fees and any fees and disbursements to our independent certified public accountants. We will not make any payment to brokers, dealers, or others soliciting acceptances of the exchange offer except for reimbursement of mailing expenses.
 
Additional solicitations may be made by telephone, facsimile or in person by our officers and employees and by persons so engaged by the exchange agent.
 
Accounting Treatment
 
The Exchange Notes will be recorded at the same carrying value as the existing Old Notes, as reflected in our accounting records on the date of exchange. Accordingly, we will recognize no gain or loss for accounting purposes. The expenses of the exchange offer will be capitalized and expensed over the term of the Exchange Notes.
 
Transfer Taxes
 
If you tender outstanding Old Notes for exchange you will not be obligated to pay any transfer taxes. However, if you instruct us to register Exchange Notes in the name of, or request that your Old Notes not tendered or not accepted in the exchange offer be returned to, a person other than the registered tendering holder, you will be responsible for paying any transfer tax owed.
 
Consequences of Failure to Exchange
 
If you do not tender your outstanding Old Notes, you will not have any further registration rights, except for the rights described in the registration rights agreements and described above, and your Old Notes will continue to be subject to the provisions of the indenture governing the Notes regarding transfer and exchange of the Old Notes and the restrictions on transfer of the Old Notes imposed by the Securities Act and states securities law when we complete the exchange offer. These transfer restrictions are required because the Old Notes were issued under an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. Accordingly, if you do not tender your Old Notes in the exchange offer, your ability to sell your Old Notes could be adversely affected. Once we have completed the exchange offer, holders who have not tendered Old Notes will not continue to be entitled to any additional interest that the indenture governing the Notes provides for if we do not complete the exchange offer.
 
Other
 
Participation in the exchange offer is voluntary, and you should carefully consider whether to accept. You are urged to consult your financial, tax, legal and other advisors in making your own decision on what action to take.
 
We may in the future seek to acquire untendered Old Notes in the open market or in privately negotiated transactions, through subsequent exchange offers or otherwise. We have no present plans to acquire any Old Notes that are not tendered in the exchange offer or to file a shelf registration statement to permit resales of any untendered Old Notes.


38


Table of Contents

 
USE OF PROCEEDS
 
The exchange offer is intended to satisfy our obligations under the registration rights agreements. We will not receive any proceeds from the issuance of the Exchange Notes. In consideration for issuing the Exchange Notes, we will receive, in exchange, Old Notes in like principal amount. The form and terms of the Exchange Notes are identical to the form and terms of the Old Notes, except as otherwise described under the heading “The Exchange Offer—Terms of the Exchange Offer.” The Old Notes properly tendered and exchanged for Exchange Notes will be retired and cancelled. Accordingly, issuance of the Exchange Notes will not result in any change in our capitalization. We have agreed to bear the expense of the exchange offer.


39


Table of Contents

 
CAPITALIZATION
 
The following table sets forth our cash and cash equivalents and the capitalization of Aviv Healthcare Properties Limited Partnership as of March 31, 2011:
 
  •     on an actual basis; and
 
  •     on an as adjusted basis to give effect to the sale of the Old Notes in April 2011 and the application of a portion of the net proceeds therefrom to repay certain outstanding indebtedness.
 
You should read this table in connection with “Selected Financial Data,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the more detailed information contained in our historical consolidated financial statements and related notes appearing elsewhere in this prospectus.
 
                 
   
As of March 31, 2011
 
   
Actual
   
As Adjusted
 
    (in millions)        
 
Cash and cash equivalents
    $10.5       $66.6  
                 
Debt:
               
Revolving credit facility (1)
    $10.2       $—  
Acquisition credit line (2)
           
Mortgage term loan (2)
    235.4       199.3  
Other secured debt (3)
    9.1       9.1  
3/4% Senior Notes due 2019 (4)
    200.0       300.0  
                 
Total debt
    454.6       508.4  
Total equity
    247.0       247.0  
                 
Total capitalization
    $701.6       $755.4  
                 
 
 
(1) In February 2011, we entered into a $25.0 million revolving credit facility.
(2) In September 2010, we refinanced all of our existing mortgage indebtedness by entering into a secured credit facility consisting of a $405.0 million mortgage term loan and a $100.0 million acquisition credit line. We have repaid all drawings made under the acquisition credit line.
(3) In November 2010, we entered into a construction and term loan agreement providing a loan of up to $6.4 million to finance the renovation of a SNF located in Arkansas, $1.3 million of which was outstanding as of March 31, 2011. Also in November 2010, we entered into loan agreements in the aggregate principal amount of $7.8 million relating to the acquisition of a SNF located in California.
 
(4) Does not reflect the premium of $2.75 million received in the offering of $100 million of our 7 3/4% Senior Notes due 2019, which premium will be amortized as an adjustment to the yield on the Notes over their term. The premium is included in As Adjusted cash and cash equivalents.


40


Table of Contents

 
SELECTED FINANCIAL DATA
 
You should read the following selected historical consolidated data in connection with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the historical consolidated financial statements and related notes thereto appearing elsewhere in this prospectus.
 
The selected historical consolidated financial data as of December 31, 2010 and 2009 and for the years ended December 31, 2010, 2009 and 2008 have been derived from the audited historical consolidated financial statements of Aviv Healthcare Properties Limited Partnership appearing elsewhere in this prospectus. The selected historical financial data as of December 31, 2008, 2007 and 2006 and for the years ended December 31, 2007 and 2006 have been derived from the audited historical consolidated financial statements of Aviv Healthcare Properties Limited Partnership, which are not included in this prospectus. The selected historical consolidated financial data as of March 31, 2011 and 2010 and for the three months ended March 31, 2011 and 2010 have been derived from the unaudited historical consolidated financial statements of Aviv Healthcare Properties Limited Partnership appearing elsewhere in this prospectus. The unaudited historical financial statements include all adjustments, consisting of normal recurring adjustments, that we consider necessary for a fair presentation of our financial condition and results of operations as of such dates and for such periods under accounting principles generally accepted in the United States. The historical results are not necessarily indicative of the results to be expected in the future.
 
                                                         
          Three Months Ended
 
   
Year Ended December 31,
   
March 31,
 
Operating Information
 
2006
   
2007
   
2008
   
2009
   
2010
   
2010
   
2011
 
    (in thousands)  
 
Revenues
                                                       
Rental income
    $42,672       $67,755       $72,143       $82,775       $84,490       $21,150       $19,690  
Tenant recoveries
    2,690       4,274       4,831       6,056       6,442       1,529       1,689  
Interest on loans to lessees
    330       370       1,859       3,493       5,226       1,131       1,332  
                                                         
Total revenues
    45,692       72,399       78,833       92,324       96,158       23,810       22,711  
Expenses
                                                       
Rent and other operating expenses
    820       658       1,088       612       575       169       202  
General and administrative
    4,337       4,929       6,809       7,741       10,725       1,424       3,468  
Offering costs
                      6,864                    
Real estate taxes
    2,664       4,306       5,116       6,232       6,475       1,605       1,689  
Depreciation
    8,158       12,938       14,616       17,528       17,854       4,362       4,799  
Loss on impairment
          2,987       932             96              
                                                         
Total expenses
    15,979       25,818       28,561       38,977       35,725       7,560       10,158  
                                                         
Operating income
    29,713       46,581       50,272       53,347       60,433       16,250       12,553  
Other income and expenses
                                                       
Interest and other income
    533       1,413       2,012       466       133       63       6  
Interest expense
    (15,767 )     (24,254 )     (26,272 )     (26,570 )     (22,723 )     (5,865 )     (7,556 )
Change in fair value of derivatives
    263       (6,946 )     (8,674 )     6,988       2,931       1,321        
Amortization of deferred financing costs
    (2,353 )     (439 )     (537 )     (550 )     (1,008 )     (139 )     (679 )
Gain on sale of assets, net
    500                         512              
Loss on extinguishment of debt
                            (2,295 )           (3,143 )
                                                         
Total other income and expenses
    (16,824 )     (30,226 )     (33,471 )     (19,666 )     (22,450 )     (4,620 )     (11,372 )
                                                         
Income from continuing operations
    12,889       16,355       16,801       33,681       37,983       11,630       1,181  
Discontinued operations
    (102 )     43       73                          
                                                         
Net income
    $12,787       $16,398       $16,874       $33,681       $37,983       $11,630       $1,181  
                                                         


41


Table of Contents

                                                         
   
As of December 31,
   
As of March 31,
 
Balance Sheet Information
 
2006
   
2007
   
2008
   
2009
   
2010
   
2010
   
2011
 
    (in thousands)  
 
Cash and cash equivalents
    $12,675       $16,377       $9,361       $15,543       $13,028       $8,162       $10,504  
Loan receivables
    2,501       34,920       20,361       28,970       36,611       34,575       30,727  
Rental properties, net of accumulated depreciation
    423,383       475,695       564,600       577,736       627,101       583,646       650,378  
Total assets
    465,730       560,230       634,368       665,130       731,400       668,243       746,990  
Mortgage and other notes payable
    303,060       386,356       463,546       480,105       440,576       477,542       454,624  
Total liabilities
    349,147       434,536       519,096       527,598       486,244       530,054       499,969  
Total equity
    99,409       94,258       77,871       74,562       245,156       73,068       247,021  


42


Table of Contents

 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
This prospectus contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in forward-looking statements for many reasons, including the risks described in “Risk Factors” and elsewhere in this prospectus. You should read the following discussion with “Special Note Regarding Forward-Looking Statements,” “Selected Financial Data,” and the consolidated financial statements and related notes included elsewhere in this prospectus.
 
Overview
 
We operate a self-administered real estate investment trust, or REIT, that focuses on the ownership of healthcare properties, principally skilled nursing facilities (“SNFs”). We generate our revenues through long-term triple-net leases with a diversified group of high quality operators throughout the United States. Through our predecessor entities, we have been in the business of financing operators of SNFs for over 30 years. We believe that we have one of the largest SNF portfolios in the United States which consisted of 187 properties, of which 168 were SNFs, with 18,300 licensed beds in 25 states leased to 32 operators as of March 31, 2011. The discussion included herein is intended to apply to Aviv REIT, Inc. and Subsidiaries and Aviv Healthcare Properties Limited Partnership and Subsidiaries as the operations of the two aforementioned entities are materially comparable for the periods presented.
 
We believe we are well positioned to benefit from our diversified portfolio of properties and extensive network of operator relationships. We focus on cultivating close relationships with our tenants by working closely with them to help them achieve their business objectives. As a result of these efforts, we are in a position to effectively manage our portfolio, make additional investments and continue to expand our business.
 
We lease our properties to a diversified group of 32 operators with no single operator representing more than 13.3% of our revenues for the twelve months ended March 31, 2011. We have a geographically diversified portfolio of properties located in 25 states, with no state representing more than 17.6% of our revenues for the twelve months ended March 31, 2011. Our properties are leased to third party tenants under long-term triple-net leases. The operators are responsible for all operating costs and expenses related to the property, including facility maintenance and insurance required in connection with the properties and the business conducted on the properties, taxes levied on or with respect to the properties (other than taxes on our income) and all utilities and other services necessary or appropriate for the properties and the business conducted on the properties. Our leases are typically master leases with initial terms of 10 years or more, annual rent escalation provisions of 2% to 3%, guarantees, cross-default provisions and security deposits and typically do not have operator purchase options. As of March 31, 2011, the leases for 185 of our 187 properties were supported by personal and/or corporate guarantees. As of March 31, 2011, our leases had an average remaining term of 8.8 years.
 
We have historically financed investments through borrowings under our credit facilities, private placements of equity securities, housing and urban development indebtedness, or a combination of these methods. We have utilized a mortgage credit facility and senior notes to provide the majority of our debt as well as project specific first mortgages in certain situations. We compete with other public and private companies who provide lease and/or mortgage financing to operators of a variety of different types of healthcare properties. While the overall landscape for healthcare finance is competitive, we are disciplined and selective about the investments we make and have a strong track record of identifying qualified operators and attractive markets in which to invest. This has enabled us to successfully complete $507.1 million of acquisitions from April 2005 to March 31, 2011, including $79.2 million of investments in 2010. From January 1, 2011 through the date of this prospectus, we have completed $71.5 million in investments. As a key part of our growth strategy, we evaluate acquisition opportunities on an ongoing basis and are in various stages of due diligence, preliminary discussions or competitive bidding with respect to a number of potential transactions, some of which would be significant. None of these potential significant transactions is subject to a letter of intent or otherwise so far advanced as to make the transaction reasonably certain.


43


Table of Contents

 
Factors Affecting Our Business and the Business of Our Tenants
 
The continued success of our business is dependent on a number of macroeconomic and industry trends. Many of these trends will influence our ongoing ability to find suitable investment properties while other factors will impact our tenants’ ability to conduct their operations profitably and meet their obligations to us.
 
Industry Trends
 
One of the primary trends affecting our business is the long-term increase in the average age of the U.S. population. This increase in life expectancy is expected to be a primary driver for growth in the healthcare and SNF industry. We believe this demographic trend is resulting in an increased demand for services provided to the elderly. We believe that the low cost healthcare setting of a SNF will benefit our tenants and facilities in relation to higher-cost healthcare providers. We believe that these trends will support a growing demand for the services provided by SNF operators, which in turn will support a growing demand for our properties.
 
The growth in demand for services provided to the elderly has resulted in an increase in healthcare spending. The Centers for Medicare and Medicaid Services, or CMS, and the Office of the Actuary forecast that U.S. healthcare expenditures will increase from approximately $2.3 trillion in 2008 to approximately $4.5 trillion in 2019. Furthermore, according to CMS, national expenditures for SNFs are expected to grow from approximately $144 billion in 2009 to approximately $246 billion in 2019, representing a compound annual growth rate, or CAGR, of 5.5%.
 
Liquidity and Access to Capital
 
Our single largest cost is the interest expense we incur on our debt obligations. In order to continue to expand and optimize our capital to expand our portfolio, we rely on access to the capital markets on an ongoing basis. We seek to balance this reliance by maintaining ready access to funds to make investments at the time opportunities arise. We have extensive experience in and a successful track record of raising debt and equity capital over the past 30 years.
 
Our outstanding indebtedness is comprised principally of borrowings under our existing credit facility and our obligations under the Notes. Substantially all of such indebtedness is scheduled to mature in late 2015 or thereafter.
 
Factors Affecting Our Tenants’ Profitability
 
Our revenues are derived from rents we receive from triple-net leases with our tenants. Certain economic factors present both opportunities and risks to our tenants and, therefore, influence their ability to meet their obligations to us. These factors directly affect our tenants’ operations and, given our reliance on their performance under our leases, present risks to us that may affect our results of operations or ability to meet our financial obligations. The recent U.S. economic slowdown and other factors could result in cost-cutting at both the federal and state levels, which could result in a reduction of reimbursement rates and levels to our tenants under both the Medicare and Medicaid programs.
 
Our tenants’ revenues are largely derived from third-party sources. Therefore, we indirectly rely on these same third-party sources to obtain our rents. The majority of these third-party payments come from the federal Medicare program and state Medicaid programs. Our tenants also receive payments from other third-party sources, such as private insurance companies or private-pay residents, but these payments typically represent a small portion of our tenants’ revenues. The sources and amounts of our tenants’ revenues are determined by a number of factors, including licensed bed capacity, occupancy rates, the acuity profile of residents and the rate of reimbursement. Changes in the acuity profile of the residents as well as the mix


44


Table of Contents

among payor types, including private pay, Medicare and Medicaid, may significantly affect our tenants’ profitability and, in turn, their ability to meet their obligations to us. Managing, billing and successfully collecting third-party payments is a relatively complex activity that requires significant experience and is critical to the successful operation of a SNF.
 
Labor and related expenses typically represent our tenants’ largest cost component. Therefore, the labor markets in which our tenants operate affect their ability to operate cost effectively and profitably. In order for our tenants to be successful, they must possess the management capability to attract and maintain skilled and motivated workforces. Much of the required labor needed to operate a SNF requires specific technical experience and education. As a result, our tenants may be required to increase their payroll costs to attract labor and adequately staff their operations. Increases in labor costs due to higher wages and greater employee benefits required to attract and retain qualified personnel could affect our tenants’ ability to meet their obligations to us.
 
While our revenues are generated from the rents our tenants pay to us, we seek to establish our rent at an appropriate level so that our tenants are able to succeed. This requires discipline to ensure that we do not overpay for the properties we acquire. While we operate in a competitive environment, we carefully assess the long-term risks facing our tenants as we consider an investment. Because our leases are long-term arrangements, we are required to assess both the short and long-term capital needs of the properties we acquire. SNFs are generally highly specialized real estate assets. We believe we have developed broad expertise in assessing the short and long-term needs of this asset class.
 
Components of Our Revenues, Expenses and Cash Flow
 
Revenues
 
Our revenues consist primarily of the rents and associated charges we collect from our tenants as stipulated in our long-term triple-net leases. In addition to rent under existing leases, a part of our revenues is made up of other cash payments owed to us by our tenants. Additionally, we recognize certain non-cash revenues. These other cash and non-cash revenues are highlighted below. While not a significant part of our revenues, we also earn interest from a variety of loans outstanding.
 
  •     Rental Income
 
Rental income represents rent under existing leases that is paid by our tenants. In addition, this includes deferred rental income relating to straight-lining of rents as well as rental income from intangible amortization. Both deferred rental income and rental income from intangible amortization are explained in further detail below under “—Components of Cash Flow—Cash Provided by Operations.”
 
  •     Tenant Recoveries
 
All of our leases have real estate escrow clauses that require our tenants to make estimated payments to us to cover their current real estate tax obligations. We collect money for these taxes and pay them on behalf of our tenants. We account for the receipt of these amounts as revenue and the payment of the actual taxes as an expense (real estate taxes). Because the escrow charges to our tenants are made on an estimated basis, the amounts recognized as revenue and corresponding expense will differ slightly in any given fiscal period.
 
  •     Interest on Loans to Tenants
 
We earn interest on certain capital advances and loans we make to our tenants for a variety of purposes, including for capital expenditures at our properties for which we receive additional rent. While we amend our leases to reflect the additional rent owed as a result of these income producing capital expenditures,


45


Table of Contents

we recognize the investment as a loan for accounting purposes when the lease term exceeds the useful life of the capital expenditure. In addition, we recognize rent associated with direct financing leases, in part, as interest income.
 
Expenses
 
We recognize a variety of cash and non-cash charges in our financial statements. Our cash expenses consist primarily of the interest expense on the borrowings we incur in order to make our investments and the general and administrative costs associated with operating our business. These interest charges are associated with both our existing credit facilities as well as certain asset specific loans.
 
  •     Rent and Other Operating Expenses
 
When we lease a property, we recognize related rent expense.
 
  •     General and Administrative
 
Our general and administrative costs consist primarily of payroll and payroll related expense, including non-cash stock based compensation. In addition to payroll, we incur accounting, legal and other professional fees as well as certain other administrative costs of running our business, along with certain expenses related to bank charges, franchise taxes and corporate filing fees.
 
  •     Real Estate Taxes
 
All of our leases have real estate escrow clauses that require our tenants to make estimated payments to us to cover their current real estate tax obligations. We collect money for these taxes and pay them on behalf of our tenants. We account for the receipt of these amounts as revenue (tenant recoveries) and the payment of the actual taxes as an expense. Because the escrow charges to our tenants are made on an estimated basis, the amounts recognized as revenue and corresponding expense will differ slightly in any given fiscal period.
 
  •     Depreciation
 
We incur depreciation expense on all of our long-lived assets. This non-cash expense is designed under generally accepted accounting principles, or GAAP, to reflect the economic useful lives of our assets.
 
  •     Loss on Impairment of Assets
 
We have implemented a policy that requires management to make quarterly assessments of the market value of our properties relative to the amounts at which we carry them on our balance sheet. This assessment requires a combination of factors. We utilize objective financial modeling that compares the sum of the undiscounted cashflows from contractual rents plus the terminal value against the depreciated book value of an asset. In addition, certain subjective factors such as market condition and property condition are considered as well as lease structure. We consider these results in our assessment of whether potential impairment indicators are present.
 
Other Income and Expenses
 
  •     Interest and Other Income
 
We sweep our excess cash balances into overnight interest-bearing accounts. In 2008 we also earned interest on loans made to entities controlled by Messrs. Bernfield and Karkomi in connection with the internalization of AAM, all of which were repaid in June 2008.


46


Table of Contents

 
  •     Interest Expense
 
We recognize the interest we incur on our existing borrowings as an interest expense.
 
  •     Change in Fair Value of Derivatives
 
We have implemented Accounting Standards Codification (ASC) 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. All of the changes in the fair market values of our derivative instruments are recorded in the consolidated statements of operations for our interest rate swaps that were terminated in September 2010. In November 2010, we entered into two interest rate swaps and account for changes in fair value of such hedges through changes in equity in our financial statements via hedge accounting.
 
  •     Amortization of Deferred Financing Costs
 
We incur non-cash charges that reflect costs incurred with arranging certain debt instruments. We generally recognize these costs over the term of the respective debt instrument for which the costs were incurred.
 
  •     Gain on Sale of Assets, Net
 
We record any gain resulting from the sale of assets at the time of sale. We record any losses resulting from the sale of assets at the time we enter into a definitive agreement for the sale of the asset.
 
  •     Loss on Extinguishment of Debt
 
We recognize costs relating to extinguishing debt prior to initial termination dates when we incur them.
 
Components of Cash Flow
 
Cash Provided by Operations
 
Cash provided by operations is derived largely from net income by adjusting our revenues for those amounts not collected in cash during the period in which the revenue is recognized and for cash collected that was billed in prior periods or will be billed in future periods. Net income is further adjusted by adding back expenses charged in the period that is not paid for in cash during the same period. We make our distributions based largely on cash provided by operations. Key non-cash add-backs, in addition to depreciation and the amortization of deferred financing charges, in deriving cash provided by operations are:
 
Deferred Rental Income.  We recognize deferred rental income as a result of the accounting treatment of many of our long-term leases that include fixed rent escalation clauses. Because most of our leases contain fixed rent escalations, we “straight-line” our lease revenue recognition. Straight-lining involves spreading the rents we expect to earn during the term of a lease under its escalation clause over the lease term. As a result, during the first half of a lease term with a fixed escalation clause, we accrue a receivable for rents owed but not paid until future periods. During the second half of the lease term, our cash receipts exceed our recognized revenues and we amortize the receivable.
 
Rental Income from Intangible Amortization.  We incur non-cash rental income adjustments from the amortization of certain intangibles resulting from the required application of purchase accounting in the initial


47


Table of Contents

recording of our real estate acquisitions. At the date of acquisition, all assets acquired and liabilities assumed are recorded at their respective fair value, including any value attributable to in-place lease agreements. Any identified above or below market lease intangible asset or liability is amortized over the remaining lease term as a non-cash adjustment to rental income.
 
Non-cash stock- based compensation.  We incur non-cash expense associated with the share-based payments to employees. The share-based payments are in the form of stock options. Expense is recognized ratably with the vesting schedule based on the grant date fair value of the options.
 
Non-cash loss on extinguishment of debt.  We incurred certain expense associated with the partial pre-payment of our secured mortgage term loan. Costs associated with the origination of this loan were capitalized and being ratably expensed over the life of the loan. When we pre-paid this loan in part, we recognized a prorated non-cash expense write-off for the unamortized capitalized debt costs.
 
Reserve for uncollected rental income and uncollectible loan receivable.  We incur an expense estimate for a reserve based upon our historical collection record of billed rental income and collections of loan receivables.
 
Cash Used in Investing Activities
 
Cash used in investing activities consists of cash that is used during a period for making new investments, capital expenditures and tenant loans.
 
Cash Provided by Financing Activities
 
Cash provided by financing activities consists of cash we received from issuances of debt and equity capital. This cash provides the primary basis for the investments in new properties, capital expenditures and tenant loans. While we invest a portion of our cash from operations into new investments, as a result of our distribution requirements to maintain our REIT status, it is likely that additional debt or equity issuances will finance the majority of our investment activity.
 
Results of Operations
 
The following is a discussion of the consolidated results of operations, financial position and liquidity and capital resources of Aviv Healthcare Properties Limited Partnership.
 
Three Months Ended March 31, 2011 Compared to Three Months Ended March 31, 2010
 
Revenues
 
Revenues decreased $1.1 million, or 4.6%, from $23.8 million for the three months ended March 31, 2010 to $22.7 million for the same period in 2011. The $1.1 million decrease was the result of an increase in rental revenue of $671,000, off-set by a write-off (expense) of deferred rent receivable of $2.2 million due to the termination of a lease and replacement of an operator. Interest on loans to lessees also increased by $201,000 as a result of interest earned on loans we made at our properties.
 
Detailed changes in revenues for the three months ended March 31, 2011 compared to the same period in 2010 were as follows:
 
  •     Rental income decreased $1.5 million, or 6.9%, from $21.2 million for the three months ended March 31, 2010 to $19.7 million for the same period in 2011. The $1.5 million decrease was the result of an increase in rental revenue of $671,000 that resulted from additional rent associated with $109 million of acquisitions and investments made in the twelve months ending March 31,


48


Table of Contents

  2011, off-set by a write-off (expense) of deferred rent receivable of $2.2 million due to the termination of a lease and replacement of an operator.
 
  •     Tenant recoveries increased $160,000, or 10.5%, from $1.5 million for the three months ended March 31, 2010 to $1.7 million for the same period in 2011. The increase was a result of the additional tenant recoveries associated with real estate taxes for newly acquired facilities included in the $109 million of acquisitions and investments made in the twelve months ended March 31, 2011 as well as the tenant recoveries from those investments made in the three months ended March 31, 2010 that were not owned for the entire 2010 period. The increase was also due to an increase in tenant recoveries related to increases in real estate taxes from investments held more than one year.
 
  •     Interest on loans to tenants increased $201,000, or 26.2%, from $1.1 million for the three months ended March 31, 2010 to $1.3 million for the same period in 2011. Most of this increase in the 2011 period was a result of loans to tenants to make capital expenditures that they made in our properties for which we receive interest.
 
Expenses
 
Expenses increased $2.6 million, or 34.3%, from $7.6 million for the three months ended March 31, 2010 to $10.2 million for the same period in 2011. This increase was primarily due to an increase in general and administrative expenses of $2.0 million which was attributable to $1.0 million of non-cash share-based compensation expense in 2011 and also an increase in professional fees of $670,000 because of a $430,000 write off of legal expenses that were recovered from a tenant in the three months ended March 31, 2010.
 
Detailed changes in expenses for the three months ended March 31, 2011 compared to the same period in 2010 were as follows:
 
  •     Rent and other operating expenses were comparable period over period.
 
  •     General and administrative expense increased $2.0 million, or 143.5%, from $1.4 million for the three months ended March 31, 2010 to $3.5 million for the same period in 2011. The increase was primarily due to $1.0 million of non-cash share-based compensation expense in 2011 and also an increase in professional fees of $670,000 due to a $430,000 write off of legal expenses in the first quarter of 2010. These legal fees were expensed in 2009 but were recovered from the tenant in the first quarter of 2010.
 
  •     Real estate tax expense was comparable period over period. Although we had an increase associated with the $109 million in acquisitions for the twelve months ended March 31, 2011, these increases were offset by property tax decreases and three property dispositions in 2010.
 
  •     Depreciation expense increased $437,000, or 10.0%, from $4.4 million for the three months ended March 31, 2010 to $4.8 million for the same period in 2011. The increase was a result of an increase in depreciation expense associated with 13 newly acquired facilities included in the $109 million of acquisitions and investments made during the twelve months ended March 31, 2011.
 
Other Income and Expenses
 
  •     Interest and other income decreased $58,000 or 91.1%, from $63,000 for the three months ended March 31, 2010 to $6,000 for the same period in 2011. Most of this decrease was a result of a decrease in average cash balances.


49


Table of Contents

 
  •     Interest expense increased $1.7 million, or 28.8%, from $5.9 million for the three months ended March 31, 2010 to $7.6 million for the same period in 2011. The majority of the increase was due to an increase in the interest rate on our debt associated with our credit facilities and senior notes offset by a lesser amount of debt outstanding in the three months ended March 31, 2011 as compared to the same period in 2010.
 
  •     Income relating to the change in fair value of derivatives decreased $1.3 million, or 100%, from a gain of $1.3 million in the three months ended March 31, 2010 to $0 in the same period in 2011. We settled our existing swaps in September 2010 as part of our debt refinancing. We entered into new swap arrangements in November 2010 and these swaps have been deemed to be eligible for hedge accounting, such changes are reported in accumulated other comprehensive income within the consolidated statement of changes in equity, exclusive of ineffectiveness amounts, which are recognized as adjustments to net income.
 
  •     Amortization of deferred financing fees increased $540,000, or 387.5%, from $139,000 for the three months ended March 31, 2010 to $679,000 for the same period in 2011. The increase was due to additional fees incurred in conjunction with our new $405 million mortgage term loan entered into in September 2010 and our $200 million issuance of Senior Notes in February of 2011.
 
  •     Loss on extinguishment of debt was $3.1 million for the three months ended March 31, 2011. This non-recurring cost was a result of prepaying certain corporate indebtedness prior to maturity.
 
Year Ended December 31, 2010 Compared to Year Ended December 31, 2009
 
Revenues
 
Revenues increased $3.8 million, or 4.2%, from $92.3 million for the year ended December 31, 2009 to $96.2 million for the same period in 2010. The $3.8 million increase was a result of the additional rent and tenant recoveries associated with $79.2 million of acquisitions and investments, consisting principally of newly acquired facilities and capital expenditures for which we receive additional rent, made in the year ended December 31, 2010.
 
Detailed changes in revenues for the year ended December 31, 2010 compared to the same period in 2009 were as follows:
 
  •     Rental income increased $1.7 million, or 2.1%, from $82.8 million for the year ended December 31, 2009 to $84.5 million for the same period in 2010. The $1.7 million increase was a result of the additional rent associated with $79.2 million of acquisitions and investments, consisting principally of newly acquired facilities for which we receive additional rent, made in the year ended December 31, 2010, as well as the rent from those investments made in the year ended December 31, 2009 that were not owned for the entire 2009 period.
 
  •     Tenant recoveries increased $386,000, or 6.4%, from $6.1 million for the year ended December 31, 2009 to $6.4 million for the same period in 2010. The increase was a result of the additional tenant recoveries associated with real estate taxes for newly acquired facilities included in the $79.2 million of acquisitions and investments made in the year ended December 31, 2010 as well as the tenant recoveries from those investments made in the year ended December 31, 2009 that were not owned for the entire 2009 period. The increase was also due to an increase in tenant recoveries related to increases in real estate taxes from investments held more than one year, offset by a real estate tax refund to tenants as a result of lower actual real estate taxes in the 2009 period.


50


Table of Contents

 
  •     Interest on loans to tenants increased $1.7 million, or 49.6%, from $3.5 million for the year ended December 31, 2009 to $5.2 million for the same period in 2010. Most of this increase in the 2010 period was a result of capital expenditures that we made in our properties for which we receive additional rent.
 
Expenses
 
Expenses decreased $3.3 million, or 8.3%, from $39.0 million for the year ended December 31, 2009 to $35.7 million for the same period in 2010. The decrease was primarily due to a decrease in one time offering costs that were expensed in 2009 when the company made the decision to not move forward with its IPO effort. This decrease was offset by an increase in general and administrative expenses of $3.0 million which was attributable to $1.6 million of share-based compensation expense in 2010. There was an additional $500,000 in bonus for employees as a result of meeting certain corporate performance goals in 2010 that were not met in 2009.
 
Detailed changes in expenses for the year ended December 31, 2010 compared to the same period in 2009 were as follows:
 
  •     Rent and other operating expenses were comparable period over period.
 
  •     General and administrative expense increased $3.0 million, or 38.5%, from $7.7 million for the year ended December 31, 2009 to $10.7 million for the same period in 2010. The increase was primarily due to $1.6 million of share-based compensation expense in 2010 and an additional $500,000 in bonus for employees as a result of meeting certain corporate performance goals in 2010 that were not met in 2009.
 
  •     Real estate tax expense increased $243,000, or 3.9%, from $6.2 million for the year ended December 31, 2009 to $6.5 million for the same period in 2010. This increase was a result of an increase in real estate expense associated with 13 newly acquired facilities included in the $79.2 million of acquisitions and investments made during the year ended December 31, 2010 as well as the real estate tax expense from those investments made in the year ended December 31, 2009 that were not owned for the entire 2009 period. The increase was also due to increases in real estate taxes from investments held more than one year, offset by a real estate tax refund to tenants as a result of lower actual real estate taxes in the 2009 period. To a much lesser extent the increase was associated with year-to-year increases in real estate taxes related to investments held more than a year.
 
  •     Depreciation expense increased $326,000, or 1.9%, from $17.5 million for the year ended December 31, 2009 to $17.9 million for the same period in 2010. The increase was a result of an increase in depreciation expense associated with 13 newly acquired facilities included in the $79.2 million of acquisitions and investments made during the year ended December 31, 2010 as well as the depreciation expense from those investments made in the year ended December 31, 2009 that were not owned for the entire 2009 period.
 
  •     Loss on impairment of assets increased $96,000, from $0 for the year ended December 31, 2009 to $96,000 for the same period in 2010. The 2010 expense was to record a property at estimated selling price less costs to dispose.
 
Other Income and Expenses Including Income (Loss) from Discontinued Operations
 
  •     Interest and other income decreased $333,000 or 71.5%, from $466,000 for the year ended December 31, 2009 to $133,000 for the same period in 2010. Most of this decrease was a result of a decrease in average cash balances.


51


Table of Contents

 
  •     Interest expense decreased $3.8 million, or 14.5%, from $26.6 million for the year ended December 31, 2009 to $22.7 million for the same period in 2010. The majority of the decrease was due to a decrease in swap interest expense relating to contracts expiring in 2010 as well as a significant paydown of debt in September 2010.
 
  •     Income relating to the change in fair value of derivatives decreased $4.1 million, or 58.1%, from a gain of $7.0 million in the year ended December 31, 2009 to a gain of $2.9 million in the same period in 2010. This is a result of a change in the fair value of our swaps during the period.
 
  •     Amortization increased $458,000, or 83.3%, from $550,000 for the year ended December 31, 2009 to $1.0 million for the same period in 2010. The increase was due to additional fees incurred in conjunction with our new $405 million mortgage term loan entered into in September 2010.
 
  •     Gain on sale of assets, net was $512,000 for the year ended December 31, 2010 as a result of the disposal of two properties in July 2010 and one property in December 2010.
 
  •     Loss on extinguishment of debt was $2.3 million for the year ended December 31, 2010. This non-recurring cost was a result of prepaying certain corporate indebtedness prior to maturity.
 
Year Ended December 31, 2009 Compared to Year Ended December 31, 2008
 
Revenues
 
Revenues increased $13.5 million, or 17.1%, from $78.8 million for the year ended December 31, 2008 to $92.3 million for the same period in 2009. The $13.5 million increase was a result of the additional rent and tenant recoveries associated with $17.9 million of investments, consisting principally of two newly acquired facilities and, to a much lesser extent, capital expenditures, made in 2009, the full year of rent and tenant recoveries related to $97.9 million of investments, consisting principally of 17 newly acquired facilities and, to a much lesser extent, capital expenditures, made during 2008 and interest income charged on loans made to tenants.
 
Detailed changes in revenues for the year ended December 31, 2009 compared to the same period in 2008 were as follows:
 
  •     Rental income increased $10.6 million, or 14.7%, from $72.1 million for the year ended December 31, 2008 to $82.8 million for the same period in 2009. The increase was a result of the additional rent associated with leases of two newly acquired facilities included in the $17.9 million of investments made in 2009 and the full year of rent related to leases of 17 newly acquired facilities included in the $97.9 million of investments made during 2008.
 
  •     Tenant recoveries increased $1.2 million, or 25.4%, from $4.8 million for the year ended December 31, 2008 to $6.1 million for the same period in 2009. The increase was a result of the additional tenant recoveries associated with real estate taxes for two newly acquired facilities included in the $17.9 million of investments made in 2009, the full year of tenant recoveries related to real estate taxes for 17 newly acquired facilities included in the $97.9 million of investments made during 2008 and to a much lesser extent increases in tenant recoveries related to increases in real estate taxes from investments held more than one year.
 
  •     Interest on loans to tenants increased $1.6 million, or 87.9%, from $1.9 million for the year ended December 31, 2008 to $3.5 million for the same period in 2009. Most of this increase was


52


Table of Contents

  a result of capital expenditures that we made in our properties for which we receive additional rent and working capital loans made to operators.
 
Expenses
 
Expenses increased $10.4 million, or 36.5%, from $28.6 million for the year ended December 31, 2008 to $39.0 million for the same period in 2009. The increase was primarily due to expenses recognized in connection with the company’s abandoned initial public offering (IPO) effort in 2009.
 
Detailed changes in expenses for the year ended December 31, 2009 compared to the same period in 2008 were as follows:
 
  •     Rent and other operating expenses decreased $476,000, or 43.8%, from $1.1 million for the year ended December 31, 2008 to $612,000 for the same period in 2009 due to the expiration of two leases we previously subleased.
 
  •     General and administrative expense increased $932,000, or 13.7%, from $6.8 million for the year ended December 31, 2008 to $7.7 million for the same period in 2009. The increase was primarily due to increased salaries associated with additional personnel.
 
  •     Offering costs of $6.9 million were expensed for professional fees and other costs that relate to the abandoned IPO effort in 2009.
 
  •     Real estate tax expense increased $1.1 million, or 21.8%, from $5.1 million for the year ended December 31, 2008 to $6.2 million for the same period in 2009. The increase was a result of an increase in real estate expense associated with two newly acquired facilities included in the $17.9 million of investments made in 2009 and the full year of costs associated with 17 newly acquired facilities included in the $97.9 million of investments made during 2008. To a far lesser extent the amount of the increase was associated with year-to-year increases in real estate taxes related to investments held more than a year.
 
  •     Depreciation expense increased $2.9 million, or 19.9%, from $14.6 million for the year ended December 31, 2008 to $17.5 million for the same period in 2009. The increase was due to incremental depreciation costs associated with two newly acquired facilities included in the $17.9 million of investments made in 2009 and the full year of depreciation costs associated with 17 newly acquired facilities included in the $97.9 million of investments made during 2008.
 
  •     Expense from loss on impairment of assets decreased $932,000, from $932,000 for the year ended December 31, 2008 to $0 for the same period in 2009. The expense in 2008 was due to the recognition of a loss incurred on a sale of a property in 2008.
 
Other Income and Expenses Including Income (Loss) from Discontinued Operations
 
  •     Interest and other income decreased $1.5 million, or 76.8%, from $2.0 million for the year ended December 31, 2008 to $466,000 for the same period in 2009. Most of this decrease was a result of loans made in connection with the internalization of AAM that were repaid in June 2008.
 
  •     Interest expense increased $298,000, or 1.1%, from $26.3 million for the year ended December 31, 2008 to $26.6 million for the same period in 2009. The increase was due to incremental interest costs on additional indebtedness related to two newly acquired facilities during 2009 and the full year of interest costs associated with additional indebtedness incurred in 2008.


53


Table of Contents

 
  •     The change in fair value of derivatives increased $15.7 million, or 180.6%, from expense of $8.7 million for the year ended December 31, 2008, as compared to income of $7.0 million for the same period in 2008. This additional expense in 2008 was a result of a change in the fair value of our swaps during the period as a result of significant increases in the 30-day LIBOR.
 
  •     Amortization increased $13,000, or 2.4%, from $537,000 for the year ended December 31, 2008 to $550,000 for the same period in 2009. The increase was due in part to additional financing fees incurred in conjunction with additional indebtedness.
 
Property Acquisitions
 
During the three months ended March 31, 2011 and 2010, the Partnerships closed the acquisition of 13 and 4 properties, respectively. Refer to the Notes to the Consolidated Financial Statements of the Partnership for further details.
 
Liquidity and Capital Resources
 
We expect to meet our short-term liquidity requirements generally through net cash provided by operations, existing cash balances and, if necessary, short-term borrowings. We believe that the net cash provided by operations and availability under our revolving credit facility will be adequate to fund our operating requirements, debt service and the payment of dividends in accordance with REIT requirements of the federal income tax laws for the next twelve months. We expect to meet our long-term liquidity requirements, such as scheduled debt maturities and property acquisitions, through long-term secured and unsecured borrowings and the issuance of additional equity securities.
 
Our organizational documents do not limit the amount of indebtedness that we may incur, and we currently do not have a target leverage ratio. We intend to repay indebtedness incurred under our credit facilities from time to time, to provide capacity for acquisitions or otherwise, out of cash flow and from the proceeds of issuances of additional equity interests and other securities.
 
We intend to invest in additional properties and portfolios as suitable opportunities arise and adequate sources of financing are available. We are currently evaluating additional potential investments consistent with the normal course of our business. These potential investments are in various stages of evaluation with both existing and new tenants and include acquisitions, development projects, income producing capital expenditures and other investment opportunities. There can be no assurance as to whether or when any portion of these investments will be completed. Our ability to complete investments is subject to a number of risks and variables, including our ability to negotiate mutually agreeable terms with the counterparties and our ability to finance the purchase price. See “Risk Factors—Risks Relating to Our Business and Operations—We may not be successful in identifying and consummating suitable acquisitions or investment opportunities, which may impede our growth and negatively affect our results of operations and may result in the use of a significant amount of management resources.” We expect that future investments in properties will depend on and will be financed by, in whole or in part, our existing cash, the proceeds from issuances of securities or borrowings (including under our acquisition credit line and our revolving credit facility).
 
Indebtedness Outstanding
 
Our outstanding indebtedness is comprised principally of borrowings under our existing credit facility and the Notes. We have a total indebtedness of approximately $454.6 million as of March 31, 2011. After giving pro forma effect to the sale of the Old Notes and the use of proceeds therefrom, we anticipate that we would have had total indebtedness of approximately $508.4 million as of March 31, 2011. Substantially all of such indebtedness is scheduled to mature in late 2015 or thereafter.


54


Table of Contents

 
Contractual Obligations
 
The following table shows the amounts due in connection with the contractual obligations described below as of March 31, 2011 as adjusted to give effect to the sale of the Old Notes in April 2011 and the use of proceeds therefrom (including future interest payments):
 
                                         
   
Payments Due by Period
 
    Less than
                More than
       
   
1 Year
   
1-3 Years
   
3-5 Years
   
5 Years
   
Total
 
    (in thousands)  
 
Mortgage term loan and other notes payable (1)
    $12,583       $34,859       $217,085  (2)     $—       $264,527  
3/4% Senior Notes due 2019 (3)
    17,438       46,500       46,500       374,917       485,355  
                                         
Total
    $30,021       $81,359       $263,585  (2)     $374,917       $749,882  
                                         
 
 
(1) Assumes $199.3 million outstanding under our existing credit facility after giving effect to use of proceeds from the Old Notes. Assumes a weighted average interest rate for total outstanding debt of 7.13%.
 
(2) Primarily relates to maturity of indebtedness under our existing credit facility in September 2015. Does not give effect to any amounts to be drawn under the acquisition credit line which would also mature in September 2015. See “—Borrowing Arrangements” below.
 
(3) Reflects $300.0 million outstanding of our 73/4% Senior Notes due 2019.
 
Borrowing Arrangements
 
Existing Credit Facility
 
On September 17, 2010, our subsidiary Aviv Financing I, L.L.C. entered into a five year credit agreement with General Electric Capital Corporation, or GE, which provides a $405.0 million mortgage term loan and a $100.0 million acquisition credit line. The acquisition credit line is available for draw until September 2013. The initial term of the existing credit facility expires in September 2015 with two one-year extension options, provided that certain conditions precedent for the extensions are satisfied, including, without limitation, payment of a fee equal to 0.25% of the then existing principal balance of the existing credit facility and meeting certain debt service coverage and debt yield tests.
 
Our GE credit facility generally requires the consolidated borrowers under the facility to maintain a debt service coverage ratio of 1.50:1.00 and a distribution coverage ratio of 1.10:1.00. In addition, Aviv Healthcare Properties Limited Partnership and its consolidated subsidiaries must maintain a debt service coverage ratio of 1.25:1.00 and a debt yield ratio of greater than 17.25%. We are permitted to include cash on hand in calculating such debt service coverage ratios. Immediately following any draw on the acquisition credit line, both before and after giving effect to such draw, the consolidated borrowers under the existing credit facility must have a pro forma debt yield ratio of at least 18%.
 
Our debt yield ratio is the ratio of (i) either consolidated EBITDA or rental revenue for the most recently completed two fiscal quarter period times two to (ii) the average daily outstanding principal balance of loans outstanding under the existing credit facility during the period. The borrowers under the existing credit facility guarantee the Notes, which guarantees are subordinated to the obligations of such borrowers under the existing credit facility. In turn, each guarantor of the Notes that is not a borrower under our existing credit facility or our revolving credit facility provided guarantees to the lenders under such facilities, which guarantees are subordinated to the obligations of such subsidiaries under the Notes.


55


Table of Contents

 
As of March 31, 2011, we are in compliance with the financial covenants of our outstanding debt and lease agreements.
 
7.75% Senior Notes due 2019
 
On February 4, 2011, we, through Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation, (the “Issuers”), issued $200.0 million aggregate principal amount of senior unsecured notes (the “Notes”) in a private placement. The Issuers are majority owned subsidiaries of Aviv REIT, Inc. (“Aviv REIT”). The Notes were sold at par, resulting in gross proceeds of $200.0 million and net proceeds of approximately $194.5 million after deducting commissions and expenses. The net proceeds from the offering of the Notes were used to repay all outstanding indebtedness under our acquisition credit line and to partially repay our outstanding mortgage term loan.
 
The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Aviv REIT and certain of our other existing and, subject to certain exceptions, future subsidiaries.
 
The Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after February 15, 2015, at the redemption prices set forth in the indenture governing the Notes (the “Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to February 15, 2015, the Issuers may redeem all or a portion of the Notes at a redemption price equal to 100% of the principal amount of the Senior Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to February 15, 2014, the Issuers may redeem up to 35% of the principal amount of the Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 107.75% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date.
 
The Indenture governing the Notes contains restrictive covenants that, among other things, restrict the ability of Aviv REIT, the Issuers and their restricted subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; (iii) pay dividends or distributions on, or redeem or repurchase, their capital stock; (iv) make certain investments or other restricted payments; (v) sell assets; (vi) create liens on their assets; (vii) enter into transactions with affiliates; (viii) merge or consolidate or sell all or substantially all of their assets; and (ix) create restrictions on the ability of Aviv REIT and its restricted subsidiaries to pay dividends or other amounts to Aviv REIT. The Indenture governing the Notes also provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the Notes, the failure to comply with certain covenants and agreements specified in the Indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then outstanding Notes may become due and payable immediately. As of March 31, 2011, we were in compliance with all applicable financial covenants under the Notes.
 
Revolving Credit Facility
 
In conjunction with the Senior Notes issuance on February 4, 2011, the Partnership, under Aviv Financing IV, LLC, entered into a $25.0 million secured revolving credit facility with Bank of America (the “Revolver”). On each payment date, the Partnership shall pay interest only in arrears on any outstanding principal balance of the Revolver. The interest rate under our Revolver is generally based on LIBOR (subject to a floor of 1.0% and subject to our option to elect to use a prime base rate) plus a margin that is determined by our leverage ratio from time to time, and the interest rate as of March 31, 2011 was 6.25%. We are permitted to include cash on hand in calculating our leverage ratio for periods through June 30, 2011. The initial term of our Revolver expires in January 2014 with a one-year extension option. We have the right to


56


Table of Contents

increase the amount of the revolving credit facility by up to $75.0 million (resulting in total availability of $100.0 million), provided that certain conditions precedent are satisfied.
 
Our revolving credit facility is secured by first lien mortgages on 14 of our properties, a pledge of the capital stock of our subsidiaries owning such properties (plus the equity of our subsidiary that acts as the holding company of the subsidiaries owning such properties) and other customary collateral, including an assignment of leases and rents with respect to such mortgaged properties. The borrowing availability under our Revolver is subject to a borrowing base calculation based on, among other factors, the lesser of (i) the amount of a hypothetical mortgage based on the net revenues for the prior four quarters (on a pro forma basis for recently acquired properties) and (ii) 65% of the appraised value, in each case, of the properties securing our revolving credit facility. As of March 31, 2011, there was $10.2 million outstanding on our Revolver.
 
The Revolver contains customary covenants that include restrictions on the ability to make acquisitions and other investments, pay dividends, incur additional indebtedness, and sell or otherwise transfer certain assets as well as customary events of default. The secured revolving credit facility also requires us to comply with specified financial covenants, which include a maximum leverage ratio, a minimum fixed charge coverage ratio and a minimum tangible net worth requirement. As of March 31, 2011, we were in compliance with all applicable financial covenants under the Revolver.
 
Subsequent Event — $100 million 7.75% Add-on Senior Notes
 
On April 5, 2011, the Partnership issued $100 million of 7.75% Senior Notes due February 2019 at a price of $102.75 for an effective yield of 7.16%. The net proceeds from this issuance were used to pay down $35.7 million of the mortgage term loan and the remaining proceeds were received as cash.
 
Cash Flows
 
Three Months Ended March 31, 2011 Compared to Three Months Ended March 31, 2010
 
  •     Cash provided by operations increased $242,000, or 1.7%, from $14.0 million for the three months ended March 31, 2010 to $14.3 million for the same period in 2011. The increase was primarily due to an increase that resulted from additional rent associated with $109 million of acquisitions and investments made in the twelve months ending March 31, 2011.
 
  •     Cash used in investing activities increased $14.6 million, or 188.1%, from cash used of $7.8 million for the three months ended March 31, 2010 to cash used of $22.3 million for the same period in 2011. This increase was largely due to the increase in acquisition and investment activity in the twelve months ended March 31, 2011, as compared to the same period in 2010.
 
  •     Cash provided by financing activities increased $19.8 million, or 145.1%, from cash used of $13.6 million for the three months ended March 31, 2010 to cash provided of $6.2 million for the same period in 2010. The increase was primarily due to a follow-on equity investment by Lindsay Goldberg in January 2011 and the issuance of our Senior Notes in February 2011.
 
Year Ended December 31, 2010 Compared to Year Ended December 31, 2009
 
  •     Cash provided by operations increased $14.6 million, or 36.6%, from $40.0 million for the year ended December 31, 2009 to $54.7 million for the same period in 2010. The increase was primarily due to an increase in our accounts payable, an increase in net income, and an increase in non-cash stock-based compensation and non-cash loss on extinguishment of debt.
 
  •     Cash used in investing activities increased $36.6 million, or 95.1%, from cash used of $38.5 million for the year ended December 31, 2009 to cash used of $75.1 million for the same


57


Table of Contents

  period in 2010. This increase was largely due to the increase in investment activity in the year ended December 31, 2010, as compared to the same period in 2009.
 
  •     Cash provided by financing activities increased $13.3 million, or 286.9%, from $4.6 million for the year ended December 31, 2009 to $17.9 million for the same period in 2010. The increase was primarily due to our transaction with Lindsay Goldberg on September 17, 2010.
 
Year Ended December 31, 2009 Compared to Year Ended December 31, 2008
 
  •     Cash provided by operations increased $8.0 million, or 24.9%, from $32.0 million for the year ended December 31, 2008 to $40.0 million for the same period in 2009. The increase was a result of the additional rent associated with $17.9 million of investments made in 2009 and the full year of rent related to $97.9 million of investments made during 2008.
 
  •     Cash used in investing activities decreased $50.6 million, or 56.8%, from $89.1 million for the year ended December 31, 2008 to $38.5 million for the same period in 2009. The decrease was primarily due to a decrease in investment activity.
 
  •     Cash provided by financing activities decreased $45.4 million, or 90.7%, from $50.0 million for the year ended December 31, 2008 to $4.6 million for the same period in 2009. The majority of the decrease was due to a decrease in financing activity.
 
Summary of Significant Accounting Policies
 
Estimates
 
The preparation of the financial statements in conformity with GAAP in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
 
Principles of Consolidation
 
The accompanying consolidated financial statements of Aviv Healthcare Properties Limited Partnership include the accounts of the partnership and all controlled subsidiaries and joint ventures. Aviv Healthcare Properties Limited Partnership considers itself to control an entity if it is the majority owner of and has voting control over such entity. The portion of the net income or loss attributed to third parties is reported as noncontrolling interests on the consolidated statements of operations, and such parties’ portion of the net equity in such subsidiaries is reported on the consolidated balance sheets as noncontrolling interests. All significant intercompany balances and transactions have been eliminated in consolidation.
 
Rental Properties
 
Aviv Healthcare Properties Limited Partnership reports all acquired properties at their estimated fair value, net of accumulated depreciation. We periodically assess the carrying value of rental properties and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the rental properties will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the rental properties and related intangibles to their estimated fair value. The estimated fair value of our rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis.


58


Table of Contents

 
Buildings and building improvements have been assigned estimated 40-year lives and are depreciated on the straight-line method. Personal property, furniture, and equipment have been assigned estimated lives ranging from 7 to 10 years and are generally depreciated on the straight-line method.
 
We may advance monies to our lessees for the purchase, generally, of furniture, fixtures, or equipment or other purposes. Required minimum lease payments due from the lessee increase to provide for the repayment of such amounts over a stated term. These advances in the instance where the depreciable life of the newly purchased asset is less than the remaining lease term are reflected as loan receivables on the consolidated balance sheets, and the incremental lease payments are bifurcated between principal and interest over the stated term. In the instance where the depreciable life of the newly purchased assets is longer than the remaining lease term, the purchase is recorded as property. In other instances, loans are made to lessees for working capital and other funding needs and provide for monthly principal and interest payments generally ranging from 5 to 10 years.
 
Purchase Accounting
 
In determining the allocation of the purchase price of partnerships and facilities between net tangible and identified intangible assets acquired and liabilities assumed, we make estimates of the fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of preacquisition due diligence, marketing, leasing activities of our diverse operator base, industry surveys of critical valuation metrics such as capitalization rates, discount rates and leasing rates and appraisals obtained by us as a requirement of the existing credit facility. We allocate the purchase price of facilities to net tangible and identified intangible assets acquired based on their fair values in accordance with the provisions of ASC 805, Business Combinations (ASC 805). The determination of fair value involves the use of significant judgment and estimation.
 
We determine fair values as follows:
 
  •     Other assets acquired and other liabilities assumed are valued at stated amounts, which approximate fair value.
 
  •     Rental properties are valued using discounted cash flow projections that assume certain future revenue and costs and consider capitalization and discount rates using current market conditions. We allocate the purchase price of facilities to net tangible and identified intangible assets acquired and liabilities assumed based on their fair values.
 
  •     Assumed debt balances are valued at fair value, with the computed discount/premium amortized over the remaining term of the obligation.
 
We determine the value of land either based on real estate tax assessed values in relation to the total value of the asset, internal analyses of recently acquired and existing comparable properties within our portfolio, or third party appraisals. The fair value of in-place leases, if any, reflects: (i) above- and below-market leases, if any, determined by discounting the difference between the estimated current market rent and the in-place rentals, the resulting intangible asset or liability of which is amortized to rental revenue over the remaining life of the associated lease plus any fixed rate renewal periods if applicable; (ii) the estimated value of the cost to obtain tenants, including tenant allowances, tenant improvements, and leasing commissions, which is amortized over the remaining life of the associated lease; and (iii) an estimated value of the absorption period to reflect the value of the rents and recovery costs foregone during a reasonable lease-up period as if the acquired space was vacant, which is amortized over the remaining life of the associated lease. We also estimate the value of tenant or other customer relationships acquired by considering the nature and extent of existing business relationships with the tenant, growth prospects for developing new business with such tenant, such tenant’s credit quality, expectations of lease renewals with such tenant, and the potential for significant, additional future leasing arrangements with such tenant. We amortize such value, if any, over the


59


Table of Contents

expected term of the associated arrangements or leases, which would include the remaining lives of the related leases. The amortization is included in the consolidated statements of operations in rental income.
 
Revenue Recognition
 
Rental income is recognized on a straight-line basis over the term of the lease when collectability is reasonably assumed. Differences between rental income earned and amounts due under the lease are charged or credited, as applicable, to deferred rent receivable. Income recognized from this policy is titled deferred rental revenue. Additional rents from expense reimbursements for insurance, real estate taxes, and certain other expenses are recognized in the period in which the related expenses are incurred and are reflected as tenant recoveries on the consolidated statements of operations.
 
Derivative Instruments
 
We have implemented ASC 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. All of the changes in the fair market values of our derivative instruments are recorded in the consolidated statements of operations if the derivative does not qualify for, or we do not elect to apply, hedge accounting. In November 2010, we entered into two interest rate swaps and account for changes in fair value of such hedges through changes in equity in our financial statements under hedge accounting.
 
Lease Accounting
 
Aviv Healthcare Properties Limited Partnership, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statement of operations as rental income for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators. Assets subject to operating leases are reported as rental properties in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to Aviv Healthcare Properties Limited Partnership’s net initial investment is established on the balance sheet entitled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a financing lease.
 
Many of Aviv Healthcare Properties Limited Partnership’s leases contain fixed or formula based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.
 
Stock-Based Compensation
 
We follow ASC 718, Stock Compensation (ASC 718), which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated statements of operations based on their fair values. We recognize expense for dividend equivalents where appropriate as dividends are declared, even if not immediately paid.


60


Table of Contents

 
Income Taxes
 
Aviv Healthcare Properties Limited Partnership is a limited partnership. Therefore, substantially all federal and state income taxes are recorded by the limited partners of Aviv Healthcare Properties Limited Partnership. Accordingly, Aviv Healthcare Properties Limited Partnership does not provide for federal income taxes. State income taxes were not significant in any of the periods presented. No uncertain income tax positions exist.
 
Aviv REIT intends to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code and applicable U.S. Treasury regulations relating to REIT qualification. Aviv REIT intends to make its election to be taxed as a REIT effective as of its taxable year ending December 31, 2010. In order to maintain this status, the regulations require us to distribute at least 90% of our taxable income to stockholders and meet certain other asset and income tests as well as other requirements. Assuming REIT qualification, we will generally not be liable for federal corporate taxes as long as we distribute 100% of our taxable income and net capital gains.
 
Aviv Healthcare Properties Limited Partnership
 
Aviv Healthcare Properties Limited Partnership was formed in 2005 for the purpose of combining various entities with varying ownership. Aviv Healthcare Properties Limited Partnership refinanced the respective debt obligations of the contributed entities, as well as covered the expenses of the transaction with our credit facilities.
 
For accounting purposes, in accordance with the provisions of ASC 805, the largest of the combining entities, Massachusetts Nursing Homes Limited Partnership (“Massachusetts”), was determined to be the accounting acquiror in the transaction and its assets, liabilities, and equity continue to be reported in the consolidated financial statements at their historical cost. All remaining real estate assets, effective on their respective acquisition dates, were deemed to have been acquired by Massachusetts and these acquired assets and liabilities were recorded on such dates at their fair value in accordance with the purchase method of accounting. The results of operations for Massachusetts are included for all periods presented. The results of operations for all other acquired real estate assets are included for periods subsequent to their acquisition date.
 
Prior to October 16, 2007, Aviv Healthcare Properties Limited Partnership was externally advised by AAM. On October 16, 2007, the owners of AAM contributed their ownership interests in AAM to Aviv Healthcare Properties Limited Partnership in exchange for a newly issued class of partnership units. Half of the partnerships units were redeemed at the time of our transaction with Lindsay Goldberg in September 2010.
 
Prior to the internalization of AAM, Aviv Healthcare Properties Limited Partnership had no employees and relied solely on AAM for investment and portfolio management services. At the time of the internalization, AAM became a wholly owned subsidiary of Aviv Healthcare Properties Limited Partnership, but the internalization did not meet all of the requirements for AAM to be deemed a consolidated subsidiary for financial reporting purposes. As a result of our transaction with Lindsay Goldberg in September 2010, AAM became a consolidated subsidiary and is reported as such for all periods presented.
 
Aviv REIT, Inc.
 
Aviv REIT was incorporated as a Maryland corporation on July 30, 2010. Aviv REIT is a holding company and its primary assets are its general partnership interest in and class G common units of Aviv Healthcare Properties Limited Partnership.


61


Table of Contents

 
Quantitative and Qualitative Disclosures About Market Risk
 
Our future income, cash flows and fair values relevant to financial instruments are dependent upon prevalent market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. We use some derivative financial instruments to manage, or hedge, interest rate risks related to our borrowings. We do not use derivatives for trading or speculative purposes and only enter into contracts with major financial institutions based on their credit rating and other factors.
 
We entered into a swap arrangement on November 5, 2010 to hedge $200 million of floating rate debt. If LIBOR were to increase by 100 basis points, we do not expect there would be any significant effect on the interest expense on our pro forma variable rate debt as our floating rate credit agreement is subject to a LIBOR floor of 125 basis points. Interest rate risk amounts were determined by considering the impact of hypothetical interest rates on our financial instruments. These analyses do not consider the effect of any change in overall economic activity that could occur in that environment. Further, in the event of a change of that magnitude, we may take actions to further mitigate our exposure to the change. However, due to the uncertainty of the specific actions that would be taken and their possible effects, these analyses assume no changes in our financial structure. The fair value of our debt outstanding as of March 31, 2011 was approximately $455.4 million.


62


Table of Contents

BUSINESS
 
Our Company
 
We operate as a self-administered, self-managed real estate investment trust, or REIT, that focuses on the ownership of healthcare properties, principally skilled nursing facilities (“SNFs”). We generate our revenues through long-term triple-net leases with a diversified group of high quality operators throughout the United States. Through our predecessor entities, we have been in the business of financing SNF operators through triple-net leases for over 30 years. We believe that we have one of the largest SNF portfolios in the United States which consisted of 187 properties, of which 168 were SNFs, with 18,300 licensed beds in 25 states leased to 32 operators, as of March 31, 2011. For the twelve months ended March 31, 2011, our revenues and Adjusted EBITDA were $95.1 million and $76.4 million, respectively. See “Presentation of Non-GAAP Financial Information and Portfolio Statistics” and “Summary Financial Data.”
 
We believe we are well positioned to benefit from our diversified portfolio of properties and extensive network of operator relationships. We focus on cultivating close relationships with our operators by working closely with them to help them achieve their business objectives. As a result of these efforts, we are in a position to effectively manage our portfolio, make additional investments and continue to expand our business. From April 2005 through March 2011, we completed $507.1 million of acquisitions. In 2010, we completed $79.2 million of acquisitions and investments. In addition, from January 1, 2011 through the date of this prospectus, we completed $71.5 million in investments. We target EBITDAR and EBITDARM coverages that we believe allow us to balance our rental income with appropriate operating and financial performance for our operators. Our EBITDAR and EBITDARM coverages for the twelve months ended December 31, 2010 were 1.4x and 1.8x, respectively, and we have collected 99.5% of the rents owed to us over the last three years.
 
The structure of our triple-net leases has significantly contributed to our consistent and stable performance and positions us to benefit from a long-term stream of rental income. Our leases typically have initial terms of 10 years or more, annual rent escalation provisions of 2% to 3% and typically do not have operator purchase options. We also seek additional support for the rental income generated by the leases through guarantees, master leases, cross-default provisions and security deposits. As of March 31, 2011, the leases for 185 of our 187 properties were supported by personal and/or corporate guarantees.
 
Our Competitive Strengths
 
We believe the following strengths serve as the foundation for our success:
 
Track Record of Disciplined Investing
 
We, through our predecessor entities, have been in the business of owning healthcare properties for over 30 years and were one of the first providers of financing to SNF operators through triple-net leases. We are disciplined and selective about the investments we make and have a strong track record of identifying operators and attractive markets in which to invest. This has enabled us to successfully complete $507.1 million of acquisitions from April 2005 to March 2011, including $79.2 million of investments in 2010. In addition, from January 1, 2011 through the date of this prospectus, we completed $71.5 million in investments. In order to effectively manage our investments, we have implemented systems and processes to monitor the performance of our operators and properties, including annual site visits, regular contact with our operators and quarterly financial reviews.
 
Large, Diverse Portfolio
 
We believe we have one of the largest portfolios of SNFs in the United States, with significant operator and geographic diversification. As of March 31, 2011, our portfolio consisted of 187 properties with 18,330 licensed beds. We lease our properties to a diversified group of 32 operators with no single operator


63


Table of Contents

representing more than 13.3% of our total rent under existing leases for the twelve months ended March 31, 2011. Our properties are located in 25 states, with no state representing more than 17.6% of our total rent under existing leases for the twelve months ended March 31, 2011. We believe our track record and extensive network of industry relationships puts us in a position to continue to identify and complete investments that enhance the quality and diversification of our portfolio.
 
High Quality Operators
 
As a result of our many years of experience and industry contacts, we have a portfolio of, and an ability to identify, high quality operators. We believe each of our 32 operators possesses local market knowledge, hands-on management and a proven track record. Many of our operators are among the largest and most established SNF operators in their respective markets, with management typically possessing 20 years or more of industry experience. We believe our management team’s extensive experience provides us with a key advantage in evaluating an operator’s prospects for success and enables us to identify the appropriate operator for each of our properties. As of March 31, 2011, 139 of our 187 properties are leased to operators with whom we have had a relationship for at least 5 years, and 71 of our 187 properties are leased to operators with whom we have had a relationship for at least 10 years.
 
Attractive Long-Term Leases
 
Our existing portfolio of leases and our lease structure position us to take advantage of a stable, long-term stream of rental income. Our leases typically have initial terms of 10 years or more, annual rent escalation provisions of 2% to 3%, guarantees, master lease or cross-default provisions and security deposits. Our leases typically are co-terminous within an operator relationship and do not have operator purchase options. As of March 31, 2011, the leases for 185 of our 187 properties were supported by personal and/or corporate guarantees. We proactively seek to extend our leases, including at the time we make additional acquisitions, capital expenditures or other investments with our operators. As of March 31, 2011, our leases had an average remaining term of 8.8 years. Our track record of successfully extending our leases enables us to benefit from continuity of management by our operators.
 
Experienced Senior Management Team Supported by Strong Equity Sponsorship
 
Many members of our management team have been with us for 10 years or more, have significant industry experience and also have a meaningful ownership stake. Our senior management team has extensive experience in the SNF industry and other relevant areas of expertise. Craig Bernfield, our Chairman, President and Chief Executive Officer and co-founder, has more than 20 years of experience as an investor in the SNF industry. In addition, Steven Insoft, our Chief Financial Officer, also has more than 20 years of experience in our industry, including with investors, operators and other REITs.
 
In September 2010, we entered into a new strategic partnership with an affiliate of Lindsay Goldberg, LLC (“Lindsay Goldberg”), a highly regarded private investment firm. We believe our relationship with Lindsay Goldberg will provide us with valuable support to facilitate our growth. Lindsay Goldberg has invested $237.8 million in our company’s equity to date, and has committed to provide additional equity capital to support our growth.


64


Table of Contents

 
Our Business Strategies
 
Our primary goal is to continue our track record of disciplined investing, which we intend to accomplish through the following business strategies:
 
Maintain Balance Sheet Strength and Liquidity
 
We plan to maintain a capital structure that will provide substantial resources and liquidity to support our business and its continued growth. After giving pro forma effect to the sale of the Old Notes, we would have had approximately $92.2 million of liquidity as of March 31, 2011, consisting of cash and cash equivalents and borrowings expected to be available under our revolving credit facility. We also have access to our $100.0 million acquisition credit line to utilize with the equity we contribute towards future acquisitions. The acquisition credit line also permits up to $25.0 million of the $100.0 million total amount to be used to fund property improvements, for which we typically receive increased rents. In the future, we intend to use a mix of debt financing sources, including unsecured term debt, credit facility borrowings and mortgage debt, to continue to optimize both our flexibility and cost of capital. In addition, Lindsay Goldberg has committed to provide additional equity capital to support our growth.
 
Continue to Grow and Enhance Portfolio Diversification
 
We plan to capitalize on our successful track record by strategically and opportunistically pursuing new investments that will further enhance the diversification, strength and success of our portfolio. We evaluate acquisition opportunities on an ongoing basis and are in various stages of due diligence, preliminary discussions or competitive bidding with respect to a number of potential transactions, some of which would be significant. We intend to continue to make disciplined investments in a broad range of property and portfolio transactions, including through the following strategies:
 
  •     Pursue Additional Investments with our Existing Operators
 
We intend to work closely with our existing operators to identify additional investment opportunities in their existing markets, as well as to leverage our experience and relationships with them to expand into new markets and property types. We believe our focus and commitment to relationships are key factors in our operators’ decisions to enter into leases with us. In addition to new property acquisitions, we plan to continue to support our operators by providing capital for modernization and improvement of our properties, for which we typically receive increased rents.
 
  •     Expand our Network of Operator Relationships
 
We intend to continue to expand our extensive network of operator relationships that we have built and cultivated over the years. We plan to strengthen these relationships that have allowed us to identify a significant number of transactions over the years. When making new investments, we will continue to focus on operators that meet our investment criteria, including our standards for quality and experience of management, credit worthiness and historical financial and operating performance. We believe our reputation, experience and credibility will lead us to relationships with new high quality operators and related investment opportunities.
 
  •     Selectively Diversify into Other Healthcare Property Types
 
We intend to continue to acquire assisted living facilities, independent living facilities, retirement communities, continuum of care facilities and other healthcare properties. When pursuing these transactions, we intend to enter into triple-net leases with experienced operators that meet our investment criteria.


65


Table of Contents

 
Our Portfolio
 
Our portfolio consists of 187 properties with 18,300 licensed beds in 25 states leased to 32 operators. As of March 31, 2010, our properties consisted of 168 SNFs, 9 assisted living facilities, 2 independent living facilities and 8 properties held for strategic repositioning. We lease our properties to a diversified group of 32 operators with no single operator representing more than 13.3% of our total rent under existing leases for the year ended December 31, 2010. We have a geographically diversified portfolio of properties located in 25 states with no state representing more than 17.6% of our total rent under existing leases for the twelve months ended March 31, 2011.
 
We continually evaluate our portfolio and work with our operators to identify potential capital expenditure and modernization projects, which has resulted in an average effective property age of 28 years based on an independent third-party appraisal of our properties completed in August 2010.
 
For the twelve months ended December 31, 2010, our Portfolio Occupancy was 74.6% and our Quality Mix was 45.0%. Since 2006, our annual Portfolio Occupancy has remained stable. When making new investments, we seek to balance these measures with value and lease rent levels.
 
The following tables set forth information about our operator and state diversification as of and for the twelve months ended March 31, 2011.
 
Operator Diversification
 
                         
    Percentage of
    Number of
    Number of
 
Operator
 
Total Rent (1)
   
Properties
   
Licensed Beds
 
 
Evergreen
    13.3 %     17       1,605  
Daybreak
    10.6       28       2,828  
SunMar
    9.4       13       1,461  
ConvaCare
    9.1       11       1,498  
Cathedral Rock
    7.5       13       1,100  
Eagle
    5.4       10       691  
Hi-Care
    5.4       6       685  
Sun
    5.0       15       969  
Saber
    4.9       12       1,469  
Brighten
    4.0       1       100  
Bridgemark
    4.0       6       702  
Preferred
    3.3       4       561  
Benchmark
    3.0       9       814  
Deseret
    2.3       8       426  
Good Samaritan
    1.7       2       212  
Markleysburg
    1.6       5       502  
Covenant Care
    1.3       2       302  
Hope
    1.1       2       104  
Lion
    1.1       1       330  
Homestead
    0.8       6       613  
Heyde
    0.8       2       157  
Gilmer
    0.7       1       112  
Orion
    0.7       1       109  
24/7
    0.6       1       85  


66


Table of Contents

                         
    Percentage of
    Number of
    Number of
 
Operator
 
Total Rent (1)
   
Properties
   
Licensed Beds
 
 
Northpoint
    0.5       1       123  
LTP Generations
    0.4       2       95  
Concepts
    0.4       2       198  
Health Dimensions
    0.3       1       90  
Fountain
    0.3       1       80  
Tana Bell
    0.3       1       37  
Safe Haven
    0.2       1       65  
Maplewood Communities
    _0.0       2       177  
                         
Total
    100.0 %     187       18,300  
                         
 
 
(1) Total rent represents the rent under existing leases for the twelve months ended March 31, 2011.
 
State Diversification
 
                         
    Percentage of
    Number of
    Number of
 
State
 
Total Rent (1)
   
Properties
   
Licensed Beds
 
 
California
    17.6 %     22       2,300  
Texas
    14.9       40       4,201  
Arkansas
    9.5       13       1,696  
Missouri
    8.1       14       1,460  
Washington
    7.1       12       716  
New Mexico
    5.8       9       782  
Illinois
    5.4       9       1,029  
Ohio
    4.9       7       765  
Massachusetts
    4.8       14       872  
Pennsylvania
    4.1       5       624  
Arizona
    3.6       5       641  
Oregon
    2.9       6       493  
Idaho
    2.2       5       468  
Kansas
    1.5       7       452  
Nebraska
    1.3       2       282  
Michigan
    1.2       2       232  
Minnesota
    1.1       3       162  
Wisconsin
    1.1       3       247  
Nevada
    0.9       1       146  
Montana
    0.7       2       174  
Utah
    0.6       1       85  
Tennessee
    0.4       1       102  
Virginia
    0.3       1       104  
Connecticut
    0.0       2       177  
Florida
    0.0       1       90  
                         
Total
    100.0 %     187       18,300  
                         
 
 
(1) Total rent represents the rent under existing leases for the twelve months ended March 31, 2011. In the case where the property’s master lease includes more than one state, rent was allocated proportionately by number of licensed beds in each state.

67


Table of Contents

 
Portfolio Occupancy
 
The following table sets forth information about our Portfolio Occupancy by state as of December 31, 2010:
 
                 
    Portfolio
  State Average
State
 
Occupancy
 
Occupancy (1)
 
California
    88.4 %     84.9 %
Texas
    60.2 %     71.3 %
Arkansas
    80.6 %     73.0 %
Missouri
    64.7 %     72.1 %
Washington
    82.2 %     83.0 %
New Mexico
    79.9 %     82.2 %
Illinois
    79.9 %     78.2 %
Ohio
    81.3 %     85.3 %
Massachusetts
    91.3 %     88.5 %
Pennsylvania
    94.2 %     91.2 %
 
 
(1) Represents Nursing Facility State Occupancy Rate as reported by American Health Care Association (AHCA). AHCA occupancy data is calculated by dividing the sum of all facility patients in the state occupying certified beds by the sum of all the certified beds in the state reported at the time of the current standard survey. The data is based on the most current standard health surveys conducted in SNFs between December 2008 and December 2010.
 
Lease Expiration
 
The following table sets forth information regarding the expiration dates of our leases as of March 31, 2011:
 
                 
    Number of Properties
    Percentage of
 
Year
 
with Leases Expiring
   
Total Rent (1)
 
 
2011
    0       0.0  
2012
    1       0.3  
2013
    5       3.9  
2014
    6       0.9  
2015
    11       4.9  
2016
    7       5.0  
2017
    10       3.4  
2018
    29       20.9  
2019
    11       9.0  
2020
    44       17.6  
2021
    45       22.1  
Thereafter
    15       12.0  
                 
Total
    184  (2)     100.0 %
                 
 
 
(1) Total rent represents the rent under existing leases for the twelve months ended March 31, 2011.
(2) The total number of properties with leases expiring excludes three properties for which we provide asset management services only, one property subject to a leasehold mortgage and one property subject to a second mortgage loan.


68


Table of Contents

 
Our Industry
 
We operate as a REIT and own healthcare properties, principally SNFs, located in the United States. According to The Centers for Medicare & Medicaid Services, or CMS, healthcare is one of the largest industries in the United States and total U.S. healthcare expenditures are projected to grow from approximately $2.3 trillion in 2008 to approximately $4.5 trillion in 2019. Within the healthcare industry, national expenditures for SNFs are expected to grow from approximately $144 billion in 2009 to approximately $246 billion in 2019, according to CMS, representing a compound annual growth rate, or CAGR, of 5.5%. The SNF market is highly fragmented and, according to the American Health Care Association, comprises approximately 15,700 facilities with approximately 1.7 million certified beds as of December 2009.
 
This growth will be driven, in part, by the aging of the population and increased life expectancies. According to the U.S. Census Bureau, the number of Americans aged 65 or older is expected to increase from approximately 37 million in 2006 to approximately 55 million in 2020, representing a CAGR of 2.8%, compared to a total U.S. population CAGR of 0.9% over the same period. In response to growing healthcare costs, the U.S. federal government has adopted cost containment measures that encourage the treatment of patients in more cost effective settings, such as SNFs. As a result, we believe that many high-acuity patients that would have been previously treated in long-term acute care hospitals and in-patient rehabilitation facilities are increasingly being cared for in SNFs. We believe that these trends will support a growing demand for the services provided by SNF operators, which in turn will support a growing demand for our properties.
 
The growth in the total demand for SNF services has resulted in a greater need for many of our operators to access capital for growth, which we believe provides an attractive opportunity for us to invest in healthcare properties. Operators are increasingly relying on capital sources, such as our company, to finance their growth plans for acquisitions and other real estate-related investments so they may deploy their capital into their operations. To generate liquidity and operating capital, operators also often decide to sell real estate assets and lease them back, enabling them to monetize the value of their real estate, while maintaining control over their operations. These sale-leaseback transactions enable us to acquire properties and benefit from continuity of management.
 
Competition
 
The market for making investments in healthcare facilities is highly competitive and fragmented. We compete with other public and private companies who provide lease and/or mortgage financing to operators of a variety of different types of healthcare properties. We also face competition leasing available properties to prospective operators. We compete with these other companies based on reputation, purchase price and financing alternatives offered and the relationship that develops during the term of the lease.
 
We have experience identifying and underwriting the abilities of qualified regional and national operators. We believe that this experience helps us identify new tenant relationships and new opportunities with existing relationships. We believe that our historical focus primarily on SNFs has enabled us to develop broad expertise in the markets in which we compete.
 
Regulation
 
Typically, operators of SNFs receive significant funding from governmental programs and are regulated by the states and the federal government. Operators of SNFs are subject to federal and state laws that regulate the type and quality of the nursing care provided, ancillary services (e.g., respiratory, occupational, physical and infusion therapies), qualifications of the administrative personnel and nursing staff, the adequacy of the physical plant and equipment, distribution of pharmaceuticals, reimbursement and rate setting and operating policies. In addition, most, if not all, of our tenants are subject to extensive laws and regulations pertaining to healthcare fraud and abuse, including kickbacks and false claims. The following discussion describes certain material U.S. federal and state healthcare laws and regulations that may affect our


69


Table of Contents

operations and those of our tenants. However, the discussion does not address all applicable federal, state and local healthcare laws and regulations that could affect our operations and those of our tenants.
 
  •     Licensing and Certification.  Our tenants and facilities are subject to regulatory and licensing requirements of federal, state and local authorities and are periodically surveyed by them to confirm compliance. Failure to obtain licensure or loss or suspension of licensure or certification may prevent a facility from operating or result in a suspension of reimbursement payments until all licensure or certification issues have been resolved and the necessary licenses or certification are obtained or reinstated. Transfers of operations of SNFs and other healthcare facilities are subject to regulatory approvals not required for transfers of other types of commercial operations and real estate.
 
  •     Certificate of Need.  Some states require that SNFs obtain governmental approval, in the form of a Certificate of Need, or CON, or similar certification, that generally varies by state and is subject to change, prior to the addition or construction of new beds, the addition of services or certain capital expenditures. The CON laws and regulations may restrict our ability to add new facilities or expand an existing facility’s size or services. In addition, CON laws may constrain our ability to lease a particular property to a new tenant.
 
  •     Medicare and Medicaid Certification.  A significant portion of the revenues of our tenants that operate SNFs is derived from participation in government-funded reimbursement programs, primarily Medicare and Medicaid, and failure to maintain certification to participate in these programs could result in a loss of funding from such programs. Medicare and Medicaid laws also require operators of SNFs to comply with extensive standards governing operations.
 
  •     Fraud and Abuse Laws and Regulations.  There are various highly complex federal and state laws governing a wide array of referrals, financial relationships and arrangements and prohibiting fraud by healthcare providers, including criminal provisions that prohibit financial inducements for referrals, filing false claims or making false statements to receive payment or certification under Medicare and Medicaid, or failing to refund overpayments or improper payments. Violations of these laws subject persons and entities to termination from participation in Medicare, Medicaid and other federally funded healthcare programs or result in the imposition of treble damages and fines or other penalties.
 
  •     Other Laws.  Other laws that impact how our tenants conduct their operations include: federal and state laws designed to protect the confidentiality and security of patient health information; state and local licensure laws; laws protecting consumers against deceptive practices; laws generally affecting our tenants’ management of property and equipment and how our tenants generally conduct their operations, such as fire, health and safety, and environmental laws; federal and state laws affecting assisted living facilities mandating quality of services and care, and quality of food service; resident rights (including abuse and neglect laws); and health standards set by the federal Occupational Safety and Health Administration.
 
  •     Legislative and Regulatory Developments.  On March 23, 2010, the President signed into law the Patient Protection and Affordable Care Act (“PPACA”) and the Health Care and Education Reconciliation Act of 2010, which amends the PPACA (collectively, the “Health Reform Laws”). Together, these two measures make the most sweeping and fundamental changes to the U.S. health care system undertaken since the creation of Medicare and Medicaid. These new laws include a large number of health-related provisions that are scheduled to take effect over the next four years, including expanding Medicaid eligibility, requiring most individuals to have health insurance, establishing new regulations on health plans, establishing health insurance exchanges and modifying certain payment systems to encourage more cost-effective care and a reduction of inefficiencies and waste, including through new tools to address fraud and abuse.


70


Table of Contents

  Because all of our properties are used as healthcare properties, we will be impacted by the risks associated with the healthcare industry, including healthcare reform. While the expansion of healthcare coverage may result in some additional demand for services provided by tenants, reimbursement levels may be lower than the costs required to provide such services, which could materially adversely affect the ability of tenants to generate profits and pay rent under their lease agreements with us and thereby could materially adversely affect our business, financial position or results of operations. The Health Reform Laws also enhance certain fraud and abuse penalty provisions that could apply to our operators and tenants in the event of one or more violations of the federal health care regulatory laws. In addition, there are provisions that impact the health coverage that we and our tenants provide to our respective employees. Furthermore, regulatory proposals and rules are released on an ongoing basis that may have an impact on the healthcare system in general and the skilled nursing and long-term care industries in particular.
 
Environmental Matters
 
In addition to environmental risks relating to releases of hazardous substances, our properties are subject to environmental laws regulating, among other things, air emissions, wastewater discharges and the handling and disposal of wastes, including medical wastes. Certain of our properties utilize above or underground storage tanks to store heating oil for use at the properties. Other properties were built during the time that asbestos-containing building materials were routinely installed in residential and commercial structures. Our leases obligate our tenants to comply with applicable environmental laws and to indemnify us if their noncompliance results in losses or claims against us. A tenant’s failure to comply could result in fines and penalties or the requirement to undertake corrective actions which may result in significant costs to the tenant and thus adversely affect their ability to meet their obligations to us.
 
Pursuant to U.S. federal, state and local environmental laws and regulations, a current or previous owner or operator of real property may be required to investigate, remove and/or remediate a release of hazardous substances or other regulated materials at, or emanating from, such property. Further, under certain circumstances, such owners or operators of real property may be held liable for property damage, personal injury and/or natural resource damage resulting from or arising in connection with such releases. Certain of these laws have been interpreted to be joint and several unless the harm is divisible and there is a reasonable basis for allocation of responsibility. We also may be liable under certain of these laws for damage that occurred prior to our ownership of a property or at a site where we sent wastes for disposal. The failure to properly remediate a property may also adversely affect the owner’s ability to lease, sell or rent the property or to borrow funds using the property as collateral.
 
In connection with the ownership of our current or past properties and any properties that we may acquire in the future, we could be legally responsible for environmental liabilities or costs relating to a release of hazardous substances or other regulated materials at or emanating from such property. In order to assess the potential for such liability, we typically engage a consultant to conduct a limited environmental assessment of each property prior to acquisition and oversee our properties in accordance with environmental laws. Most of our leases require tenants to conduct all activities in compliance with environmental laws and to indemnify the owner for any harm caused by the failure to do so. We are not aware of any environmental issues that are expected to have a material impact on the operations of any of our properties. See “Risk Factors—Risks Relating to Our Business and Operations.”
 
Insurance
 
Under the terms of our leases, our tenants are required to maintain comprehensive general liability, fire, flood, earthquake, boiler and machinery, nursing home or long-term care professional liability and extended coverage insurance with respect to our properties with policy specifications, limits and deductibles set forth in the lease agreement or other written agreement between us and the tenant. In some limited situations, we have agreed in our leases to pay half of the cost of earthquake insurance. We believe that our properties are covered by adequate insurance provided by reputable companies and with commercially


71


Table of Contents

reasonable deductibles and limits. Our leases provide that insurance premiums are the responsibility of the tenant, and our tenants are responsible for any increases in premiums. In addition, we carry contingent property and liability coverage for our properties encumbered by the existing credit facility.
 
Employees
 
As of March 31, 2011, we had 22 full-time employees and two part-time employees. We believe that our relationships with our employees are good. None of our employees is represented by a union.
 
Offices
 
Our corporate headquarters are located at 303 West Madison Street, Suite 2400, Chicago, Illinois 60606. We believe that our current offices are adequate for our present and future business operations.
 
Legal Proceedings
 
We are not involved in any material litigation nor, to our knowledge, is any material litigation pending or threatened against us, other than routine litigation arising out of the ordinary course of business or which is expected to be covered by insurance and not expected to materially harm our business, financial condition or results of operations.


72


Table of Contents

 
MANAGEMENT
 
Directors and Executive Officers
 
Set forth below are the names, ages (as of March 31, 2011) and positions of Aviv REIT’s directors and executive officers:
 
             
Name
 
Age
 
Position
 
Craig M. Bernfield
    50     Chairman of the Board (Class B), Chief Executive Officer and President
Steven J. Insoft 
    47     Chief Financial Officer and Treasurer
Michael W. Dees
    37     Director (Class A)
Alan E. Goldberg
    56     Director (Class A)
Robert D. Lindsay
    56     Director (Class A)
Ari Ryan
    36     Director (Class C)
J. Russell Triedman
    41     Director (Class A)
 
The following are biographical summaries of the experience of Aviv REIT’s directors and executive officers.
 
Craig M. Bernfield.  Mr. Bernfield is our Chief Executive Officer and President and has served in such capacity since he co-founded Aviv Healthcare Properties Limited Partnership in 2005. Since September 2010, Mr. Bernfield has also served as the Chairman of our board of directors. Prior to co-founding our company, Mr. Bernfield was Chief Executive Officer and President of Karell Capital Ventures, Inc., or KCV, which he joined in 1990. KCV managed the entities that were combined in 2005 in connection with the formation of Aviv Healthcare Properties Limited Partnership. Mr. Bernfield has been an investor in the nursing home industry for approximately 20 years and was the co-founder of some of the entities that were combined in 2005. Mr. Bernfield received a J.D. degree from The University of Chicago Law School and a B.S. degree in Finance from the College of Business at the University of Illinois at Urbana-Champaign. Mr. Bernfield brings extensive business, managerial and leadership experience to our board of directors. With over 20 years of experience as an investor in the SNF industry, Mr. Bernfield provides the board of directors with a vital understanding and appreciation of our business and the industry. His position as co-founder, Chief Executive Officer and President of our company also make Mr. Bernfield uniquely qualified to serve as the Chairman of our board of directors.
 
Steven J. Insoft.  Mr. Insoft is our Chief Financial Officer and Treasurer and has served in such capacity since 2005. Prior to joining our company in 2005, Mr. Insoft spent eight years as a Vice President and Senior Investment Officer of Nationwide Health Properties, Inc., a publicly-traded REIT. Before that, he was President and Chief Financial Officer of CMI Senior Housing & Healthcare, Inc., a privately-held nursing home and assisted living facility operations and development company, for seven years. Mr. Insoft received an M.B.A. from Columbia University and a B.S.E. in Electrical Engineering from the University of Pennsylvania.
 
Michael W. Dees.  Mr. Dees has served as a member of our board of directors since September 2010. Mr. Dees serves as a Partner at Lindsay Goldberg, LLC, which he joined in 2004. Previously, he worked at Morgan Stanley in the mergers and acquisitions and the Capital Partners groups in New York and in the Real Estate Private Equity group in Tokyo. Mr. Dees also serves as a director of Bell Nursery Holdings, LLC, Rosetta LLC and Crane & Co., Inc. Mr. Dees’ experience advising growth-oriented companies and his position with an affiliate of Aviv REIT’s largest stockholder, LG Aviv L.P., qualify him for service on our board of directors.
 
Alan E. Goldberg.  Mr. Goldberg has served as a member of our board of directors since September 2010. Mr. Goldberg is a Co-Managing Partner of Goldberg Lindsay & Co., LLC, which he co-founded in 2001. Previously, he served as Chairman and Chief Executive Officer of Morgan Stanley Private Equity from


73


Table of Contents

February 1998 to January 2001. Mr. Goldberg joined Morgan Stanley in 1978. Mr. Goldberg serves as a director of Energy Solutions, Inc., Wacker Construction Equipment AG, Klöckner & Co. AG, FSB Global Holdings, Inc., Alliant Insurance Services, Inc., Keystone Foods Holdings LLC and Smurfit-Stone Container Corporation. Mr. Goldberg also serves as a director of FAPS Holdings, Inc., Maine Beverage Company, LLC, PL Olefins LLC, Continental Energy Systems LLC, Intermex Holdings, Inc., The Brock Group, Inc., Brightstar Corp., Rosetta LLC, PL Propylene LLC, RECON Holdings III Inc., Ambulatory Services of America, Inc., Crane & Co., Inc., Scandza AS, PSC, LLC, Panadero Aggregates Holdings, LLC and Pacific Architects and Engineers Incorporated. He also serves as a trustee of Yeshiva University. Mr. Goldberg’s years of business, financial, managerial, executive and board experience across a broad spectrum of industries make him a valuable member of our board of directors. He also indirectly controls (together with Robert D. Lindsay) Aviv REIT’s largest stockholder, LG Aviv L.P.
 
Robert D. Lindsay.  Mr. Lindsay has served as a member of our board of directors since September 2010. Mr. Lindsay is a Co-Managing Partner of Goldberg Lindsay & Co., LLC, which he co-founded in 2001. In addition, Mr. Lindsay serves as the Managing General Partner of Bessemer Holdings, which he joined in 1991. Prior to Bessemer Holdings, Mr. Lindsay was a Managing Director at Morgan Stanley Private Equity. Mr. Lindsay serves as a director of Energy Solutions, Inc., Wacker Construction Equipment AG, Klöckner & Co. AG, FSB Global Holdings, Inc. and Alliant Insurance Services, Inc. He also serves as President and CEO of Bessemer Securities LLC, a director of The Bessemer Group, Incorporated and its subsidiary banks, including Bessemer Trust Company, N.A., and as a director of Pike Electric Corporation, FAPS Holdings, Inc., Maine Beverage Company, LLC, Keystone Foods Holdings LLC, PL Olefins LLC, Continental Energy Systems LLC, Intermex Holdings, Inc., The Brock Group LLC, Bell Nursery Holdings, LLC, Brightstar Corporation, Rosetta LLC, PL Propylene LLC, Ambulatory Services of America, Inc., Crane & Co., Inc., Scandza AS, PSC, LLC, Panadero Aggregates Holdings, LLC and Pacific Architects and Engineers Incorporated. He also serves as a trustee of the Cold Spring Harbor Biological Laboratory and St. Paul’s School in Concord, New Hampshire. Mr. Lindsay’s years of business, financial, managerial, executive and board experience across a broad spectrum of industries make him a valuable member of our board of directors. He also indirectly controls (together with Alan E. Goldberg) Aviv REIT’s largest stockholder, LG Aviv L.P.
 
Ari Ryan.  Mr. Ryan has served as a member of our board of directors since September 2010. Mr. Ryan is an independent real estate investor and developer and entrepreneur. Mr. Ryan participates in real estate syndications and financing and as a consultant to start up enterprises of all types. He currently manages a private commercial and residential real estate portfolio and serves on the board of directors of the Friends of the Israel Defense Forces, Western Region. Mr. Ryan is the grandson of the late Zev Karkomi, our co-founder. Mr. Ryan’s entrepreneurial experience in the real estate industry and his familial connection to our co-founder make him a valuable member of our board of directors.
 
J. Russell Triedman.  Mr. Triedman has served as a member of our board of directors since September 2010. Mr. Triedman also serves as a Partner at Lindsay Goldberg, LLC, which he joined in 2001. Previously, he worked as a principal at Bessemer Holdings from 2000 to 2001. He also worked as a Director at Fox Paine & Company, LLC, a San Francisco-based private equity firm, in the mergers and acquisitions and high yield finance groups at Cravath, Swaine & Moore LLP, in the private equity group of Brown Brothers Harriman & Co. and as a director of Keystone Foods Holdings LLC and FSB Global Holdings, Inc. Mr. Triedman also serves as a director of Continental Energy Systems LLC, Pike Electric Corporation and Pacific Architects and Engineers Incorporated. Mr. Triedman’s experience advising growth-oriented companies and his position with an affiliate of Aviv REIT’s largest stockholder, LG Aviv L.P., qualify him for service on our board of directors.
 
Board of Directors
 
Aviv REIT’s charter provides for three classes of directors: Class A Directors, Class B Directors and Class C Directors. Each director serves for a term expiring at the next annual meeting of stockholders and


74


Table of Contents

when his successor has been duly elected and qualifies. The number and identity of directors serving on Aviv REIT’s board of directors is determined pursuant to a Stockholders Agreement (the “Stockholders Agreement”) entered into by Aviv REIT, Lindsay Goldberg, an entity formed by Mr. Bernfield and Mr. Ryan, as representative of certain limited partners (the “Karkomi Investors”) related to the family of Zev Karkomi, who co-founded Aviv Healthcare Properties Limited Partnership with Mr. Bernfield. The Stockholders Agreement provides for a total of eleven votes to be cast at all meetings of Aviv REIT’s board of directors. Subject to certain exceptions, the Class A Directors, who are designated by Lindsay Goldberg, are entitled to cast a total of four such votes, the Class B Directors, who are designated by Mr. Bernfield, are entitled to cast a total of six such votes and the Class C Directors, who are designated by the Karkomi Investors, are entitled to cast one such vote. If Mr. Bernfield dies or becomes disabled, the Class B Directors will be designated by an individual previously designated by Mr. Bernfield and agreed to by Lindsay Goldberg. For additional information regarding our relationship with Lindsay Goldberg, see “Certain Relationships and Related Transactions.”


75


Table of Contents

 
COMPENSATION DISCUSSION AND ANALYSIS
 
The primary goal of our executive compensation program is to attract, motivate and retain top-caliber talent needed to lead us in achieving business success. Our compensation approach has traditionally been reflective of the operation of our business as a closely held private company and the compensation tools available to us in that structure. Historically, the principal owners have been solely responsible for setting and adjusting the overall design of our pay programs for the named executive officers. Our Chief Executive Officer has negotiated executive compensation packages as part of the hiring process and reviewed each executive’s compensation as part of the annual performance review and budgeting process.
 
Historically, in setting or adjusting our executive compensation packages, management has relied upon “going rate” information provided by recruiting firms, our historical pay practices, and wage increase information from various publicly available sources when making decisions about the amounts and forms of compensation provided to our executives. Additionally, the Chief Executive Officer has considered the following:
 
  •  seniority, skill and responsibilities of each executive;
 
  •  internal equity among pay levels of our executive officers; and
 
  •  the individual performance of each executive officer.
 
Our current executive compensation program consists of the following elements, each of which is described in more detail below:
 
         
Element
 
Description
 
Rationale
 
Base salary
 
•   Based on position-specific responsibilities and performance

•   Paid at a rate established at the beginning of each year
  •   Required to deliver competitive pay and attract and retain required talent
Annual incentive
 
•   Opportunity to earn a percentage of base salary based upon performance against pre-determined company and individual performance objectives
  •   Provide compensation opportunity that encourages strong performance and focuses individuals on key goals

•   Provide competitive earning opportunity
Equity
       
1. Class D Units
  2. Phantom Class C Units
  3. Management Incentive Plan (MIP)
 
•   Differentiated equity awards granted based on level of responsibility, seniority and/or ability to influence value creation
  •   Aligns executives with shareholder value creation

•   Provides a long-term incentive vehicle to provide additional performance-based pay opportunity

•   Creates a retention mechanism
Benefits and Perquisites
 
•   Consistent with those offered to all employees
  •   Executives should not receive preferential perquisite, health or welfare treatment
 
Our compensation philosophy and structure were established in 2008 following our engagement of Towers Perrin, the “Consultant”, (now Towers Watson as a result of the 2010 merger between Towers Perrin and Watson Wyatt). Our principal owners engaged the Consultant to conduct a review of and assist in formalizing our executive compensation program.


76


Table of Contents

The competitive assessment covered base salary levels, short-term incentive awards, and equity incentive awards for our named executive officers. Towers Perrin relied on data from three primary sources in order to define competitive market compensation levels and assist us in formulating compensation ranges and in developing incentive program design for our named executive officers. The three data sources included:
 
  •  proxy data obtained from publicly-traded non-healthcare REITs;
 
  •  proxy data obtained from publicly-traded healthcare industry REITs; and
 
  •  general industry data obtained from Towers Perrin’s compensation database.
 
The review has remained relevant for our organization and workforce and provided the general framework within which decisions regarding executive compensation were made for 2010.
 
Base salary
 
Salaries for named executive officers are established based on position-specific responsibilities, taking into account competitive market compensation for similar positions, the skills and experience of the individual, internal equity among executive officers, individual performance, and other subjective relevant factors. Base salaries have historically been reviewed annually and adjustments made where deemed appropriate, or at other times to reflect significant changes in job responsibilities or market conditions.
 
Annual incentive awards
 
For fiscal year 2010, bonuses were awarded under our annual incentive program. Target annual bonus opportunities were set based on our employee pay structure and internal equity considerations. Bonuses are paid in lump sum by March 15th of the following fiscal year.
 
The table below illustrates the annual incentive award opportunity levels for our named executive officers, as a percent of base salary. All employees have the opportunity to earn a maximum of 150% of their target award, depending on performance.
 
                                 
                Portion of Award
                Tied to Corporate
Officer
  Threshold   Target   High   Performance
 
Craig M. Bernfield
    25 %     50 %     75 %     100 %
Steven J. Insoft
    12.5 %     25 %     37.5 %     65 %
 
The measures used for the determination of the award are largely objective and reflect the applicable named executive officer’s role in the overall success of our business. Mr. Insoft also has select departmental and team-based goals in addition to his corporate performance goals. The achievement of such departmental and team-based goals is determined through our formal review process, which includes both a mid-year and year-end review for each of such named executive officers.
 
All employees have some portion of their annual incentive opportunity tied to the performance of the business as a whole. The corporate performance goals used in determining 2010 bonuses are set forth below.
 
         
Measure of Corporate Performance
 
Weighting (as a % of Total Corporate Component)
 
AFFO Growth
    50.0 %
Rent Collection
    12.5 %
EBITDARM Coverage
    12.5 %
Gross Investment
    25.0 %


77


Table of Contents

Equity Awards
 
D Unit Awards
 
Mr. Insoft, along with a number of our employees, has been granted Class D units.
 
Mr. Insoft received a grant of 2,000 Class D units in January of 2006 following his commencement of employment with us. His award of 2,000 Class D units reflected his relative status in the organization as the Senior Vice President, Finance, in consideration of the size of the awards provided to other employees and expectations for him to become the Chief Financial Officer and contribute to our long-term success. We also intended for his award to provide a meaningful retention value.
 
The Class D units vest as follows:
 
  •     20% on December 31, 2010;
 
  •     40% on December 31, 2011; and
 
  •     40% upon the earlier of:
 
  •     expiration of a lock-up period with respect an “initial public offering” by us; and
 
  •     at the time of certain “fundamental transactions” involving Aviv Healthcare Properties Limited Partnership;
 
subject to the named executive officer’s employment with us through the applicable vesting date.
 
Phantom Class C Units
 
In 2007, Mr. Insoft was also granted phantom Class C units with a value equal to 5% of the Class C units as of any date. Mr. Insoft was granted the phantom Class C units as part of discussions related to his hiring, given our desire for him to participate in an equity-based arrangement that would align him with investors. The final value and terms and conditions of the grant itself were finalized after his hiring date. The grant was made in November of 2007 in recognition of our goals to align him with investors and his anticipated role as CFO. In addition, we wanted to recognize the value of unvested awards that Mr. Insoft was forfeiting at his prior employer in his decision to join our organization.
 
Of the original phantom Class C units granted, 60% were settled in 2010 in Class C Units. The remaining 40% of such phantom Class C units will vest in two tranches, with 20% vesting on each of December 31 of 2011 and 2012, generally subject to Mr. Insoft’s continued employment with us through the applicable vesting date. The vesting of such phantom Class C units will accelerate in the event of a “change in control” following which Mr. Bernfield ceases to control our organization. If such phantom Class C units become vested, then they will be settled in Class C units or cash at our discretion on January 1, 2018. In addition, certain earnings on the Class C units underlying such phantom interest, once vested, are payable annually to Mr. Insoft until such interest is settled.
 
Management Incentive Plan
 
Each of our named executive officers was granted awards under our Management Incentive Program (MIP), which was adopted in 2010 in conjunction with our Lindsay Goldberg recapitalization. Outstanding awards granted under the MIP have two components, which are described in the table below.
 


78


Table of Contents

         
MIP Award Type
 
Description
 
Vesting Treatment
 
Time-Based Nonqualified Stock Options   Option to purchase shares of Aviv REIT, Inc. at a price established at the time of grant, subject to time-based vesting   Annually in 25% tranches over 4 years beginning on 1st anniversary of grant date, with accelerated vesting upon a “liquidity event,” subject to employment with us through the applicable vesting date
Performance-Based Nonqualified Stock Options   Option to purchase shares of Aviv REIT, Inc. at a price established at the time of grant, subject to performance-based vesting   Fully upon a “liquidity event,” provided that Lindsay Goldberg has achieved a 15% internal rate of return on its investment in us, subject to employment with us through such date
 
In addition, named executive officers are entitled to receive dividend equivalents on their time-based and performance-based nonqualified stock options (NSOs). Dividend equivalents accrued since the date of grant of each NSO are paid to the named executive officer upon vesting of the portion of the NSO on which such dividend equivalent is based. Following vesting and until the NSO is exercised or terminated, periodic additional dividend equivalents will be paid generally on the earlier of:
 
  •     the last day of the calendar quarter in which such dividends were paid to shareholders of Aviv REIT, Inc.; and
 
  •     three business days following the named executive officer’s termination of employment with us.
 
Benefits and perquisites
 
Each of our named executive officers participates in the retirement and health/welfare benefit plans generally available to all employees. In 2010, we did not offer any perquisites to our named executive officers.
 
Employment agreements
 
We have no agreements in place with either of our named executive officers, and they are considered “at will” employees.

79


Table of Contents

EXECUTIVE COMPENSATION
 
The following table sets forth the compensation paid to our Chief Executive Officer and President and our Chief Financial Officer and Treasurer, each of whom was serving as an executive officer on December 31, 2010.
 
Summary compensation table
 
The following table sets forth the annual base salary, bonus, long-term equity incentive awards and other compensation earned by or granted with respect to our named executive officers during 2010, 2009 and 2008.
 
                                                         
                    Non-Equity
       
                Stock
  Incentive Plan
  All Other
   
Name and Principal Position
 
Year
 
Salary ($)
 
Bonus ($)
 
Awards(1)
 
Compensation ($)
 
Compensation ($) (2)
 
Total ($)
 
Craig M. Bernfield
    2010     $ 490,286     $ 0     $ 1,017,138     $ 275,783     $ 0     $ 1,783,207  
Chief Executive Officer & President
    2009     $ 480,673     $ 0     $ 0     $ 60,085     $ 0     $ 540,758  
      2008     $ 432,858     $ 0     $ 0     $ 0     $ 22,620     $ 455,478  
Steven J. Insoft
    2010     $ 300,579     $ 0     $ 542,492     $ 94,395     $ 176,225     $ 1,113,691  
Chief Financial Officer & Treasurer
    2009     $ 294,685     $ 0     $ 0     $ 50,648     $ 206,798     $ 552,131  
      2008     $ 290,330     $ 0     $ 0     $ 72,582     $ 41,611     $ 404,523  
 
 
(1) Reflects the value of time-based MIP awards which were granted in 2010. While the time-based NSOs have a grant date fair market value for financial reporting purposes, the performance-based NSOs do not, as it is impossible to know at the time of grant the likelihood of vesting due to the return threshold and employment requirements.
 
(2) Mr. Bernfield was provided a transportation allowance in 2008. Mr. Insoft received distributions from unsettled Phantom Class C Units in 2008, 2009, and 2010.
 
Grants of plan-based awards
 
The following table shows certain information relating to our non-equity incentive plan awards and options to purchase shares of our common stock granted to the named executive officers in 2010.
 
                                                                         
                    All Other
  All Other
           
                    Stock
  Option
           
                    Awards:
  Awards:
          Grant Date
                    Number of
  Number of
  Exercise Price or
      Fair Value
        Estimated Possible Potential Payments
  Shares of
  Securities
  Base Price of
  Grant Date Closing
  of Stock and
       
Under Non-Equity Incentive Plan Awards
  Stock or
  Underlying
  Option Awards
  Price of Common
  Option
Name
 
Grant Date
 
Threshold ($)
 
Target ($)
 
Maximum ($)
 
Units (#)
 
Options (#)
 
($/Share)
 
Stock ($/Share)
 
Awards
 
Craig M. Bernfield
        $ 122,572     $ 245,143     $ 367,715                                
      9/17/2010(1 )                                     9,167     $ 1,000.00     $ 1,000.00     $ 990,861  
      9/17/2010(2 )                                     18,334     $ 1,000.00     $ 1,000.00     $ 0  
      9/30/2010(1 )                                     204     $ 1,083.93     $ 1,083.93     $ 26,277  
      9/30/2010(2 )                                     407     $ 1,083.93     $ 1,083.93     $ 0  
Steven J. Insoft
        $ 37,572     $ 75,145     $ 112,717                                
      9/17/2010(1 )                                     4,889     $ 1,000.00     $ 1,000.00     $ 528,452  
      9/17/2010(2 )                                     9,778     $ 1,000.00     $ 1,000.00     $ 0  
      9/30/2010(1 )                                     109     $ 1,083.93     $ 1,083.93     $ 14,040  
      9/30/2010(2 )                                     217     $ 1,083.93     $ 1,083.93     $ 0  
 
 
(1) Time-based nonqualified stock options.


80


Table of Contents

(2) Performance-based nonqualified stock options. As noted in the Summary Compensation Table, there is no grant date fair value for these awards, as it is impossible to know at the time of grant the likelihood of vesting due to the return threshold and employment requirements.
 
Outstanding equity awards at fiscal year end
 
The following table sets forth certain information concerning unexercised options held by the named executive officers at December 31, 2010.
 
                                             
    Option Awards   Stock Awards
    Number of
  Number of
               
    Securities
  Securities
               
    Underlying
  Underlying
              Market Value of
    Unexcerised
  Unexcerised
  Option
  Option
  Number of Shares or
  Shares or Units of
    Options-
  Options-
  Exercise
  Expiration
  Units of Stock Not
  Stock that Have
Name
 
Exercisable
 
Unexercisable
 
Price
 
Date
 
Yet Vested
 
Not Yet Vested ($)
 
Craig M. Bernfield
          27,501     $ 1,000.00                
            611     $ 1,083.93                
Steven J. Insoft
          14,667     $ 1,000.00           1,600 Class D Units   $ 489,392  
            326     $ 1,083.93           Phantom Class C Units   $ 636,288  
 
Option exercises and stock vested at fiscal year end
 
No options were exercised in 2010. The table below shows stock awards that vested on December 31, 2010. No other awards vested during the year.
 
                 
    Number of Shares
    Value Realized on
 
Name
 
Acquired on Vesting
   
Vesting
 
 
Craig M. Bernfield
           
Steven J. Insoft(1)
    400       $122,348  
      1       $318,144  
 
 
(1) Includes 400 Class D Units and 1% of Class C value vested on 12/31/10.
 
Potential payments upon change of control
 
As described above, the following will result from certain change in control transactions:
 
  •     40% of the Class D units held by a named executive officer will become vested upon the earlier of:
 
  •     expiration of a lock-up period with respect an “initial public offering” by us; and
 
  •     at the time of certain “fundamental transactions” involving Aviv Healthcare Properties Limited Partnership.
 
  •     Any unvested phantom Class C units held by Mr. Insoft will become fully vested upon a “change in control” following which Mr. Bernfield ceases to control our organization, subject to his employment with us through such date.
 
  •     Unvested time-based NSOs under the MIP become vested upon a “liquidity event,” subject to employment with us through such date.


81


Table of Contents

 
  •     Performance-based NSOs under the MIP become fully vested upon a “liquidity event,” provided that Lindsay Goldberg has achieved a 15% internal rate of return on its investment in us, subject to employment with us through such date.
 
Assuming a change in control event occurred on December 31, 2010, the table below summarizes the estimate of the full benefit that would be realized by our executives. The table shows the full value of all equity that would vest related to the change in control. No other payments or benefits are provided under a change in control. No payments or benefits are provided under any other potential termination event.
 
         
Name
 
Change-in-Control
 
 
Craig M. Bernfield
       
Cash Severance
    $0  
Class D Unit
    $0  
MIP
    $1,017,138  
         
Total
    $1,017,138  
         
Steven J. Insoft
       
Cash Severance
    $0  
Class D Unit
    $489,392  
Phantom Class C Unit
    $0  
MIP
    $542,492  
         
Total
    $1,031,884  
         


82


Table of Contents

 
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
 
Strategic Equity Transaction with Lindsay Goldberg
 
In September 2010, we consummated a strategic equity transaction with an affiliate of Lindsay Goldberg, LLC (“Lindsay Goldberg”). Lindsay Goldberg is a private investment firm that focuses on partnering with well-managed, closely-held businesses and entrepreneur-led enterprises to help facilitate growth and value creation in industries such as healthcare, consumer products, commodity-based manufacturing, energy services, business services, financial services and energy infrastructure. Lindsay Goldberg manages approximately $10 billion of capital across three funds and its team of investment professionals has collectively completed more than 120 transactions with an aggregate value in excess of $15 billion. Some of its other investments include ASA Medical, Brightstar, Brock, Continental Energy Systems, PetroLogistics and PSC.
 
In connection with the transaction, Lindsay Goldberg, through the formation of our current general partner, Aviv REIT, made an aggregate investment in us, including through the contribution of limited partnership interests it purchased from certain of our limited partners concurrently with its investment, of $217.8 million. Lindsay Goldberg also has committed (subject to certain conditions) to make additional equity investments in Aviv REIT, up to an aggregate of $50.0 million in additional investments ($20.0 million of which has been funded to date), and may elect to make additional discretionary equity investments in Aviv REIT. As a result of the transaction, Lindsay Goldberg owns a majority of the equity of Aviv REIT.
 
In connection with the transaction, we entered into a Stockholders Agreement with Lindsay Goldberg, a representative of certain limited partners related to the family of Zev Karkomi and an entity formed by Mr. Bernfield. The Stockholders Agreement sets forth certain provisions regarding the governance and control of Aviv REIT. The Stockholders Agreement provides that, subject to certain exceptions, Lindsay Goldberg is entitled to designate up to four Class A Directors, with such directors being entitled to cast a total of four votes on any matter before the board of directors, Mr. Bernfield is entitled to designate up to four Class B Directors, with such directors being entitled to cast a total of six votes on any matter before the board of directors, and the Karkomi Investors are entitled to designate one Class C Director, with such director entitled to cast one vote on any matter before the board of directors. If Mr. Bernfield dies or becomes disabled, the Class B Directors will be designated by an individual previously designated by Mr. Bernfield and agreed to by Lindsay Goldberg. The Stockholders Agreement also requires that certain material corporate activities must be approved by all Class A Directors in addition to the Class B Directors. Further, during any period in which the value of the common stock of Aviv REIT held by Lindsay Goldberg, as calculated at any fiscal year end in accordance with the Stockholders Agreement among the stockholders of Aviv REIT, is less than 79.5% of the aggregate amount of investments made by Lindsay Goldberg in Aviv REIT, the Class A Directors shall be entitled to cast such number of votes equal to the percentage of Lindsay Goldberg’s fully diluted ownership of Aviv REIT multiplied by eleven, the Class C Director shall be entitled to cast one vote and the Class B Directors shall be entitled to cast any remaining votes.
 
Loans to Mr. Insoft
 
On November 1, 2007, Steven Insoft, our Chief Financial Officer and Treasurer, was granted phantom partnership units in Aviv Healthcare Properties Limited Partnership equal to a percentage of the value of units held by certain of the limited partners. The award vests ratably over time and may be settled in cash or in class C units of Aviv Healthcare Properties Limited Partnership. On September 17, 2010 and December 31, 2010, Mr. Insoft’s award vested in part and Mr. Insoft was awarded class C units representing the vested portion of his award. In addition, we paid Mr. Insoft an amount of cash representing the taxes due on the vested portion of his award. In exchange, Mr. Insoft executed promissory notes payable to us in the aggregate principal amount of $311,748.45 that accrued interest at the then-applicable long-term Federal rate. On April 29, 2011, Mr. Insoft repaid the promissory notes in full. The aggregate amount repaid was $315,420.92. From the date of issuance to the date of repayment, Mr. Insoft paid an aggregate of $5,787.68 of interest on the notes.


83


Table of Contents

 
POLICIES WITH RESPECT TO CERTAIN ACTIVITIES
 
The following is a discussion of our policies with respect to investments, financing and certain other activities. These policies may be amended and revised from time to time at the discretion of the board of directors of Aviv REIT. The indenture governing the Notes offered hereby, our existing credit facility and our revolving credit facility limit our ability to make certain investments, incur or guarantee indebtedness or sell our assets. See “Description of Exchange Notes—Covenants” and “Description of Other Indebtedness.”
 
Investment Policies
 
Investments in Real Estate or Interests in Real Estate
 
We conduct all of our investment activities through our operating partnership and its subsidiaries. Our investment objectives are to increase cash flow, provide quarterly cash distributions, maximize the value of our properties and acquire properties with cash flow growth potential. Additionally, we will seek to selectively expand and upgrade both our current properties and any newly-acquired properties. Our business is focused primarily on healthcare properties, principally SNFs, and activities directly related thereto. We have not established a specific policy regarding the relative priority of our investment objectives. We currently lease our properties to our tenants pursuant to long-term triple-net leases which require the tenant to bear all of the costs associated with the property. For a discussion of our portfolio and our business and other strategic objectives, see “Business.”
 
We expect to pursue our investment objectives through the ownership of properties by our subsidiaries, but may also make investments in other entities, including joint ventures. We currently intend to focus on acquiring SNFs in those areas in which we own and also strategically select new markets when opportunities are available that meet our investment criteria. We anticipate that future investment and development activity will be focused primarily in the United States, but will not be limited to any geographic area. We intend to engage in such future investment activities in a manner that is consistent with requirements applicable to REITs for U.S. federal income tax purposes. Provided we comply with these requirements, however, there are no limitations on the percentage of our assets that may be invested in any one real estate asset.
 
We may enter into joint ventures from time to time, if we determine that doing so would be the most effective means of raising capital. Equity investments may be subject to existing mortgage financing and other indebtedness or such financing or indebtedness may be incurred in connection with acquiring properties, or a combination of these methods. Any such financing or indebtedness will have priority over our equity interest in such property. Investments are also subject to our policy not to be treated as an investment company under the Investment Company Act of 1940, as amended, or the 1940 Act.
 
We do not have a specific policy as to the amount or percentage of our assets which will be invested in any specific property, but anticipate that our real estate investments will continue to be diversified among a relatively large number of facilities. As of March 31, 2011, our portfolio of investments consists of 187 properties located in 25 states leased to 32 operators.
 
From time to time, we may make investments or agree to terms that support the objectives of our tenants without necessarily maximizing our short-term financial return, which may allow us to build long-term relationships and acquire properties otherwise unavailable to our competition. We believe these dynamics create long-term, sustainable relationships and, in turn, profitability for us.
 
Purchase, Sale and Development of Properties
 
Our policy is to acquire properties primarily for generation of current income and long-term value. Although we do not currently intend to sell any properties, we will sell certain properties where our


84


Table of Contents

management determines such properties do not fit our strategic objectives or where such action would be in the best interest of our company. From time to time, we may also engage in strategic development opportunities. These opportunities may involve replacing or renovating properties in our portfolio that have become economically obsolete or identifying new sites that present an attractive opportunity and complement our existing portfolio.
 
Investments in Real Estate Mortgages
 
While we emphasize equity real estate investments in healthcare real estate properties, we may invest in mortgages and other real estate interests consistent with the rules applicable to REITs. The mortgages in which we may invest may be either first mortgages or junior mortgages, and may or may not be insured by a governmental agency. Investments in real estate mortgages are subject to the risk that one or more borrowers may default and that the collateral securing mortgages may not be sufficient to enable us to recover our full investment.
 
Investments in Securities or Interests in Entities Primarily Engaged in Real Estate Activities and Other Issuers
 
Subject to the gross income and asset requirements required for REIT qualification, we may, but do not presently intend to, invest in securities of entities engaged in real estate activities or securities of other issuers (normally partnership interests, limited liability company interests or other joint venture interests in special purpose entities owning properties), including for the purpose of exercising control over such entities. We may acquire some, all or substantially all of the securities or assets of other REITs or entities engaged in real estate activities where such investment would be consistent with our investment policies and the REIT requirements. There are no limitations on the amount or percentage of our total assets that may be invested in any one issuer, other than those imposed by the gross income and asset tests we must meet in order to qualify as a REIT under the Internal Revenue Code of 1986, as amended (the “Code”). In any event, we do not intend that our investments in securities will require us to register as an “investment company” under the 1940 Act, and we would generally divest appropriate securities before any such registration would be required.
 
Financing Policies
 
We employ leverage in our capital structure in amounts that we determine from time to time. Our board of directors has not adopted a policy which limits the total amount of indebtedness that we may incur, but we will consider a number of factors in evaluating our level of indebtedness from time to time, as well as the amount of such indebtedness that will be either fixed or variable rate. Our charter and bylaws do not limit the amount or percentage of indebtedness that we may incur nor do they restrict the form in which our indebtedness will be taken (including recourse or non-recourse debt, cross collateralized debt, etc.). We may from time to time modify our debt policy in light of then-current economic conditions, relative costs of debt and equity capital, market values of our properties, general market conditions for debt and equity securities, growth and acquisition opportunities and other factors.
 
To the extent that our board of directors or management determines that it is necessary to raise additional capital, we may borrow under our credit facilities, issue debt or equity securities, including additional partnership units, retain earnings (subject to the REIT distribution requirements for U.S. federal income tax purposes), assume secured indebtedness, obtain mortgage financing on a portion of our owned properties, engage in a joint venture, or employ a combination of these methods. As long as our operating partnership is in existence, the proceeds of all equity capital raised by us will be contributed to our operating partnership in exchange for additional interests in our operating partnership, which will dilute the ownership interests of the limited partners in our operating partnership.


85


Table of Contents

 
Other Investment Policies
 
We may, but do not presently intend to, make investments other than as previously described. We may offer shares of our common stock or other equity or debt securities in exchange for cash or property and to repurchase or otherwise re-acquire shares of our common stock or other equity or debt securities in exchange for cash or property. We may issue additional series of our preferred stock from time to time. We have not engaged in trading, underwriting or the agency distribution or sale of securities of other issuers and do not intend to do so. At all times, we intend to make investments in a manner consistent with the REIT requirements of the Code unless, because of business circumstances or changes in the Code (or the U.S. Treasury regulations promulgated thereunder), our board of directors determines that it is no longer in our best interests for us to qualify as a REIT. We intend to make investments in such a way that we will not be treated as an “investment company” under the 1940 Act. Our policies with respect to such activities may be reviewed and modified from time to time by our board of directors without notice to or the vote of our stockholders.
 
Lending Policies
 
We do not have a policy limiting our ability to make loans to other persons. Subject to REIT qualification rules, we may make loans to third parties. For example, we may consider offering purchase money financing in connection with the sale of properties where the provision of that financing will increase the value to be received by us for the property sold or we may consider making loans to joint ventures in which we or they participate or may participate in the future. We may choose to guarantee the debt of certain joint ventures with third parties. Consideration for those guarantees may include, but are not limited to, fees, long-term management contracts, options to acquire additional ownership and promoted equity positions.


86


Table of Contents

 
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
 
The following table sets forth certain information regarding the beneficial ownership of Aviv REIT’s common stock as of June 1, 2011 for the following: (i) each of Aviv REIT’s directors and Named Executive Officers, (ii) all persons who are directors and executive officers of Aviv REIT as a group and (iii) any person who is known by Aviv REIT to be the beneficial owner of more than 5% of Aviv REIT’s common stock. No director or Named Executive Officer is the beneficial owner of Aviv REIT’s preferred stock, and no person is known by Aviv REIT to be the beneficial owner of more than 5% of Aviv REIT’s preferred stock.
 
                 
    Amount of Common
  Percent of
    Stock Beneficially
  Common
Name of Beneficial Owner
 
Owned (1)
 
Stock
 
Directors and Named Executive Officers:
               
Craig M. Bernfield
    1       *  
Steven J. Insoft. 
           
Michael W. Dees
           
Alan E. Goldberg
    235,897  (2)     99.99 %
Robert D. Lindsay
    235,897  (2)     99.99 %
Ari Ryan
           
J. Russell Triedman
           
All persons who are directors and executive officers as a group (7 persons, each of whom is named above)
    235,898       100.00 %
5% Stockholder:
               
LG Aviv L.P. 
    235,897  (3)     99.99 %
Alan E. Goldberg
    235,897  (2)     99.99 %
Robert D. Lindsay
    235,897  (2)     99.99 %
 
 
* Less than 1.00%.
 
(1) Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Percentage ownership is determined based on 235,898 shares of Aviv REIT common stock outstanding as of June 1, 2011. Except as indicated in the footnotes to this table and pursuant to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially owned.
 
(2) Mr. Lindsay and Mr. Goldberg, through intermediate entities, indirectly have shared control over LG Aviv L.P., the majority stockholder of Aviv REIT, Inc. By virtue of this relationship, they may be deemed to have or share beneficial ownership of securities held by LG Aviv L.P. Mr. Lindsay and Mr. Goldberg expressly disclaim beneficial ownership of such securities, except to the extent of their respective pecuniary interests therein. The address for Mr. Lindsay and Mr. Goldberg is c/o Lindsay Goldberg LLC, 630 Fifth Avenue, 30th Floor, New York, New York 10111.
 
(3) Represents 159,903 shares held by LG Aviv L.P. on behalf of Lindsay Goldberg III REIT AIV L.P., 67,666 shares held by LG Aviv L.P. on behalf of Lindsay Goldberg III—A REIT AIV L.P., 3,383 shares held by LG Aviv L.P. on behalf of Lindsay Goldberg III—BT REIT AIV L.P. and 4,945 shares held by LG Aviv, L.P. (held generally for any co-investment vehicles and Dean Ventures X, L.L.C.). LG Aviv L.P. disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. The address for LG Aviv L.P. is c/o Lindsay Goldberg LLC, 630 Fifth Avenue, 30th Floor, New York, New York, 10111.


87


Table of Contents

 
The following table sets forth certain information regarding the beneficial ownership of each class of the partnership units of Aviv Healthcare Properties Limited Partnership as of June 1, 2011 for the following: (i) each of Aviv REIT’s directors and Named Executive Officers, (ii) all persons who are directors and executive officers of Aviv REIT as a group and (iii) any person who is known by Aviv REIT to be the beneficial owner of more than 5% of Aviv Healthcare Properties Limited Partnership’s units.
 
                                                                                                                 
                                                                            Amount of
       
    Amount of
          Amount of
          Amount of
          Amount of
          Amount of
          Amount of
          Class G
       
    Class A
          Class B
          Class C
          Class D
          Class F
          Class G
          Preferred
    Percent of
 
    Units
    Percent of
    Units
    Percent of
    Units
    Percent of
    Units
    Percent of
    Units
    Percent of
    Units
    Percent of
    Units
    Class G
 
    Beneficially
    Class A
    Beneficially
    Class B
    Beneficially
    Class C
    Beneficially
    Class D
    Beneficially
    Class F
    Beneficially
    Class G
    Beneficially
    Preferred
 
Name of Beneficial Owner
  Owned (1)     Units     Owned (1)     Units     Owned (1)     Units     Owned (1)     Units     Owned (1)     Units     Owned (1)     Units     Owned (1)     Units  
 
                                                                                                                 
Directors and Named Executive Officers:
                                                                                                               
                                                                                                                 
Craig M. Bernfield
    1,099,793       8.2 %     932,247       20.6 %     48.5  (2)     48.5 %                 100       100.0 %     235,898  (3)     100.0 %            
                                                                                                                 
Steven J. Insoft. 
                            3.0  (4)     3.0 %     400       5.0 %                                    
                                                                                                                 
Michael W. Dees
                                                                                   
                                                                                                                 
Alan E. Goldberg
                                                                235,897  (5)     99.99 %            
                                                                                                                 
Robert D. Lindsay
                                                                235,897  (5)     99.99 %            
                                                                                                                 
Ari Ryan (6)
    6,853,477       50.9 %     2,683,820       59.3 %     48.5  (7)     48.5 %                                                
                                                                                                                 
J. Russell Triedman
                                                                                   
                                                                                                                 
All persons who are directors and executive officers as a group (7 persons, each of whom is named above)
    7,958,988       59.1 %     3,616,067       79.9 %     100.0       100.0 %     900       11.2 %     100       100.0 %     235,897       100.0 %            
                                                                                                                 
5% Unitholder:
                                                                                                               
                                                                                                                 
Aviv REIT, Inc. (8)
                                                                235,897       100.0 %            
                                                                                                                 
Alan E. Goldberg (5)
                                                                235,897  (5)     100.0 %            
                                                                                                                 
Robert D. Lindsay (5)
                                                                235,897  (5)     100.0 %            
                                                                                                                 
Craig M. Bernfield (9)
    1,099,793       8.2 %     932,247       20.6 %     48.5  (2)     48.5 %                 100       100.0 %     235,898  (3)     100.0 %            
                                                                                                                 
Steven J. Insoft (9)
                                        400       5.0 %                                    
                                                                                                                 
Ari Ryan (6)(9)
    6,853,477       50.9 %     2,683,820       59.3 %     48.5  (7)     48.5 %                                                
 
 
(1) Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Percentage ownership is determined based on 13,467,223 Class A Units, 4,523,145 Class B Units, 100 Class C Units, 8,050 Class D Units, 100 Class F Units, 235,898 Class G Units and 125 Class G Preferred Units of Aviv Healthcare Properties Limited Partnership outstanding as of June 1, 2011. Except as indicated in the footnotes to this table and pursuant to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all units beneficially owned.
 
(2) Includes 1 unit that is held by Mr. Bernfield subject to a phantom unit award grant to Mr. Insoft.
 
(3) Represents 235,897 Class G Units held by Aviv REIT, Inc. and 1 Class G Unit held by Craig M. Bernfield REIT, L.L.C. Mr. Bernfield, as Chief Executive Officer and President of Aviv REIT, Inc., has shared control over Aviv REIT, Inc. By virtue of his position, he may be deemed to have beneficial ownership of securities beneficially owned by Aviv REIT, Inc. Mr. Bernfield expressly disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
 
(4) Reflects Class C Units held by Steven J. Insoft Investments, L.L.C., which is 99% owned by Mr. Insoft and 1% owned by his wife, Susan M. Insoft. Such units are also pledged as collateral to secure a loan in favor of Mr. Insoft.
 
(5) Mr. Lindsay and Mr. Goldberg, through intermediate entities, indirectly have shared control over LG Aviv L.P., the majority stockholder of Aviv REIT, Inc., which is the general partner of Aviv Healthcare Properties Limited Partnership. By virtue of this relationship, they may be deemed to have or share beneficial ownership of securities held by Aviv REIT, Inc. Mr. Lindsay and Mr. Goldberg expressly disclaim beneficial ownership of such securities, except to the extent of their respective pecuniary interests therein. The address for Mr. Lindsay and Mr. Goldberg is c/o Lindsay Goldberg LLC, 630 Fifth Avenue, 30th Floor, New York, New York 10111.
 
(6) Mr. Ryan holds Class A Units, Class B Units and Class C Units through various trusts and limited liability companies, of which he is the sole beneficial owner. Such units are also pledged as collateral to secure various loans.


88


Table of Contents

 
(7) Includes 1 unit that is held by Mr. Ryan subject to a phantom unit award grant to Mr. Insoft.
 
(8) The address for Aviv REIT, Inc. is 303 West Madison Street, Suite 2400, Chicago, Illinois, 60606.
 
(9) The address for Mr. Bernfield, Mr. Insoft and Mr. Ryan is c/o Aviv REIT, Inc., 303 West Madison Street, Suite 2400, Chicago, Illinois, 60606.
 
No director or Named Executive Officer is the beneficial owner of Aviv Healthcare Capital Corporation’s common stock. As of June 1, 2011, Aviv Healthcare Properties Limited Partnership was the beneficial owner of 100% of Aviv Healthcare Capital Corporation’s common stock. Aviv Healthcare Properties Limited Partnership’s address is c/o Aviv REIT, Inc., 303 West Madison Street, Suite 2400, Chicago, Illinois, 60606.


89


Table of Contents

 
DESCRIPTION OF OTHER INDEBTEDNESS
 
Mortgage Term Loan and Acquisition Credit Line
 
In September 2010, we refinanced all of our existing mortgage indebtedness by entering into a secured credit facility (the “existing credit facility”) consisting of a $405.0 million mortgage term loan and a $100.0 million acquisition credit line. The acquisition credit line may be used for financing acquisitions and certain property improvements. Draws on the acquisition credit line are limited to 70% of the total cost of the applicable acquisition or renovation, and draws for renovation projects are further limited to an aggregate of $25.0 million outstanding at any one time. Aviv Healthcare Properties Limited Partnership provides a limited unsecured guarantee of the existing credit facility.
 
The interest rate applicable to the existing credit facility is based upon LIBOR (subject to adjustment based on the level of reserves required by the Federal Reserve Bank to be held for Eurocurrency fundings), subject to a 1.25% floor, plus 4.5%. At our option, the interest rate may be calculated at the prime rate plus 4.5%. The interest rate under the existing credit facility was 5.75% on March 31, 2011.
 
The balance outstanding under the mortgage term loan as of March 31, 2011 was $235.4 million. There was no outstanding balance under the acquisition credit line as of March 31, 2011. After giving pro forma effect to the application of the proceeds of the sale of the Old Notes, the balance outstanding under the mortgage term loan as of March 31, 2011 would have been $199.3 million and there would have been no balance outstanding under our acquisition credit line. The acquisition credit line is available for draw until September 2013. The initial term of the existing credit facility expires in September 2015 with two one-year extension options, provided that certain conditions precedent for the extensions are satisfied, including, without limitation, payment of a fee equal to 0.25% of the then existing principal balance of the existing credit facility and meeting certain debt service coverage and debt yield tests.
 
Principal payments on the existing credit facility are payable in monthly installments. The monthly payment for the mortgage term loan is based upon a 25-year amortization schedule. Prior to September 17, 2013, the monthly payment for the acquisition credit line is interest only in arrears on any outstanding principal balance of the acquisition credit line. Following September 17, 2013 through the remainder of the term, the monthly payment for the acquisition credit line is based upon a 25-year amortization schedule. Prior September 17, 2013, a fee equal to 1% per annum of the daily unused balance of the acquisition credit line is due monthly.
 
Our existing credit facility generally requires the consolidated borrowers under the facility to maintain a debt service coverage ratio of 1.50:1.00 and a distribution coverage ratio of 1.10:1.00. In addition, Aviv Healthcare Properties Limited Partnership and its consolidated subsidiaries must maintain a debt service coverage ratio of 1.25:1.00 and a debt yield ratio of greater than 17.25%. We are permitted to include cash on hand in calculating such debt service coverage ratios.
 
Immediately following any draw on the acquisition credit line, both before and after giving effect to such draw, the consolidated borrowers under the existing credit facility must have a pro forma debt yield ratio of at least 18%. Our debt yield ratio is the ratio of (i) either consolidated EBITDA or rental revenue for the most recently completed two fiscal quarter period times two to (ii) the average daily outstanding principal balance of loans outstanding under the existing credit facility during the period.
 
The borrowers under the existing credit facility guarantee the Notes, which guarantees are subordinated to the obligations of such borrowers under the existing credit facility. In turn, each guarantor of the Notes that is not a borrower under our existing credit facility or our revolving credit facility provided guarantees to the lenders under such facilities, which guarantees are subordinated to the obligations of such subsidiaries under the Notes.


90


Table of Contents

 
Senior Secured Revolving Credit Facility
 
In February 2011, we entered into a new $25.0 million senior secured revolving credit facility (the “revolving credit facility”). The interest rate under our revolving credit facility is generally based on LIBOR (subject to a floor of 1.0% and subject to our option to elect to use a prime base rate) plus a margin that is determined by our leverage ratio from time to time, and the interest rate as of March 31, 2011 was 6.25%. We are permitted to include cash on hand in calculating our leverage ratio for periods through June 30, 2011.
 
The initial term of our revolving credit facility expires in January 2014 with a one-year extension option. We have the right to increase the amount of the revolving credit facility by up to $75.0 million (resulting in total availability of $100.0 million), provided that certain conditions precedent are satisfied. Our revolving credit facility is secured by first lien mortgages on 14 of our properties, a pledge of the capital stock of our subsidiaries owning such properties (plus the equity of our subsidiary that acts as the holding company of the subsidiaries owning such properties) and other customary collateral, including an assignment of leases and rents with respect to such mortgaged properties. The borrowing availability under our revolving credit facility is subject to a borrowing base calculation based on, among other factors, the lesser of (i) the amount of a hypothetical mortgage based on the net revenues for the prior four quarters (on a pro forma basis for recently acquired properties) and (ii) 65% of the appraised value, in each case, of the properties securing our revolving credit facility. As of the date of this prospectus, $14.8 million of borrowings are available to us under the revolving credit facility.
 
Other Indebtedness
 
In November 2010, we entered into a construction and term loan agreement providing a loan of up to $6.4 million to finance the renovation of a SNF located in Arkansas. The loan, which is secured by a first lien on the property, is expected to be repaid upon completion of the renovations and no later than December 2013. The interest rate under the agreement is calculated at the prime rate plus 0.38%. As of March 31, 2011, the principal balance of the loan was $1.3 million.
 
Also in November 2010, we entered into loan agreements in the aggregate principal amount of $7.8 million relating to the acquisition of a SNF located in California. The loans accrue interest at the rate of 6.0% per annum and are secured by a lien on the property. Payments of principal and accrued interest are made monthly and the loan is to be paid in full no later than December 2015.


91


Table of Contents

 
DESCRIPTION OF EXCHANGE NOTES
 
The indenture under which the Exchange Notes are to be issued is the same indenture under which the Old Notes were issued. Any Old Note that remains outstanding after the completion of the exchange offer, together with the Exchange Notes issued in connection with the exchange offer, will be treated as a single class of securities under the indenture. As used in this “Description of Exchange Notes,” except as otherwise specified or the context otherwise requires, the Old Notes and the Exchange Notes are referred to together as the “Notes.”
 
The following is a summary of the material provisions of the indenture governing the Notes among Aviv REIT, Inc., Aviv Healthcare Properties Limited Partnership, Aviv Healthcare Capital Corporation, the subsidiary guarantors and The Bank of New York Mellon Trust Company, N.A., as trustee. It does not restate that agreement, and we urge you to read the indenture in its entirety, which is available upon request to Aviv REIT at the address indicated under “Where You Can Find More Information” elsewhere in this prospectus, because it, and not this description, defines your rights as a noteholder.
 
You can find the definitions of certain capitalized terms used in this description under the subheading “—Certain Definitions.” The term “Partnership” as used in this section refers only to Aviv Healthcare Properties Limited Partnership and not any of its subsidiaries, the term “Issuers” as used in this section refers only to Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation and not to any of their subsidiaries and the term “Aviv REIT” or “Parent” as used in this section refers only to Aviv REIT, Inc. and not to any of its subsidiaries.
 
General
 
On February 4, 2011, the Issuers, Aviv REIT and the subsidiary guarantors entered into an indenture providing for the issuance by the Issuers of their 7 3/4% Senior Notes due 2019, and the Issuers issued an initial $200,000,000 aggregate principal amount of such notes. On April 5, 2011, the Issuers issued an additional $100,000,000 aggregate principal amount of 7 3/4% Senior Notes due 2019. The Issuers may issue additional notes from time to time under the indenture, subject to the terms and conditions of the indenture. The Notes and any additional notes issued under the indenture will be treated as a single class for all purposes under the indenture, including waivers, amendments, redemptions and offers to purchase. Additional notes will not necessarily be fungible with the Notes for U.S. federal income tax purposes.
 
The Notes are unsecured senior obligations of the Issuers and will mature on February 15, 2019. The Notes bear interest at a rate of 7.750% per annum, payable semiannually to holders of record at the close of business on the February 1 or the August 1 immediately preceding the interest payment date on February 15 and August 15 of each year, commencing August 15, 2011.
 
Principal of, premium, if any, and interest on the Notes will be payable, and the Notes may be exchanged or transferred, in accordance with the terms of the indenture.
 
Interest on the Exchange Notes will accrue from February 4, 2011 or from the date of the last payment of interest on the Old Notes, whichever is later. Interest will be computed on the basis of a 360-day year comprised of twelve 30-day months. We will not pay interest on Old Notes tendered and accepted for exchange.
 
The Exchange Notes will be issued only in fully registered form, without coupons, in denominations of $2,000 of principal amount and any integral multiple of $1,000 in excess thereof. No service charge will be made for any registration of transfer or exchange of Exchange Notes, but the Issuers are entitled to require payment of a sum sufficient to cover any transfer tax or other similar governmental charge payable in connection with a registration of transfer.


92


Table of Contents

 
Guaranties and Subsidiary Guarantors
 
The Notes are guaranteed on an unsecured senior basis by Aviv REIT and certain subsidiaries of the Partnership (such subsidiaries are referred to herein as “Senior Guaranty Subsidiaries”) and on an unsecured subordinated basis by certain other subsidiaries of the Partnership that are borrowers under our existing Acquisition Line and Term Loan (such subsidiaries are referred to herein as “Subordinated Guaranty Subsidiaries”). The Subordinated Guaranty Subsidiaries have agreed in the indenture that they will not incur or suffer to exist any indebtedness that is senior in right of payment to the applicable Subordinated Guaranty Subsidiary’s guarantee other than the Acquisition Line and the Term Loan (or any Permitted Refinancing Indebtedness incurred in exchange for, or the net proceeds of which are used to refund, refinance or replace, the Acquisition Line or Term Loan and that was otherwise permitted by the indenture) and any secured Currency Agreements or Interest Rate Agreements with the lenders under the Acquisition Line and the Term Loan. See “—Covenants—Prohibition on Incurrence of Senior Debt by the Subordinated Guaranty Subsidiaries.” Certain other subsidiaries of the Partnership hold properties that are subject to mortgages the terms of which prohibit such subsidiaries from entering into guarantees of other indebtedness, including the Notes and our revolving credit facility (such subsidiaries are referred to herein as “Real Property Non-Guarantor Subsidiaries”). Accordingly, the Notes will not be guaranteed by the Real Property Non-Guarantor Subsidiaries, any Unrestricted Subsidiaries we may create in the future or any future Restricted Subsidiaries that do not otherwise guarantee (or become a co-borrower in respect of) Indebtedness of the Issuers or of a Subsidiary Guarantor that ranks equally with or subordinate in right of payment to the Notes (or the applicable Subsidiary Guaranty). As of the date of this prospectus, there are no Unrestricted Subsidiaries.
 
Our revenues attributable to the properties held by the Subordinated Guaranty Subsidiaries were $47.0 million for the twelve months ended March 31, 2011, and, as of March 31, 2011, these properties accounted for 56.6% of our total real estate investments, net of accumulated depreciation. After giving pro forma effect to the sale of the Old Notes and the use of proceeds therefrom, as of March 31, 2011, the Subordinated Guaranty Subsidiaries would have had aggregate secured indebtedness to third parties of approximately $199.3 million. Our revenues attributable to the properties held by the Real Property Non-Guarantor Subsidiaries were $0.5 million for the twelve months ended March 31, 2011, and, as of March 31, 2011, these properties accounted for 2.7% of our total real estate investments, net of accumulated depreciation. As of March 31, 2011, the Real Property Non-Guarantor Subsidiaries had aggregate mortgage indebtedness to third parties of approximately $9.1 million.
 
The guarantees of Aviv REIT and the Subsidiary Guarantors will be unconditional regardless of the enforceability of the Notes and the indenture. Subject to certain exceptions, each future Restricted Subsidiary that subsequently guarantees Indebtedness of the Issuers or of a Subsidiary Guarantor (or the applicable Subsidiary Guaranty) will be required to execute a Subsidiary Guaranty. See “—Covenants—Future Guaranties by Restricted Subsidiaries.”
 
Pursuant to the indenture, (A) a Subsidiary Guarantor may consolidate with, merge with or into, or transfer all or substantially all its assets to any other Person to the extent described below under “—Covenants—Consolidation, Merger and Sale of Assets” and (B) the Capital Stock of a Subsidiary Guarantor may be sold or otherwise disposed of to another Person to the extent described below under “—Covenants—Limitation on Asset Sales”; provided, however, that, in the case of a consolidation, merger or transfer of all or substantially all the assets of such Subsidiary Guarantor, if such other Person is not the Parent, the Issuers or a Subsidiary Guarantor, such Subsidiary Guarantor’s obligations under its Subsidiary Guaranty must be expressly assumed by such other Person, except that such assumption will not be required in the case of:
 
  (1)  the sale (including any sale pursuant to any exercise or remedies by a holder of Indebtedness of the Company or of a Subsidiary Guarantor) or other disposition (including by way of consolidation or merger) of a Subsidiary Guarantor, including the sale or disposition of Capital


93


Table of Contents

  Stock of a Subsidiary Guarantor, following which such Subsidiary Guarantor is no longer a Subsidiary of the Parent; or
 
  (2)  the sale or disposition of all or substantially all the assets of a Subsidiary Guarantor;
 
in each case other than to the Parent or a Subsidiary of the Parent and as permitted by the indenture and if in connection therewith the Parent provides a certificate to the trustee to the effect that the Parent will comply with its obligations described below under “—Covenants—Limitation on Asset Sales” in respect of such disposition. Upon any sale or disposition described in clause (1) or (2) above, the obligor on the related Subsidiary Guaranty will be released from its obligations thereunder.
 
The Subsidiary Guaranty of a Subsidiary Guarantor also will be released under specified circumstances, including in connection with a disposition of a Subsidiary Guarantor’s Capital Stock if various conditions are satisfied. See “—Covenants—Future Guaranties by Restricted Subsidiaries.”
 
Optional Redemption
 
Optional Redemption.  Except as described below, the Issuers are not entitled to redeem any Notes prior to February 15, 2015. The Notes will be redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on and after February 15, 2015, upon not less than 30 days’ nor more than 60 days’ notice, at the following redemption prices (expressed as percentages of the principal amount thereof) if redeemed during the 12-month period commencing on February 15 of the years indicated below, in each case together with accrued and unpaid interest thereon to the redemption date:
 
         
Year
  Redemption Price
 
2015
    103.875 %
2016
    101.938 %
2017 and thereafter
    100.00 %
 
Prior to February 15, 2015, the Issuers will be entitled, at their option, to redeem all or a portion of the Notes at a redemption price equal to 100% of the principal amount of the Notes plus the Applicable Premium as of, and accrued and unpaid interest to, the redemption date (subject to the right of holders on the relevant record date to receive interest due on the relevant interest payment date). Notice of such redemption must be mailed by first-class mail to each holder’s registered address or as otherwise provided in accordance with the procedures of DTC, not less than 30 nor more than 60 days prior to the redemption date.
 
“Applicable Premium” means with respect to a Note at any redemption date, the greater of (1) 1.00% of the principal amount of such Note and (2) the excess of (A) the present value at such redemption date of (i) the redemption price of such Note on February 15, 2015 (such redemption price being described in the first paragraph in this “—Optional Redemption” section exclusive of any accrued interest) plus (ii) all required remaining scheduled interest payments due on such Note through February 15, 2015 (but excluding accrued and unpaid interest to the redemption date), computed using a discount rate equal to the Adjusted Treasury Rate, over (B) the principal amount of such Note on such redemption date.
 
“Adjusted Treasury Rate” means, with respect to any redemption date, (1) the yield, under the heading which represents the average for the immediately preceding week, appearing in the most recently published statistical release designated “H.15(519)” or any successor publication which is published weekly by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption “Treasury Constant Maturities,” for the maturity corresponding to the Comparable Treasury Issue (if no maturity is within three months before or after February 15, 2015, yields for the two published maturities most closely corresponding to the Comparable Treasury Issue shall be determined and the Adjusted Treasury Rate shall be interpolated or extrapolated from such yields on a straight line basis, rounding to the nearest month) or (2) if such release (or any successor


94


Table of Contents

release) is not published during the week preceding the calculation date or does not contain such yields, the rate per year equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date, in each case calculated by the Issuers on the third Business Day immediately preceding the redemption date, in each case, plus 0.50%.
 
“Comparable Treasury Issue” means the United States Treasury security selected by the Quotation Agent as having a maturity comparable to the remaining term of the Notes from the redemption date to February 15, 2015, that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of a maturity most nearly equal to February 15, 2015.
 
“Comparable Treasury Price” means, with respect to any redemption date, if clause (2) of the Adjusted Treasury Rate definition is applicable, the average of three, or such lesser number as is obtained by the Issuers, Reference Treasury Dealer Quotations for such redemption date.
 
“Quotation Agent” means the Reference Treasury Dealer selected by the Issuers.
 
“Reference Treasury Dealer” means each of Banc of America Securities LLC and its successors and assigns, Morgan Stanley & Co. Incorporated and its successors and assigns and RBC Capital Markets, LLC and its successors and assigns.
 
“Reference Treasury Dealer Quotations” means with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by the Issuers, of the bid and asked prices for the Comparable Treasury Issue, expressed in each case as a percentage of its principal amount, quoted in writing to the trustee by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third Business Day immediately preceding such redemption date.
 
Optional Redemption upon Equity Offerings.  At any time, or from time to time, on or prior to February 15, 2014, the Issuers are entitled, at their option, to use an amount equal to all or a portion of the Net Cash Proceeds of one or more Equity Offerings to redeem up to 35% of the principal amount of the Notes (together with any additional notes) issued under the indenture at a redemption price of 107.750% of the principal amount thereof plus accrued and unpaid interest thereon, if any, to the date of redemption; provided, however, that:
 
  (1)  at least 65% of the principal amount of Notes originally issued under the indenture remains outstanding immediately after such redemption; and
 
  (2)  the Issuers make such redemption not more than 120 days after the consummation of any such Equity Offering.
 
The Issuers or their Affiliates are entitled to acquire Notes by means other than a redemption from time to time, including through open market purchases, privately negotiated transactions, tender offers, exchange offers or otherwise, so long as such acquisition does not otherwise violate the terms of the indenture, upon such terms and at such prices as the Issuers or their Affiliates may determine, which may be more or less than the consideration for which the Notes offered hereby are being sold and may be less than any redemption price then in effect and could be for cash or other consideration.


95


Table of Contents

 
Selection and Notice of Redemption for Optional Redemptions
 
In the event that the Issuers elect to redeem less than all of the Notes, selection of the Notes for redemption will be made by the trustee either:
 
  (1)  in compliance with the requirements of the principal national securities exchange, if any, on which the Notes are then listed; or
 
  (2)  on a pro rata basis, by lot or by such method as the trustee will deem fair and appropriate.
 
No Notes of a principal amount of $2,000 or less will be redeemed in part. If a partial redemption is made with the proceeds of an Equity Offering, the trustee will select the Notes on a pro rata basis to the extent practicable, by lot or such other method as the trustee in its sole discretion shall deem to be fair and appropriate, unless another method is required by law or applicable exchange or depositary requirements (subject to DTC procedures). Notice of redemption will be mailed by first-class mail or as otherwise provided in accordance with the procedures of DTC at least 30 but not more than 60 days before the redemption date to each holder of Notes to be redeemed at its registered address, except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with a defeasance of the Notes or a satisfaction and discharge of the indenture. Notices of redemption may be given prior to the completion of an Equity Offering, and any redemption or notice may, at the Issuers’ discretion, be subject to the completion of an Equity Offering. Unless the Issuers default in the payment of the redemption price, on and after the redemption date, interest will cease to accrue on Notes or portions thereof called for redemption.
 
Sinking Fund
 
There will be no sinking fund payments for the Notes.
 
Ranking
 
The Notes are senior unsecured obligations of the Issuers, and rank equally in right of payment with other existing and future unsecured senior Indebtedness of the Issuers. The Notes are effectively junior to all of the Issuers’ secured Indebtedness to the extent of the value of the collateral securing such debt, including our $25.0 million revolving credit facility, contractually subordinated to the Indebtedness of the Subordinated Guaranty Subsidiaries under the Acquisition Line and the Term Loan (and any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan, including our existing swap arrangements relating to $200.0 million of our outstanding Indebtedness under the Term Loan) and structurally subordinated to all Indebtedness of the Real Property Non-Guarantor Subsidiaries. As of March 31, 2011, after giving pro forma effect to the sale of the Old Notes and the use of proceeds therefrom:
 
  (1)  the Issuers and Subsidiary Guarantors, on a consolidated basis, would have had approximately $501.0 million of Indebtedness outstanding, including the Notes, $199.3 million of which would have been comprised of secured Indebtedness of the Subordinated Guaranty Subsidiaries outstanding under our Term Loan (all of which would be contractually and effectively senior to the subordinated guaranties in favor of the Notes);
 
  (2)  the Issuers and Senior Guaranty Subsidiaries would have had $14.8 million in secured borrowings available under our revolving credit facility given the borrowing base requirements of the facility (all of which would be effectively senior to the Notes to the extent of the value of the underlying assets);


96


Table of Contents

 
  (3)  the Subordinated Guaranty Subsidiaries would have had $100.0 million in secured borrowings available under our Acquisition Line (all of which would be contractually and effectively senior to the subordinated guaranties in favor of the Notes); and
 
  (4)  the Real Property Non-Guarantor Subsidiaries would have had $9.1 million of Indebtedness outstanding (all of which would have been structurally senior to the Notes).
 
The guarantee of each Senior Guaranty Subsidiary is an unsecured senior obligation of such Senior Guaranty Subsidiary and ranks equally in right of payment with all existing and future unsecured senior Indebtedness of such Senior Guaranty Subsidiary. The guarantee of each Subordinated Guaranty Subsidiary is an unsecured subordinated obligation of such Subordinated Guaranty Subsidiary and ranks equally with all existing and future unsecured senior Indebtedness of such Subordinated Guaranty Subsidiary except that the such guarantee is subordinated to the Indebtedness of such Subordinated Guaranty Subsidiary under the Acquisition Line and the Term Loan (or any Permitted Refinancing Indebtedness incurred in exchange for, or the net proceeds of which are used to refund, refinance or replace, the Acquisition Line or Term Loan and that was otherwise permitted by the indenture) and any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan. See “—Guaranties and Subsidiary Guarantors” for a description of which entities will guarantee the Notes.
 
Subordination of Guaranties of Subordinated Guaranty Subsidiaries
 
The indenture provides that no payments or distributions may be made by the Subordinated Guaranty Subsidiaries on their guaranties of the Notes until the full and final payment in cash and performance of all obligations under the documents governing the Acquisition Line and the Term Loan and any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan. If any payment or distribution is received by the Trustee or any holder of Notes prior to the full and final payment in cash and performance of all obligations under the documents governing the Acquisition Line and the Term Loan and any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan, then the holder thereof will generally be required to deliver such payment or distribution to General Electric Capital Corporation in its capacity as Administrative Agent (the “Senior Agent”) for the lenders under the Acquisition Line and the Term Loan and the counterparties under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan to the extent necessary to pay the Acquisition Line, the Term Loan and any obligations under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan in full in cash, and, until so delivered, the same shall be held in trust as the property of the Senior Agent and the lenders under the Acquisition Line and the Term Loan and the counterparties under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan. Notwithstanding the foregoing, subject to compliance with the documents governing the Acquisition Line and the Term Loan and any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan, the Subordinated Guaranty Subsidiaries will be entitled to make dividends and distributions to their equity owners (including, ultimately, the Senior Guaranty Subsidiaries and the Issuers which are not subject to subordination provisions under the indenture).
 
Neither the Trustee nor any holder of Notes shall challenge the existence or priority of the Acquisition Line, the Term Loan or any secured Currency Agreements or Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan or declare any of the Subordinated Guaranty Subsidiaries’ guaranties of the Notes to be due and payable or otherwise accelerate the maturity of the principal of such guaranties until the full and final payment in cash and performance of all obligations under the documents governing the Acquisition Line and the Term Loan and any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan.


97


Table of Contents

 
Further, neither the Trustee nor any holder of Notes shall contest the validity, perfection, priority or enforceability of any Lien granted or ostensibly granted by any Subordinated Subsidiary Guarantor to, or arising in favor of, the Senior Agent or any lender under the Acquisition Line or the Term Loan or any counterparty under any secured Currency Agreements or Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan, any payment on the Acquisition Line, the Term Loan or any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan, or the allowance of the Acquisition Line, the Term Loan or any secured Currency Agreements or Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan as a senior secured claim. Further, neither the Trustee nor any holder of Notes shall have any right to seek, be party to, or accept any Lien granted by any Subordinated Subsidiary Guarantor or enforce any such Lien.
 
Upon any payment or distribution of the assets of the Subordinated Guaranty Subsidiaries upon a total or partial liquidation or dissolution or reorganization of or bankruptcy or similar proceeding relating to such Subordinated Guaranty Subsidiaries or their property:
 
  (1)  the lenders under the Acquisition Line and the Term Loan and the counterparties under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan shall first be fully and finally paid in cash before the holders of the Notes are entitled to receive any payment;
 
  (2)  until the Acquisition Line, the Term Loan and any obligations under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan are fully and finally paid in cash, any payment or distribution to which the holders of the Notes would be entitled but for the subordination provisions of the indenture will be made to lenders under the Acquisition Line and the Term Loan and the counterparties under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan in accordance with the priorities then existing among such lenders to the extent necessary to pay in full all such amounts then remaining unpaid, except that the holders of the Notes may receive certain securities that are subordinate and junior in right of payment to the payment of the Acquisition Line, the Term Loan and any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan;
 
  (3)  until the Acquisition Line, the Term Loan and any obligations under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan are fully and finally paid in cash, (i) all or any lenders under the Acquisition Line and the Term Loan and any counterparties under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan may provide financing to the applicable Subordinated Guaranty Subsidiaries or any of their affiliates and subsidiaries pursuant to Section 364 of the U.S. federal Bankruptcy Code or other applicable law on such terms and conditions and in such amounts as such lenders, in their sole discretion, may decide, without seeking or obtaining the consent of the Trustee or any holder of Notes and (ii) the Trustee and the holders of the Notes shall not oppose or object to the payment of interest as provided under Section 506(b) and (c) of the U.S. federal Bankruptcy Code to any lenders under the Acquisition Line and the Term Loan or counterparties under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan; and
 
  (4)  if a distribution is made to holders of Notes that, due to the subordination provisions of the indenture, should not have been made to them, such holders of Notes are required to hold it in trust for the lenders under the Acquisition Line and the Term Loan and the counterparties under


98


Table of Contents

  any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan.
 
Notwithstanding the foregoing, the holders of the Notes and the Trustee (i) may file a proof of claim in a bankruptcy or similar proceeding involving any Subordinated Guaranty Subsidiary, which proof of claim shall indicate the subordination provisions of the indenture and (ii) shall be entitled to file any necessary responsive or defensive pleadings in opposition to any motion, claim, adversary proceeding or other pleading made by any Person objecting to or otherwise seeking the disallowance of the claims of the holders of the Notes.
 
The Subordinated Guaranty Subsidiaries have agreed in the indenture that they will not incur or suffer to exist any indebtedness that is senior in right of payment to the applicable Subordinated Guaranty Subsidiary’s guaranty other than the Acquisition Line and the Term Loan (or any Permitted Refinancing Indebtedness incurred in exchange for, or the net proceeds of which are used to refund, refinance or replace, the Acquisition Line or Term Loan and that was otherwise permitted by the indenture) and any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan. In the event that the Acquisition Line or the Term Loan are refinanced by Permitted Refinancing Indebtedness, the subordination provisions described above will be permitted to apply equivalently to such Permitted Refinancing Indebtedness.
 
The subordination provisions described above will not prevent a Default from occurring under the indenture upon the failure of the Issuers to pay interest or principal with respect to the Notes when due by their terms.
 
Because amounts otherwise payable to the holders of the Notes by the Subordinated Guaranty Subsidiaries in a bankruptcy or similar proceeding are required to be paid to the lenders under the Acquisition Line and the Term Loan and the counterparties under any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan instead, the holders of the Notes may receive less, ratably, than the holders of trade payables or other unsecured, unsubordinated creditors in any such proceeding. Holders of the Notes may not be fully repaid if we or the Subordinated Guaranty Subsidiaries become insolvent or otherwise fail to make payment on the Notes.
 
A holder by its acceptance of Notes agrees to be bound by such provisions and authorizes and expressly directs the Trustee, on its behalf, to take such action as may be necessary or appropriate to effectuate the subordination provided for in the indenture and appoints the Trustee its attorney-in-fact for such purpose.
 
Suspension of Covenants
 
During a Suspension Period, the Parent and its Restricted Subsidiaries will not be subject to the following corresponding provisions of the indenture:
 
  •     “—Covenants—Limitation on Indebtedness”;
 
  •     “—Covenants—Maintenance of Total Unencumbered Assets”;
 
  •     “—Covenants—Limitation on Restricted Payments”;
 
  •     “—Covenants—Limitation on Dividend and other Payment Restrictions Affecting Restricted Subsidiaries”;
 
  •     “—Covenants—Future Guaranties by Restricted Subsidiaries”;


99


Table of Contents

 
  •     “—Covenants—Limitation on Transactions with Affiliates”;
 
  •     “—Covenants—Limitation on Asset Sales”;
 
  •     “—Covenants—Prohibition on Incurrence of Senior Debt by the Subordinated Guaranty Subsidiaries”; and
 
  •     clause (3) of the “Consolidation, Merger and Sale of Assets” covenant.
 
All other provisions of the indenture will apply at all times during any Suspension Period so long as any Notes remain outstanding thereunder.
 
“Suspension Period” means any period:
 
  (1)  beginning on the date that:
 
  (A)  the Notes have Investment Grade Status;
 
  (B)  no Default or Event of Default has occurred and is continuing; and
 
  (C)  the Issuers have delivered an officers’ certificate to the trustee certifying that the conditions set forth in clauses (A) and (B) above are satisfied; and
 
  (2)  ending on the date (the “Reversion Date”) that the Notes cease to have Investment Grade Status.
 
On each Reversion Date, all Indebtedness, liens thereon and dividend blockages incurred during the Suspension Period prior to such Reversion Date will be deemed to have been outstanding on the Issue Date.
 
For purposes of calculating the amount available to be made as Restricted Payments under clause (C) of the first paragraph of the “—Limitation on Restricted Payments” covenant, calculations under that clause will be made with reference to the Transaction Date, as set forth in that clause. Accordingly, (x) Restricted Payments made during the Suspension Period not otherwise permitted pursuant to any of clauses (1) through (12) under the third paragraph under the “Limitation on Restricted Payments” covenant will reduce the amount available to be made as Restricted Payments under clause (C) of the first paragraph of such covenant; provided, however, that the amount available to be made as a Restricted Payment on the Transaction Date shall not be reduced to below zero solely as a result of such Restricted Payments, but may be reduced to below zero as a result of negative cumulative Adjusted Funds From Operations during the Suspension Period for the purpose of the first bullet under clause (C) of the first paragraph of such covenant, and (y) the items specified in the five bullets under clause (C) of the first paragraph of such covenant that occur during the Suspension Period will increase the amount available to be made as a Restricted Payment under clause (C) of the first paragraph of such covenant. Any Restricted Payment made during the Suspension Period that is of the type described in the third paragraph of the “Limitation on Restricted Payments” covenant (other than the Restricted Payment referred to in clause (2) of the such third paragraph or an exchange of Capital Stock for Capital Stock or Indebtedness referred to in clause (3) or (4) of such third paragraph), and the Net Cash Proceeds from any issuance of Capital Stock referred to in clauses (3) and (4) of the third paragraph of the “Limitation on Restricted Payments” covenant, shall be included in calculating the amounts permitted to be incurred under such clause (C) on each Reversion Date. For purposes of the “—Limitation on Asset Sales” covenant, on each Reversion Date, the unutilized Excess Proceeds will be reset to zero. No Default or Event of Default will be deemed to have occurred on the Reversion Date (or thereafter) under any Suspended Covenant solely as a result of any actions taken by the Parent, the Issuers or any Restricted Subsidiaries thereof, or events occurring, during the Suspension Period. For purposes of the “—Maintenance of Total Unencumbered Assets” covenant, if the Issuers and their Restricted Subsidiaries are not in compliance with such covenant as of a Reversion Date, no Default or Event of Default will be deemed to have occurred for up


100


Table of Contents

to 120 days following the Reversion Date, provided that neither the Issuers nor any of their Restricted Subsidiaries shall incur any Secured Indebtedness until such time that the requirements of such covenant have been satisfied.
 
Covenants
 
The indenture contains, among others, the following covenants:
 
Limitation on Indebtedness
 
  (1)  The Parent will not Incur any Indebtedness (including Acquired Indebtedness) other than the guarantees issued on the Issue Date, other Indebtedness existing on the Issue Date, and guarantees of Indebtedness of the Issuers or any other Restricted Subsidiary of the Parent provided such Indebtedness is permitted by and Incurred in accordance with this covenant. The Parent will not permit any of its Restricted Subsidiaries (including the Issuers) to Incur any Indebtedness (including Acquired Indebtedness) if, immediately after giving effect to the Incurrence of such additional Indebtedness and the receipt and application of the proceeds therefrom, the aggregate principal amount of all outstanding Indebtedness of the Parent and its Restricted Subsidiaries on a consolidated basis is greater than 60% of Adjusted Total Assets.
 
  (2)  The Issuers will not, and will not permit any of their Restricted Subsidiaries to, Incur any Secured Indebtedness (including Acquired Indebtedness) if, immediately after giving effect to the Incurrence of such additional Secured Indebtedness and the receipt and application of the proceeds therefrom, the aggregate principal amount of all outstanding Secured Indebtedness of the Issuers and their Restricted Subsidiaries on a consolidated basis is greater than 40% of Adjusted Total Assets.
 
  (3)  The Parent will not permit any of its Restricted Subsidiaries (including the Issuers) to Incur any Indebtedness (including Acquired Indebtedness); provided, however, that the Issuers or any of the Subsidiary Guarantors may Incur Indebtedness (including Acquired Indebtedness) if, after giving effect to the Incurrence of such Indebtedness and the receipt and application of the proceeds therefrom, the Interest Coverage Ratio of the Issuers and their Restricted Subsidiaries on a consolidated basis would be at least 2.0 to 1.0.
 
  (4)  Notwithstanding paragraphs (1), (2) or (3) above, the Parent or any of its Restricted Subsidiaries (except as specified below) may Incur each and all of the following:
 
  (A)  Indebtedness of the Parent, the Issuers or any of the Subsidiary Guarantors outstanding under any Credit Facility at any time in an aggregate principal amount not to exceed $400 million;
 
  (B)  Indebtedness of the Issuers or any of their Restricted Subsidiaries owed to:
 
  •     the Issuers evidenced by an unsubordinated promissory note, or
 
  •     any Restricted Subsidiary;
 
provided, however, that any event that results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary of the Issuers or any subsequent transfer of such Indebtedness (other than to the Issuers or any other Restricted Subsidiary of the Issuers) shall be deemed, in each case, to constitute an Incurrence of such Indebtedness not permitted by this clause (B);


101


Table of Contents

 
  (C)  Indebtedness of the Issuers or any of their Restricted Subsidiaries under Currency Agreements and Interest Rate Agreements; provided that such agreements (i) are designed primarily to protect the Issuers or any of their Restricted Subsidiaries against fluctuations in foreign currency exchange rates or interest rates (whether fluctuations of fixed to floating rate interest or floating to fixed rate interest) and (ii) do not increase the Indebtedness of the obligor outstanding at any time other than as a result of fluctuations in foreign currency exchange rates or interest rates or by reason of fees, indemnities and compensation payable thereunder;
 
  (D)  Indebtedness of the Issuers or any of the Subsidiary Guarantors, to the extent the net proceeds thereof are promptly:
 
  •     used to purchase Notes tendered in an Offer to Purchase made as a result of a Change in Control,
 
  •     used to redeem all the Notes as described above under “Optional Redemption,”
 
  •     deposited to defease the Notes as described below under “Defeasance,” or
 
  •     deposited to discharge the obligations under the Notes and indenture as described below under “Satisfaction and Discharge”;
 
  (E)  (i) Guarantees by the Parent of Indebtedness of the Issuers or any of the Subsidiary Guarantors, (ii) Guarantees by any Restricted Subsidiaries of the Issuers of Indebtedness of the Issuers provided the guarantee of such Indebtedness is permitted by and made in accordance with the “Future Guaranties by Restricted Subsidiaries” covenant described below, and (iii) any Guarantees by a Subsidiary Guarantor of any Indebtedness of any other Subsidiary Guarantor;
 
  (F)  Existing Indebtedness;
 
  (G)  Indebtedness represented by the Notes and the Guaranties issued on the Issue Date and the exchange notes and related exchange guarantees to be issued in exchange for such Notes and Guaranties pursuant to the registration rights agreement;
 
  (H)  Indebtedness consisting of obligations to pay insurance premiums incurred in the ordinary course of business;
 
  (I)  Indebtedness in respect of any bankers’ acceptance, bank guarantees, letter of credit, warehouse receipt or similar facilities, and reinvestment obligations related thereto, entered into in the ordinary course of business;
 
  (J)  Indebtedness in respect of workers’ compensation claims, self-insurance obligations, indemnities, bankers’ acceptances, performance, completion and surety bonds or guarantees and similar types of obligations in the ordinary course of business;
 
  (K)  Indebtedness represented by cash management obligations and other obligations in respect of netting services, automatic clearinghouse arrangements, overdraft protections and similar arrangements in each case in connection with deposit accounts;
 
  (L)  Indebtedness supported by a letter of credit procured by the Issuers or their Restricted Subsidiaries in a principal amount not in excess of the stated amount of such letter of credit and where the underlying Indebtedness would otherwise be permitted;


102


Table of Contents

 
  (M)  Guarantees (a) incurred in the ordinary course of business or (b) constituting Investments that are (i) included in the calculation of the amount available to be made as Restricted Payments under clause (C) of the first paragraph of the “—Limitation on Restricted Payments” covenant, (ii) made pursuant to clause (11) under the third paragraph under the “—Limitation on Restricted Payments” covenant or (iii) made in reliance on clause (9) or (18) of the definition of “Permitted Investments”;
 
  (N)  Permitted Refinancing Indebtedness incurred in exchange for, or the net proceeds of which are used to refund, refinance or replace, Indebtedness (other than intercompany Indebtedness) that was permitted by the indenture to be incurred under the provisions of paragraphs (1), (2) or (3) of this covenant or clauses (F), (G), (N), (O) or (P) of this paragraph (4);
 
  (O)  Indebtedness of Restricted Subsidiaries that are not Subsidiary Guarantors in an aggregate principal amount at any time outstanding not to exceed, when taken together with all then outstanding net Investments in Unrestricted Subsidiaries and joint ventures made in reliance on clause (9) of the definition of “Permitted Investments,” the greater of $20 million and 2.0% of the Adjusted Total Assets of such Restricted Subsidiaries; provided, however, that any Permitted Refinancing Indebtedness incurred under clause (N) above in respect of Indebtedness incurred under this clause (O) shall be deemed to have been incurred under this clause (O) for purposes of determining the amount of Indebtedness that may at any time be incurred under this clause (O); or
 
  (P)  additional Indebtedness of the Issuers and Restricted Subsidiaries in an aggregate principal amount at any time outstanding not to exceed the greater of $20 million and 2.0% of the Parent’s Adjusted Total Assets; provided, however, that any Permitted Refinancing Indebtedness incurred under clause (N) above in respect of Indebtedness incurred under this clause (P) shall be deemed to have been incurred under this clause (P) for purposes of determining the amount of Indebtedness that may at any time be incurred under this clause (P).
 
  (5)  Notwithstanding any other provision of this “Limitation on Indebtedness” covenant, the maximum amount of Indebtedness that the Parent or any of its Restricted Subsidiaries may Incur pursuant to this “Limitation on Indebtedness” covenant shall not be deemed to be exceeded, with respect to any outstanding Indebtedness, due solely to the result of fluctuations in the exchange rates of currencies. Further, notwithstanding any other provision of this “Limitation on Indebtedness” covenant, the maximum principal amount of Indebtedness, other than obligations under Currency Agreements and Interest Rate Agreements, that the Subordinated Guaranty Subsidiaries may Incur pursuant to this “Limitation on Indebtedness” covenant shall not exceed $340 million, which amount shall be permanently reduced by any scheduled amortization or mandatory repayments (other than out of the net proceeds of any Permitted Refinancing Indebtedness incurred which are used to refund, refinance or replace such Indebtedness) of such Indebtedness of such Subordinated Guaranty Subsidiaries.
 
  (6)  For purposes of determining any particular amount of Indebtedness under this “Limitation on Indebtedness” covenant,
 
  •     Indebtedness Incurred and outstanding under the Credit Agreement, our Acquisition Line or our Term Loan on or prior to the Issue Date shall be treated as Incurred pursuant to clause (A) of paragraph (4) of this “Limitation on Indebtedness” covenant, and
 
  •     Guarantees, Liens or obligations with respect to letters of credit supporting Indebtedness otherwise included in the determination of such particular amount shall not be included.


103


Table of Contents

 
For purposes of determining compliance with this covenant, in the event that an item of Indebtedness meets the criteria of more than one of the categories of permitted Indebtedness described in clauses (A) through (P) of paragraph (4) above or is entitled to be incurred pursuant to paragraphs (1), (2) and (3) above, the Issuers shall, in their sole discretion, be entitled to classify all or a portion of such item of Indebtedness on the date of its incurrence or issuance and determine the order of such incurrence or issuance (and may later reclassify such item of Indebtedness) and may divide and classify such Indebtedness in more than one of the types of Indebtedness described. At any time that the Issuers would be entitled to have incurred any then outstanding Indebtedness under paragraphs (1), (2) and (3) of this covenant, such Indebtedness shall be automatically reclassified into Indebtedness incurred pursuant to those paragraphs. Indebtedness permitted by this covenant need not be permitted solely by reference to one provision permitting such Indebtedness, but may be permitted in part by one such provision and in part by one or more other provisions of this covenant permitting such Indebtedness. For the avoidance of doubt, the outstanding principal amount of any particular Indebtedness shall be counted only once and any obligations arising under any guarantee, Lien, letter of credit or similar instrument supporting such Indebtedness shall not be double counted.
 
For purposes of determining compliance with any U.S. dollar-denominated restriction on the incurrence of Indebtedness, the U.S. dollar-equivalent principal amount of Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was incurred, in the case of term debt, or first committed, in the case of revolving credit debt; provided, however, that if such Indebtedness is incurred to refinance other Indebtedness denominated in a foreign currency, and such refinancing would cause the applicable U.S. dollar-denominated restriction to be exceeded if calculated at the relevant currency exchange rate in effect on the date of such refinancing, such U.S. dollar-denominated restriction shall be deemed not to have been exceeded so long as the principal amount of such refinancing Indebtedness does not exceed the principal amount of such Indebtedness being refinanced, plus the amount of any reasonable premium (including reasonable tender premiums), defeasance costs and any reasonable fees and expenses incurred in connection with the issuance of such new Indebtedness. The principal amount of any Indebtedness incurred to refinance other Indebtedness, if incurred in a different currency from the Indebtedness being refinanced, shall be calculated based on the currency exchange rate applicable to the currencies in which such respective Indebtedness is denominated that is in effect on the date of such refinancing.
 
Maintenance of Total Unencumbered Assets
 
The Issuers and their Restricted Subsidiaries will maintain Total Unencumbered Assets of not less than 150% of the aggregate outstanding principal amount of the Unsecured Indebtedness of the Issuers and their Restricted Subsidiaries on a consolidated basis.
 
Limitation on Restricted Payments
 
The Parent will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly:
 
  (1)  declare or pay any dividend or make any distribution on or with respect to Capital Stock of the Parent or of any Restricted Subsidiary of the Parent held by Persons other than the Parent or any of its Restricted Subsidiaries, other than (i) dividends or distributions payable solely in shares of its Capital Stock (other than Disqualified Stock) and (ii) pro rata dividends or other distributions made by a Subsidiary that is not wholly owned to minority stockholders (or owners of equivalent interests in the event the Subsidiary is not a corporation);
 
  (2)  purchase, redeem, retire or otherwise acquire for value any shares of Capital Stock of the Parent held by any Person (other than a Restricted Subsidiary of the Parent);
 
  (3)  make any voluntary or optional principal payment, or voluntary or optional redemption, repurchase, defeasance, or other acquisition or retirement for value, of Indebtedness of the Issuers


104


Table of Contents

  that is subordinated in right of payment to the Notes or Indebtedness of a Subsidiary Guarantor that is subordinated in right of payment to the Subsidiary Guaranty of such Subsidiary Guarantor, in each case excluding (i) any intercompany Indebtedness between or among the Parent, the Issuers or any of the Subsidiary Guarantors and (ii) the payment, purchase, redemption, defeasance, acquisition or retirement (collectively, a “purchase”) of such subordinated Indebtedness purchased in anticipation of satisfying a sinking fund obligation, principal installment or final maturity, in each case due within one year of the date of such purchase; or
 
  (4)  make an Investment, other than a Permitted Investment, in any Person
 
(such payments or any other actions described in clauses (1) through (4) above being collectively “Restricted Payments”) if, at the time of, and after giving effect to, the proposed Restricted Payment:
 
  (A)  a Default or Event of Default shall have occurred and be continuing,
 
  (B)  the Issuers could not Incur at least $1.00 of Indebtedness in compliance with both paragraphs (1) and (3) of the “Limitation on Indebtedness” covenant, or
 
  (C)  the aggregate amount of all Restricted Payments (the amount, if other than in cash, to be determined in good faith by the Board of Directors of the Parent, whose determination shall be conclusive and evidenced by a Board Resolution) made after the Issue Date shall exceed the sum of, without duplication:
 
  •     95% of the aggregate amount of the Adjusted Funds From Operations (or, if the Adjusted Funds From Operations is a loss, minus 100% of the amount of such loss) accrued on a cumulative basis during the period (taken as one accounting period) beginning on the first day of the fiscal quarter during which the Issue Date occurs and ending on the last day of the last fiscal quarter preceding the Transaction Date for which reports have been filed with the SEC or provided to the trustee pursuant to the “SEC Reports and Reports to Holders” covenant (or if no such reports have yet been required to be filed with the SEC pursuant to the indenture, for which internal financial statements are available), plus
 
  •     100% of the aggregate Net Cash Proceeds received by the Parent after the Issue Date from the issuance and sale of its Capital Stock (other than Disqualified Stock) to a Person who is not a Subsidiary of the Parent, including from an issuance or sale permitted by the indenture of Indebtedness of the Parent or any of its Restricted Subsidiaries for cash subsequent to the Issue Date upon the conversion of such Indebtedness into Capital Stock (other than Disqualified Stock) of the Parent but excluding any options, warrants or other rights that are redeemable at the option of the holder for cash or Indebtedness, or are required to be redeemed, prior to the Stated Maturity of the Notes, plus
 
  •     an amount equal to the net reduction in Investments (other than reductions in Permitted Investments) in any Person after the Issue Date resulting from payments of interest on Indebtedness, dividends, repayments of loans or advances, or other transfers of assets, in each case to the Parent or any of its Restricted Subsidiaries or from the Net Cash Proceeds from the sale of any such Investment (except, in each case, to the extent any such payment or proceeds are included in the calculation of Adjusted Funds From Operations) or from redesignations of Unrestricted Subsidiaries as Restricted Subsidiaries (valued in each case as provided in the definition of “Investments”) not to exceed, in each case, the amount of Investments previously made by the Parent and its Restricted Subsidiaries in such Person or Unrestricted Subsidiary and treated as a Restricted Payment, plus


105


Table of Contents

 
  •     the fair market value of noncash tangible assets or Capital Stock acquired in exchange for an issuance of Capital Stock (other than Disqualified Stock or Capital Stock issued in exchange for Capital Stock of the Parent utilized pursuant to clauses (3) or (4) of the second succeeding paragraph) of the Parent subsequent to the Issue Date (including upon conversion or exchange of the Common Units for Capital Stock of the Parent, in which case the fair market value shall equal the fair market value received upon issuance of such Common Units), plus
 
  •     without duplication, in the event the Parent or any Restricted Subsidiary of the Parent makes any Investment in a Person that, as a result of or in connection with such Investment, becomes a Restricted Subsidiary of the Parent, an amount not to exceed the amount of Investments previously made by the Parent and its Restricted Subsidiaries in such Person and treated as a Restricted Payment.
 
Notwithstanding the foregoing, the Parent and any of its Restricted Subsidiaries may declare or pay any dividend or make any distribution or take other action (that would have otherwise been a Restricted Payment) that is necessary to maintain the Parent’s status as a REIT under the Code if (i) the aggregate principal amount of all outstanding Indebtedness of the Parent and its Restricted Subsidiaries on a consolidated basis at such time is less than 60% of Adjusted Total Assets and (ii) no Default or Event of Default shall have occurred and be continuing.
 
The foregoing provisions shall not be violated by reason of:
 
  (1)  the payment of any dividend or distribution or the consummation of any redemption within 60 days after the date of declaration thereof or the giving of a redemption notice related thereto, as the case may be, if, at said date of declaration or notice, such payment would comply with the foregoing paragraph;
 
  (2)  the payment, redemption, repurchase, defeasance or other acquisition or retirement for value of Indebtedness that is subordinated in right of payment to the Notes or to a Subsidiary Guaranty including premium, if any, and accrued and unpaid interest, with the proceeds of, or in exchange for, Indebtedness Incurred in compliance with paragraph (1), (2) or (3) or pursuant to clause (N) of paragraph (4) of the “—Limitation on Indebtedness” covenant;
 
  (3)  (a) the making of any Restricted Payment in exchange for, or out of the proceeds of the substantially concurrent sale of, Capital Stock of the Parent (other than any Disqualified Stock or any Capital Stock sold to a Restricted Subsidiary of the Parent or to an employee stock ownership plan or any trust established by the Parent) or from substantially concurrent contributions to the equity capital of the Parent (collectively, including any such contributions, “Refunding Capital Stock”) (with any offering within 90 days deemed as substantially concurrent); and (b) the declaration and payment of accrued dividends on any Capital Stock redeemed, repurchased, retired, defeased or acquired out of the proceeds of the sale of Refunding Capital Stock within 90 days of such sale; provided, that the amount of any such proceeds or contributions that are utilized for any Restricted Payment pursuant to this clause (3) shall be excluded from the amount described in the second bullet of clause (4)(C) of this covenant;
 
  (4)  the making of any principal payment on, or the repurchase, redemption, retirement, defeasance or other acquisition for value of, Indebtedness of the Issuers that is subordinated in right of payment to the Notes or Indebtedness of a Subsidiary Guarantor that is subordinated in right of payment to the Subsidiary Guaranty of such Subsidiary Guarantor in exchange for, or out of the proceeds of, an issuance of, shares of the Capital Stock (other than Disqualified Stock) of the


106


Table of Contents

  Parent within 90 days of such principal payment, repurchase, redemption, retirement, defeasance or other acquisition;
 
  (5)  payments or distributions to dissenting stockholders pursuant to applicable law pursuant to or in connection with a consolidation, merger or transfer of assets that complies with the provisions of the indenture applicable to mergers, consolidations and transfers of all or substantially all of the property and assets of the Parent;
 
  (6)  the payment of regularly scheduled cash dividends on shares of Redeemable Cumulative Preferred Stock in an amount not to exceed $15,625 per calendar year;
 
  (7)  the repurchase, redemption or other acquisition or retirement for value of any shares of Capital Stock of the Parent held by any current or former officer, director, consultant or employee of the Parent or any of its Restricted Subsidiaries (or any permitted transferees, assigns, estates or heirs of any of the foregoing); provided, however, the aggregate amount paid by the Parent and its Restricted Subsidiaries pursuant to this clause (7) shall not exceed $5.0 million in any calendar year (excluding for purposes of calculating such amount the amount paid for Capital Stock repurchased, redeemed, acquired or retired with the cash proceeds from the repayment of outstanding loans previously made by the Parent or a Restricted Subsidiary thereof for the purpose of financing the acquisition of such Capital Stock), with unused amounts in any calendar year being carried over for one additional calendar year; provided further, that such amount in any calendar year may be increased by an amount not to exceed: (A) the net cash proceeds from the sale of Capital Stock (other than Disqualified Stock) of the Parent, in each case, to officers, directors, consultants or employees of the Parent or any of its Subsidiaries that occurs after the Issue Date, to the extent such cash proceeds (i) have not otherwise been and are not thereafter applied to permit the payment of any other Restricted Payment or (ii) are not attributable to loans made by the Parent or a Restricted Subsidiary thereof for the purpose of financing the acquisition of such Capital Stock, plus (B) the cash proceeds of key man life insurance policies received by the Parent and its Restricted Subsidiaries after the Issue Date, less (C) the amount of any Restricted Payments previously made pursuant to clauses (A) and (B) of this clause (7); provided further, however, that cancellation of Indebtedness owing to the Parent from members of management of the Parent or any Restricted Subsidiary thereof in connection with a repurchase of Capital Stock of the Parent shall not be deemed to constitute a Restricted Payment for purposes of the indenture;
 
  (8)  the repurchase of Capital Stock deemed to occur (i) upon the exercise of options or warrants if such Capital Stock represents all or a portion of the exercise price thereof, and (ii) in connection with the withholding of a portion of the Capital Stock granted or awarded to a director or an employee to pay for the taxes payable by such director or employee upon such grant or award;
 
  (9)  upon the occurrence of a Change of Control (or similarly defined term in other Indebtedness) and within 90 days after completion of the Offer to Purchase (including the purchase of all Notes tendered), any repayment, repurchase, redemption, defeasance or other acquisition or retirement for value of any Indebtedness of the Issuers or any Subsidiary Guarantor that is contractually subordinated to the Notes or to any Subsidiary Guaranty that is required to be repurchased or redeemed pursuant to the terms thereof as a result of such Change of Control (or similarly defined term in other Indebtedness), at a purchase price not greater than 101% of the outstanding principal amount or liquidation preference thereof (plus accrued and unpaid interest and liquidated damages, if any);
 
  (10)  within 90 days after completion of any offer to repurchase Notes pursuant to the covenant described above under the caption “—Limitation on Asset Sales” (including the purchase of all Notes tendered), any repayment, repurchase, redemption, defeasance or other acquisition or


107


Table of Contents

  retirement for value of any Indebtedness of the Issuers or any Subsidiary Guarantor that is contractually subordinated to the Notes or to any Subsidiary Guaranty that is required to be repurchased or redeemed pursuant to the terms thereof as a result of such Asset Sale (or similarly defined term in such other Indebtedness), at a purchase price not greater than 100% of the outstanding principal amount or liquidation preference thereof (plus accrued and unpaid interest and liquidated damages, if any);
 
  (11)  the payment of cash in lieu of the issuance of fractional shares of Capital Stock upon exercise or conversion of securities exercisable or convertible into Capital Stock of the Parent; or
 
  (12)  additional Restricted Payments in an aggregate amount not to exceed $20 million;
 
provided, however, that, except in the case of clauses (1) and (3), no Default or Event of Default shall have occurred and be continuing or occur as a direct consequence of the actions or payments set forth therein.
 
The net amount of any Restricted Payment permitted pursuant to the second paragraph of this covenant and clause (1) of the immediately preceding paragraph shall be included in calculating whether the conditions of clause (C) of the first paragraph of this covenant have been met with respect to any subsequent Restricted Payments. The net amount of any Restricted Payment permitted pursuant to clauses (2) through (12) of the immediately preceding paragraph shall be excluded in calculating whether the conditions of clause (C) of the first paragraph of this covenant have been met with respect to any subsequent Restricted Payments. The amount of all Restricted Payments (other than cash) shall be the fair market value on the date of the Restricted Payment of the asset(s) or securities proposed to be transferred or issued to or by the Parent or such Restricted Subsidiary, as the case may be, pursuant to the Restricted Payment. In determining whether any Restricted Payment is permitted by this covenant, the Parent and its Restricted Subsidiaries may allocate all or any portion of such Restricted Payment among the categories described in clauses (1) through (12) of the immediately preceding paragraph or among such categories and the types of Restricted Payments described in the first paragraph of this covenant (including categorization in whole or in part as a Permitted Investment); provided that, at the time of such allocation, all such Restricted Payments, or allocated portions thereof, would be permitted under the various provisions of this covenant.
 
Limitation on Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries
 
The Parent will not, and will not permit any of its Restricted Subsidiaries to, create or otherwise cause or suffer to exist or become effective any consensual encumbrance or restriction of any kind on the ability of any Restricted Subsidiary to:
 
  •     pay dividends or make any other distributions permitted by applicable law on any Capital Stock of such Restricted Subsidiary owned by the Parent or any of its Restricted Subsidiaries,
 
  •     pay any Indebtedness owed to the Parent or any other Restricted Subsidiary,
 
  •     make loans or advances to the Parent or any other Restricted Subsidiary, or
 
  •     transfer its property or assets to the Parent or any other Restricted Subsidiary.
 
The foregoing provisions shall not restrict any encumbrances or restrictions:
 
  (1)  existing under, by reason of or with respect to, the indenture, the Notes, the Guaranties, the Credit Agreement, the Acquisition Line, the Term Loan and any other agreement in effect on the Issue Date as in effect on the Issue Date, and any amendments, modifications, restatements, extensions, increases, supplements, refundings, refinancing, renewals or replacements of such agreements; provided, however, that the encumbrances and restrictions in any such amendments,


108


Table of Contents

  modifications, restatements, extensions, increases, supplements, refundings, refinancing, renewals or replacements are not materially less favorable, taken as a whole, to the holders of the Notes than those in effect on the Issue Date;
 
  (2)  existing under, by reason of or with respect to any other Credit Facility of the Issuers permitted under the indenture; provided, however, that the encumbrances and restrictions contained in the agreement or agreements governing the other Credit Facility are not materially less favorable, taken as a whole, to the holders of the Notes than those contained in any of the Credit Agreement, the Acquisition Line or the Term Loan (with respect to other credit agreements) or the indenture (with respect to other indentures), in each case as in effect on the Issue Date;
 
  (3)  existing under, by reason of or with respect to applicable law, rule, regulation or administrative or court order;
 
  (4)  existing with respect to any Person or the property or assets of such Person acquired by the Parent or any Restricted Subsidiary, existing at the time of such acquisition and not incurred in contemplation thereof, which encumbrances or restrictions are not applicable to any Person or the property or assets of any Person other than such Person or the property or assets of such Person so acquired and any amendments, modifications, restatements, extensions, increases, supplements, refundings, refinancing, renewals or replacements thereof; provided, however, that the encumbrances and restrictions in any such amendments, modifications, restatements, extensions, increases, supplements, refundings, refinancing, renewals or replacements are entered into in the ordinary course of business or not materially less favorable, taken as a whole, to the holders of the Notes than those contained in the instruments or agreements with respect to such Person or its property or assets as in effect on the date of such acquisition;
 
  (5)  existing under, by reason of or with respect to provisions in joint venture, operating or similar agreements to the extent they are limited in application to the Restricted Subsidiary party to such agreement;
 
  (6)  in the case of the last bullet in the first paragraph of this “Limitation on Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries” covenant:
 
  •     that restrict in a customary manner the subletting, assignment or transfer of any property or asset that is a lease, license, conveyance or contract or similar property or asset,
 
  •     existing by virtue of any transfer of, agreement to transfer, option or right with respect to, or Lien on, any property or assets of the Parent or any Restricted Subsidiary not otherwise prohibited by the indenture,
 
  •     existing under, by reason of or with respect to (i) purchase money obligations for property acquired in the ordinary course of business or (ii) capital leases or operating leases that impose encumbrances or restrictions on the property so acquired or covered thereby, or
 
  •     arising or agreed to in the ordinary course of business, not relating to any Indebtedness, and that do not, individually or in the aggregate, detract from the value of property or assets of the Parent or any Restricted Subsidiary in any manner material to the Parent and its Restricted Subsidiaries taken as a whole;
 
  (7)  with respect to a Restricted Subsidiary and imposed pursuant to an agreement that has been entered into for the sale or disposition of the Capital Stock of, or property and assets of, such Restricted Subsidiary that restricts distributions by that Restricted Subsidiary pending the closing of such sale or other disposition;


109


Table of Contents

 
  (8)  existing under, by reason of or with respect to Indebtedness permitted to be incurred pursuant to paragraph (4)(N) of the covenant described under “—Limitation on Indebtedness;” provided, that the encumbrances and restrictions contained in the agreements governing such Indebtedness are not materially less favorable, taken as a whole, to the holders of the Notes than those contained in the agreements governing the Indebtedness being refinanced; and
 
  (9)  contained in the terms of any Indebtedness or any agreement pursuant to which such Indebtedness was issued if:
 
  •     the encumbrance or restriction applies only in the event of a payment default or a default with respect to a financial covenant contained in such Indebtedness or agreement,
 
  •     the encumbrance or restriction is not materially less favorable, taken as a whole, to the holders of the Notes than is customary in comparable financings (as determined by the good faith judgment of the Parent), and
 
  •     the Parent, in its good faith, determines that such an encumbrance or restriction will not materially affect the Issuers’ ability to make principal or interest payments on the Notes.
 
Nothing contained in this “Limitation on Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries” covenant shall prevent the Parent or any Restricted Subsidiary from restricting the sale or other disposition of property or assets of the Parent or any of its Restricted Subsidiaries that secure Indebtedness of the Issuers or any of their Restricted Subsidiaries. For purposes of determining compliance with this covenant, (1) the priority of any Preferred Stock in receiving dividends or liquidating distributions prior to distributions being paid on common stock shall not be deemed a restriction on the ability to make distributions on Capital Stock, and (2) the subordination of loans or advances made to a Restricted Subsidiary to other Indebtedness incurred by such Restricted Subsidiary shall not be deemed a restriction on the ability to make loans or advances.
 
Future Guaranties by Restricted Subsidiaries
 
The Parent will not permit any Restricted Subsidiary of the Issuers, directly or indirectly, to Guarantee any Indebtedness of the Issuers or of a Subsidiary Guarantor (“Guaranteed Indebtedness”), unless in either case such Restricted Subsidiary within 30 calendar days executes and delivers a supplemental indenture to the indenture providing for a Subsidiary Guaranty by such Restricted Subsidiary; provided, however, that this paragraph shall not be applicable to any Guarantee of any Restricted Subsidiary that existed at the time such Person became a Restricted Subsidiary and was not Incurred in connection with, or in contemplation of, such person becoming a Restricted Subsidiary. The Parent may elect, in its sole discretion, to cause any Subsidiary that is not otherwise required to be a Guarantor to become a Guarantor, in which case such Subsidiary shall not be required to comply with the 30 calendar day period described above.
 
If the Guaranteed Indebtedness:
 
  •     ranks equally with the Notes (or the applicable Subsidiary Guaranty) in right of payment, then the Guarantee of such Guaranteed Indebtedness shall rank equally with, or subordinate to, the Subsidiary Guaranty issued pursuant to this covenant in right of payment; or
 
  •     is subordinate in right of payment to the Notes (or the applicable Subsidiary Guaranty), then the Guarantee of such Guaranteed Indebtedness shall be subordinated in right of payment to the Subsidiary Guaranty issued pursuant to this covenant at least to the extent that the Guaranteed Indebtedness is subordinated to the Notes (or the applicable Subsidiary Guaranty).


110


Table of Contents

 
Any such Subsidiary Guaranty by a Restricted Subsidiary issued pursuant to this covenant shall provide by its terms that it shall be automatically and unconditionally released and discharged:
 
  (1)  upon any sale, exchange or transfer (including by way of merger or consolidation), to any Person not a Subsidiary of the Parent, of Capital Stock held by the Parent and its Restricted Subsidiaries in, or all or substantially all the assets of, such Restricted Subsidiary (which sale, exchange or transfer is not prohibited by the indenture) such that, immediately after giving effect to such transaction, such Restricted Subsidiary would no longer constitute a Subsidiary of the Parent,
 
  (2)  in connection with the merger or consolidation of such Restricted Subsidiary with (a) an Issuer or (b) any other Guarantor (provided that the surviving entity remains a Guarantor),
 
  (3)  if the Parent properly designates such Restricted Subsidiary as an Unrestricted Subsidiary under the indenture,
 
  (4)  upon the Legal Defeasance (as defined below) or Covenant Defeasance (as defined below) or satisfaction and discharge of the indenture,
 
  (5)  upon a liquidation or dissolution of such Restricted Subsidiary permitted under the indenture, or
 
  (6)  upon the release or discharge of the Guarantee that resulted in the creation of such Subsidiary Guaranty, except a discharge or release by or as a result of payment under such Guarantee.
 
Limitation on Transactions with Affiliates
 
The Parent will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly, enter into, renew or extend any transaction (including the purchase, sale, lease or exchange of property or assets, or the rendering of any service) with any holder (or any Affiliate of such holder) of 10% or more of any class of Capital Stock of the Parent or with any Affiliate of the Parent or any of its Restricted Subsidiaries, in each case involving consideration in excess of $2.5 million, except upon terms that are not materially less favorable, taken as a whole, to the Parent or such Restricted Subsidiary than could be obtained, at the time of such transaction or, if such transaction is pursuant to a written agreement, at the time of the execution of the agreement providing therefor, in a comparable arm’s length transaction with a Person that is not such a holder or an Affiliate.
 
The foregoing limitation does not limit, and shall not apply to:
 
  (1)  transactions (A) approved by a majority of the disinterested directors of the Board of Directors of the Parent or (B) for which the Parent or any Restricted Subsidiary delivers to the trustee a written opinion of a nationally recognized investment banking, appraisal or accounting firm stating that the transaction is fair to the Parent or such Restricted Subsidiary from a financial point of view;
 
  (2)  any transaction solely between the Parent and any of its Restricted Subsidiaries or solely between Restricted Subsidiaries;
 
  (3)  the payment of reasonable fees and compensation to, and indemnification and similar arrangements on behalf of, current, former or future directors of the Parent or any Restricted Subsidiary;
 
  (4)  the issuance or sale of Capital Stock (other than Disqualified Stock) of the Parent;
 
  (5)  any Restricted Payments not prohibited by the “—Limitation on Restricted Payments” covenant;


111


Table of Contents

 
  (6)  any contracts, instruments or other agreements or arrangements in each case as in effect on the date of the indenture, and any transactions pursuant thereto or contemplated thereby, or any amendment, modification or supplemental thereto or any replacement thereof entered into from time to time, as long as such agreement or arrangements as so amended, modified, supplemented or replaced, taken as a whole, is not materially more disadvantageous to the Parent and the Restricted Subsidiaries, taken as a whole, at the time executed than the original agreement or arrangements as in effect on the date of the indenture;
 
  (7)  any employment, consulting, service or termination agreement, or customary indemnification arrangements, entered into by the Parent or any Restricted Subsidiary with current, former or future officers and employees of the Parent or such Restricted Subsidiary and the payment of compensation to officers and employees of the Parent or any Restricted Subsidiary (including amounts paid pursuant to employee benefit plans, employee stock option or similar plans), in each case in the ordinary course of business;
 
  (8)  loans and advances to officers and employees of the Parent or any Restricted Subsidiary or guarantees in respect thereof (or cancellation of such loans, advances or guarantees), for bona fide business purposes, including for reasonable moving and relocation, entertainment and travel expenses and similar expenses, made in the ordinary course of business and consistent with past practice;
 
  (9)  transactions with a Person that is an Affiliate of the Parent solely because the Parent, directly or indirectly, owns Capital Stock of, or controls such Person; or
 
  (10)  any transaction with a Person who is not an Affiliate immediately before the consummation of such transaction that becomes an Affiliate as a result of such transaction.
 
Notwithstanding the foregoing, any transaction or series of related transactions covered by the first paragraph of this “Limitation on Transactions with Affiliates” covenant and not covered by (2) through (11) of the immediately foregoing paragraph:
 
  •     the aggregate amount of which exceeds $10 million in value must be approved or determined to be fair in the manner provided for in clause (1)(A) or (B) above; and
 
  •     the aggregate amount of which exceeds $25 million in value, must be determined to be fair in the manner provided for in clause (1)(B) above.
 
Limitation on Asset Sales
 
The Parent will not, and will not permit any of its Restricted Subsidiaries to, consummate any Asset Sale, unless:
 
  (1)  the consideration received by the Parent or such Restricted Subsidiary is at least equal to the fair market value of the assets sold or disposed of; and
 
  (2)  at least 75% of the consideration received consists of cash, Temporary Cash Investments or Replacement Assets, or a combination of cash, Temporary Cash Investments or Replacement Assets; provided, however, that, with respect to the sale of one or more properties up to 75% of the consideration may consist of Indebtedness of the purchaser of such properties so long as such Indebtedness is secured by a first priority Lien on the property or properties sold.


112


Table of Contents

 
For purposes of this provision, each of the following shall be deemed to be cash:
 
  (a)  any liabilities of the Parent or any Restricted Subsidiary (as shown on the most recent consolidated balance sheet of the Parent and its Restricted Subsidiaries other than contingent liabilities and liabilities that are by their terms subordinated to the Notes or any Guaranty) that are assumed by the transferee of any such assets pursuant to an agreement that releases the Parent or any such Restricted Subsidiary from further liability with respect to such liabilities or that are assumed by contract or operation of law;
 
  (b)  any securities, notes or other obligations received by the Issuers or any such Restricted Subsidiary from such transferee that are converted by the Issuers or such Restricted Subsidiary into cash or Temporary Cash Investments within 180 days (to the extent of the cash or Temporary Cash Investments received in that conversion); and
 
  (c)  any Designated Non-Cash Consideration received by the Issuers or any such Restricted Subsidiary in such Asset Sale having an aggregate fair market value, taken together with all other Designated Non-Cash Consideration received pursuant to this clause (c) that is at the time outstanding, not to exceed the greater of (x) $20 million and (y) 2.0% of the Parent’s Adjusted Total Assets at the time of the receipt of such Designated Non-Cash Consideration, with the fair market value of each item of Designated Non-Cash Consideration being measured at the time received and without giving effect to subsequent changes in value.
 
Within 365 days after the receipt of any Net Cash Proceeds from an Asset Sale, the Parent or any such Restricted Subsidiary may apply such Net Cash Proceeds to:
 
  (1)  prepay, repay, redeem or purchase Pari Passu Indebtedness of the Issuer or a Subsidiary Guarantor that is Secured Indebtedness (in each case other than Indebtedness owed to the Parent or an Affiliate of the Parent);
 
  (2)  make an Investment in (provided such Investment is in the form of Capital Stock), or to acquire all or substantially all of the assets of, a Person engaged in a Permitted Business if, in the case of an Investment, such Person is, or will become as a result thereof, a Restricted Subsidiary;
 
  (3)  prepay, repay, redeem or purchase Pari Passu Indebtedness of the Issuer or of any Subsidiary Guarantor or any Indebtedness of a Restricted Subsidiary that is not a Subsidiary Guarantor; provided, however, that if the Parent, the Issuers or a Subsidiary Guarantor shall so prepay, repay, redeem or purchase any such Pari Passu Indebtedness, the Issuers will equally and ratably reduce obligations under the Notes if the Notes are then prepayable or, if the Notes may not then be prepaid, the Issuers shall make an offer (in accordance with the procedures set forth below) with the ratable proceeds to all holders to purchase their Notes at 100% of the principal amount thereof, plus accrued but unpaid interest, if any, thereon, up to the principal amount of Notes that would otherwise be prepaid;
 
  (4)  fund all or a portion of an optional redemption of the Notes as described under “—Optional Redemption”;
 
  (5)  make one or more capital expenditures;
 
  (6)  acquire Replacement Assets to be used or that are useful in a Permitted Business; or
 
  (7)  undertake any combination of the foregoing;


113


Table of Contents

 
provided, that the Parent will be deemed to have complied with the provisions described in clauses (2), (5) and (6) of this paragraph if and to the extent that, within 365 days after the Asset Sale that generated the Net Cash Proceeds, the Parent or any of its Restricted Subsidiaries has entered into and not abandoned or rejected a binding agreement to acquire the assets or Capital Stock of a Permitted Business, make a capital expenditure or acquire Replacement Assets in compliance with the provisions described in clauses (2), (5) and (6) of this paragraph, and that acquisition, purchase or capital expenditure is thereafter completed within 180 days after the end of such 365-day period. Pending the final application of any such excess Net Cash Proceeds, the Parent may temporarily reduce the revolving Indebtedness under any Credit Facility or otherwise invest such excess Net Cash Proceeds in any manner that is not prohibited by the indenture. The amount of such excess Net Cash Proceeds required to be applied (or to be committed to be applied) during such 365 day period as set forth in this paragraph and not so applied by the end of such period shall constitute “Excess Proceeds.”
 
If, as of the first day of any calendar month, the aggregate amount of Excess Proceeds not previously subject to an Offer to Purchase pursuant to this “Limitation on Asset Sales” covenant totals at least $15 million, the Issuers shall commence, not later than the fifteenth Business Day of such month, and consummate an Offer to Purchase from the holders of the Notes and, to the extent required by the terms of any Pari Passu Indebtedness, to all holders of such Pari Passu Indebtedness on a pro rata basis an aggregate principal amount of Notes (and Pari Passu Indebtedness) equal to the Excess Proceeds on such date, at a purchase price equal to 100% of the principal amount of the Notes (and Pari Passu Indebtedness), plus, in each case, accrued and unpaid interest (if any) to the Payment Date. If any Excess Proceeds remain after consummation of an Offer to Purchase, the Parent may use such Excess Proceeds for any purpose not prohibited by the indenture. If the aggregate purchase price of the Notes and the other Pari Passu Indebtedness tendered into such Offer to Purchase exceeds the amount of Excess Proceeds, the Parent shall select the Notes to be purchased on a pro rata basis but in round denominations, which in the case of the Notes will be denominations of $2,000 initial principal amount and multiples of $1,000 thereafter. Upon completion of each Offer to Purchase, the amount of Excess Proceeds shall be reset at zero. The Parent may satisfy the foregoing obligation with respect to any Net Cash Proceeds prior to the expiration of the relevant 365 day period (as such period may be extended in accordance with the indenture). Nothing in this paragraph shall preclude the Issuers from making an Offer to Purchase even if the amount of Excess Proceeds not previously subject to an Offer to Purchase pursuant to this “Limitation on Asset Sales” covenant totals less than $15 million.
 
Prohibition on Incurrence of Senior Debt by the Subordinated Guaranty Subsidiaries
 
The Subordinated Guaranty Subsidiaries will not incur or suffer to exist any Indebtedness that is senior in right of payment to the applicable Subordinated Guaranty Subsidiary’s guarantee other than the Acquisition Line and the Term Loan (or any Permitted Refinancing Indebtedness incurred in exchange for, or the net proceeds of which are used to refund, refinance or replace, the Acquisition Line or Term Loan and that was otherwise permitted by the indenture) and any secured Currency Agreements and Interest Rate Agreements provided to the lenders under the Acquisition Line and the Term Loan.
 
Consolidation, Merger and Sale of Assets
 
The Parent will not consolidate with or merge with or into, or sell, convey, transfer or otherwise dispose of all or substantially all of its and its Restricted Subsidiaries’ (taken as a whole) property and assets (as an entirety or substantially an entirety in one transaction or a series of related transactions) to, any Person or permit any Person to merge with or into the Parent unless:
 
  (1)  the Parent shall be the continuing Person, or the Person (if other than the Parent) formed by such consolidation or into which the Parent is merged or that acquired such property and assets of the Parent shall be a corporation, limited liability company, partnership (including a limited partnership) or trust organized and validly existing under the laws of the United States of America or any state or jurisdiction thereof and shall expressly assume, by a supplemental indenture, executed and delivered to the trustee, all of the obligations of the Parent on its


114


Table of Contents

  Guaranty and under the indenture (provided that in the case of a limited liability company, partnership (including a limited partnership) or trust, there shall also be a corporation organized and validly existing under the laws of the United States of America or any state or jurisdiction thereof which shall expressly jointly with such limited liability company, partnership (including a limited partnership) or trust, assume, by a supplemental indenture, executed and delivered to the trustee, all of the obligations of the Parent on its Guaranty and under the indenture);
 
  (2)  immediately after giving effect to such transaction, no Default or Event of Default shall have occurred and be continuing;
 
  (3)  immediately after giving effect to such transaction and any related financing transactions as if the same had occurred at the beginning of the applicable four-quarter period, on a pro forma basis the Issuers, or any Person becoming the successor obligor of the Notes, as the case may be, could Incur at least $1.00 of Indebtedness in compliance with both paragraphs (1) and (3) of the “—Limitation on Indebtedness” covenant; provided, however, that this clause (3) shall not apply to a consolidation or merger with or into a Wholly Owned Restricted Subsidiary; and
 
  (4)  the Parent delivers to the trustee an officers’ certificate (attaching the arithmetic computations to demonstrate compliance with clause (3) above) and an opinion of counsel, in each case stating that such consolidation, merger or transfer and such supplemental indenture complies with this covenant and that all conditions precedent provided for herein relating to such transaction have been complied with and, with respect to the opinion of counsel, that the supplemental indenture constitutes a valid and binding obligation enforceable against the Parent, or the Person (if other than the Parent) formed by such consolidation or into which the Parent is merged or that acquired all or substantially all of the Parent’s and its Restricted Subsidiaries’ property and assets;
 
provided, however, that clause (3) above does not apply if, in the good faith determination of the Board of Directors of the Parent, whose determination shall be evidenced by a Board Resolution, the principal purpose of such transaction is to change the state of domicile of the Parent; provided further, however, that any such transaction shall not have as one of its purposes the evasion of the foregoing limitations.
 
The Parent will not permit the Issuers or any Subsidiary Guarantor to consolidate with or merge with or into, or convey or transfer, in one transaction or a series of transactions, all or substantially all of its assets to any Person unless:
 
  (1)  the resulting, surviving or transferee Person (if not such Issuer or such Subsidiary) shall be a Person organized and existing under the laws of the jurisdiction under which such Issuer or Subsidiary was organized or under the laws of the United States of America or any state or jurisdiction thereof, and such Person shall expressly assume, by a supplemental indenture, all the obligations of such Issuer or Subsidiary Guarantor, as applicable, under the Notes or its Subsidiary Guaranty, as applicable; provided, however, that the foregoing requirement will not apply in the case of a Subsidiary Guarantor or all or substantially all of its assets (x) that has been disposed of in its entirety to another Person (other than to the Parent or an Affiliate of the Parent), whether through a merger, consolidation or sale of Capital Stock or assets or (y) that, as a result of the disposition of all or a portion of its Capital Stock, ceases to be a Subsidiary, so long as, in both cases, in connection therewith the Parent provides an Officers’ Certificate to the trustee to the effect that the Parent will comply with its obligations under the covenant described under “—Limitation on Asset Sales;”
 
  (2)  immediately after giving effect to such transaction or transactions on a pro forma basis (and treating any Indebtedness which becomes an obligation of the resulting, surviving or transferee Person as a result of such transaction as having been issued by such Person at the time of such transaction), no Default shall have occurred and be continuing; and


115


Table of Contents

 
  (3)  the Parent delivers to the trustee an officers’ certificate and an opinion of counsel, each stating that such consolidation, merger or transfer and such supplemental indenture, if any, complies with the indenture and, with respect to the opinion of counsel, that the supplemental indenture constitutes a valid and binding obligation enforceable against the Issuers, the Subsidiary Guarantors, the Parent and the surviving Persons.
 
Notwithstanding the foregoing, any Subsidiary Guarantor may (i) merge with an Affiliate of the Parent or an Affiliate of the Parent or a Restricted Subsidiary of the Parent or another Subsidiary Guarantor solely for the purpose of changing the state of domicile of the Subsidiary Guarantor, (ii) merge with or into or transfer all or part of its properties and assets to another Subsidiary Guarantor, the Issuers or the Parent (provided that this clause (ii) shall not permit a Senior Guaranty Subsidiary to merge with or into or transfer all or part of its properties and assets to any Subordinated Guaranty Subsidiary), or (iii) convert into a corporation, partnership, limited partnership, limited liability company or trust organized under the laws of the jurisdiction of organization of such Subsidiary Guarantor.
 
Repurchase of Notes upon a Change of Control
 
The Issuers shall commence, within 30 days of the occurrence of a Change of Control, and consummate an Offer to Purchase for all Notes then outstanding, at a purchase price equal to 101% of the principal amount of the Notes, plus accrued and unpaid interest (if any) to the Payment Date.
 
There can be no assurance that the Issuers will have sufficient funds available at the time of any Change of Control to make any debt payment (including repurchases of Notes) required by the foregoing covenant (as well as any covenant that may be contained in other securities of the Issuers that might be outstanding at the time). The above covenant requiring the Issuers to repurchase the Notes will, unless consents are obtained, require the Issuers to repay all indebtedness then outstanding which by its terms would prohibit such Note repurchase, either prior to or concurrently with such Note repurchase.
 
The Issuers will not be required to make an Offer to Purchase upon a Change of Control if a third party makes the Offer to Purchase in the manner, at the times and otherwise in compliance with the requirements set forth in the indenture applicable to a Offer to Purchase made by the Issuers and purchases all Notes validly tendered and not withdrawn under such Offer to Purchase or if notice of redemption has been given pursuant to “Optional Redemption” above. Notwithstanding anything to the contrary contained herein, an Offer to Purchase may be made in advance of a Change of Control, subject to one or more conditions precedent, including but not limited to the consummation of such Change of Control, if a definitive agreement is in place for the Change of Control at the time the Offer to Purchase is made.
 
The Change of Control purchase feature of the Notes may in certain circumstances make more difficult or discourage a sale or takeover of the Parent and, thus, the removal of incumbent management. The Change of Control purchase feature is a result of negotiations between the Initial Purchasers and the Parent. As of the Issue Date, we have no present intention to engage in a transaction involving a Change of Control, although it is possible that we could decide to do so in the future. Subject to the limitations discussed below, we could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control under the indenture, but that could increase the amount of indebtedness outstanding at such time or otherwise affect our capital structure or credit ratings. Restrictions on our ability to incur additional Indebtedness are contained in the covenant described under “—Covenants—Limitations on Indebtedness.” Such restrictions in the indenture can be waived only with the consent of the holders of a majority in principal amount of the Notes then outstanding. Except for the limitations contained in such covenants, however, the indenture does not contain any covenants or provisions that may afford holders of the Notes protection in the event of a highly leveraged transaction.
 
The Term Loan, the Acquisition Line and the Credit Agreement provide that the occurrence of certain change of control events with respect to the Parent would constitute a default thereunder. Future credit


116


Table of Contents

agreements that the Parent enters into may contain similar provisions. Such defaults could result in amounts outstanding under the Term Loan, the Acquisition Line and the Credit Agreement and such other agreements being declared immediately due and payable or lending commitments being terminated.
 
The definition of Change of Control includes a phrase relating to the sale, exchange or other transfer of “all or substantially all” of the properties or assets of the Parent and its Subsidiaries, taken as a whole. Although there is a limited body of case law interpreting the phrase “substantially all,” there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of Notes to require the Issuers to repurchase such Notes as a result of a sale, exchange or other transfer of less than all of the assets of the Parent and its Subsidiaries taken as a whole to another Person or group may be uncertain. Because the Parent and its Subsidiaries are in the business of leasing their assets, the lease of all or substantially all of the assets of the Parent and its Subsidiaries would not constitute a Change of Control.
 
A Change of Control would be triggered at such time as the majority of the members of the Board of Directors of the Parent no longer include individuals who constitute the Board of Directors of the Parent on the Issue Date (together with any new or replacement directors whose election or nomination was approved by a vote of at least a majority of the members of the Board of Directors then in office who were members on the Issue Date or whose election or nomination was so approved or whose election was made in accordance with any voting agreement to which Parent is then a party). You should note, however, that recent case law suggests that, in the event that incumbent directors are replaced as a result of a contested election, the Parent may nevertheless avoid triggering a Change of Control under a clause similar to the provision described in the prior sentence if the outgoing directors were to approve the new directors for the purpose of such Change of Control clause.
 
The provisions under the indenture relative to the Issuers’ obligation to make an offer to repurchase the Notes as a result of a Change of Control may be waived or modified with the written consent of the holders of a majority in principal amount of the Notes.
 
The Issuers will comply, to the extent applicable, with the requirements of Section 14(e) of, and Rule 14e-1 under, the Exchange Act and any other securities laws and regulations in connection with the repurchase of the Notes as a result of a Change of Control. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control provisions of the indenture, the Issuers will comply with the applicable securities laws and regulations and will not be deemed to have breached their obligations under the Change of Control provisions of the indenture by virtue of such compliance.
 
SEC Reports and Reports to Holders
 
Whether or not the Parent is then required to file reports with the SEC, the Parent shall file with the SEC all such reports and other information as it would be required to file with the SEC by Sections 13(a) or 15(d) under the Exchange Act if it was subject thereto; provided, however, that, if filing such documents by the Parent with the SEC is not permitted under the Exchange Act, the Parent shall, within 15 days after the time the Parent would be required to file such information with the SEC if it were subject to Section 13 or 15(d) under the Exchange Act, provide such documents and reports to the trustee and upon written request supply copies of such documents and reports to any holder and shall post such documents and reports on the Parent’s public website. The Parent shall supply the trustee and each holder, without cost to such holder, copies of such reports and other information.
 
Notwithstanding the foregoing, such requirements to file such reports shall be deemed satisfied either (1) prior to the report required for the fiscal quarter ending June 30, 2011 by providing the financial information (including a “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section) that would be required by such reports to the trustee and upon written request supplying copies of such information to any holder and posting such information on the Parent’s public website or (2) prior to and including the report required for the fiscal quarter ending June 30, 2011 to the extent the


117


Table of Contents

information required by such reports is contained in the exchange offer registration statement or shelf registration statement required by the registration rights agreement then on file with the SEC, including any amendments thereto.
 
So long as permitted by the SEC, at any time that either (x) one or more Subsidiaries of the Parent is an Unrestricted Subsidiary or (y) the Parent holds directly any material assets (including Capital Stock) other than the Capital Stock of the Issuers and, in either case, such Unrestricted Subsidiary or other assets taken together would represent 5% or more of the Total Assets of the Parent and its Subsidiaries as of the latest quarterly financial statements, then the quarterly and annual financial information required by this covenant will include a reasonably detailed presentation, either in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” or any other comparable section, of the financial condition and results of operations of the Issuers and their Restricted Subsidiaries separate from the financial condition and results of operations of such Unrestricted Subsidiaries and other material assets of the Parent.
 
Beginning with the results and information for the fiscal quarter ending June 30, 2011, the Parent shall also, within a reasonably prompt period of time following the disclosure of the annual and quarterly information required above, conduct a conference call with respect to such information and results of operations for the relevant reporting period. No fewer than three Business Days prior to (i) the disclosure of the annual, quarterly and periodic information required above and (ii) the date of the conference call required to be held in accordance with the preceding sentence, the Parent shall issue a press release to the appropriate internationally recognized wire services announcing the date that such information will be available and the time and date of such conference call.
 
Notwithstanding anything herein to the contrary, the Parent will not be deemed to have failed to comply with any of its obligations under this covenant for purposes of clause (4) under “Events of Default” until 30 days after the date any report hereunder is due.
 
Events of Default
 
Events of Default under the indenture include the following:
 
  (1)  default in the payment of principal of, or premium, if any, on any Note when they are due and payable at maturity, upon acceleration, redemption or otherwise;
 
  (2)  default in the payment of interest on any Note when they are due and payable, and such default continues for a period of 30 days;
 
  (3)  default in the performance or breach of the provisions of the indenture applicable to mergers, consolidations and transfers of all or substantially all of the assets of the Parent or the failure by the Issuers to consummate an Offer to Purchase in accordance with the “—Covenants—Limitations on Asset Sales” or “—Repurchase of Notes upon a Change of Control” covenants;
 
  (4)  the Parent defaults in the performance of or breaches any other covenant or agreement of the Parent in the indenture or under the Notes (other than a default specified in clause (1), (2) or (3) above) and such default or breach continues for 60 consecutive days after written notice by the trustee or the holders of 25% or more in aggregate principal amount of the Notes;
 
  (5)  there occurs with respect to any issue or issues of Indebtedness of the Parent or any Significant Subsidiary having an outstanding principal amount of $20 million or more in the aggregate for all such issues of all such Persons, whether such Indebtedness now exists or shall hereafter be created,


118


Table of Contents

 
  •     an event of default that has caused the holder thereof to declare such Indebtedness to be due and payable prior to its Stated Maturity and such Indebtedness has not been discharged in full or such acceleration has not been rescinded or annulled within 30 days of such acceleration, and/or
 
  •     the failure to make a principal payment at the final (but not any interim) fixed maturity and such defaulted payment shall not have been made, waived or extended within 30 days of such payment default;
 
  (6)  any final and non-appealable judgment or order (not covered by insurance) for the payment of money in excess of $20 million in the aggregate for all such final judgments or orders against all such Persons (treating any deductibles, self-insurance or retention as not covered by insurance):
 
  •     shall be rendered against the Parent or any Significant Subsidiary and shall not be paid or discharged, and
 
  •     there shall be any period of 60 consecutive days following entry of the final judgment or order that causes the aggregate amount for all such final judgments or orders outstanding and not paid or discharged against all such Persons to exceed $20 million during which a stay of enforcement of such final judgment or order, by reason of a pending appeal or otherwise, shall not be in effect;
 
  (7)  a court of competent jurisdiction enters a decree or order for:
 
  •     relief in respect of the Parent or any Significant Subsidiary in an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect,
 
  •     appointment of a receiver, liquidator, assignee, custodian, trustee, sequestrator or similar official of the Parent or any Significant Subsidiary or for all or substantially all of the property and assets of the Parent or any Significant Subsidiary, or
 
  •     the winding up or liquidation of the affairs of the Parent or any Significant Subsidiary and, in each case, such decree or order shall remain unstayed and in effect for a period of 60 consecutive days; or
 
  (8)  the Parent or any Significant Subsidiary:
 
  •     commences a voluntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or consents to the entry of an order for relief in an involuntary case under such law,
 
  •     consents to the appointment of or taking possession by a receiver, liquidator, assignee, custodian, trustee, sequestrator or similar official of the Parent or such Significant Subsidiary or for all or substantially all of the property and assets of the Parent or such Significant Subsidiary, or
 
  •     effects any general assignment for the benefit of its creditors.
 
If an Event of Default (other than an Event of Default specified in clause (7) or (8) above that occurs with respect to the Parent or the Issuers) occurs and is continuing under the indenture, the trustee or the holders of at least 25% in aggregate principal amount of the Notes then outstanding, by written notice to the Issuers (and to the trustee if such notice is given by the holders), may, and the trustee at the request of the holders of at least 25% in aggregate principal amount of the Notes then outstanding shall, declare the principal


119


Table of Contents

of, premium, if any, and accrued interest on the Notes to be immediately due and payable. Upon a declaration of acceleration, such principal of, premium, if any, and accrued interest shall be immediately due and payable. In the event of a declaration of acceleration because an Event of Default set forth in clause (5) above has occurred and is continuing, such declaration of acceleration shall be automatically rescinded and annulled if the event of default triggering such Event of Default pursuant to clause (5) shall be remedied or cured by the Parent or the relevant Significant Subsidiary or waived by the holders of the relevant Indebtedness within 60 days after the declaration of acceleration with respect thereto.
 
If an Event of Default specified in clause (7) or (8) above occurs with respect to the Parent or the Issuers, the principal of, premium, if any, and accrued interest on the Notes then outstanding shall automatically become and be immediately due and payable without any declaration or other act on the part of the trustee or any holder. The holders of at least a majority in principal amount of the outstanding Notes by written notice to the Issuers and to the trustee, may waive all past defaults and rescind and annul a declaration of acceleration and its consequences if:
 
  •     all existing Events of Default, other than the nonpayment of the principal of, premium, if any, and interest on the Notes that have become due solely by such declaration of acceleration, have been cured or waived, and
 
  •     the rescission would not conflict with any judgment or decree of a court of competent jurisdiction.
 
As to the waiver of defaults, see “—Modification and Waiver.”
 
The holders of at least a majority in aggregate principal amount of the outstanding Notes may direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee. However, the trustee may refuse to follow any direction that conflicts with law or the indenture, that may involve the trustee in personal liability, or that the trustee determines in good faith may be unduly prejudicial to the rights of holders of Notes not joining in the giving of such direction and may take any other action it deems proper that is not inconsistent with any such direction received from holders of Notes. A holder may not pursue any remedy with respect to the indenture or the Notes unless:
 
  (1)  the holder gives the trustee written notice of a continuing Event of Default;
 
  (2)  the holders of at least 25% in aggregate principal amount of outstanding Notes make a written request to the trustee to pursue the remedy;
 
  (3)  such holder or holders offer the trustee indemnity satisfactory to the trustee against any costs, liability or expense;
 
  (4)  the trustee does not comply with the request within 60 days after receipt of the request and the offer of indemnity; and
 
  (5)  during such 60-day period, the holders of a majority in aggregate principal amount of the outstanding Notes do not give the trustee a direction that is inconsistent with the request.
 
However, such limitations do not apply to the right of any holder of a Note to receive payment of the principal of, premium, if any, or interest on, such Note or to bring suit for the enforcement of any such payment on or after the due date expressed in the Notes, which right shall not be impaired or affected without the consent of the holder.


120


Table of Contents

The indenture requires certain officers of the Parent to certify, on or before a date not more than 120 days after the end of each fiscal year, that a review has been conducted of the activities of the Parent and its Restricted Subsidiaries and of its performance under the indenture and that the Parent has fulfilled all obligations thereunder, or, if there has been a default in fulfillment of any such obligation, specifying each such default and the nature and status thereof. The Parent will also be obligated to notify the trustee of any default or defaults in the performance of any covenants or agreements under the indenture within 30 days of becoming aware of any such default unless such default has been cured before the end of the 30 day period.
 
Defeasance
 
The Issuers may, at their option and at any time, elect to have their obligations and the obligations of the Guarantors discharged with respect to the outstanding Notes (“Legal Defeasance”) and cure all then existing Events of Default. Legal Defeasance means that the Issuers and the Guarantors shall be deemed to have paid and discharged the entire indebtedness represented by the Notes and the Guaranties, and the indenture shall cease to be of further effect as to all outstanding Notes and Guaranties, except as to
 
  (1)  rights of holders to receive payments in respect of the principal of and interest on the Notes when such payments are due from the trust funds referred to below,
 
  (2)  the Issuers’ obligations with respect to the Notes concerning issuing temporary Notes, registration of Notes, mutilated, destroyed, lost or stolen Notes, and the maintenance of an office or agency for payment and money for security payments held in trust,
 
  (3)  the rights, powers, trust, duties, and immunities of the trustee, and the Issuers’ obligations in connection therewith, and
 
  (4)  the Legal Defeasance provisions of the indenture.
 
In addition, the Issuers may, at their option and at any time, elect to have their obligations and the obligations of the Guarantors released with respect to most of the covenants under the indenture, except as described otherwise in the indenture (“Covenant Defeasance”), and thereafter any omission to comply with such obligations shall not constitute a Default. In the event Covenant Defeasance occurs, certain Events of Default (not including non-payment, bankruptcy, receivership, rehabilitation and insolvency events) will no longer apply. The Issuers may exercise their Legal Defeasance option regardless of whether they previously exercised Covenant Defeasance.
 
In order to exercise either Legal Defeasance or Covenant Defeasance:
 
  (1)  the Issuers must irrevocably deposit with the trustee, in trust, for the benefit of the holders, U.S. legal tender, U.S. Government Obligations or a combination thereof, in such amounts as will be sufficient (without reinvestment) in the opinion of a nationally recognized firm of independent public accountants selected by the Issuers, to pay the principal of and interest on the Notes on the stated date for payment or on the redemption date of the Notes,
 
  (2)  in the case of Legal Defeasance, the Issuers shall have delivered to the trustee an opinion of counsel in the United States confirming that:
 
  (a)  the Issuers have received from, or there has been published by the Internal Revenue Service, a ruling, or
 
  (b)  since the date of the indenture, there has been a change in the applicable U.S. federal income tax law,


121


Table of Contents

 
in either case to the effect that, and based thereon this opinion of counsel shall confirm that, the holders will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the Legal Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred,
 
  (3)  in the case of Covenant Defeasance, the Issuers shall have delivered to the trustee an opinion of counsel in the United States reasonably acceptable to the trustee confirming that the holders will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Covenant Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if the Covenant Defeasance had not occurred,
 
  (4)  no Default shall have occurred and be continuing on the date of such deposit (other than a Default resulting from the borrowing of funds to be applied to such deposit and any similar and simultaneous deposit relating to other Indebtedness and, in each case, the granting of Liens on the funds deposited in connection therewith),
 
  (5)  the Legal Defeasance or Covenant Defeasance shall not result in a breach or violation of, or constitute a default under, any other material agreement or instrument (other than the indenture) to which the Parent or any of its Subsidiaries is a party or by which the Parent or any of its Subsidiaries is bound (other than any such Default or default relating to any Indebtedness being defeased from any borrowing of funds to be applied to such deposit and any similar and simultaneous deposit relating to such Indebtedness, and the granting of Liens on the funds deposited in connection therewith),
 
  (6)  the Issuers shall have delivered to the trustee an officers’ certificate stating that the deposit was not made by them with the intent of preferring the holders over any other creditors of the Issuers or with the intent of defeating, hindering, delaying or defrauding any other creditors of the Issuers or others, and
 
  (7)  the Issuers shall have delivered to the trustee an officers’ certificate and an opinion of counsel, each stating that the conditions provided for in, in the case of the officers’ certificate, clauses (1) through (6) and, in the case of the opinion of counsel, clauses (2) and/or (3) and (5) of this paragraph have been complied with.
 
Satisfaction and Discharge
 
The indenture will be discharged and will cease to be of further effect (except as to surviving rights or registration of transfer or exchange of the Notes, as expressly provided for in the indenture) as to all outstanding Notes when
 
  (1)  either:
 
  (a)  all the Notes theretofore authenticated and delivered (except lost, stolen or destroyed Notes which have been replaced or paid and Notes for whose payment money has theretofore been deposited in trust or segregated and held in trust by the Issuers and thereafter repaid to the Issuers or discharged from such trust) have been delivered to the trustee for cancellation; or
 
  (b)  all Notes not theretofore delivered to the trustee for cancellation (1) have become due and payable or (2) will become due and payable within one year, or are to be called for redemption within one year, under arrangements reasonably satisfactory to the trustee for the giving of notice of redemption by the trustee in the name, and at the expense, of the Issuers, and the Issuers have irrevocably deposited or caused to be deposited with the trustee funds in


122


Table of Contents

  an amount sufficient to pay and discharge the entire Indebtedness on the Notes not theretofore delivered to the trustee for cancellation, for principal of, premium, if any, and interest on the Notes to the date of maturity or redemption, as the case may be, together with irrevocable instructions from the Issuers directing the trustee to apply such funds to the payment thereof at maturity or redemption, as the case may be;
 
  (2)  the Issuers have paid all other sums payable under the indenture by the Parent or the Issuers; and
 
  (3)  the Issuers have delivered to the trustee an officers’ certificate and an opinion of counsel stating that all conditions precedent under the indenture relating to the satisfaction and discharge of the indenture have been complied with.
 
Modification and Waiver
 
Subject to certain limited exceptions, modifications and amendments of the indenture may be made by the Issuers and the trustee with the consent of the holders of not less than a majority in aggregate principal amount of the outstanding Notes; provided, however, that no such modification or amendment may, without the consent of each holder affected thereby:
 
  (1)  change the Stated Maturity of the principal of, or any installment of interest on, any Note,
 
  (2)  reduce the principal amount of, or premium, if any, or interest on, any Note,
 
  (3)  change the place of payment of principal of, or premium, if any, or interest on, any Note,
 
  (4)  impair the right to institute suit for the enforcement of any payment on or after the Stated Maturity (or, in the case of a redemption, on or after the Redemption Date) of any Note,
 
  (5)  reduce the above-stated percentage of outstanding Notes the consent of whose holders is necessary to modify or amend the indenture,
 
  (6)  waive a default in the payment of principal of, premium, if any, or interest on the Notes (except a rescission of the declaration of acceleration of the Notes by the holders of at least a majority in aggregate principal amount of the Notes then outstanding and a waiver of the payment default that resulted from such acceleration, so long as all other existing Events of Default, other than the nonpayment of the principal of, premium, if any, and interest on the Notes that have become due solely by such declaration of acceleration, have been cured or waived),
 
  (7)  voluntarily release a Guarantor of the Notes, except as permitted by the indenture,
 
  (8)  reduce the percentage or aggregate principal amount of outstanding Notes the consent of whose holders is necessary for waiver of compliance with certain provisions of the indenture or for waiver of certain defaults, or
 
  (9)  modify or change any provisions of the indenture affecting the ranking of the Notes or the Guaranties as to right of payment or in any manner adverse to the holders of the Notes in any material.
 
Notwithstanding the preceding, without the consent of any holder, the Parent, the Issuers, the Subsidiary Guarantors and the trustee may amend the indenture:
 
  (1)  to cure any ambiguity, omission, defect or inconsistency;


123


Table of Contents

 
  (2)  to provide for the assumption by a successor corporation or other entity of the obligations of the Parent, the Issuers or any Subsidiary Guarantor under the indenture;
 
  (3)  to provide for uncertificated Notes in addition to or in place of certificated Notes;
 
  (4)  to add guaranties with respect to the Notes, including any Subsidiary Guaranties, or to secure the Notes;
 
  (5)  to add to the covenants of the Parent, the Issuers or a Subsidiary Guarantor for the benefit of the holders or to surrender any right or power conferred upon the Parent, the Issuers or a Subsidiary Guarantor;
 
  (6)  to make any change that does not adversely affect the rights of any Holder in any material respect;
 
  (7)  to comply with any requirement of the SEC in order to effect or maintain the qualification of the indenture under the Trust Indenture Act;
 
  (8)  to make any amendment to the provisions of the indenture relating to the transfer and legending of Notes; provided, however, that (a) compliance with the indenture as so amended would not result in Notes being transferred in violation of the Securities Act or any other applicable securities law and (b) such amendment does not materially and adversely affect the rights of holders to transfer Notes;
 
  (9)  to conform the text of the indenture or the Guaranties or the Notes to any provision of the “Description of Notes” section of the offering memoranda relating to the Old Notes to the extent that such provision in the “Description of Notes” section of the offering memoranda relating to the Old Notes was intended to be a substantially verbatim recitation of a provision of the indenture, the Guaranties or the Notes;
 
  (10)  to evidence and provide for the acceptance of appointment by a successor trustee, provided that the successor trustee is otherwise qualified and eligible to act as such under the terms of the indenture;
 
  (11)  to release a Subsidiary Guarantor from its Subsidiary Guaranty as permitted by and in accordance with the indenture;
 
  (12)  to provide for a reduction in the minimum denominations of the Notes;
 
  (13)  to comply with the rules of any applicable securities depositary; or
 
  (14)  to provide for the issuance of additional notes and related guarantees in accordance with the limitations set forth in the indenture.
 
The consent of the holders is not necessary under the indenture to approve the particular form of any proposed amendment. It is sufficient if such consent approves the substance of the proposed amendment.
 
After an amendment under the indenture becomes effective, the Parent is required to mail to holders a notice briefly describing such amendment. However, the failure to give such notice to all holders, or any defect therein, will not impair or affect the validity of the amendment.
 
Neither the Parent nor any Affiliate of the Parent may, directly or indirectly, pay or cause to be paid any consideration, whether by way of interest, fee or otherwise, to any holder for or as an inducement to any


124


Table of Contents

consent, waiver or amendment of any of the terms or provisions of the indenture or the Notes unless such consideration is offered to all holders and is paid to all holders that so consent, waive or agree to amend in the time frame set forth in solicitation documents relating to such consent, waiver or agreement.
 
No Personal Liability of Incorporators, Stockholders, Officers, Directors, or Employees
 
The indenture provides that no recourse for the payment of the principal of, premium, if any, or interest on any of the Notes or for any claim based thereon or otherwise in respect thereof, and no recourse under or upon any obligation, covenant or agreement of the Parent, the Issuers or the Guarantors in the indenture, or in any of the Notes or Guarantees or because of the creation of any Indebtedness represented thereby, shall be had against any incorporator, stockholder, officer, director, employee or controlling person of the Parent, the Issuers or the Subsidiary Guarantors or of any successor Person thereof. Each holder, by accepting the Notes, waives and releases all such liability.
 
Concerning the Trustee
 
The indenture provides that, except during the continuance of a Default, the trustee will not be liable, except for the performance of such duties as are specifically set forth in the indenture. If an Event of Default has occurred and is continuing, the trustee will use the same degree of care and skill in its exercise of the rights and powers vested in it under the indenture as a prudent person would exercise under the circumstances in the conduct of such person’s own affairs.
 
The trustee shall be under no obligation to exercise any of the rights or powers vested in it by the indenture at the request or direction of any of the holders pursuant to the indenture, unless such holders shall have offered to the trustee security or indemnity satisfactory to the trustee against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction.
 
The indenture and provisions of the Trust Indenture Act of 1939 incorporated by reference into the indenture contain limitations on the rights of the trustee, should it become a creditor of the Parent or the Issuers, to obtain payment of claims in certain cases or to realize on certain property received by it in respect of any such claims, as security or otherwise. The trustee is permitted to engage in other transactions; provided, however, that if it acquires any conflicting interest, it must eliminate such conflict or resign.
 
Certain Definitions
 
Set forth below are definitions of certain terms contained in the indenture that are used in this Description of Exchange Notes. Please refer to the indenture for the definition of other capitalized terms used in this Description of Exchange Notes that are not defined below.
 
“Acquired Indebtedness” means Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary or that is assumed in connection with an Asset Acquisition from such Person by a Restricted Subsidiary and not incurred by such Person in connection with, or in anticipation of, such Person becoming a Restricted Subsidiary or such Asset Acquisition; provided, however, that Indebtedness of such Person that is redeemed, defeased, retired or otherwise repaid at the time of or immediately upon consummation of the transactions by which such Person becomes a Restricted Subsidiary or such Asset Acquisition shall not be Acquired Indebtedness.
 
“Acquisition Line” means the $100 million revolving credit line under a credit agreement dated as of September 17, 2010, among Aviv Financing I, L.L.C., as the parent borrower, the other borrowers named therein, General Electric Capital Corporation, as administrative agent and a lender, and the other lenders named therein.


125


Table of Contents

 
“Adjusted Consolidated EBITDA” means, for any period, Adjusted Consolidated Net Income for such period plus, to the extent such amount was deducted in calculating such Adjusted Consolidated Net Income (without duplication):
 
  (1)  Consolidated Interest Expense;
 
  (2)  provision for taxes based on income or profits or capital gains, including federal, state, provincial, franchise, excise and similar taxes and foreign withholding taxes;
 
  (3)  depreciation and amortization (including amortization or impairment write-offs of goodwill and other intangibles but excluding amortization of prepaid cash expenses that were paid in a prior period);
 
  (4)  the amount of integration costs deducted (and not added back) in such period in computing Adjusted Consolidated Net Income, including any one-time direct transaction or restructuring costs incurred in connection with acquisitions, not to exceed for any period 10% of Adjusted Consolidated EBITDA (calculated on a pro forma basis for any relevant transaction giving rise to the calculation of Adjusted Consolidated EBITDA but before giving effect to the costs described in this clause (4));
 
  (5)  proceeds from any business interruption insurance;
 
  (6)  any non-cash compensation expense attributable to grants of stock options, restricted stock or similar rights to officers, directors and employees of the Parent and any of its Subsidiaries;
 
  (7)  all extraordinary or non-recurring non-cash gain or loss or expense, together with any related provision for taxes; and
 
  (8)  all other non-cash items (other than deferred rental loss) reducing Adjusted Consolidated Net Income (other than items that will require cash payments and for which an accrual or reserve is, or is required by GAAP to be, made), including any impairment charge or asset write-offs or write-downs related to intangible assets (including goodwill) and long-lived assets pursuant to GAAP, less all non-cash items (other than deferred rental income) increasing Adjusted Consolidated Net Income, all as determined on a consolidated basis for the Parent and its Restricted Subsidiaries in conformity with GAAP.
 
Notwithstanding the preceding, the income taxes of, and the depreciation and amortization and other non-cash items of, a Subsidiary shall be added (or subtracted) to Adjusted Consolidated Net Income to compute Adjusted Consolidated EBITDA only to the extent (and in the same proportion) that net income of such Subsidiary was included in calculating Adjusted Consolidated Net Income.
 
“Adjusted Consolidated Net Income” means, for any period, the aggregate net income (or loss) (before giving effect to cash dividends on preferred stock of the Parent or charges resulting from the redemption of preferred stock of the Parent) of the Parent and its Restricted Subsidiaries for such period determined on a consolidated basis in conformity with GAAP; provided, however, that the following items shall be excluded in computing Adjusted Consolidated Net Income, without duplication:
 
  (1)  the net income of any Person, other than the Parent or a Restricted Subsidiary, except to the extent of the amount of dividends or other distributions actually paid in cash (or to the extent converted into cash) or Temporary Cash Investments to the Parent or any of its Restricted Subsidiaries by such Person during such period;


126


Table of Contents

 
  (2)  the net income of any Restricted Subsidiary to the extent that the declaration or payment of dividends or similar distributions by such Restricted Subsidiary of such net income is not at the time permitted by the operation of the terms of its charter or any agreement, instrument, judgment, decree, order, statute, rule or governmental regulation applicable to such Restricted Subsidiary, unless such restrictions with respect to the declaration and payment of dividends or distributions have been properly waived for such entire period; provided, however, that Adjusted Consolidated Net Income will be increased by the amount of dividends or other distributions or other payments made in cash (or to the extent converted into cash) or Temporary Cash Investments to the Parent or a Restricted Subsidiary thereof in respect of such period, to the extent not already included therein;
 
  (3)  the cumulative effect of a change in accounting principles;
 
  (4)  costs associated with initiating public company reporting, including compliance with the Sarbanes-Oxley Act of 2002, not to exceed an aggregate of $5.0 million;
 
  (5)  any after-tax gains or losses attributable to Asset Sales; and
 
  (6)  all extraordinary gains and extraordinary losses.
 
“Adjusted Funds From Operations” for any period means Adjusted Consolidated Net Income for such period, plus depreciation and amortization of real property (including furniture and equipment) and other real estate assets and excluding (to the extent such amount was added or deducted, as applicable, in calculating such Adjusted Consolidated Net Income):
 
  (1)  gains or losses from (a) the restructuring or refinancing of Indebtedness or (b) sales of properties;
 
  (2)  non-cash asset impairment charges;
 
  (3)  non-cash charges related to redemptions of Preferred Stock of the Parent;
 
  (4)  any non-cash compensation expense attributable to grants of stock options, restricted stock or similar rights to officers, directors and employees of the Parent and any of its Subsidiaries;
 
  (5)  the amortization of financing fees and the write-off of financing costs;
 
  (6)  deferred rental income (loss); and
 
  (7)  any other non-cash charges associated with the sale or settlement of any Interest Rate Agreement or other hedging or derivative instruments.
 
“Adjusted Total Assets” means, for any Person, the sum of:
 
  (1)  Total Assets for such Person as of the end of the fiscal quarter preceding the Transaction Date; and
 
  (2)  any increase in Total Assets following the end of such quarter determined on a pro forma basis, including any pro forma increase in Total Assets resulting from the application of the proceeds of any additional Indebtedness.
 
“Affiliate” means, as applied to any Person, any other Person directly or indirectly controlling, controlled by, or under direct or indirect common control with, such Person. For purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common


127


Table of Contents

control with”), as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise.
 
“Asset Acquisition” means:
 
  (1)  an investment by the Parent or any of its Restricted Subsidiaries in any other Person pursuant to which such Person shall become a Restricted Subsidiary or shall be merged into or consolidated with the Parent or any of its Restricted Subsidiaries; provided, however, that such Person’s primary business is related, ancillary, incidental or complementary to the businesses of the Issuers or any of their Restricted Subsidiaries on the date of such investment; or
 
  (2)  an acquisition by the Parent or any of its Restricted Subsidiaries from any other Person of assets that constitute all or substantially all of a division or line of business, or one or more properties, of such Person; provided, however, that the assets and properties acquired are related, ancillary, incidental or complementary to the businesses of the Issuers or any of their Restricted Subsidiaries on the date of such acquisition.
 
“Asset Disposition” means the sale or other disposition by the Parent or any of its Restricted Subsidiaries, other than to the Parent, the Issuers or another Restricted Subsidiary, of:
 
  (1)  all or substantially all of the Capital Stock of any Restricted Subsidiary; or
 
  (2)  all or substantially all of the assets that constitute a division or line of business, or one or more properties, of the Parent or any of its Restricted Subsidiaries.
 
“Asset Sale” means any sale, transfer or other disposition, including by way of merger, consolidation or Sale and Leaseback Transaction, in one transaction or a series of related transactions by the Parent or any of its Restricted Subsidiaries to any Person other than the Parent, the Issuers or any of their Restricted Subsidiaries of:
 
  (1)  all or any of the Capital Stock of any Restricted Subsidiary of the Parent;
 
  (2)  all or substantially all of the assets that constitute a division or line of business of the Parent or any of its Restricted Subsidiaries; or
 
  (3)  any property and assets of the Parent or any of its Restricted Subsidiaries outside the ordinary course of business of the Parent or such Restricted Subsidiary and, in each case, that is not governed by the provisions of the indenture applicable to mergers, consolidations and sales of assets of the Parent;
 
provided, however, that “Asset Sale” shall not include:
 
  •     the lease or sublease of any Real Estate Asset;
 
  •     sales, leases, assignments, licenses, sublicenses, subleases or other dispositions of inventory, receivables and other current assets;
 
  •     the sale, conveyance, transfer, disposition or other transfer of all or substantially all of the assets of the Parent as permitted by the covenant described under “Consolidation, Merger and Sale of Assets”;
 
  •     the license or sublicense of intellectual property or other general intangibles;


128


Table of Contents

 
  •     the issuance of Capital Stock by a Restricted Subsidiary in which the percentage interest (direct and indirect) in the Capital Stock of such Restricted Subsidiary owned by the Parent after giving effect to such issuance is at least equal to the percentage interest prior to such issuance;
 
  •     any issuance of Capital Stock (other than Disqualified Stock) by the Parent or the Issuers in order to acquire assets used or useful in a Permitted Business;
 
  •     the surrender or waiver of contract rights or the settlement, release or surrender of a contract, tort or other litigation claim in the ordinary course of business;
 
  •     any Restricted Payment permitted by the “Limitation on Restricted Payments” covenant or that constitutes a Permitted Investment;
 
  •     sales, transfers or other dispositions of assets with a fair market value not in excess of $5.0 million in any transaction or series of related transactions;
 
  •     sales or other dispositions of assets for consideration at least equal to the fair market value of the assets sold or disposed of, to the extent that the consideration received would satisfy clause (2) of the third paragraph of the “Limitation on Asset Sales” covenant;
 
  •     sales or other dispositions of cash or Temporary Cash Investments;
 
  •     the creation, granting, perfection or realization of any Lien permitted under the indenture;
 
  •     the lease, assignment or sublease of property in the ordinary course of business so long as the same does not materially interfere with the business of the Parent and its Restricted Subsidiaries, taken as a whole;
 
  •     any transfer or other disposition constituting a taking, seizure, condemnation or other eminent domain proceeding; and
 
  •     sales, exchanges, transfers or other dispositions of damaged, worn-out or obsolete or otherwise unsuitable or unnecessary equipment or assets that, in the Parent’s reasonable judgment, are no longer used or useful in the business of the Parent or its Restricted Subsidiaries and any sale or disposition of property in connection with scheduled turnarounds, maintenance and equipment and facility updates.
 
“Attributable Debt” in respect of a Sale and Leaseback Transaction means, at the time of determination, the present value of the total obligations of the lessee for net rental payments during the remaining term of the lease included in such Sale and Leaseback Transaction. For purposes hereof such present value shall be calculated using a discount rate equal to the rate of interest implicit in such Sale and Leaseback Transaction, determined by the lessee in good faith on a basis consistent with comparable determinations of Capitalized Lease Obligations under GAAP; provided, however, that if such sale and leaseback transaction results in a Capitalized Lease Obligation, the amount of Indebtedness represented thereby will be determined in accordance with the definition of “Capitalized Lease Obligations.”
 
“Average Life” means at any date of determination with respect to any debt security, the quotient obtained by dividing:
 
  (1)  the sum of the products of:
 
  •     the number of years from such date of determination to the dates of each successive scheduled principal payment of such debt security; and


129


Table of Contents

 
  •     the amount of such principal payment, by
 
  (2)  the sum of all such principal payments.
 
“Board of Directors” means, as to any Person, the board of directors (or similar governing body) of such Person or any duly authorized committee thereof.
 
“Board Resolution” means, with respect to any Person, a copy of a resolution certified by the Secretary or an Assistant Secretary of such Person to have been duly adopted by the Board of Directors of such Person and to be in full force and effect on the date of such certification, and delivered to the trustee.
 
“Business Day” means a day other than a Saturday, Sunday or any other day on which banking institutions in New York City are authorized or required by law, regulation or executive order to close.
 
“Capital Stock” means, with respect to any Person, any and all shares, interests, participations or other equivalents (however designated, whether voting or non-voting), including partnership or limited liability company interests, whether general or limited, and including options, warrants and other rights to purchase such shares, interests, participations or other equivalents, in the equity of such Person, whether outstanding on the Issue Date or issued thereafter, including all Common Stock and Preferred Stock.
 
“Capitalized Lease” means, as applied to any Person, any lease of any property, whether real, personal or mixed, of which the discounted present value of the rental obligations of such Person as lessee, in conformity with GAAP, is required to be capitalized on the balance sheet of such Person. For clarity purposes, GAAP for purposes of this definition shall be deemed GAAP as in effect on the date of the indenture.
 
“Capitalized Lease Obligations” means, at the time any determination is to be made, the amount of the liability in respect of a Capitalized Lease that would at that time be required to be capitalized on a balance sheet in accordance with GAAP.
 
“Change of Control” means the occurrence of one or more of the following events:
 
  (1)  any sale, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all of the assets of the Parent and its Subsidiaries taken as a whole to any “person” or “group” (as such terms are defined in Sections 13(d) and 14(d)(2) of the Exchange Act), together with any Affiliates thereof (whether or not otherwise in compliance with the provisions of the indenture) (other than to a Permitted Holder, the Parent or its Restricted Subsidiaries); provided, however, that for the avoidance of doubt, the lease of all or substantially all of the assets of the Parent and its Subsidiaries taken as a whole shall not constitute a Change of Control;
 
  (2)  a “person” or “group” (as such terms are defined in Sections 13(d) and 14(d)(2) of the Exchange Act), other than a Permitted Holder, becomes the ultimate “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act) of more than 50% of the total voting power of the Voting Stock of the Parent on a fully diluted basis;
 
  (3)  the approval by the holders of Capital Stock of the Parent of any plan or proposal for the liquidation or dissolution of the Parent (whether or not otherwise in compliance with the provisions of the indenture); or
 
  (4)  individuals who on the Issue Date constitute the Board of Directors (together with any new or replacement directors whose election by the Board of Directors or whose nomination by the Board of Directors for election by the Parent’s shareholders was (a) approved by a vote of at least a majority of the members of the Board of Directors then still in office who either were members


130


Table of Contents

  of the Board of Directors on the Issue Date or whose election or nomination for election was so approved or (b) made in accordance with any voting agreement to which the Parent is then a party and which was in effect on the Issue Date) cease for any reason to constitute a majority of the members of the Board of Directors then in office.
 
“Code” means the Internal Revenue Code of 1986, as amended.
 
“Common Stock” means, with respect to any Person, any and all shares, interests, participations or other equivalents (however designated, whether voting or non-voting) that have no preference on liquidation or with respect to distributions over any other class of Capital Stock, including partnership interests, whether general or limited, of such Person’s equity, whether outstanding on the Issue Date or issued thereafter, including all series and classes of common stock.
 
“Common Units” means the common units of the Partnership, each having the rights and obligations set forth in the Partnership’s limited partnership agreement, as such agreement may be amended from time to time.
 
“Consolidated Interest Expense” means, for any period, the aggregate amount of interest expense, less the aggregate amount of interest income for such period, in respect of Indebtedness of the Parent and the Restricted Subsidiaries during such period, all as determined on a consolidated basis in conformity with GAAP including (without duplication):
 
  •     the interest portion of any deferred payment obligations;
 
  •     all commissions, discounts and other fees and expenses owed with respect to letters of credit and bankers’ acceptance financing;
 
  •     the net cash costs associated with Interest Rate Agreements and Indebtedness that is Guaranteed or secured by assets of the Parent or any of its Restricted Subsidiaries; and
 
  •     all but the principal component of rentals in respect of Capitalized Lease Obligations paid, accrued or scheduled to be paid or to be accrued by the Parent and its Restricted Subsidiaries;
 
excluding, to the extent included in interest expense above, (A) the amount of such interest expense of any Restricted Subsidiary if the net income of such Restricted Subsidiary is excluded in the calculation of Adjusted Consolidated Net Income pursuant to clause (2) of the definition thereof (but only in the same proportion as the net income of such Restricted Subsidiary is excluded from the calculation of Adjusted Consolidated Net Income pursuant to clause (2) of the definition thereof), as determined on a consolidated basis (without taking into account Unrestricted Subsidiaries) in conformity with GAAP and (B) (i) accretion of accrual of discounted liabilities not constituting Indebtedness, (ii) any expense resulting from the discounting of any outstanding Indebtedness in connection with the application of purchase accounting in connection with any acquisition, (iii) amortization of deferred financing fees, debt issuance costs, commissions, fees and expenses, (iv) any expensing of bridge, commitment or other financing fees (but not revolving loan commitment fees) and (v) non-cash costs associated with Interest Rate Agreements and Currency Agreements.
 
“Credit Agreement” means the Credit Agreement, dated as of February 4, 2011, by and among the Restricted Subsidiaries of the Parent now or hereafter party thereto as borrowers or guarantors, the Parent as guarantor, the lenders party thereto in their capacities as lenders thereunder and Bank of America, N.A., as administrative agent, together with the related documents thereto (including any guarantee agreements and security documents).
 
“Credit Facility” means one or more credit or debt facilities (including any credit or debt facilities provided under the Credit Agreement, Term Loan or Acquisition Line), financings, commercial paper


131


Table of Contents

facilities, note purchase agreements or other debt instruments, indentures or agreements, providing for revolving credit loans, term loans, notes, securities, letters of credit or other debt obligations, in each case, as amended, restated, modified, renewed, refunded, restructured, supplemented, replaced or refinanced in whole or in part from time to time, including any amendment increasing the amount of Indebtedness incurred or available to be borrowed thereunder, extending the maturity of any Indebtedness incurred thereunder or contemplated thereby or deleting, adding or substituting one or more parties thereto (whether or not such added or substituted parties are banks or other lenders or investors).
 
“Currency Agreement” means any foreign exchange contract, currency swap agreement or other similar agreement or arrangement.
 
“Default” means any event that is, or after notice or passage of time or both would be, an Event of Default.
 
“Designated Non-cash Consideration” means the fair market value of non-cash consideration received by the Parent or any of its Restricted Subsidiaries in connection with an Asset Sale that is so designated as Designated Non-cash Consideration pursuant to an Officer’s Certificate, setting forth the basis of such valuation, executed by the principal financial officer of the Parent, less the amount of cash or Temporary Cash Investments received in connection with a subsequent sale of or collection on such Designated Non-cash Consideration.
 
“Disqualified Stock” means any class or series of Capital Stock of any Person that by its terms or otherwise is:
 
  (1)  required to be redeemed on or prior to the date that is 91 days after the Stated Maturity of the Notes;
 
  (2)  redeemable at the option of the holder of such class or series of Capital Stock, at any time on or prior to the date that is 91 days after the Stated Maturity of the Notes (other than into shares of Capital Stock that is not Disqualified Stock); or
 
  (3)  convertible into or exchangeable for Capital Stock referred to in clause (1) or (2) above or Indebtedness having a scheduled maturity on or prior to the date that is 91 days after the Stated Maturity of the Notes;
 
provided, however, that any Capital Stock that would not constitute Disqualified Stock but for provisions thereof giving holders thereof the right to require such Person to repurchase or redeem such Capital Stock upon the occurrence of an “asset sale” or “change of control” occurring prior to the Stated Maturity of the Notes shall not constitute Disqualified Stock if the “asset sale” or “change of control” provisions applicable to such Capital Stock are no more favorable to the holders of such Capital Stock than the provisions contained in “Limitation on Asset Sales” and “Repurchase of Notes upon a Change of Control” covenants described above and such Capital Stock specifically provides that such Person will not repurchase or redeem any such stock pursuant to such provisions unless such repurchase or redemption complies with the covenant described above under the caption “—Covenants—Limitation on Restricted Payments.” Disqualified Stock shall not include Capital Stock which is issued to any plan for the benefit of employees of the Parent or its Subsidiaries or by any such plan to such employees solely because it may be required to be repurchased by the Parent or its Subsidiaries in order to satisfy applicable statutory or regulatory obligations. Disqualified Stock shall not include Common Units.
 
“Equity Offering” means a public or private offering of Capital Stock (other than Disqualified Stock) of the Parent or any successor entity of the Parent permitted pursuant to the indenture.


132


Table of Contents

 
“Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor statute or statutes thereto.
 
“Existing Indebtedness” means the aggregate principal amount of Indebtedness of the Parent and its Subsidiaries that was in existence on the date of the indenture until such amounts are repaid.
 
“fair market value” means the price that would be paid in an arm’s-length transaction between an informed and willing seller under no compulsion to sell and an informed and willing buyer under no compulsion to buy. For purposes of determining compliance with the provisions of the indenture described under the caption “—Covenants,” any determination that the fair market value of assets other than cash or Temporary Cash Investments is equal to or greater than $20 million will be as determined in good faith by the Board of Directors of the Parent, whose determination shall be conclusive if evidenced by a Board Resolution, and otherwise by the principal financial officer of the Parent acting in good faith, each of whose determination will be conclusive.
 
“Four Quarter Period” means, for purposes of calculating the Interest Coverage Ratio with respect to any Transaction Date, the then most recent four fiscal quarters prior to such Transaction Date for which reports have been filed with the SEC or provided to the trustee pursuant to the “—Covenants—SEC Reports and Reports to Holders” covenant (or if no such reports have yet been required to be filed with the SEC, for which internal financial statements are available).
 
“GAAP” means generally accepted accounting principles in the United States of America as in effect as of the Issue Date, including those set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as approved by a significant segment of the accounting profession. Except as otherwise specifically provided in the indenture, all ratios and computations contained or referred to in the indenture shall be computed in conformity with GAAP applied on a consistent basis. For clarity purposes, in determining whether a lease is a Capitalized Lease or an operating lease and whether interest expense exists, such determination shall be made in accordance with GAAP as in effect on the date of the indenture.
 
“Guarantee” means any obligation, contingent or otherwise, of any Person directly or indirectly guaranteeing any Indebtedness of any other Person and, without limiting the generality of the foregoing, any obligation of such Person:
 
  (1)  to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness of such other Person (whether arising by virtue of partnership arrangements, or by agreements to keep-well or to maintain financial statement conditions or otherwise); or
 
  (2)  entered into for purposes of assuring in any other manner the obligee of such Indebtedness of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part);
 
provided, however, that the term “Guarantee” shall not include endorsements for collection or deposit in the ordinary course of business. The term “Guarantee” used as a verb has a corresponding meaning.
 
“Guarantor” means the Parent and each Subsidiary Guarantor.
 
“Guaranty” means a Guaranty by each Guarantor for payment of the Notes by such Guarantor.
 
“Incur” means, with respect to any Indebtedness, to incur, create, issue, assume, Guarantee or otherwise become liable for or with respect to, or become responsible for, the payment of, contingently or otherwise, such Indebtedness, including an “Incurrence” of Acquired Indebtedness; provided, however, that neither the accrual of interest, the payment of interest on any Indebtedness in the form of additional Indebtedness with the same terms, nor the accretion of original issue discount shall be considered an Incurrence of Indebtedness.


133


Table of Contents

 
“Indebtedness” means, with respect to any Person at any date of determination (without duplication):
 
  (1)  all indebtedness of such Person for borrowed money;
 
  (2)  all obligations of such Person evidenced by bonds, debentures, notes or other similar instruments;
 
  (3)  the face amount of letters of credit or other similar instruments (excluding obligations with respect to letters of credit (including trade letters of credit) securing obligations (other than obligations described in (1) or (2) above or (5), (6) or (7) below) entered into in the ordinary course of business of such Person to the extent such letters of credit are not drawn upon or, if drawn upon, to the extent such drawing is reimbursed no later than the fifth Business Day following receipt by such Person of a demand for reimbursement);
 
  (4)  all unconditional obligations of such Person to pay the deferred and unpaid purchase price of property or services, which purchase price is due more than six months after the date of placing such property in service or taking delivery and title thereto or the completion of such services, except Trade Payables;
 
  (5)  all Capitalized Lease Obligations and Attributable Debt;
 
  (6)  all Indebtedness of other Persons secured by a Lien on any asset of such Person, whether or not such Indebtedness is assumed by such Person; provided, however, that the amount of such Indebtedness shall be the lesser of (A) the fair market value of such asset at that date of determination and (B) the amount of such Indebtedness;
 
  (7)  all Indebtedness of other Persons Guaranteed by such Person to the extent such Indebtedness is Guaranteed by such Person; and
 
  (8)  to the extent not otherwise included in this definition or the definition of Consolidated Interest Expense, obligations under Currency Agreements and Interest Rate Agreements.
 
The amount of Indebtedness of any Person at any date shall be the outstanding balance at such date of all unconditional obligations of the type described above and, with respect to obligations under any Guarantee, the maximum liability upon the occurrence of the contingency giving rise to the obligation; provided, however, that:
 
  •     the amount outstanding at any time of any Indebtedness issued with original issue discount shall be deemed to be the face amount with respect to such Indebtedness less the remaining unamortized portion of the original issue discount of such Indebtedness at the date of determination in conformity with GAAP;
 
  •     Indebtedness shall not include any liability for foreign, federal, state, local or other taxes;
 
  •     Indebtedness shall not include any indemnification, earnouts, adjustment or holdback of purchase price or similar obligations, in each case, incurred or assumed in connection with the acquisition or disposition of any business, assets or a Subsidiary, other than guarantees of Indebtedness incurred by any Person acquiring all or any portion of such business, assets or Subsidiary for the purpose of financing such acquisition; and
 
  •     Indebtedness shall not include contingent obligations under performance bonds, performance guarantees, surety bonds, appeal bonds or similar obligations incurred in the ordinary course of business and consistent with past practices.


134


Table of Contents

 
“Interest Coverage Ratio” means, on any Transaction Date, the ratio of:
 
  •     the aggregate amount of Adjusted Consolidated EBITDA for the then applicable Four Quarter Period to
 
  •     the aggregate Consolidated Interest Expense during such Four Quarter Period.
 
In making the foregoing calculation,
 
  (1)  pro forma effect shall be given to any Indebtedness Incurred or repaid (other than in connection with an Asset Acquisition or Asset Disposition) during the period (“Reference Period”) commencing on the first day of the Four Quarter Period and ending on the Transaction Date (other than Indebtedness Incurred or repaid under a revolving credit or similar arrangement), in each case as if such Indebtedness had been Incurred or repaid on the first day of such Reference Period;
 
  (2)  Consolidated Interest Expense attributable to interest on any Indebtedness (whether existing or being Incurred) computed on a pro forma basis and bearing a floating interest rate shall be computed as if the rate in effect on the Transaction Date (taking into account any Interest Rate Agreement applicable to such Indebtedness if such Interest Rate Agreement has a remaining term in excess of 12 months or, if shorter, at least equal to the remaining term of such Indebtedness) had been the applicable rate for the entire period;
 
  (3)  pro forma effect shall be given to Asset Dispositions, Asset Acquisitions and Permitted Mortgage Investments (including giving pro forma effect to the application of proceeds of any Asset Disposition and any Indebtedness Incurred or repaid in connection with any such Asset Acquisitions or Asset Dispositions) that occur during such Reference Period or subsequent to the end of the related Four Quarter Period as if they had occurred and such proceeds had been applied on the first day of such Reference Period and after giving effect to Pro Forma Cost Savings;
 
  (4)  pro forma effect shall be given to asset dispositions and asset acquisitions (including giving pro forma effect to (i) the application of proceeds of any asset disposition and any Indebtedness Incurred or repaid in connection with any such asset acquisitions or asset dispositions, (ii) expense and cost reductions calculated on a basis consistent with Regulation S-X under the Exchange Act and (iii) Pro Forma Cost Savings) that have been made by any Person that has become a Restricted Subsidiary or has been merged with or into the Parent or any of its Restricted Subsidiaries during such Reference Period but subsequent to the end of the related Four Quarter Period and that would have constituted Asset Dispositions or Asset Acquisitions during such Reference Period but subsequent to the end of the related Four Quarter Period had such transactions occurred when such Person was a Restricted Subsidiary as if such asset dispositions or asset acquisitions were Asset Dispositions or Asset Acquisitions and had occurred on the first day of such Reference Period;
 
  (5)  the Consolidated Interest Expense attributable to discontinued operations, as determined in accordance with GAAP, shall be excluded, but only to the extent that the obligations giving rise to such Consolidated Interest Expense will not be obligations of the specified Person or any of its Restricted Subsidiaries following the Transaction Date; and
 
  (6)  consolidated interest expense attributable to interest on any Indebtedness (whether existing or being incurred) computed on a pro forma basis and bearing a floating interest rate shall be computed as if the rate in effect on the Transaction Date (taking into account any Interest Rate Agreement applicable to such Indebtedness if such Interest Rate Agreement has a remaining term


135


Table of Contents

  in excess of 12 months or, if shorter, at least equal to the remaining term of such Indebtedness) had been the applicable rate for the entire period. Interest on Indebtedness that may optionally be determined at an interest rate based on a factor of a prime or similar rate, a Eurocurrency interbank offered rate, or other rate, shall be deemed to have been based upon the rate actually chosen, or, if not, then based upon such operational rate chosen as the Parent may designate. Interest on any Indebtedness under a revolving credit facility computed on a pro forma basis shall be computed based on the average daily balance of such Indebtedness during the applicable period except as set forth in clause (1) of this definition. Interest on a Capitalized Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by a responsible financial or accounting officer of the Parent to be the rate of interest implicit in such Capitalized Lease Obligation in accordance with GAAP;
 
provided, however, that to the extent that clause (3) or (4) of this paragraph requires that pro forma effect be given to an Asset Acquisition, Asset Disposition, Permitted Mortgage Investment, asset acquisition or asset disposition, as the case may be, such pro forma calculation shall be based upon the four full fiscal quarters immediately preceding the Transaction Date of the Person, or division or line of business, or one or more properties, of the Person that is acquired or disposed of to the extent that such financial information is available or otherwise a reasonable estimate thereof is available.
 
“Interest Rate Agreement” means any interest rate protection agreement, interest rate future agreement, interest rate option agreement, interest rate swap agreement, interest rate cap agreement, interest rate collar agreement, interest rate hedge agreement, option or future contract or other similar agreement or arrangement with respect to interest rates.
 
“Investment” in any Person means any direct or indirect advance, loan or other extension of credit (including by way of Guarantee or similar arrangement, but excluding advances to customers in the ordinary course of business that are, in conformity with GAAP, recorded as accounts receivable on the consolidated balance sheet of the Parent and its Restricted Subsidiaries and commission, travel and similar advances to employees, directors, officers, managers and consultants in each case made in the ordinary course of business) or capital contribution to (by means of any transfer of cash or other property (tangible or intangible) to others or any payment for property or services solely for the account or use of others, or otherwise), or any purchase or acquisition of Capital Stock, bonds, notes, debentures or other similar instruments issued by, such Person and shall include:
 
  (1)  the designation of a Restricted Subsidiary as an Unrestricted Subsidiary; and
 
  (2)  the fair market value of the Capital Stock (or any other Investment) held by the Parent or any of its Restricted Subsidiaries of (or in) any Person that has ceased to be a Restricted Subsidiary;
 
provided, however, that the fair market value of the Investment remaining in any Person that has ceased to be a Restricted Subsidiary shall be deemed not to exceed the aggregate amount of Investments previously made in such Person valued at the time such Investments were made, less the net reduction of such Investments. For purposes of the definition of “Unrestricted Subsidiary” and the “Limitation on Restricted Payments” covenant described above:
 
  •     “Investment” shall include the fair market value of the assets (net of liabilities (other than liabilities to the Parent or any of its Restricted Subsidiaries)) of any Restricted Subsidiary at the time such Restricted Subsidiary is designated an Unrestricted Subsidiary;
 
  •     the fair market value of the assets (net of liabilities (other than liabilities to the Parent or any of its Restricted Subsidiaries)) of any Unrestricted Subsidiary at the time that such Unrestricted Subsidiary is designated a Restricted Subsidiary shall be considered a reduction in outstanding Investments; and


136


Table of Contents

 
  •     any property transferred to or from an Unrestricted Subsidiary shall be valued at its fair market value at the time of such transfer.
 
“Investment Grade Status” means, with respect to the Parent or the Issuers, when the Notes have both (1) a rating of “Baa3” or higher from Moody’s and (2) a rating of “BBB-” or higher from S&P (or, if either such agency ceases to rate the Notes for reasons outside the control of the Parent, the equivalent investment grade credit rating from any other “nationally recognized statistical rating organization” within the meaning of Rule 15c3-l(c)(2)(vi)(F) under the Exchange Act selected by the Parent as a replacement agency), in each case published by the applicable agency.
 
“Issue Date” means February 4, 2011.
 
“Lien” means any mortgage, pledge, security interest, encumbrance, lien or charge of any kind (including any conditional sale or other title retention agreement or lease in the nature thereof or any agreement to give any security interest).
 
“Moody’s” means Moody’s Investors Service, Inc. and its successors.
 
“Net Cash Proceeds” means:
 
  (1)  with respect to any Asset Sale, the proceeds of such Asset Sale in the form of cash or Temporary Cash Investments, including payments in respect of deferred payment obligations (to the extent corresponding to the principal, but not interest, component thereof) when received in the form of cash or Temporary Cash Investments (except to the extent such obligations are financed or sold with recourse to the Parent or any of its Restricted Subsidiaries) and proceeds from the conversion or sale of other property received when converted to or sold for cash or cash equivalents, net of:
 
  •     brokerage commissions and other fees and expenses (including fees and expenses of counsel and investment bankers) related to such Asset Sale;
 
  •     provisions for all taxes actually paid or payable as a result of such Asset Sale by the Parent and its Restricted Subsidiaries, taken as a whole, after taking into account any available tax credits or deductions and any tax sharing arrangements;
 
  •     payments made to repay Indebtedness or any other obligation outstanding at the time of such Asset Sale that either (A) is secured by a Lien on the property or assets sold or (B) is required to be paid as a result of such sale;
 
  •     so long as after giving pro forma effect to any such distribution (i) the aggregate principal amount of all outstanding Indebtedness of the Parent and its Restricted Subsidiaries on a consolidated basis at such time is less than 60% of Adjusted Total Assets; and (ii) no Default or Event of Default shall have occurred and be continuing, the amount required to be distributed to the holders of Parent’s Capital Stock as a result of such Asset Sale in order for Parent to maintain its status as a REIT and any related pro rata distributions to holders of the Partnership’s Capital Stock; and
 
  •     amounts reserved by the Parent and its Restricted Subsidiaries against any liabilities associated with such Asset Sale, including pension and other post-employment benefit liabilities, liabilities related to environmental matters and liabilities under any indemnification obligations associated with such Asset Sale, all as determined on a consolidated basis in conformity with GAAP; and


137


Table of Contents

 
  (2)  with respect to any issuance or sale of Capital Stock, the proceeds of such issuance or sale in the form of cash or Temporary Cash Investments, including payments in respect of deferred payment obligations (to the extent corresponding to the principal, but not interest, component thereof) when received in the form of cash or Temporary Cash Investments (except to the extent such obligations are financed or sold with recourse to the Parent or any of its Restricted Subsidiaries) and proceeds from the conversion of other property received when converted to cash or Temporary Cash Investments, net of attorney’s fees, accountants’ fees, underwriters’ or placement agents’ fees, discounts or commissions and brokerage, consultant and other fees actually incurred in connection with such issuance or sale and net of tax paid or payable as a result thereof.
 
“Offer to Purchase” means an offer to purchase Notes by the Issuers from the holders commenced by sending a notice to the trustee and each holder electronically or by first class mail at its registered address or otherwise in accordance with the procedures of DTC stating:
 
  (1)  the covenant pursuant to which the offer is being made and that all Notes validly tendered will be accepted for payment on a pro rata basis;
 
  (2)  the purchase price and the date of purchase (which shall be a Business Day no earlier than 30 days nor later than 60 days from the date such notice is mailed) (the “Payment Date”);
 
  (3)  that any Note not tendered will continue to accrue interest pursuant to its terms;
 
  (4)  that, unless the Issuers default in the payment of the purchase price, any Note accepted for payment pursuant to the Offer to Purchase shall cease to accrue interest on and after the Payment Date;
 
  (5)  that holders electing to have a Note purchased pursuant to the Offer to Purchase will be required to surrender the Note, together with the form entitled “Option of the Holder to Elect Purchase” on the reverse side of the Note completed, to the Paying Agent at the address specified in the notice or otherwise in accordance with DTC’s applicable procedures prior to the close of business on the Business Day immediately preceding the Payment Date;
 
  (6)  that holders will be entitled to withdraw their election by using the ATOP System in accordance with DTC’s applicable procedures or if the Paying Agent receives, not later than the close of business on the third Business Day immediately preceding the Payment Date, a telegram, facsimile transmission or letter or instruction to DTC, as applicable, setting forth the name of such holder, the principal amount of Notes delivered for purchase and, if applicable, a statement that such holder is withdrawing his election to have such Notes purchased; and
 
  (7)  that holders whose Notes are being purchased only in part will be issued new Notes equal in principal amount to the unpurchased portion of the Notes surrendered; provided, however, that each Note purchased and each new Note issued shall be in a principal amount of $2,000 or integral multiples of $1,000 in excess thereof.
 
On the Payment Date, the Issuers shall:
 
  •     accept for payment on a pro rata basis Notes or portions thereof tendered pursuant to an Offer to Purchase;
 
  •     deposit with the Paying Agent no later than 12:00 p.m. New York City time money sufficient to pay the purchase price of all Notes or portions thereof so accepted; and


138


Table of Contents

 
  •     promptly thereafter deliver, or cause to be delivered, to the trustee all Notes or portions thereof so accepted together with an Officers’ Certificate specifying the Notes or portions thereof accepted for payment by the Issuers.
 
The Paying Agent shall promptly wire to the holders of Notes so accepted payment in an amount equal to the purchase price, and the trustee shall promptly authenticate and mail to such holders a new Note equal in principal amount to any unpurchased portion of any Note surrendered (and in the case of Notes held in book entry form, the trustee shall hold such global notes as custodian for DTC); provided, however, that each Note purchased and each new Note issued shall be in a principal amount of $2,000 or integral multiples of $1,000 in excess thereof. The Issuers will publicly announce the results of an Offer to Purchase as soon as practicable after the Payment Date. The Issuers will comply with Rule 14e-l under the Exchange Act and any other securities laws and regulations thereunder to the extent such laws and regulations are applicable, in the event that the Issuers are required to repurchase Notes pursuant to an Offer to Purchase.
 
“Pari Passu Indebtedness” means any Indebtedness of the Issuers or any Guarantor that ranks pari passu in right of payment with, or senior in right of payment to, the Notes or the Guaranty thereof by such Guarantor, as applicable, including Indebtedness outstanding under the Credit Agreement, the Acquisition Line and the Term Loan.
 
“Permitted Business” means any business activity (including Permitted Mortgage Investments) in which the Parent and its Restricted Subsidiaries are engaged or propose to be engaged in (as described in the offering memoranda relating to the Old Notes) on the Issue Date, any business activity related to properties customarily constituting assets of a healthcare REIT, or any business reasonably related, ancillary or complementary thereto, or reasonable expansions or extensions thereof.
 
“Permitted Holders” means LG Aviv L.P. (and any other investment fund that is an Affiliate of Lindsay Goldberg LLC) and Craig Bernfield.
 
“Permitted Investment” means:
 
  (1)  an Investment in (a) the Parent or any of its Restricted Subsidiaries or (b) a Person that will, upon the making of such Investment, become a Restricted Subsidiary or be merged or consolidated with or into or transfer or convey all or substantially all its assets to, the Parent or any of its Restricted Subsidiaries and, in each case, any Investment held by such Person, provided that such Investment was not acquired by such Person in contemplation of such acquisition, merger, consolidation or transfer, and provided further that such Investment was not an Investment in any Subordinated Guaranty Subsidiary consisting of any Real Estate Assets in existence on the Issue Date of any of the Issuers or the Senior Guaranty Subsidiaries;
 
  (2)  investments in cash and Temporary Cash Investments;
 
  (3)  Investments made by the Parent or its Restricted Subsidiaries as a result of consideration received in connection with an Asset Sale made in compliance with the “Limitation on Asset Sales” covenant or from any other disposition or transfer of assets not constituting an Asset Sale;
 
  (4)  Investments represented by Guarantees that are otherwise permitted under the indenture;
 
  (5)  payroll, travel and similar advances to cover matters that are expected at the time of such advances ultimately to be treated as expenses in accordance with GAAP;
 
  (6)  Investments received in satisfaction of judgments or in settlements of debt or compromises of obligations incurred in the ordinary course of business;


139


Table of Contents

 
  (7)  any Investment acquired solely in exchange for Capital Stock (other than Disqualified Stock) of the Parent or the Partnership, which the Parent or the Partnership did not receive in exchange for a cash payment, Indebtedness or Disqualified Stock, but excluding any new cash Investments made thereafter;
 
  (8)  any Investment existing on the Issue Date;
 
  (9)  Investments in Unrestricted Subsidiaries and joint ventures in an aggregate amount, taken together with all other Investments made in reliance on this clause and all Indebtedness then outstanding pursuant to clause 4(O) of the covenant described under “— Covenants—Limitation on Indebtedness,” not to exceed the greater of $20 million and 2.0% of Adjusted Total Assets (net of, with respect to the Investment in any particular Person, the cash return thereon received after the Issue Date as a result of any sale for cash, repayment, redemption, liquidating distribution or other cash realization (not included in Adjusted Consolidated Net Income), not to exceed the amount of Investments in such Person made after the Issue Date in reliance on this clause);
 
  (10)  obligations under Currency Agreements and Interest Rate Agreements otherwise permitted under the indenture;
 
  (11)  Permitted Mortgage Investments;
 
  (12)  any transaction which constitutes an Investment to the extent permitted and made in accordance with the provisions of the second paragraph of the covenant described under “— Covenants—Limitation on Transactions with Affiliates” (except transactions described under clauses (1), (5), (9) and (10) of such paragraph);
 
  (13)  any Investment consisting of prepaid expenses, negotiable instruments held for collection and lease, endorsements for deposit or collection in the ordinary course of business, utility or workers compensation, performance and similar deposits entered into as a result of the operations of the business in the ordinary course of business;
 
  (14)  pledges or deposits by a Person under workers compensation laws, unemployment insurance laws or similar legislation, or deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases to which such Person is a party, or deposits as security for contested taxes or import duties or for the payment of rent, in each case incurred in the ordinary course of business;
 
  (15)  any Investment acquired by the Parent or any of its Restricted Subsidiaries (a) in exchange for any other Investment or accounts receivable held by the Parent or any such Restricted Subsidiary in connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment or accounts receivable or (b) as a result of a foreclosure by the Parent or any of its Restricted Subsidiaries with respect to any secured Investment or other transfer of title with respect to any secured Investment in default;
 
  (16)  any Investment consisting of a loan or advance to officers, directors or employees of the Parent or any of its Restricted Subsidiaries (a) in connection with the purchase by such Persons of Capital Stock of the Parent or (b) made in the ordinary course of business not to exceed $2.5 million at any one time outstanding;
 
  (17)  any Investment made in connection with the funding of contributions under any non-qualified employee retirement plan or similar employee compensation plan in an amount not to exceed


140


Table of Contents

  the amount of compensation expenses recognized by the Parent and any of its Restricted Subsidiaries in connection with such plans; and
 
  (18)  additional Investments not to exceed the greater of $25 million and 2.5% of Adjusted Total Assets at any time outstanding.
 
“Permitted Mortgage Investment” means any Investment in secured notes, mortgages, deeds of trust, collateralized mortgage obligations, commercial mortgage-backed securities, other secured debt securities, secured debt derivatives or other secured debt instruments, so long as such investment relates directly or indirectly to real property that constitutes or is used as a skilled nursing home center, hospital, assisted living facility, independent living facility, medical office or other property customarily constituting an asset of a real estate investment trust specializing in healthcare or senior housing property.
 
“Permitted Refinancing Indebtedness” means any Indebtedness of the Parent or any of its Restricted Subsidiaries issued in exchange for, or the net proceeds of which are used to extend, refinance, renew, replace, defease or refund other Indebtedness (including Acquired Indebtedness) of the Parent or any of its Restricted Subsidiaries (other than intercompany Indebtedness); provided that:
 
  (1)  the principal amount (or accreted value, if applicable) of such Permitted Refinancing Indebtedness does not exceed the principal amount (or accreted value, if applicable) of the Indebtedness so extended, refinanced, renewed, replaced, defeased or refunded (plus all accrued interest thereon and the amount of any reasonably determined premium necessary to accomplish such refinancing and such reasonable fees and expenses incurred in connection therewith);
 
  (2)  such Permitted Refinancing Indebtedness has:
 
  (a)  a final maturity date later than (x) the final maturity date of the Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded or (y) the date that is 91 days after the maturity of the Notes, and
 
  (b)  an Average Life equal to or greater than the Average Life of the Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded or 91 days more than the Average Life of the Notes;
 
  (3)  if the Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded is contractually subordinated in right of payment to the Notes or any Guaranty, such Permitted Refinancing Indebtedness is contractually subordinated in right of payment to the Notes or such Guaranty on terms at least as favorable to the holders of Notes as those contained in the documentation governing the Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded;
 
  (4)  if the Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded is pari passu in right of payment with the Notes or any Guaranty, such Permitted Refinancing Indebtedness is pari passu in right of payment with, or subordinated in right of payment to, the Notes or such Guaranty; and
 
  (5)  such Indebtedness is incurred either (a) by the Parent, an Issuer or any Subsidiary Guarantor or (b) by the Restricted Subsidiary who is the obligor on the Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded.
 
“Person” means any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity.


141


Table of Contents

 
“Preferred Stock” means, with respect to any Person, any and all shares, interests, participations or other equivalents (however designated, whether voting or non-voting) that have a preference on liquidation or with respect to distributions over any other class of Capital Stock, including preferred partnership interests, whether general or limited, or such Person’s preferred or preference stock, whether outstanding on the Issue Date or issued thereafter, including all series and classes of such preferred or preference stock.
 
“Pro Forma Cost Savings” means, with respect to any period, the reductions in costs (including such reductions resulting from employee terminations, facilities consolidations and closings, standardization of employee benefits and compensation policies, consolidation of property, casualty and other insurance coverage and policies, standardization of sales and distribution methods, reductions in taxes other than income taxes) that occurred during such period that are (1) directly attributable to an asset acquisition or (2) implemented and that are supportable and quantifiable by the underlying records of such business, as if, in the case of each of clauses (1) and (2), all such reductions in costs had been effected as of the beginning of such period, decreased by any incremental expenses incurred or to be incurred during such period in order to achieve such reduction in costs, all such costs to be determined in good faith by the chief financial officer of the Parent.
 
“Real Estate Assets” of a Person means, as of any date, the real estate assets of such Person and its Restricted Subsidiaries on such date, on a consolidated basis determined in accordance with GAAP.
 
“Real Estate Revenues” means, with respect to any Real Estate Asset of the Parent and its Restricted Subsidiaries owned as of December 31, 2010, the annualized rental revenues for such Real Estate Asset, calculated based on the monthly rental revenue for such Real Estate Asset as of December 31, 2010 and assuming such Real Estate Asset had been held by the Parent and its Restricted Subsidiaries during the four-quarter period ended December 31, 2010, all as set forth on a schedule attached to the indenture.
 
“Redeemable Cumulative Preferred Stock” means the 12.5% Series A Redeemable Cumulative Preferred Stock of the Parent existing on the Issue Date having a maximum liquidation preference of $125,000.
 
“Replacement Assets” means (1) tangible non-current assets that will be used or useful in a Permitted Business or (2) substantially all the assets of a Permitted Business or a majority of the Voting Stock of any Person engaged in a Permitted Business that will become on the date of acquisition thereof a Restricted Subsidiary.
 
“Restricted Subsidiary” means, with respect to a Person, any Subsidiary of such Person other than an Unrestricted Subsidiary. Unless the context otherwise requires, any reference herein to a “Restricted Subsidiary” shall be to a Restricted Subsidiary of the Issuers. For the avoidance of doubt, the Issuers are considered Restricted Subsidiaries of the Parent for purposes of the indenture.
 
“Sale and Leaseback Transaction” means any direct or indirect arrangement with any Person or to which any such Person is a party, providing for the leasing to the Parent or any Restricted Subsidiary of any property, whether owned by the Parent or any such Restricted Subsidiary at the Issue Date or later acquired, which has been or is to be sold or transferred by the Parent or any such Restricted Subsidiary to such Person or any other Person from whom funds have been or are to be advanced by such Person on the security of such property.
 
“Secured Indebtedness” means any Indebtedness secured by a Lien upon the property of the Parent or any of its Restricted Subsidiaries.
 
“Senior Guaranty Subsidiaries” means all Subsidiary Guarantors other than the Subordinated Guaranty Subsidiaries.


142


Table of Contents

 
“Significant Subsidiary,” with respect to any Person, means any Restricted Subsidiary of such Person that satisfies the criteria for a “significant subsidiary” set forth in Rule 1-02(w) of Regulation S-X under the Exchange Act.
 
“S&P” means Standard & Poor’s Ratings Services and its successors.
 
“Stated Maturity” means:
 
  (1)  with respect to any debt security, the date specified in such debt security as the fixed date on which the final installment of principal of such debt security is due and payable; and
 
  (2)  with respect to any scheduled installment of principal of or interest on any debt security, the date specified in such debt security as the fixed date on which such installment is due and payable,
 
provided, that Stated Maturity shall not include any contingent obligations to repay, redeem or repurchase any such interest or principal prior to the date originally scheduled for the payment thereof.
 
“Subordinated Guaranty Subsidiaries” means (i) the Subsidiary Guarantors that are borrowers or guarantors in respect of the Acquisition Line or the Term Loan on the Issue Date plus (ii) any Subsidiary Guarantors that become borrowers or guarantors in respect of the Acquisition Line or the Term Loan (or any Permitted Refinancing Indebtedness incurred in exchange for, or the net proceeds of which are used to refund, refinance or replace, the Acquisition Line or Term Loan and that was otherwise permitted by the indenture, to the extent such Permitted Refinancing Indebtedness is designated by the Issuers as “Designated Senior Debt” for purposes of the indenture) in the future in connection with acquisitions or other investments but, in case of this clause (ii), excluding any Restricted Subsidiaries of the Issuers in existence on the Issue Date that are not party to the credit agreement governing the Acquisition Line or the Term Loan on the Issue Date; provided, however, that any Subsidiary Guarantor that ceases to be a borrower or guarantor in respect of the Acquisition Line or the Term Loan (or such Permitted Refinancing Indebtedness) in accordance with the terms thereof shall, from and after such date, no longer be a Subordinated Subsidiary Guarantor for purposes of the indenture (but, for the avoidance of doubt, shall remain a Subsidiary Guarantor unless released in accordance with the terms of the indenture).
 
“Subsidiary” means, with respect to any Person, any corporation, association or other business entity of which more than 50% of the voting power of the outstanding Voting Stock is owned, directly or indirectly, by such Person and one or more other Subsidiaries of such Person and the accounts of which would be consolidated with those of such Person in its consolidated financial statements in accordance with GAAP, if such statements were prepared as of such date.
 
“Subsidiary Guarantors” means (i) each Subsidiary of the Issuers on the Issue Date, including the Senior Guaranty Subsidiaries and the Subordinated Guaranty Subsidiaries, but excluding the Real Property Non-Guarantor Subsidiaries, and (ii) each other Person that is required to become a Guarantor by the terms of the indenture after the Issue Date, in each case, until such Person is released from its Subsidiary Guaranty.
 
“Subsidiary Guaranty” means a Guaranty by a Subsidiary Guarantor.
 
“Temporary Cash Investment” means any of the following:
 
  (1)  United States dollars;
 
  (2)  direct obligations of the United States of America or any agency thereof or obligations fully and unconditionally guaranteed by the United States of America or any agency thereof;


143


Table of Contents

 
  (3)  time deposit accounts, term deposit accounts, time deposits, bankers’ acceptances, certificates of deposit, Eurodollar time deposits and money market deposits maturing within twelve months or less of the date of acquisition thereof issued by a bank or trust company which is organized under the laws of the United States of America or any state or jurisdiction thereof, and which bank or trust company has capital, surplus and undivided profits aggregating in excess of $500 million and has outstanding debt which is rated “A” (or such similar equivalent rating) or higher by at least one “nationally recognized statistical rating organization” (within the meaning of Rule 15c3-l(c)(2)(vi)(F) under the Exchange Act) or any money-market fund sponsored by a registered broker dealer or mutual fund distributor;
 
  (4)  repurchase obligations with a term of not more than 30 days for underlying securities of the types described in clauses (2) and (3) above entered into with a bank meeting the qualifications described in clause (3) above;
 
  (5)  commercial paper, maturing not more than six months after the date of acquisition, issued by a corporation (other than an Affiliate of the Parent) organized and in existence under the laws of the United States of America or any state or jurisdiction thereof with a rating at the time as of which any investment therein is made of “P-2” (or higher) according to Moody’s or “A-2” (or higher) according to S&P;
 
  (6)  securities with maturities of six months or less from the date of acquisition issued or fully and unconditionally guaranteed by any state, commonwealth or territory of the United States of America, or by any political subdivision or taxing authority thereof, and rated at least “A” by S&P or Moody’s; and
 
  (7)  any fund investing substantially all of its assets in investments that constitute Temporary Cash Investments of the kinds described in clauses (1) through (6) of this definition.
 
“Term Loan” means the $405 million term loan under a credit agreement dated as of September 17, 2010, among Aviv Financing I, L.L.C., as the parent borrower, the other borrowers named therein, General Electric Capital Corporation, as administrative agent and a lender, and the other lenders named therein.
 
“Total Assets” means, for any Person as of any date, the sum of (i) in the case of any Real Estate Assets that were owned as of December 31, 2010, the Real Estate Revenues specified for such Real Estate Assets divided by 0.0975, plus (ii) the cost (original cost plus capital improvements before depreciation and amortization) of all Real Estate Assets acquired after December 31, 2010 that are then owned by such Person or any of its Restricted Subsidiaries, plus (iii) the book value of all assets (excluding Real Estate Assets, intangibles and deferred rent receivable) of such Person and its Restricted Subsidiaries on a consolidated basis determined in accordance with GAAP.
 
“Total Unencumbered Assets” means, for any Person as of any date, the Total Assets of such Person and its Restricted Subsidiaries as of such date, that do not secure any portion of Secured Indebtedness, on a consolidated basis determined in accordance with GAAP.
 
“Trade Payables” means, with respect to any Person, any accounts payable or any other indebtedness or monetary obligation to trade creditors created, assumed or Guaranteed by such Person or any of its Subsidiaries arising in the ordinary course of business in connection with the acquisition of goods or services.
 
“Transaction Date” means, with respect to the Incurrence of any Indebtedness by the Parent or any of its Restricted Subsidiaries, the date such Indebtedness is to be Incurred and, with respect to any Restricted Payment, the date such Restricted Payment is to be made.


144


Table of Contents

 
“Unrestricted Subsidiary” means
 
  (1)  any Subsidiary of the Issuers that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors of the Parent in the manner provided below; and
 
  (2)  any Subsidiary of an Unrestricted Subsidiary.
 
Except during a Suspension Period, the Board of Directors of the Parent may designate any Subsidiary (including any newly acquired or newly formed Subsidiary of the Issuers) to be an Unrestricted Subsidiary unless such Subsidiary owns any Capital Stock of, or owns or holds any Lien on any property of, the Parent or any of its Restricted Subsidiaries; provided, however, that:
 
  •     any Guarantee by the Parent or any of its Restricted Subsidiaries of any Indebtedness of the Subsidiary being so designated shall be deemed an “Incurrence” of such Indebtedness and an “Investment” by the Parent or such Restricted Subsidiary (or all, if applicable) at the time of such designation;
 
  •     either (i) the Subsidiary to be so designated has total assets of $1,000 or less or (ii) if such Subsidiary has assets greater than $1,000, such designation would be permitted under the “Limitation on Restricted Payments” covenant described above; and
 
  •     if applicable, the Incurrence of Indebtedness and the Investment referred to in the first bullet of this proviso would be permitted under the “Limitation on Indebtedness” and “Limitation on Restricted Payments” covenants described above.
 
The Board of Directors of the Parent may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided, however, that:
 
  •     no Default or Event of Default shall have occurred and be continuing at the time of or after giving effect to such designation; and
 
  •     all Liens and Indebtedness of such Unrestricted Subsidiary outstanding immediately after such designation would, if Incurred at such time, have been permitted to be Incurred (and shall be deemed to have been Incurred) for all purposes of the indenture.
 
Any such designation by the Board of Directors of the Parent shall be evidenced to the trustee by promptly filing with the trustee a copy of the Board Resolution giving effect to such designation and an officers’ certificate certifying that such designation complied with the foregoing provisions.
 
“Unsecured Indebtedness” means any Indebtedness of the Parent or any of its Restricted Subsidiaries that is not Secured Indebtedness.
 
“U.S. Government Obligations” means direct obligations of, obligations guaranteed by, or participations in pools consisting solely of obligations of or obligations guaranteed by, the United States of America for the payment of which obligations or guarantee the full faith and credit of the United States of America is pledged and that are not callable or redeemable at the option of the issuer thereof.
 
“Voting Stock” means with respect to any Person, Capital Stock of any class or kind ordinarily having the power to vote for the election of directors, managers or other voting members of the governing body of such Person.
 
“Wholly Owned” means, with respect to any Subsidiary of any Person, the ownership of all of the outstanding Capital Stock of such Subsidiary (other than any director’s qualifying shares or Investments by individuals mandated by applicable law) by such Person or one or more Wholly Owned Subsidiaries of such Person.


145


Table of Contents

MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS
 
To ensure compliance with IRS Circular 230, you are hereby informed that any discussion of U.S. federal tax issues set forth in this prospectus was written in connection with the promotion and marketing by the Issuer of the Notes. Such discussion is not intended or written to be legal or tax advice to any person and it is not intended or written to be used, and cannot be used, by any person for the purpose of avoiding any U.S. federal tax penalties that may be imposed on such person. You should seek advice based on your particular circumstances from an independent tax advisor.
 
The following is a general discussion of the material U.S. federal income tax consequences to beneficial owners of the Notes of (i) the exchange of the Old Notes for Exchange Notes pursuant to the exchange offer and (ii) the acquisition, ownership, and disposition of the Notes. This discussion is based upon the Internal Revenue Code of 1986, as amended (the “Code”), the U.S. Treasury regulations promulgated thereunder, administrative pronouncements and judicial decisions, all as of the date hereof and all of which are subject to change, possibly on a retroactive basis.
 
This discussion applies only to beneficial owners of Old Notes whose Old Notes are tendered and accepted in the exchange offer and that have held the Old Notes, and will hold the Exchange Notes, as “capital assets” within the meaning of section 1221 of the Code. This discussion does not address all aspects of U.S. federal income taxation that might be important to particular investors in light of their individual circumstances or the U.S. federal income tax consequences applicable to special classes of taxpayers, such as banks and other financial institutions, insurance companies, real estate investment trusts, regulated investment companies, tax-exempt organizations, partnerships (or entities properly classified as partnerships for U.S. federal income tax purposes) or other pass-through entities, dealers in securities or currencies, traders in securities that elect to use a mark-to-market method of accounting, persons liable for U.S. federal alternative minimum tax, U.S. Holders (as defined below) whose functional currency is not the U.S. dollar, former citizens or residents of the United States, and persons holding the Notes as part of a hedging or conversion transaction or a straddle. The discussion does not address any foreign, state, local or non-income tax consequences of the acquisition, ownership or disposition of the Notes to beneficial owners of the Notes.
 
As used in this prospectus, the term “U.S. Holder” means a beneficial owner of a Note who or which is for U.S. federal income tax purposes:
 
  •     a citizen or individual resident of the United States;
 
  •     a corporation (or other entity properly classified as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state within the United States, or the District of Columbia;
 
  •     an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or
 
  •     a trust, if (i) a U.S. court is able to exercise primary supervision over the trust’s administration and one or more “United States persons” (as defined in the Code) have the authority to control all substantial decisions of the trust, or (ii) in the case of a trust that was treated as a domestic trust under the laws in effect before 1997, a valid election is in place under applicable U.S. Treasury regulations to treat such trust as a domestic trust.
 
The term “Non-U.S. Holder” means any beneficial owner of a Note who or which is not a U.S. Holder and is not a partnership or other entity properly classified as a partnership for U.S. federal income tax purposes. For the purposes of this prospectus, U.S. Holders and Non-U.S. Holders are referred to collectively as “Holders.”


146


Table of Contents

 
If a partnership or other entity properly classified as a partnership for U.S. federal income tax purposes is a beneficial owner of a Note, the tax treatment of a partner will generally depend upon the status of the partner and the activities of the entity. Such entities and partners in such entities should consult their own tax advisors about the U.S. federal income and other tax consequences of the acquisition, ownership and disposition of a Note.
 
This discussion is for general purposes only. Holders should consult their own tax advisors regarding the application of the U.S. federal income tax laws to their particular situations and the consequences under federal estate or gift tax laws, as well as foreign, state or local laws and tax treaties, and the possible effects of changes in tax laws.
 
U.S. Federal Income Taxation of U.S. Holders
 
Exchange Offer
 
The exchange of the Old Notes for the Exchange Notes pursuant to the exchange offer will not be a taxable event for U.S. federal income tax purposes because the Exchange Notes will not be considered to differ materially in kind or extent from the Old Notes. As a result, a U.S. Holder will not be required to recognize any gain or loss as a result of an exchange of Old Notes for Exchange Notes. In addition, each U.S. Holder will have the same tax basis and holding period in the Exchange Notes as the Old Notes.
 
Payments of Interest
 
Stated interest on Notes beneficially owned by a U.S. Holder generally will be taxable as ordinary interest income at the time payments are accrued or are received in accordance with the U.S. Holder’s regular method of accounting for U.S. federal income tax purposes.
 
Pre-Issuance Accrued Stated Interest
 
A portion of the price paid upon initial issuance for an Old Note issued on April 5, 2011, was allocable to stated interest that “accrued” prior to the date the Note was issued (the “pre-issuance accrued stated interest”). We intend to take the position that a portion of the stated interest received, in an amount equal to the pre-issuance accrued stated interest, on the first interest payment date of such a Note should be treated as a return of the pre-issuance accrued stated interest to an initial Holder of the Note and not as a payment of stated interest on the Note. Amounts treated as a return to the U.S. Holder of pre-issuance accrued stated interest should not be taxable when received but should reduce a U.S. Holder’s adjusted tax basis in a Note by a corresponding amount.
 
Amortizable Bond Premium
 
If a U.S. Holder purchases a Note for an amount (excluding any amounts that are treated as pre-issuance accrued stated interest as described above) that exceeds the sum of all amounts payable on the Note after the purchase date other than stated interest, a U.S. Holder will be considered to have purchased the Note with amortizable bond premium equal to that excess. A U.S. Holder generally may elect to amortize the premium using a constant yield method over the remaining term of the Note and may offset income otherwise required to be included in respect of the Note during any taxable year by the amortized amount of such excess for the taxable year. The election to amortize premium on a constant yield method will also apply to all debt obligations (other than debt obligations the interest on which is excludable from gross income) a U.S. Holder holds at the beginning of or acquires in or after the first taxable year to which the election applies and may not be revoked without the consent of the Internal Revenue Service. If a U.S. Holder does not elect to amortize bond premium, that premium will decrease the gain or increase the loss that the U.S. Holder would otherwise recognize on the sale, exchange, redemption or other disposition of the Note.


147


Table of Contents

 
Market Discount
 
If a U.S. Holder acquires a Note in a secondary market transaction for an amount that is less than, in general, its principal amount, the amount of such difference is treated as “market discount” for U.S. federal income tax purposes to such U.S. Holder, unless such difference is considered to be de minimis, as described in section 1278(a)(2)(C) of the Code. Under the market discount rules of the Code, a U.S. Holder is required to treat any principal payment on, or any gain on the sale, exchange or redemption or other taxable disposition of, a Note as ordinary income to the extent of the accrued market discount that has not previously been included in income. In general, the amount of market discount that has accrued is determined on a ratable basis, although in certain circumstances an election may be made to accrue market discount on a constant interest basis. A U.S. Holder may not be allowed to deduct immediately a portion of the interest expense on any indebtedness incurred or maintained to purchase or to carry Notes with market discount. A U.S. Holder may elect to include market discount in income currently as it accrues, in which case the interest deferral rule set forth in the preceding sentence will not apply. Such an election will apply to all debt instruments acquired on or after the first day of the taxable year to which such election applies and is irrevocable without the consent of the IRS. The tax basis in a Note will be increased by the amount of market discount included in income as a result of such election. U.S. Holders are urged to consult their tax advisors regarding the tax consequences of the acquisition, ownership, and disposition of Notes with market discount.
 
Payments under Certain Events
 
In certain circumstances, we may be obligated to pay amounts in excess of the stated interest on and stated redemption price at maturity of the Notes. See, e.g., “Description of Exchange Notes—Optional Redemption” and “Description of Exchange Notes—Repurchase of Notes Upon a Change of Control.” These contingencies could subject the Notes to the provisions of the U.S. Treasury regulations relating to “contingent payment debt instruments.” We believe and intend to take the position that the foregoing contingencies should not result in the Notes being treated as contingent payment debt instruments. Our position is binding on a holder, unless the holder discloses in the proper manner to the Internal Revenue Service that it is taking a different position. If the Internal Revenue Service were to successfully challenge this position, the amount, timing and character of payments under the Notes may differ, which could increase the present value of a U.S. Holder’s U.S. federal income tax liability with respect to the Notes. The remainder of this discussion assumes that the Notes will not be treated as contingent payment debt instruments.
 
Sale, Exchange or Redemption of the Notes
 
Upon the sale, redemption, exchange (other than pursuant to the exchange offer) or other taxable disposition of the Notes, a U.S. Holder generally will recognize gain or loss equal to the difference, if any, between (i) the amount realized upon the sale, exchange, redemption or other taxable disposition of the Notes, other than amounts attributable to accrued and unpaid interest (which will be taxed as ordinary interest income to the extent such interest has not been previously included in income), and (ii) the U.S. Holder’s adjusted tax basis in the Notes. The amount realized by a U.S. Holder is the sum of cash plus the fair market value of all other property received on such sale, exchange, redemption or other taxable disposition. A U.S. Holder’s adjusted tax basis in the Notes generally will be its cost for the Notes increased by the amount of any market discount previously included in the U.S. Holder’s gross income and decreased by (i) any amortized premium on the Notes and (ii) any pre-issuance accrued stated interest.
 
Except as described above under “—Payments under Certain Events” and “—Market Discount,” the gain or loss a U.S. Holder recognizes on the sale, exchange, redemption or other taxable disposition of the Notes generally will be capital gain or loss. Such gain or loss generally will be long-term capital gain or loss if a U.S. Holder has held the Notes for more than 12 consecutive months. For non-corporate U.S. Holders, long-term capital gains are currently taxed at a lower rate than ordinary income. The deductibility of capital losses is subject to limitations. A U.S. Holder should consult its own tax advisor regarding the deductibility of capital losses in its particular circumstances.


148


Table of Contents

 
Backup Withholding and Information Reporting
 
In general, a U.S. Holder that is not an “exempt recipient” will be subject to U.S. federal backup withholding tax at the applicable rate (currently 28%) with respect to payments on the Notes and the proceeds of a sale, exchange, redemption or other taxable disposition of the Notes, unless the U.S. Holder provides its taxpayer identification number to the paying agent and certifies, under penalties of perjury, that it is not subject to backup withholding on an Internal Revenue Service Form W-9 (Request for Taxpayer Identification Number and Certification) and otherwise complies with the applicable requirements of the backup withholding rules. Backup withholding is not an additional tax. The amount of any backup withholding from a payment to a U.S. Holder may be allowed as a credit against such U.S. Holder’s U.S. federal income tax liability and may entitle such U.S. Holder to a refund, provided the required information is furnished to the Internal Revenue Service in a timely manner. In addition, payments on the Notes made to, and the proceeds of a sale or other taxable disposition by, a U.S. Holder that is not an exempt recipient generally will be subject to information reporting requirements.
 
U.S. Federal Income Taxation of Non-U.S. Holders
 
Payments of Interest
 
Subject to the discussion below under “—Backup Withholding and Information Reporting,” a Non-U.S. Holder generally will not be subject to U.S. federal withholding tax on interest paid on the Notes so long as:
 
  •     the Non-U.S. Holder does not actually or constructively own 10% or more of the total combined voting power of all of the stock of Aviv Healthcare Capital Corporation entitled to vote;
 
  •     the Non-U.S. Holder is not a “controlled foreign corporation” that is related to us, actually or by attribution, through stock ownership;
 
  •     the Non-U.S. Holder does not actually or constructively own 10% or more of the capital or profits interest in Aviv Healthcare Properties Limited Partnership; and
 
  •     either (i) the Non-U.S. Holder certifies under penalties of perjury on Internal Revenue Service Form W-8BEN (Certificate of Foreign Status of Beneficial Owner for United States Tax Withholding) or a suitable substitute form that it is not a United States person (as defined in the Code), and provides its name and address, and U.S. taxpayer identification number, if any, or (ii) a securities clearing organization, bank or other financial institution that holds customers’ securities in the ordinary course of its trade or business and holds the Notes on behalf of the Non-U.S. Holder certifies under penalties of perjury that the certification referred to in clause (i) has been received from the Non-U.S. Holder, and furnishes to us a copy thereof.
 
A Non-U.S. Holder that does not qualify for exemption from withholding as described above generally will be subject to withholding of U.S. federal income tax at a rate of 30% on payments of interest on the Notes. A Non-U.S. Holder may be entitled to the benefits of an income tax treaty under which interest on the Notes is subject to a reduced rate of U.S. withholding tax or is exempt from U.S. withholding tax, provided the Non-U.S. Holder furnishes us a properly completed and executed Internal Revenue Service Form W-8BEN claiming the reduction or exemption and the Non-U.S. Holder complies with any other applicable procedures.
 
Special rules regarding exemption from, or reduced rates of, U.S. withholding tax may apply in the case of Notes held by partnerships or certain types of trusts. Partnerships and trusts that are prospective purchasers should consult their tax advisors regarding special rules that may be applicable in their particular circumstances.


149


Table of Contents

 
Sale, Exchange or Redemption of the Notes
 
Generally, any gain recognized by a Non-U.S. Holder on the sale, exchange, redemption or other taxable disposition of a Note (other than amounts attributable to accrued and unpaid interest, which will be treated as described under “—Payments of Interest” above) will be exempt from U.S. federal income and withholding tax, unless:
 
  •     the gain is effectively connected with the Non-U.S. Holder’s conduct of a trade or business within the United States (and, if a treaty applies, is attributable to a permanent establishment maintained by the Non-U.S. Holder in the United States); or
 
  •     the Non-U.S. Holder is an individual who is present in the United States for 183 days or more during the taxable year, and certain other conditions are met.
 
Effectively Connected Income
 
If interest, gain or other income recognized by a Non-U.S. Holder on a Note is “effectively connected” with the Non-U.S. Holder’s conduct of a trade or business within the United States (and, if a treaty applies, is attributable to a permanent establishment maintained by the Non-U.S. Holder in the United States), the Non-U.S. Holder will not be subject to the withholding tax discussed above if the Non-U.S. Holder provides us with a properly completed and executed Internal Revenue Service Form W-8ECI (Certificate of Foreign Person’s Claim That Income Is Effectively Connected With the Conduct of a Trade or Business in the United States), but the Non-U.S. Holder generally will be subject to U.S. federal income tax on such interest, gain or other income as if it were a United States person (as defined in the Code). In addition to such U.S. federal income tax, if the Non-U.S. Holder is a corporation, it may be subject to an additional 30% branch profits tax.
 
Backup Withholding and Information Reporting
 
We must report annually to the Internal Revenue Service and to a Non-U.S. Holder the amount of interest paid to such Non-U.S. Holder and the tax withheld from those payments. These reporting requirements apply regardless of whether U.S. withholding tax on such payments was reduced or eliminated by any applicable tax treaty or otherwise. Copies of the information returns reporting those payments and the amounts withheld may also be made available to the tax authorities in the country where a Non-U.S. Holder is a resident under the provisions of an applicable income tax treaty or agreement.
 
Under some circumstances, U.S. Treasury regulations require backup withholding and additional information reporting on payments of interest and other “reportable payments.” Such backup withholding and additional information reporting will not apply to payments on the Notes made by us or our paying agent to a Non-U.S. Holder if the certification described above under “—Payments of Interest” is received from the Non-U.S. Holder.
 
Backup withholding and information reporting generally will not apply to payments of proceeds from the sale or other disposition of a Note made to a Non-U.S. Holder by or through the foreign office of a broker. However, information reporting requirements, and possibly backup withholding, will apply if such broker is, for U.S. federal income tax purposes, a United States person (as defined in the Code) or has certain other enumerated connections with the United States, unless such broker has documentary evidence in its records that the Non-U.S. Holder is not a United States person (as defined in the Code) and certain other conditions are met, or the Non-U.S. Holder otherwise establishes an exemption. Payments of proceeds from the sale or other disposition of a Note made to a Non-U.S. Holder by or through the U.S. office of a broker are subject to information reporting and backup withholding at the applicable rate unless the Non-U.S. Holder certifies, under penalties of perjury, that it is not a United States person (as defined in the Code) and it satisfies certain other conditions or otherwise establishes an exemption. Backup withholding is not an additional tax. A


150


Table of Contents

Non-U.S. Holder may obtain a refund or credit against its U.S. federal income tax liability of any amounts withheld under the backup withholding rules, provided the required information is furnished to the Internal Revenue Service in a timely matter.
 
Non-U.S. Holders should consult their tax advisors regarding the application of information reporting and backup withholding in their particular situations, the availability of an exemption therefrom, and the procedures for obtaining such an exemption, if available.
 
The U.S. federal income tax discussion set forth above is included for general information only and may not be applicable depending upon a Holder’s particular situation. Prospective purchasers of the Notes should consult their own tax advisors with respect to the tax consequences to them of the acquisition, ownership and disposition of the Notes, including the tax consequences under state, local, estate, foreign and other tax laws and tax treaties and the possible effects of changes in U.S. or other tax laws.


151


Table of Contents

 
PLAN OF DISTRIBUTION
 
If you are a broker-dealer that receives Exchange Notes for your own account pursuant to the exchange offer, you must acknowledge that you will deliver a prospectus meeting the requirements of the Securities Act in connection with any resale of such Exchange Notes. This prospectus, as it may be amended or supplemented from time to time, may be used in connection with resales of Exchange Notes received in exchange for Old Notes where such Old Notes were acquired as a result of market-making activities or other trading activities. To the extent any broker-dealer participates in the exchange offer and so notifies us, we have agreed, for 180 days after the exchange offer is consummated, to make this prospectus, as amended or supplemented, available to that broker-dealer for use in connection with resales, and will promptly send additional copies of this prospectus and any amendment or supplement to this prospectus to any broker-dealer that requests those documents in the letter of transmittal.
 
  •     We will not receive any proceeds from any sale of Exchange Notes by broker-dealers.
 
  •     Exchange Notes received by broker-dealers for their own account pursuant to the exchange offer may be sold from time to time in one or more transactions in the over-the-counter market, in negotiated transactions, through the writing of options on the Exchange Notes or a combination of such methods of resale, at prevailing market prices at the time of resale, at prices related to such prevailing market prices or at negotiated prices.
 
  •     Any resale may be made directly to purchasers or to or through brokers or dealers who may receive compensation in the form of commissions or concessions from any such broker-dealer or the purchasers or any such Exchange Notes.
 
  •     Any broker-dealer that resells Exchange Notes that were received by it for its own account pursuant to the exchange offer and any broker or dealer that participates in a distribution of such Exchange Notes may be deemed to be an “underwriter” within the meaning of the Securities Act, and any profit on any such resale of Exchange Notes and any commissions or concessions received by any such persons may be deemed to be underwriting compensation under the Securities Act.
 
  •     The letter of transmittal states that, by acknowledging that it will deliver and by delivering a prospectus, a broker-dealer will not be deemed to admit that it is an “underwriter” within the meaning of the Securities Act.
 
We have agreed to pay all expenses incident to the exchange offer (other than commissions and concessions of any broker-dealer), subject to certain prescribed limitations, and will provide indemnification against certain liabilities, including certain liabilities that may arise under the Securities Act, to broker-dealers that make a market in the Old Notes and exchange Old Notes in the exchange offer for Exchange Notes.
 
By its acceptance of the exchange offer, any broker-dealer that receives Exchange Notes pursuant to the exchange offer hereby agrees to notify us prior to using the prospectus in connection with the sale or transfer of Exchange Notes. It also agrees that, upon receipt of notice from us of the happening of any event which makes any statement in this prospectus untrue in any material respect or which requires the making of any changes in this prospectus in order to make the statements therein not misleading or which may impose upon us disclosure obligations that may have a material adverse effect on us (which notice we agree to deliver promptly to such broker-dealer), such broker-dealer will suspend use of this prospectus until we have notified such broker-dealer that delivery of this prospectus may resume and have furnished copies of any amendment or supplement to this prospectus to such broker-dealer.


152


Table of Contents

 
LEGAL MATTERS
 
Certain legal matters relating to the validity of the Exchange Notes will be passed upon by Sidley Austin LLP, Chicago, Illinois. Certain legal matters relating to Maryland law will be passed upon by Venable LLP. Certain legal matters relating to New Mexico law will be passed upon by Jones & Smith Law Firm, LLC. Certain legal matters relating to Texas law will be passed upon by McDonald Sanders, P.C.
 
EXPERTS
 
The consolidated financial statements and schedule of Aviv REIT, Inc. and Subsidiaries and Aviv Healthcare Properties Limited Partnership and Subsidiaries as of December 31, 2010 and 2009 and for each of the three years in the period ended December 31, 2010 included in this prospectus and registration statement have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their reports thereon appearing elsewhere herein, and are included in reliance upon such reports given on the authority of such firm as experts in auditing and accounting.
 
WHERE YOU CAN FIND MORE INFORMATION
 
The Issuers and the guarantors are not currently subject to the periodic reporting and other informational requirements of the Exchange Act. Following the offering of the Exchange Notes, the Issuers and the guarantors will file periodic reports and other information with the SEC.
 
We have filed with the SEC a registration statement on Form S-4, including exhibits and schedules filed with the registration statement, under the Securities Act with respect to the Exchange Notes being offered hereby. This prospectus, which forms a part of the registration statement, does not contain all of the information set forth in the registration statement. For further information with respect to us and the Exchange Notes, reference is made to the registration statement, including the exhibits and schedules to the registration statement. Statements contained in this prospectus as to the contents of any contract or other document referred to in this prospectus are not necessarily complete and, where that contract or other document is an exhibit to the registration statement, we refer you to the full text of the contract or other document filed as an exhibit to the registration statement.
 
Copies of the registration statement, including the exhibits and schedules to the registration statement, may be examined without charge at the public reference room of the SEC, 100 F Street, N.E., Room 1580, Washington, DC 20549. Information about the operation of the public reference room may be obtained by calling the SEC at 1-800-SEC-0330. Copies of all or a portion of the registration statement can be obtained from the public reference room of the SEC upon payment of prescribed fees. Our SEC filings, including our registration statement, are also available to you on the SEC’s website at www.sec.gov. The SEC filings of the Issuers and the guarantors will be made available free of charge at our website at www.avivreit.com. We are not incorporating by reference into this prospectus the information on our website, and you should not consider it to be a part of this prospectus. Information may also be obtained from us at Aviv REIT, Inc., 303 West Madison Street, Chicago, Illinois, 60606, Attention: Investor Relations, telephone (312) 855-0930.
 
We have not authorized anyone to give you any information or to make any representations about us or the transactions we discuss in this prospectus other than those contained in this prospectus. If you are given any information or representations about these matters that is not discussed in this prospectus, you must not rely on that information.


153


 

 
INDEX TO FINANCIAL STATEMENTS
 
AVIV REIT, INC. AND SUBSIDIARIES
 
         
    F-2  
    F-3  
    F-4  
    F-5  
    F-6  
    F-7  
 
FINANCIAL STATEMENT SCHEDULE
       
    F-29  
 
AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
       
    F-34  
    F-35  
    F-36  
    F-37  
    F-38  
    F-39  
 
FINANCIAL STATEMENT SCHEDULE
       
    F-68  
 
AVIV REIT, INC. AND SUBSIDIARIES
       
    F-73  
    F-74  
    F-75  
    F-76  
    F-77  
 
AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
       
    F-91  
    F-92  
    F-93  
    F-94  
    F-95  
 
All other schedules for which provision is made in the applicable accounting regulation of the Securities and Exchange Commission are not required under the related instructions or are inapplicable or have been omitted because sufficient information has been included in the notes to the Consolidated Financial Statements.


F-1


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
The Board of Directors and the Stockholders
Aviv REIT, Inc. and Subsidiaries
 
We have audited the accompanying consolidated balance sheets of Aviv REIT, Inc. and Subsidiaries (the Company) as of December 31, 2010 and 2009, and the related consolidated statements of operations, changes in equity, and cash flows for each of the three years in the period ended December 31, 2010. Our audits also included the financial statement schedule listed in the accompanying index to the financial statements. These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.
 
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Aviv REIT, Inc. and Subsidiaries at December 31, 2010 and 2009, and the consolidated results of their operations and their cash flows for each of the three years in the period ended December 31, 2010 in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
 
/s/  Ernst & Young LLP
 
Chicago, Illinois
March 15, 2011
except for Schedule III, as to which the date is
April 28, 2011


F-2


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
 
                 
   
December 31,
 
   
2010
   
2009
 
 
Assets
               
Cash and cash equivalents
    $13,029,474       $15,542,507  
Deferred rent receivable
    30,660,773       27,715,217  
Due from related parties
          15,816  
Tenant receivables
    1,168,842       2,407,737  
Rental properties and financing leases, at cost:
               
Land
    76,466,020       69,844,477  
Buildings and improvements
    615,806,273       555,931,485  
Assets under direct financing leases
    10,777,184       10,633,306  
                 
      703,049,477       636,409,268  
Less accumulated depreciation
    (75,948,944 )     (58,673,377 )
                 
Net rental properties
    627,100,533       577,735,891  
Deferred finance costs, net
    9,957,636       989,658  
Loan receivables
    36,610,638       28,970,129  
Other assets
    12,872,323       11,753,540  
                 
Total assets
    $731,400,219       $665,130,495  
                 
                 
Liabilities and equity                
Accounts payable and accrued expenses
    $6,012,809       $3,241,478  
Tenant security and escrow deposits
    13,658,384       12,314,790  
Other liabilities
    25,996,492       31,936,322  
Mortgage and other notes payable
    440,575,916       480,105,226  
                 
Total liabilities
    486,243,601       527,597,816  
Class E Preferred Units
          62,970,571  
Equity:
               
Stockholders’ equity
               
Common stock (par value $0.01; 227,002 shares outstanding)
    2,270        
Additional paid-in-capital
    223,838,999        
Accumulated deficit
    (2,261,839 )      
Accumulated other comprehensive income
    2,188,155        
                 
Stockholders’ equity
    223,767,585        
Partners’ equity
          73,385,093  
Noncontrolling interests
    21,389,033       1,177,015  
                 
Total equity
    245,156,618       74,562,108  
                 
Total liabilities and equity
    $731,400,219       $665,130,495  
                 
 
See accompanying notes to consolidated financial statements.


F-3


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
 
                         
   
Year Ended December 31,
 
   
2010
   
2009
   
2008
 
 
Revenues
                       
Rental income
    $84,490,144       $82,775,078       $72,142,847  
Tenant recoveries
    6,441,786       6,055,703       4,830,733  
Interest on loans to lessees—capital expenditures
    1,779,620       1,662,107       725,939  
Interest on loans to lessees—working capital and capital lease
    3,446,226       1,830,791       1,133,146  
                         
Total revenues
    96,157,776       92,323,679       78,832,665  
Expenses
                       
Rent and other operating expenses
    574,646       612,185       1,088,220  
General and administrative
    10,725,122       7,741,087       6,808,795  
Offering costs
          6,863,948        
Real estate taxes
    6,475,230       6,231,776       5,116,431  
Depreciation
    17,853,799       17,527,656       14,615,770  
Loss on impairment
    96,000             931,629  
                         
Total expenses
    35,724,797       38,976,652       28,560,845  
                         
Operating income
    60,432,979       53,347,027       50,271,820  
Other income and expenses:
                       
Interest and other income
    133,286       466,177       2,012,046  
Interest expense
    (22,722,785 )     (26,570,071 )     (26,272,012 )
Change in fair value of derivatives
    2,931,309       6,987,825       (8,673,771 )
Amortization of deferred financing costs
    (1,008,059 )     (550,327 )     (536,620 )
Gain on sale of assets, net
    511,552              
Loss on extinguishment of debt
    (2,295,562 )            
                         
Total other income and expenses
    (22,450,259 )     (19,666,396 )     (33,470,357 )
                         
Income from continuing operations
    37,982,720       33,680,631       16,801,463  
Discontinued operations
                72,730  
                         
Net income
    37,982,720       33,680,631       16,874,193  
Distributions and accretion on Class E Preferred Units
    (17,371,893 )     (14,569,875 )     (8,842,980 )
Net income allocable to common units of Partnership/noncontrolling interests
    (16,779,731 )     (19,110,756 )     (8,031,213 )
                         
Net income allocable to stockholders
    $3,831,096       $—       $—  
                         
Net income
    $37,982,720                  
Unrealized gain on derivative instrument
    4,094,432                  
                         
Total comprehensive income
    $42,087,152                  
                         
Net income allocable to stockholders
    $3,831,096                  
Unrealized gain on derivative instruments, net of noncontrolling interest of $1,906,277
    2,188,155                  
                         
Total comprehensive income allocable to stockholders
    $6,019,251                  
                         
 
See accompanying notes to consolidated financial statements.


F-4


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
 
                                                                         
   
Stockholders’ Equity
                   
                            Accumulated
                         
                Additional
          Other
    Total
                   
   
Common Stock
    Paid-In-
    Accumulated
    Comprehensive
    Stockholders’
    Partners’
    Noncontrolling
    Total
 
   
Shares
   
Amount
   
Capital
   
Deficit
   
income
   
Equity
   
Equity
   
Interests
   
Equity
 
 
                                                                         
Balance at January 1, 2008
          $—       $—       $—       $—       $—       $92,835,547       $1,422,456       $94,258,003  
                                                                         
Net income
                                        16,719,167       155,026       16,874,193  
                                                                         
Issuance of warrants
                                        1,349,494             1,349,494  
                                                                         
Non-cash stock-based compensation
                                        406,000             406,000  
                                                                         
Distributions to partners and accretion on Class E Preferred Units and other
                                        (34,394,877 )     (621,621 )     (35,016,498 )
                                                                         
                                                                         
Balance at January 1, 2009
                                        76,915,331       955,861       77,871,192  
                                                                         
Net income
                                        33,459,477       221,154       33,680,631  
                                                                         
Issuance of warrants
                                        8,399,117             8,399,117  
                                                                         
Non-cash unit-based compensation
                                        406,000             406,000  
                                                                         
Distributions to partners and accretion on Class E Preferred Units and other
                                        (45,794,832 )           (45,794,832 )
                                                                         
                                                                         
Balance at December 31, 2009
                                        73,385,093       1,177,015       74,562,108  
                                                                         
Net income
                                        30,583,743       230,305       30,814,048  
                                                                         
Non-cash unit-based compensation
                                        304,500             304,500  
                                                                         
Distributions to partners and accretion on Class E Preferred Units and other
                                        (68,635,411 )           (68,635,411 )
                                                                         
Capital contributions
                                              268,902       268,902  
                                                                         
Redemption of warrants
                                        (17,001,453 )           (17,001,453 )
                                                                         
Reclassification of equity at Merger date
                                        (18,636,472 )     18,636,472        
                                                                         
                                                                         
Subtotal at September 17, 2010 (Merger—See Note 1)
                                              20,312,694       20,312,694  
                                                                         
Non-cash stock (unit)-based compensation
                337,598                   337,598             989,900       1,327,498  
                                                                         
Distributions to partners
                                                            (5,251,962 )     (5,251,962 )
                                                                         
Capital contributions
    227,002       2,270       234,977,172                   234,979,442             94,548       235,073,990  
                                                                         
Cost of raising capital
                (11,475,771 )                 (11,475,771 )                 (11,475,771 )
                                                                         
Unrealized gain on derivative instruments
                            2,188,155       2,188,155             1,906,277       4,094,432  
                                                                         
Dividends to stockholders
                      (6,092,935 )           (6,092,935 )                 (6,092,935 )
                                                                         
Net income
                      3,831,096             3,831,096             3,337,576       7,168,672  
                                                                         
                                                                         
Balance at December 31, 2010
    227,002       $2,270       $223,838,999       $(2,261,839 )     $2,188,155       $223,767,585       $—       $21,389,033       $245,156,618  
                                                                         
 
See accompanying notes to consolidated financial statements.


F-5


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
 
                         
   
Year Ended December 31,
 
   
2010
   
2009
   
2008
 
 
Operating activities
                       
Net income
    $37,982,720       $33,680,631       $16,874,193  
Adjustments to reconcile net income to net cash provided by operating activities:
                       
Depreciation
    17,853,799       17,527,656       14,661,586  
Amortization
    1,008,059       550,327       536,620  
Change in fair value of derivatives
    (2,931,309 )     (6,987,825 )     8,673,771  
Deferred rental income
    (3,056,430 )     (6,388,600 )     (5,531,005 )
Rental income from intangible amortization, net
    (3,681,109 )     (2,097,655 )     (2,518,376 )
Non-cash stock (unit)-based compensation
    1,631,998       406,000       406,000  
Gain on sale of assets, net
    (511,552 )            
Non-cash loss on extinguishment of debt
    1,437,233              
Loss on impairment of assets
    96,000             931,629  
Loss on disposal of assets, net
                183,903  
Reserve for uncollectible loans
    750,000              
Changes in assets and liabilities:
                       
Due from related parties
    15,816       10,000       642,662  
Tenant receivables
    (317,123 )     (365,523 )     (2,087,939 )
Other assets
    177,666       3,022,578       (2,439,953 )
Accounts payable and accrued expenses
    3,357,961       145,652       1,634,170  
Tenant security deposits and other liabilities
    866,527       1,141,304       978,499  
Due to related parties
          (602,253 )     (897,456 )
                         
Net cash provided by operating activities
    54,680,256       40,042,292       32,048,304  
Investing activities
                       
Purchase of rental properties
    (54,884,043 )     (16,375,694 )     (94,392,262 )
Sales of rental properties
    4,085,825             3,071,177  
Payment of earn-out provision for previously acquired rental properties
    (9,600,731 )            
Capital improvements and other developments
    (7,883,130 )     (13,507,673 )     (1,833,252 )
Proceeds of collections on loan receivables to related parties
                32,000,000  
Loan receivables funded to others, net
    (6,834,568 )     (8,609,528 )     (17,440,989 )
Funding of direct financing leases, net
                (10,479,323 )
                         
Net cash used in investing activities
    (75,116,647 )     (38,492,895 )     (89,074,649 )
Financing activities
                       
Borrowings of debt
    442,789,570       35,651,073       80,915,249  
Repayment of debt
    (482,522,690 )     (19,091,756 )     (4,218,338 )
Payment of financing costs
    (10,567,931 )     (102,803 )      
Payment for swap termination
    (3,380,160 )            
Capital contributions
    235,342,892              
Cost of raising capital
    (11,475,771 )            
Redemption of Class E Preferred Units and warrants
    (92,001,451 )            
Redemption of Class F Units
    (23,602,649 )              
Proceeds from issuance of warrants
          8,399,117       1,349,494  
Net proceeds from issuance of Class E Preferred Units
          17,898,975       1,813,836  
Cash distributions to partners
    (36,658,452 )     (38,122,989 )     (29,849,750 )
                         
Net cash provided by financing activities
    17,923,358       4,631,617       50,010,491  
                         
Net (decrease) increase in cash and cash equivalents
    (2,513,033 )     6,181,014       (7,015,854 )
Cash and cash equivalents:
                       
Beginning of year
    15,542,507       9,361,493       16,377,347  
                         
End of year
    $13,029,474       $15,542,507       $9,361,493  
                         
Supplemental cash flow information
                       
Cash paid for interest
    $20,983,000       $27,771,260       $25,447,062  
Supplemental disclosure of noncash activity
                       
Accrued dividends payable to stockholders
    $6,092,935       $—        
Accrued distributions payable to partners
    $5,246,840       $3,650,000       $395,046  
Write-off of deferred rent receivable
    $3,367,164       $—       $—  
Write-off of in-place lease intangibles, net
    $1,392,034       $—       $—  
Write-off of deferred finance costs, net
    $1,235,969       $—       $—  
Write-off of debt discount
    $202,307       $—       $—  
Mortgage and other notes payable assumed
    $—       $—       $5,350,939  
 
See accompanying notes to consolidated financial statements.


F-6


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements
 
1.   Description of Operations and Formation
 
Aviv REIT, Inc., a Maryland corporation, and Subsidiaries (the REIT) is the sole general partner of Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership, and Subsidiaries (the Partnership). The Partnership is a majority owned subsidiary that owns all of the real estate properties. In these footnotes, the Company refers generically to Aviv REIT, Inc., the Partnership, and their subsidiaries. The Partnership was formed in 2005 and directly or indirectly owned or leased 181 and 169 properties, principally skilled nursing facilities, across the United States at December 31, 2010 and 2009, respectively. The Company generates the majority of its revenues by entering into long-term triple-net leases with qualified local, regional, and national operators. In addition to the base rent, leases provide for tenants to pay the Company an ongoing escrow for real estate taxes. Furthermore, all operating and maintenance costs of the buildings are the responsibility of the tenants. Substantially all depreciation expense reflected in the consolidated statements of operations relates to the ownership of senior living properties. The Company manages its business as a single business segment as defined in Accounting Standards Codification (ASC) 280, Segment Reporting.
 
The Partnership is the general partner of Aviv Healthcare Properties Operating Partnership I, L.P. (the Operating Partnership), a Delaware limited partnership. The Operating Partnership has six wholly owned subsidiaries: Aviv Development JV, LLC (Aviv Development), a Delaware limited liability company; Aviv Financing I, LLC (Aviv Financing I), a Delaware limited liability company; Aviv Financing II, LLC (Aviv Financing II), a Delaware limited liability company; Aviv Financing III, LLC (Aviv Financing III), a Delaware limited liability company; Aviv Financing IV, LLC (Aviv Financing IV), a Delaware limited liability company; and Aviv Financing V, LLC (Aviv Financing V), a Delaware limited liability company.
 
On September 17, 2010, the Partnership entered into an agreement (the Merger Agreement), by and among the REIT, Aviv Healthcare Merger Sub LP, a Delaware limited partnership of which the REIT is the general partner (Merger Sub), Aviv Healthcare Merger Sub Partner LLC, a Delaware limited liability company and a wholly owned subsidiary of the REIT, and the Partnership. Pursuant to the Merger Agreement, the Partnership merged (the Merger) with and into Merger Sub, with Merger Sub continuing as the surviving entity with the identical name (the Surviving Partnership). Following the Merger, the REIT remains as the sole general partner of the Surviving Partnership and the Surviving Partnership, as the successor to the Partnership, became the general partner of the Operating Partnership. All of the business, assets, and operations will continue to be held by the Operating Partnership and its subsidiaries. The REIT’s equity interest in the Surviving Partnership will be linked to future investments in the REIT, such that future equity issuances by the REIT (pursuant to the Stockholders Agreement, the REIT’s management incentive plan or otherwise as agreed between the parties) will result in a corresponding increase in the REIT’s equity interest in the Surviving Partnership. The REIT is authorized to issue 2 million shares of common stock (par value $0.01) and 1,000 shares of preferred stock (par value $1,000). At December 31, 2010, there are 227,002 shares of common stock and 125 shares of preferred stock outstanding. Dividends on each outstanding share of preferred stock accrue on a daily basis at the rate of 12.5% per annum of the sum of $1,000 plus all accumulated and unpaid dividends thereon which are in arrears. The REIT makes annual distributions on the shares in the aggregate amount of $15,625 per year. With respect to the payment of dividends or other distributions and the distribution of the REIT’s assets upon dissolution, liquidation, or winding up, the preferred stock will be senior to all other classes and series of stock of the REIT. Due to the immateriality, the preferred stock has not been shown separately in the consolidated balance sheets.
 
As a result of the common control of the REIT (which was newly formed) and the Partnership, the Merger, for accounting purposes, did not result in any adjustment to the historical carrying value of the assets or liabilities of the Partnership. The REIT was funded in September 2010 with approximately $235 million from its stockholders. The REIT contributed the net proceeds of its capital raise to the Partnership in exchange


F-7


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
for Class G Units in the Partnership. Periods prior to September 17, 2010 represent the results of operations and financial condition of the Partnership, as predecessor to the Company.
 
The operating results of the Surviving Partnership are allocated based upon the respective economic interests therein. For the period from September 17, 2010 through December 31, 2010, the REIT owned 53.4% of the Surviving Partnership.
 
2.   Summary of Significant Accounting Policies
 
Estimates
 
The preparation of the financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
 
Noncontrolling Interests
 
In December 2007, the Financial Accounting Standards Board (FASB) issued ASC 810, Consolidations (ASC 810) to improve the relevance, comparability, and transparency of the financial information that a reporting entity provides in its consolidated financial statements by establishing accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. ASC 810 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008.
 
Effective January 1, 2009, the Company retrospectively adopted the provisions of ASC 810, which requires a noncontrolling interest in a subsidiary to be reported as equity and the amount of consolidated net income specifically attributable to the noncontrolling interest to be included within consolidated net income.
 
ASC 810 also requires consistency in the manner of reporting changes in the parent’s ownership interest and requires fair value measurement of any noncontrolling equity investment retained in a deconsolidation. Further, as a result of the adoption of ASC 810, net income attributable to noncontrolling interests is now excluded from the determination of consolidated net income.
 
Principles of Consolidation
 
The accompanying consolidated financial statements include the accounts of the REIT, the Surviving Partnership, the Operating Partnership, and all controlled subsidiaries and joint ventures. The Company considers itself to control an entity if it is the majority owner of and has voting control over such entity. The portion of the net income or loss attributed to third parties is reported as net income allocable to noncontrolling interests on the consolidated statements of operations, and such parties’ portion of the net equity in such subsidiaries is reported on the consolidated balance sheets as noncontrolling interests. All significant intercompany balances and transactions have been eliminated in consolidation.
 
Cash and Cash Equivalents
 
Cash and cash equivalents consist of cash and highly liquid short-term investments with original maturities of three months or less. The Company maintains cash and cash equivalents in United States banking


F-8


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
institutions that exceed amounts insured by the Federal Deposit Insurance Corporation. The Company believes the risk of loss from exceeding this insured level is minimal.
 
Rental Properties
 
The Company periodically assesses the carrying value of rental properties and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the rental properties will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the rental properties and related intangibles to their estimated fair value. The estimated fair value of the Company’s rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis. As part of the impairment evaluation during 2010, a building in Hometown, Texas was impaired for $96,000 to reflect the difference between the book value and estimated selling price less costs to dispose. The property was sold on December 31, 2010, with an immaterial gain subsequent to the impairment of $96,000 previously taken. As part of the impairment evaluation during 2008, the Company recorded a loss on the anticipated sale of a building of approximately $932,000.
 
Buildings and building improvements have been assigned estimated 40-year lives and are depreciated on the straight-line method. Personal property, furniture, and equipment have been assigned estimated lives ranging from 7 to 10 years and are depreciated on the straight-line method.
 
The Company may advance monies to its lessees for the purchase, generally, of furniture, fixtures, or equipment or other purposes. Required minimum lease payments due from the lessee increase to provide for the repayment of such amounts over a stated term. These advances in the instance where the depreciable life of the newly purchased asset is less than the remaining lease term are reflected as loan receivables on the consolidated balance sheets, and the incremental lease payments are bifurcated between principal and interest over the stated term. In the instance where the depreciable life of the newly purchased assets is longer than the remaining lease term, the purchase is recorded as property. In other instances, explicit loans are made to lessees for working capital and other funding needs and provide for monthly principal and interest payments generally ranging from 5 to 10 years. Such advances, net of repayments, equaled $36,610,638 and $28,970,129 at December 31, 2010 and 2009, respectively.
 
Purchase Accounting
 
In determining the allocation of the purchase price of partnerships and facilities between net tangible and identified intangible assets acquired and liabilities assumed, the Company makes estimates of the fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of preacquisition due diligence, marketing, leasing activities of the Company’s diverse operator base, industry surveys of critical valuation metrics such as capitalization rates, discount rates and leasing rates and appraisals obtained as a requirement of the Mortgage. The Company allocates the purchase price of facilities to net tangible and identified intangible assets acquired based on their fair values in accordance with the provisions of ASC 805, Business Combinations (ASC 805). The determination of fair value involves the use of significant judgment and estimation.
 
The Company determines fair values as follows:
 
  •     Other assets acquired and other liabilities assumed are valued at stated amounts, which approximate fair value.


F-9


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
  •     Rental properties are valued using discounted cash flow projections that assume certain future revenue and costs and consider capitalization and discount rates using current market conditions. The Company allocates the purchase price of facilities to net tangible and identified intangible assets acquired and liabilities assumed based on their fair values.
 
  •     Assumed debt balances are valued at fair value, with the computed discount/premium amortized over the remaining term of the obligation.
 
The Company determines the value of land either based on real estate tax assessed values in relation to the total value of the asset, internal analyses of recently acquired and existing comparable properties within the Company’s portfolio, or third party appraisals. The fair value of in-place leases, if any, reflects: (i) above- and below-market leases, if any, determined by discounting the difference between the estimated current market rent and the in-place rentals, the resulting intangible asset or liability of which is amortized to rental revenue over the remaining life of the associated lease plus any fixed rate renewal periods if applicable; (ii) the estimated value of the cost to obtain tenants, including tenant allowances, tenant improvements, and leasing commissions, which is amortized over the remaining life of the associated lease; and (iii) an estimated value of the absorption period to reflect the value of the rents and recovery costs foregone during a reasonable lease-up period as if the acquired space was vacant, which is amortized over the remaining life of the associated lease. The Company also estimates the value of tenant or other customer relationships acquired by considering the nature and extent of existing business relationships with the tenant, growth prospects for developing new business with such tenant, such tenant’s credit quality, expectations of lease renewals with such tenant, and the potential for significant, additional future leasing arrangements with such tenant. The Company amortizes such value, if any, over the expected term of the associated arrangements or leases, which would include the remaining lives of the related leases. The amortization is included in the consolidated statements of operations in rental income.
 
Prior to the Merger on September 17, 2010, Aviv Asset Management, L.L.C. (AAM) was a non-consolidated management company to the Partnership based on the application of appropriate accounting guidance (as discussed in Footnote 11). Upon the Merger, AAM became a consolidated entity of the Company and is presented as such for all periods included herein with all periods shown at historical cost (carryover basis with no adjustments to fair value). This treatment is in accordance with ASC 805 due to the fact that AAM was under common control prior and subsequent to the Merger.
 
Revenue Recognition
 
Rental income is recognized on a straight-line basis over the term of the lease when collectibility is reasonably assumed. Differences between rental income earned and amounts due under the lease are charged or credited, as applicable, to deferred rent receivable. Income recognized from this policy is titled deferred rental revenue. Additional rents from expense reimbursements for insurance, real estate taxes, and certain other expenses are recognized in the period in which the related expenses are incurred and are reflected as tenant recoveries on the consolidated statements of operations.


F-10


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
Below is a summary of the components of rental income for the years ended December 31, 2010, 2009, and 2008:
 
                         
   
2010
   
2009
   
2008
 
 
Rental income
    $77,752,605       $74,288,823       $64,093,466  
Deferred rental revenue
    3,056,430       6,388,600       5,531,005  
Rental income from intangible amortization
    3,681,109       2,097,655       2,518,376  
                         
Total rental income
    $84,490,144       $82,775,078       $72,142,847  
                         
 
During the year ended December 31, 2010, deferred rental revenue includes an off-setting write-off (expense) of deferred rent receivable of $3,367,164 due to the terminations of leases and replacement of operators.
 
Lease Accounting
 
The Company, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statement of operations as rental income for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators. Assets subject to operating leases are reported as rental properties in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to the Company’s net initial investment is established on the balance sheet titled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a financing lease. Such accretion was $143,878, $153,983, and $95,793 for the years ended December 31, 2010, 2009, and 2008, respectively.
 
All of the Company’s leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.
 
Deferred Finance Costs
 
Deferred finance costs are being amortized using the straight-line method, which approximates the interest method, over the term of the respective underlying debt agreement.
 
Loan Receivables
 
Loan receivables consist of capital improvement loans to tenants and working capital loans to operators. Loan receivables are carried at their principal amount outstanding. Management, periodically evaluates outstanding loans and notes receivable for collectability. When management identifies potential loan impairment indicators, such as nonpayment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator, or other circumstances that may impair full execution of the loan documents, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan, the loan is written down to the present value of the expected future cash flows. As of December 31, 2010, loan receivable reserves amounted to $750,000. No other circumstances exist that


F-11


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
would suggest that additional reserves are necessary at the balance sheet date. As of December 31, 2009, loan receivable reserves are immaterial.
 
Stock-Based Compensation
 
The Company follows ASC 718, Stock Compensation (ASC 718), which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated statements of operations based on their grant date fair values. On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction. A pro-rata allocation of non-cash stock-based compensation expense is made to the Company for awards granted under the Plan. The Plan’s non-cash stock-based compensation expense by the Company since the Merger date through December 31, 2010 is summarized in Footnote 9.
 
Fair Value of Financial Instruments
 
ASC 820, Fair Value Measurements and Disclosures, (ASC 820) establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels are defined as follows:
 
  •     Level 1—Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or;
 
  •     Level 2—Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and
 
  •     Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
 
The Company’s interest rate swaps are valued using models developed internally by the respective counterparty that use as their basis readily observable market parameters and are classified within Level 2 of the valuation hierarchy.
 
Cash and cash equivalents, cash and escrow deposits—restricted, and derivative financial instruments are reflected in the accompanying consolidated balance sheets at amounts considered by management to reasonably approximate fair value. Management estimates the fair value of its long-term debt using a discounted cash flow analysis based upon the Company’s current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Company had outstanding mortgage and other notes payable obligations with a carrying value of approximately $440.6 million and $480.1 million as of December 31, 2010 and 2009, respectively. The estimated fair value of debt (Level 2) as of December 31, 2010 approximated its carrying value based upon interest rates available to the Company on similar borrowings, and was $458.4 million as of December 31, 2009.
 
Derivative Instruments
 
The Company has implemented ASC 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments


F-12


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. Changes in the fair market values of the Company’s derivative instruments are recorded in the consolidated statements of operations if the derivative does not qualify for or the Company does not elect to apply hedge accounting. If the derivative is deemed to be eligible for hedge accounting, such changes are reported in accumulated other comprehensive income within the consolidated statements of changes in equity, exclusive of ineffectiveness amounts, which are recognized as adjustments to net income.
 
Initial Public Offering Costs
 
During 2009, the Company pursued an initial public offering (the IPO) of common stock. Costs related to the IPO incurred by the Company were capitalized on the consolidated balance sheets in other assets as they were incurred.
 
On November 2, 2009, the Company abandoned its IPO effort. As a result, the Company wrote off the IPO costs incurred to date to the consolidated statement of operations. In the year ended December 31, 2009, approximately $6.9 million of IPO-related costs were expensed.
 
Income Taxes
 
For federal income tax purposes, the Company intends to elect, with the filing of its initial 1120 REIT, U.S. Income Tax Return for Real Estate Investment Trusts, to be taxed as a Real Estate Investment Trust (REIT) effective at the time of the Merger. To qualify as a REIT, the Company must meet certain organizational, income, asset and distribution tests. The Company currently intends to comply with these requirements and maintain REIT status. If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes at regular corporate rates (including any applicable alternative minimum tax) and may not elect REIT status for four subsequent years. However, the Company may still be subject to federal excise tax. In addition, the Company may be subject to certain state and local income and franchise taxes. Historically, the Company and its predecessor have generally only incurred certain state and local income and franchise taxes, but these amounts were immaterial in any of the years presented. Prior to the Merger, the Partnership was a limited partnership and the consolidated operating results were included in the income tax returns of the individual partners. No uncertain income tax positions exist as of December 31, 2010 and 2009, respectively.
 
The rental properties of the Company have an income tax basis of approximately $598,846,000 as of December 31, 2010.
 
Dividends paid to common stockholders, for federal income tax purposes, are as follows:
 
         
    Year Ended
    December 31,
   
2010
 
Per Share:
       
Ordinary income
    $12.52  
Return of capital
    14.30  
         
Totals
    $26.82  
         


F-13


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
Risks and Uncertainties
 
The Company is subject to certain risks and uncertainties affecting the healthcare industry as a result of healthcare legislation and continuing regulation by federal, state, and local governments. Additionally, the Company is subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the growth in cost of healthcare services.
 
Reclassifications
 
Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Company’s consolidated financial position or results of operations.
 
3.   Rental Property Activity
 
The Company had the following rental property activity during 2010 as described below:
 
  •     In March 2010, Aviv Financing III recognized an additional $8,121,000 addition to the purchase price for the August 2008 acquisitions of eight properties in California and Oregon from an unrelated third party as per the guidance within ASC 805. The addition is related to the earn-out provision defined at closing. Such $8,121,000 additions along with $1,480,000 previously accrued amounts at December 31, 2009 related to the acquisitions of two properties in April 2009 in California and Nevada under Aviv Financing I, were paid out in the amount of approximately $9,601,000.
 
  •     In June 2010, Aviv Financing III acquired a property in Tennessee from an unrelated third party for a purchase price of approximately $3,380,000. The Company financed this purchase through cash.
 
  •     In July 2010, Aviv Financing I disposed of two properties in California to an unrelated third party for a total selling price of approximately $3,988,000, which resulted in a gain on disposal of approximately $582,000. The proceeds from the sale were primarily used to pay down a portion of the existing Credit Facility (see Footnote 7) by approximately $3,883,000.
 
  •     In September 2010, Aviv Financing I acquired a property in Virginia from an unrelated third party for a purchase price of approximately $5,000,000. The Company financed this purchase through borrowings of approximately $3,162,000 under the Revolver (see Footnote 7).
 
  •     In October 2010, Aviv Financing I acquired four properties in Missouri from various unrelated third parties for a purchase price of approximately $10,460,000. The Company financed this purchase through borrowings of approximately $7,718,000 under the Revolver (see Footnote 7).
 
  •     In November 2010, Aviv Financing III acquired a property in California from an unrelated third party for a purchase price of approximately $11,500,000. The Company financed this purchase through borrowings of approximately $7,800,000 under an acquisition loan.
 
  •     In December 2010, Aviv Financing III acquired a property in Connecticut from an unrelated third party for a purchase price of approximately $2,600,000. The Company financed this purchase through cash.


F-14


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
  •     In December 2010, Aviv Financing I acquired four properties in Kansas, Texas and Connecticut, from unrelated third parties for a purchase price of approximately $21,944,000. The Company financed this purchase through borrowings of approximately $15,666,000 under the Revolver (see Footnote 7).
 
  •     In December 2010, Aviv Financing I sold a property located in Texas to an unrelated third party for a sales price of approximately $96,000.
 
In accordance with ASC 805, the Company allocated the approximate net purchase price of these properties acquired in 2010 as follows:
 
         
Land
    $7,094,000  
Buildings and improvements
    55,911,000  
         
Borrowings and available cash
    $63,005,000  
         
 
The Company had the following rental property activity during 2009 as described below:
 
  •     In January 2009, Aviv Financing III acquired a property in Arkansas from an unrelated third party for a purchase price of approximately $5,250,000. The Company financed this purchase through borrowings of approximately $2,625,000 via an acquisition loan, which was subsequently paid in full in August 2009.
 
  •     In April 2009, Aviv Financing III acquired two properties in California and Nevada from an unrelated third party for a purchase price of approximately $12,606,000. The Company financed this purchase through borrowings of approximately $8,625,000 via an acquisition loan.
 
In accordance with ASC 805, the Company allocated the approximate net purchase price of these properties acquired in 2009 as follows:
 
         
Land
    $4,675,000  
Buildings and improvements
    13,181,000  
         
Borrowings and available cash
    $17,856,000  
         
 
The Company acquired additional rental properties during 2008 as described below:
 
  •     In April 2008, Aviv Financing I acquired vacant land in Arkansas from an unrelated third party for a purchase price of approximately $625,000 to be used for construction of a replacement facility and acquired two properties in Arkansas from an unrelated third party for a purchase price of approximately $12,800,000. The Company financed this purchase through borrowings of approximately $9,785,000 under the Credit Facility and from proceeds from the issuance of Class E Units.
 
  •     In August 2008, Aviv Financing I acquired eight properties in California and Oregon from an unrelated third party for a purchase price of approximately $60,600,000. The Company financed this purchase through borrowings of approximately $47,400,000 under the Credit Facility.


F-15


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
  •     In September 2008, Aviv Financing I acquired a property in Illinois from an unrelated third party for a purchase price of approximately $6,200,000. The Company financed this purchase through borrowings of approximately $5,571,000 via the assumption of HUD debt.
 
  •     In November 2008, Aviv Financing I acquired four properties in Arkansas from an unrelated third party for a purchase price of approximately $19,617,500. The Company financed this purchase through borrowings of approximately $15,694,000 under the Credit Facility.
 
  •     In December 2008, Aviv Financing I acquired two properties, in two separate transactions, in Kansas and California from an unrelated third party for a purchase price of approximately $3,350,000. The Company financed this purchase through borrowings of approximately $2,680,000 under the Credit Facility.
 
In accordance with ASC 805, the Company allocated the approximate net purchase price plus any related closing costs of these properties acquired in 2008 as follows:
 
         
Land
    $12,719,000  
Buildings and improvements
    80,325,000  
Assets under direct financing leases
    10,390,000  
Mortgage and other notes payable assumed
    (5,571,000 )
         
Borrowings and issuances of Class E Units
    $97,863,000  
         
 
The Company considers renewals on below-market leases when ascribing value to the in-place lease intangible liabilities at the date of a property acquisition. In those instances where the renewal lease rate pursuant to the terms of the lease does not adjust to a current market rent, the Company evaluates whether the stated renewal rate is below current market rates and considers the past and current operations of the property, the current rent coverage ratio of the tenant, and the number of years until potential renewal option exercise. If renewal is considered probable based on these factors, an additional lease intangible liability is recorded at acquisition and amortized over the renewal period.
 
4.   Deferred Finance Costs
 
The following summarizes the Company’s deferred finance costs at December 31, 2010 and 2009:
 
                 
   
2010
   
2009
 
 
Gross amount
    $10,567,931       $2,620,295  
Accumulated amortization
    (610,295 )     (1,630,637 )
                 
Net
    $9,957,636       $989,658  
                 
 
Amortization of deferred financing costs is reported in the amortization expense line item in the consolidated statements of operations.


F-16


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
The estimated annual amortization of the deferred finance costs for each of the five succeeding years is as follows:
 
         
2011
    $2,116,711  
2012
    2,116,711  
2013
    2,116,021  
2014
    2,108,699  
2015
    1,499,494  
         
Total
    $9,957,636  
         
 
5.   Loan Receivables
 
The following summarizes the Company’s loan receivables at December 31, 2010 and 2009:
 
                 
   
2010
   
2009
 
 
Beginning balance
    $28,970,129       $20,360,601  
New capital improvement loans issued
    1,415,579       2,816,733  
Working capital and other loans issued
    14,705,259       7,963,189  
Reserve for uncollectible loans
    (750,000 )      
Loan amortization and repayments
    (7,730,329 )     (2,170,394 )
                 
      $36,610,638       $28,970,129  
                 
 
During 2010 and 2009, the Company funded loans for both working capital and capital improvement purposes to various operators and tenants. All loans held by the Company accrue interest. The payments received from the operator or tenant cover both interest accrued as well as amortization of the principal balance due. Any payments received from the tenant or operator made outside of the normal loan amortization schedule are considered principal prepayments and reduce the outstanding loan receivables balance.
 
Interest income earned on loan receivables for the years ended December 31, 2010, 2009, and 2008 was $3,823,223, $2,117,461, and $909,645, respectively.
 
6.   In-Place Lease Intangibles
 
The following summarizes the Company’s in-place lease intangibles classified as part of other assets or other liabilities at December 31, 2010 and 2009:
 
                                 
   
2010
   
2009
 
   
Assets
   
Liabilities
   
Assets
   
Liabilities
 
 
Gross amount
    $8,393,488       $25,798,147       $11,336,489       $34,275,494  
Accumulated amortization
    (3,049,093 )     (14,049,691 )     (3,836,456 )     (16,690,291 )
                                 
Net
    $5,344,395       $11,748,456       $7,500,033       $17,585,203  
                                 


F-17


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
The estimated annual amortization expense of the identified intangibles for each of the five succeeding years is as follows:
 
                 
   
Assets
   
Liabilities
 
 
2011
    $644,570       $2,065,305  
2012
    644,570       1,953,351  
2013
    636,847       1,838,732  
2014
    461,961       923,735  
2015
    402,147       678,961  
Thereafter
    2,554,300       4,288,372  
                 
      $5,344,395       $11,748,456  
                 
 
Amortization expense for the in-place lease intangible assets for the years ended December 31, 2010, 2009, and 2008 was $743,890, $986,871, and $1,020,315, respectively. Accretion for the in-place lease intangible liabilities for the years ended December 31, 2010, 2009, and 2008 was $2,468,500, $3,084,525, and $3,538,691 respectively.
 
During 2010, the Company wrote-off in-place lease intangible assets of $2,943,001 with accumulated amortization of $1,531,253, and in-place lease intangible liabilities of $8,477,347 with accumulated accretion of $5,109,101, for a net recognition of $1,956,498 in rental income from intangible amortization, respectively.


F-18


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
7.   Mortgage and Other Notes Payable
 
The Company’s mortgage and other notes payable consisted of the following:
 
                 
   
December 31,
 
   
2010
   
2009
 
 
Mortgage (interest rate of 5.75% on December 31, 2010)
    $402,794,111       $—  
Revolver (interest rate of 5.75% on December 31, 2010)
    28,677,230        
Construction loan (interest rate of 5.95% on December 31, 2010)
    1,312,339        
Acquisition loans (interest rate of 6.00% on December 31, 2010)
    7,792,236        
Term A loans (interest rates of 3.25% on December 31, 2009)
          7,000,000  
Term A loan (interest rate of 2.73% on December 31, 2009)
          150,000,000  
Term A loan (interest rate of 2.73% on December 31, 2009)
          50,000,000  
Term B loans (interest rates of 3.25% on December 31, 2009)
          11,062,192  
Term B loan (interest of 2.73% on December 31, 2009)
          200,000,000  
Construction loan (interest rates of 3.25% on December 31, 2009)
          5,188,837  
Construction loan (interest rate of 5.00% on December 31, 2009)
          7,187,276  
HUD-related debt (interest rates ranging from 5.23% to 7.25% on eight HUD properties)
          29,154,033  
Other loan (interest rates of 3.75% on December 31, 2009)
          12,000,000  
Acquisition loan (interest rate of 4.50% on December 31, 2009)
          8,512,888  
                 
Total
    $440,575,916       $480,105,226  
                 
 
In conjunction with the Merger, Aviv Financing I refinanced its debt by paying off all existing mortgages on September 17, 2010 in the amount of $471,064,380 (outstanding balances at the Merger), and entering into a five-year credit agreement (the Credit Agreement) that provided a $405 million mortgage term loan facility (the Mortgage) and a $100 million revolver (the Revolver).
 
The Mortgage
 
Principal payments on the Mortgage are payable in monthly installments beginning on November 1, 2010. The payment schedule for the Mortgage is based upon a 25-year mortgage style amortization as defined in the Credit Agreement. Interest rates, at the Company’s option, are based upon the base rate or Eurodollar base rate (0.29% at December 31, 2010 with a 1.25% floor) plus 4.5%. The base rate, as defined in the Credit Agreement, is the rate announced from time to time by the Base Rate Bank as its “prime rate”. The Base Rate Bank is Bank of America, N.A. The balance outstanding on the Term Loan as of December 31, 2010 was $402.8 million. This loan matures in September 2015 and has two one-year extensions.


F-19


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
The Revolver
 
Under the Credit Agreement, the Company also has a $100 million Revolver. On each payment date, the Company shall pay interest only in arrears on any outstanding principal balance of the Revolver. Interest rates, at the Company’s option, are based upon the base rate or Eurodollar base rate (0.29% at December 31, 2010 with a 1.25% floor) plus 4.5%. The base rate, as defined in the GE Credit Agreement, is the rate announced from time to time by the Base Rate Bank as its “prime rate”. The Base Rate Bank is Bank of America, N.A. Additionally, an unused fee equal to 1% per annum of the daily unused balance on the Revolver is due monthly.
 
As of December 31, 2010, approximately $28.7 million had been drawn on The Revolver. The ability to draw on the Revolver terminates in September 2013 at which time principal and interest are payable until the Revolver maturity date in September 2015.
 
Other Loans
 
On November 1, 2010, a subsidiary of Aviv Financing III entered into two acquisition loan agreements on the same terms that provided for borrowings of $7.8 million. Principal and interest payments are due monthly beginning on December 1, 2010 through the maturity date of December 1, 2015. Interest is a fixed rate of 6.00%. These loans are collateralized by a skilled nursing facility controlled by Aviv Financing III. The balance outstanding on these loans at December 31, 2010 was approximately $7.8 million.
 
On November 12, 2010, a subsidiary of Aviv Financing III entered into a construction loan agreement that provides for borrowings up to $6.4 million. Interest-only payments at the prime rate (3.25% at December 31, 2010) plus 0.38%, or a minimum of 5.95%, are due monthly from December 1, 2010 through April 1, 2012. From May 1, 2012 through the maturity date of December 1, 2013, monthly payments of principal and interest are due based on a 20-year amortization schedule. This loan is collateralized by a skilled nursing facility controlled by Aviv Financing III. The balance outstanding on this loan at December 31, 2010 was approximately $1.3 million.
 
Future annual maturities of all debt obligations for five fiscal years subsequent to December 31, 2010, are as follows:
 
         
2011
    $7,321,285  
2012
    7,717,628  
2013
    9,650,608  
2014
    9,227,220  
2015
    406,659,175  
         
      $440,575,916  
         
 
8.   Partnership Equity and Incentive Program
 
In conjunction with the formation of the Partnership, the Partnership issued 10,323,213 Class A Units and 3,294,733 Class B Units in exchange for all ownership interests of the Roll-up contributed to the Partnership in 2005. The Partnership issued an additional 3,144,010 Class A Units and 1,228,372 Class B Units in 2006. The Class A Units issued as a result of the formation of the Partnership have a par value of $10.00 per unit, while Class A Units issued on December 29, 2006, as a result of the addition of additional properties have a par value of $11.49 per unit. Operating distributions accrue at the rate of 10% per year for


F-20


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
Class A Units. The Class A Units have distribution preference, which decreases ratably after the full return of capital to the Class A Unitholders through distributions, and also have a liquidation preference and a profit interest in the event of sale, disposition, or refinancing as defined in the Agreement of Limited Partnership (the Partnership Agreement).
 
Also in connection with the formation of the Partnership, the Partnership awarded Class C Unit profit interests. These Class C Units do not have a par value, and no capital was contributed in consideration for their issuance. These Class C Units were issued to the General Partner of the Partnership, which is owned by two parties that have significant ownership holdings in the Partnership. When operating distributions are paid in full to the Class A Units as described above, the Class B and Class C Units receive all excess distributions, with 40% to Class B Unitholders and 60% to the Class C Unitholders until the Class B Units receive $3 million in any partnership year to the extent that all Class B Units have been issued per the Partnership Agreement. After reaching this threshold, the remaining distributions are allocated 100% to the Class C Unitholders.
 
The Class D Units represent profit interests in the Partnership, which may be granted periodically to employees of AAM. A total of 10,000 Class D Units have been authorized. A total of 8,050 and 7,800 Class D Units are outstanding at December 31, 2010 and 2009, respectively. The Class D Units are not entitled to any distributions of the Partnership, except in the event of sale, disposition, or refinancing as defined. Class C Units also have an interest in these proceeds. The terms of the Class D Units were amended at the Merger. Part of the Class D Units are defined as performance-based awards under ASC 718 and require employment of the recipient on the date of sale, disposition, or refinancing (Liquidity Event). If the employee is no longer employed on such date, the award is forfeited. For accounting purposes, the grant date fair value will be recognized as an expense when a Liquidity Event becomes imminent and such fair value on the grant date was determined to be $0.9 million. The remainder of the Class D Units are time-based awards under ASC 718 and such fair value determined on the grant date is recognized over the vesting period. During 2010, 3,220 of the time-based D Units vested, resulting in the recognition of $888,400 in expense. No expense relating to these awards was recognized in 2009.
 
Distributions to the Partnership partners are summarized as follows for the years ended December 31:
 
                                                         
   
Class A
 
Class B
 
Class C
 
Class D
 
Class E
 
Class F
 
Class G
 
2010
    $13,594,547       $2,894,457       $12,683,113       $—       $5,342,466       $3,792,881       $6,092,935  
2009
    $13,562,740       $2,894,457       $10,339,900       $—       $6,898,235       $4,430,085       $—  
2008
    $13,562,740       $2,774,081       $4,161,121       $—       $4,692,899       $5,223,778       $—  
 
Weighted-average Units outstanding are summarized as follows for the respective years ended December 31:
 
                                                         
   
Class A
 
Class B
 
Class C
 
Class D
 
Class E
 
Class F
 
Class G
 
2010
    13,467,223       4,523,145       2       7,386       5,342,489       4,597,432       65,338  
2009
    13,467,223       4,523,145       2       8,033       6,901,950       5,369,800        
2008
    13,467,223       4,523,145       2       9,006       4,693,784       5,369,800        
 
The Partnership had established an officer incentive program linked to its future value. Awards vest annually over a five-year period assuming continuing employment by the recipient. The awards can be settled in Class C Units or cash at the Company’s discretion at the settlement date of December 31, 2012. For accounting purposes, expense recognition under the program commenced in 2008, and the related expense for


F-21


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
the year ended December 31, 2010, 2009, and 2008 was approximately $406,000, $406,000, and $406,000, respectively.
 
As a result of the Merger on September 17, 2010, such incentive program was modified such that 40% of the previously granted award settled immediately on the Merger date with another 20% vesting and settling on December 31, 2010. The remaining 40% will vest equally on December 31, 2011 and December 31, 2012, and will settle in 2018, subject to the terms and conditions of the amended incentive program agreement. In accordance with ASC 718, Compensation—Stock Compensation (ASC 718), such incentive program will continue to be expensed through general and administrative expenses as non-cash compensation on the statements of operations through the ultimate vesting date of December 31, 2012.
 
9.   Option Awards
 
On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction.
 
In connection with the Merger, 64,168 options were granted to certain members of management and advisory board members on September 17, 2010 with an exercise price of $1,000 per option. Two thirds of the options granted, or 42,778 shares, are performance based awards whose criteria for vesting is tied to a future liquidity event (as defined) and also contingent upon meeting certain return thresholds (as defined). At this time, the Company does not believe it is probable that these options will vest and therefore has not recorded any expense in the December 31, 2010 financial statements in accordance with ASC 718. The grant date fair value associated with all performance based award options of the Company aggregates approximately $4.0 million as of December 31, 2010. One third, or 21,390 shares, of the options granted were time based awards and the service period for these options is four years with shares vesting at a rate of 25% on September 17, 2010, 2011, 2012, and 2013.
 
An additional 1,425 options were granted to certain members of management and advisory board members on September 30, 2010 with an exercise price of $1,084 per option. Two thirds of the options granted, or 949 shares, are performance based awards (as defined above). One third, or 476 shares, of the options granted were time based awards (as defined above). The grant date fair value of each time based award is charged to non-cash compensation expense on a graded basis over the vesting period. No option awards were granted prior to September 17, 2010. The following table represents the time based option awards activity for the year ended December 31, 2010.
 
         
    December 31,
 
   
2010
 
 
Outstanding at beginning of period
     
Granted
    21,866  
Exercised
     
Cancelled/Forfeited
     
         
Outstanding at end of period
    21,866  
Options exercisable at end of period
     
         
Weighted average fair value of options granted
    $108.55  
         
Weighted average remaining contractual life
    9.72  
         


F-22


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
The following table represents the time based option awards outstanding for the year ended December 31, 2010 as well as other Plan data:
 
                         
        Remaining
   
        Contractual Life
  Weighted Average
Range of Exercise Prices
 
Outstanding
 
(Years)
 
Exercise Price
 
$1,000—$1,084
    21,866       9.72       $1,002  
 
The Company has used the Black-Scholes option pricing model to estimate the grant date fair value of the options. The following table includes the assumptions that were made in estimating the grant date fair value for options awarded in 2010.
 
         
   
2010 Grants
 
Dividend yield
    10.28 %
Risk-free interest rate
    2.1 %
Expected life
    7.0 years  
Estimated volatility
    38.00 %
Weighted average exercise price
    $1,001.83  
Weighted average fair value of options granted (per option)
    $108.55  
 
The Company recorded non-cash compensation expenses of $337,598 for the year ended December 31, 2010, related to the time based stock options accounted for as equity awards, as a component of general and administrative expenses in the consolidated statements of operations.
 
At December 31, 2010, the total compensation cost related to outstanding, non-vested time based equity option awards that are expected to be recognized as compensation cost in the future aggregates approximately $2,036,000.
 
         
For the Year Ended December 31,
     
 
2011
    $1,056,730  
2012
    572,691  
2013
    298,647  
2014
    107,809  
         
Total
    $2,035,877  
         
 
Dividend equivalent rights associated with the Plan, amounted to $586,630 for the year ended December 31, 2010, which were incurred during the fourth quarter of 2010, and are included in general and administrative expense in the consolidated statements of operations. These dividend rights will be paid in four installments as the option vests.
 
10.   Minimum Future Rentals
 
The Company’s rental properties are leased under noncancelable triple-net operating leases. Under the provisions of the leases, the Company receives fixed minimum monthly rentals, generally with annual increases, and the tenants are responsible for the payment of all operating expenses, including repairs and maintenance, insurance, and real estate taxes of the property throughout the term of the leases.


F-23


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
At December 31, 2010, future minimum annual rentals to be received under the noncancelable lease terms are as follows:
 
         
2011
    $84,992,545  
2012
    88,174,683  
2013
    90,498,508  
2014
    88,768,851  
2015
    88,841,343  
Thereafter
    473,832,636  
         
      $915,108,566  
         
 
11.   Related Parties
 
Related party receivables and payables represent amounts due from/to various affiliates of the Company, including advances to members of the Company, amounts due to certain acquired companies and limited liability companies for transactions occurring prior to the formation of the Company, and various advances to entities controlled by affiliates of the Company’s management.
 
The Partnership had entered into a management agreement, as amended, effective April 1, 2005, with AAM, an entity affiliated by common ownership. Under the management agreement, AAM had been granted the exclusive right to oversee the portfolio of the Partnership, providing, among other administrative services, accounting and all required financial services; legal administration and regulatory compliance; investor, tenant, and lender relationship services; and transactional support to the Partnership. Except as otherwise provided in the Partnership Agreement, all management powers of the business and affairs of the Partnership are exclusively vested in the General Partner. The annual fee for such services equals six-tenths of one percent (0.6%) of the aggregate fair market value of the properties as determined by the Partnership and AAM annually. This fee arrangement was amended as discussed below. In addition, the Partnership reimbursed AAM for all reasonable and necessary out-of-pocket expenses incurred in AAM’s conduct of its business, including, but not limited to, travel, legal, appraisal, and brokerage fees, fees and expenses incurred in connection with the acquisition, disposition, or refinancing of any property, and reimbursement of compensation and benefits of the officers and employees of AAM. This agreement was terminated on September 17, 2010 when the Merger occurred, effectively consolidating AAM into the Company, and eliminating the necessity for reimbursement.
 
On October 16, 2007, the Company legally acquired AAM through a Manager Contribution and Exchange Agreement dated October 16, 2007 (the Contribution Agreement). As stipulated in the Contribution Agreement and the Second Amended and Restated Agreement of Limited Company on October 16, 2007 (Partnership Agreement), the Company issued a new class of Company Unit, Class F Units, as consideration to the contributing members of AAM. The contributing members of AAM served as the general partner of the Partnership. The Class F Units have subordinated payment and liquidity preference to the Class E Units but are senior in payment and liquidity preference, where applicable, to the Class A, B, C, and D Units of the Partnership. The Class F Units paid in quarterly installments an annual dividend of 8.25% of the preliminary face amount of $53,698,000. The preliminary pricing was based upon trading multiples of comparably sized publicly traded healthcare REITs. The ultimate Class F Unit valuation was subject to a true-up formula at the time of a Liquidity Event, as defined in the Partnership Agreement.
 
For accounting purposes, prior to the Merger, AAM had not been consolidated by the Company, nor had any value been ascribed to the Class F Units issued due to the ability of the Class E Unitholders to


F-24


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
unwind the acquisition as described above. Such action was outside the control of the Company, and accordingly, the acquisition is not viewed as having been consummated. The dividends earned by the Class F Unitholders were reflected as a component of management fees as described above. Subsequent to October 16, 2007, the fee for management services to the Company are equal to the dividend earned on the Class F Unit and was reported as management fee expense.
 
Under certain circumstances, the Partnership Agreement did permit the Class E Unitholders to unwind this transaction and requires the Company to redeem the Class F Units by returning to the affiliates all membership interests in AAM. On September 17, 2010, the Company settled the investment with JER Aviv Acquisition, LLC (JER). For accounting purposes, this treatment triggered the retroactive consolidation of AAM by the Company. The original and follow-on investments of Class E Unitholders were made subject to the Unit Purchase Agreement and related documents (UPA) between the Company and JER dated May 26, 2006.
 
The UPA did not give either party the right to settle the investment prior to May 26, 2011. However, the UPA did have an economic arrangement as to how either party could settle the arrangement on or after that date. This economic construct guided the discussions and negotiations of settlement. The UPA allowed the Company to call the E Units and warrants anytime after May 26, 2011 as long as it provided JER with a 15% IRR from date of inception. The IRR would be calculated factoring interim distributions as well as exit payments. The units were settled for $92,001,451 contemporaneous with the Merger. A portion of the settlement related to outstanding warrants held by JER and originally issued in connection with the E Units issuance.
 
Coincident with the Merger, 50% of the Class F Unit was purchased and settled by the Company for $23,602,649 and is reported as a component of distributions to partners and accretion on Class E Preferred Units in the consolidated statements of changes in equity. The remaining Class F Units will pay in quarterly installments an annual dividend of 9.38% of the face amount of $23,602,649.
 
12.   Derivatives
 
During the periods presented, the Company was party to various interest rate swaps, which were purchased to fix the variable interest rate on the denoted notional amount under the original debt agreements.
 
At December 31, 2009, the Company was party to the following interest rate swaps, which were purchased to fix the variable interest rate on the denoted notional amount under the Original and Amended Credit Agreements and on the acquisition loan, which was obtained in April 2009:
 
     
Total notional amount
  $289,976,000
Fixed interest rates range
  1.54% — 5.20%
Effective date range
  April 18, 2005 — July 17, 2009
Termination date range
  February 26, 2010 — September 16, 2011
Asset balance at December 31, 2009 (included in other assets)
  $—
Liability balance at December 31, 2009 (included in other liabilities)
  $6,311,470
 
On September 17, 2010 in connection with the extinguishment of the original credit facility, the Company settled all related interest rate swaps at a fair value of $3,380,160.


F-25


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
At December 31, 2010, the Company is party to two interest rate swaps, with identical terms for $100 million each. They were purchased to fix the variable interest rate on the denoted notional amount under the Mortgage which was obtained in September, 2010, and qualify for hedge accounting. For presentational purposes they are shown as one derivative due to the identical nature of their economic terms.
 
     
Total notional amount
  $200,000,000
Fixed rates
  6.49% (1.99% effective swap base rate plus 4.5% spread per credit agreement)
Floor rate
  1.25%
Effective date
  November 9, 2010
Termination date
  September 17, 2015
Asset balance at December 31, 2010 (included in other assets)
  $4,094,432
Liability balance at December 31, 2010 (included in other liabilities)
  $—
 
The fair value of each interest rate swap agreement may increase or decrease due to changes in market conditions but will ultimately decrease to zero over the term of each respective agreement.
 
For the years ended December 31, 2010, 2009, and 2008, the Company recognized approximately $2.9 million and $7.0 million of net income, and recognized approximately $8.7 million of net expense, respectively, in the consolidated statements of operations related to the change in the fair value of interest rate swap agreements, where the Company did not elect to apply hedge accounting.
 
The following table provides the Company’s derivative assets and liabilities carried at fair value as measured on a recurring basis as of December 31, 2010 (dollars in thousands):
 
                                 
                Significant
       
          Quoted Prices
    Other
    Significant
 
    Total Carrying
    in Active
    Observable
    Unobservable
 
    Value at
    Markets
    Inputs
    Inputs
 
   
December 31, 2010
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
 
Derivative assets
    $4,094       $       $4,094       $  
Derivative liabilities
                       
                                 
      $4,094       $       $4,094       $  
                                 
 
The Company’s derivative assets and liabilities include interest rate swaps that effectively convert a portion of the Company’s variable rate debt to fixed rate debt. The derivative positions are valued using models developed internally by the respective counterparty that use as their basis readily observable market parameters (such as forward yield curves) and are classified within Level 2 of the valuation hierarchy. The Company considers its own credit risk as well as the credit risk of its counterparties when evaluating the fair value of its derivatives.
 
13.   Commitments and Contingencies
 
The Company has a contractual arrangement with a tenant to reimburse quality assurance fees levied by the California Department of Health Care Services from August 1, 2005 through July 31, 2008. The Company is obligated to reimburse the fees to the tenant if and when the state withholds these fees from the tenant’s Medi-Cal reimbursements associated with 5 facilities that were formerly leased to Trinity Health


F-26


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
Systems. The total possible obligation for these fees is $1,655,286, of which approximately $1.0M has been paid to date. For the year ended December 31, 2010, the Company’s indemnity expense for these fees was $1,003,000 which equaled the actual amount paid during the period.
 
Judicial proceedings seeking declaratory relief for these fees are in process which if successful would provide for recovery of such amounts from the State of California. The Company has certain rights to seek relief against Trinity Health Systems for monies paid out under the indemnity claim; however, it is uncertain whether the Company will be successful in receiving any amounts from Trinity.
 
In the normal course of business, the Company is involved in legal actions arising from the ownership of its property. In management’s opinion, the liabilities, if any, that may ultimately result from such legal actions are not expected to have a material adverse effect on the financial position, operations, or liquidity of the Company.
 
14.   Concentration of Credit Risk
 
As of December 31, 2010, the Company’s portfolio of investments consisted of 181 healthcare facilities, located in 24 states and operated by 32 third party operators. At December 31, 2010, approximately 50.7% (measured as a percentage of total assets) were leased by five private operators: Evergreen Healthcare (13.6%), Daybreak Healthcare (12.4%), Sun Mar Healthcare (9.0%), HiCare (8.1%), and Convacare (7.6%). No other operator represents more than 6.3% of our total assets. The five states in which the Company had its highest concentration of total assets were California (19.3%), Texas (16.3%), Missouri (9.6%), Arkansas (8.0%), and Pennsylvania (6.1%) at December 31, 2010.
 
For the year ended December 31, 2010, the Company’s rental income from operations totaled approximately $84.5 million, of which approximately $11.6 million was from Evergreen Healthcare (13.7%), $9.1 million from Daybreak Healthcare (10.7%), and $9.1 million was from Sun Mar Healthcare (10.7%). No other operator generated more than 8.3% of the Company’s rental income from operations for the year ended December 31, 2010.
 
Below is a summary of unaudited financial information as of and for the year ended December 31, 2009 for the two lessees (operators) of our properties whose total assets, in the aggregate, exceeds 10% of the Company’s total assets at December 31, 2010. Financial performance under the terms of lease agreements with these lessees is, by agreement, guaranteed by the entities whose financial data is as follows:
 
                 
    Evergreen
   
   
Healthcare
 
Daybreak
 
Financial position
               
Current assets
    $50,975,393       $14,723,053  
Noncurrent assets
    41,653,895       37,043,192  
Current liabilities
    60,991,351       42,847,531  
Noncurrent liabilities
    115,053,022       57,073,485  
(Deficit) equity
    (83,415,085 )     (48,154,771 )
Results of operations
               
Revenues
    $260,280,330       $248,922,846  
Gross profit
    21,988,553       19,982,130  
Income from continuing operations
    5,773,223       9,143,933  
Net income
    7,757,958       8,802,933  


F-27


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
15.   Subsequent Events
 
On January 4, 2011, Aviv Financing I acquired a property in Kansas from an unrelated third party for a purchase price of $3,045,000. The Company financed this purchase through borrowings of $2,131,000 under the Mortgage (as described in Footnote 7).
 
On February 4, 2011, the Company issued $200 million in Senior Notes at 7.75%. The proceeds from this bond issuance were used to pay down $194 million of the Mortgage.
 
On March 1, 2011, the Company replaced an operator of three buildings in Pennsylvania and one in Massachusetts from the operator Brighten to the operator Saber. The Company anticipates that it will recognize a charge to write-off a deferred rent receivable balance relating to the terminated lease of approximately $2.4 million in the first quarter of 2011.
 
The Company has evaluated events subsequent to December 31, 2010 through March 15, 2011, and determined that no events other than those noted above would require additional disclosure.


F-28


Table of Contents

 
AVIV REIT, INC. AND SUBSIDIARIES
 
 
                                                                                                     
                                                                              Life on Which
                                    Costs Capitalized Subsequent
    Gross Amount Carried at
                Depreciation
    Type
                  Initial Cost to Company     to Acquisition     December 31, 2010 (g)                 in Statement
    of
                        Buildings &
          Impairment /
          Buildings &
    Accumulated
    Year of
    Date
    of Operations
Description
  Asset     Encumbrances     City   State   Land     Improvements     Improvements     Dispositions     Land     Improvements     Depreciation     Construction     Acquired     Computed
 
SunBridge Care/Rehab-Broadway
     (a )      (2 )   Methuen   MA   $ 31,469     $ 495,552     $     $ (130,000 )   $ 31,469     $ 365,552     $ (155,360 )     1910       1993     40 years
SunBridge—Colonial Heights
     (a )      (2 )   Lawrence   MA     63,160       958,681             (225,000 )     63,160       733,681       (311,815 )     1963       1993     40 years
SunBridge—Fall River
     (c )      (2 )   Fall River   MA     90,707       1,308,677             (1,308,677 )     90,707                         1993     40 years
SunBridge Care Center—Glenwood
     (a )      (2 )   Lowell   MA     82,483       1,210,652             (252,500 )     82,483       958,152       (407,210 )     1964       1993     40 years
SunBridge—Hammond House
     (a )      (2 )   Worchester   MA     42,062       663,598       488,598       (663,598 )     42,062       488,598       (207,654 )     1965       1993     40 years
SunBridge for North Reading
     (a )      (2 )   North Reading   MA     113,195       1,567,397             (252,500 )     113,195       1,314,897       (558,831 )     1966       1993     40 years
Robbin House Nursing and Rehab
     (c )      (2 )   Quincy   MA     66,000       1,051,668             (1,051,668 )     66,000                         1993     40 years
SunBridge Care Center—Rosewood
     (a )      (2 )   Fall River   MA     31,893       512,984             (142,500 )     31,893       370,484       (157,455 )     1882       1993     40 years
SunBridge Care/Rehab-Sandalwood
     (a )      (2 )   Oxford   MA     64,435       940,982       497,782       (192,500 )     64,435       1,246,264       (345,474 )     1966       1993     40 years
SunBridge—Spring Valley
     (a )      (2 )   Worchester   MA     71,084       1,030,725             (205,000 )     71,084       825,725       (350,933 )     1960       1993     40 years
SunBridge Care/Rehab-Town Manor
     (c )      (2 )   Lawrence   MA     89,790       1,305,518             (1,305,518 )     89,790                         1993     40 years
SunBridge Care/Rehab-Woodmill
     (a )      (2 )   Lawrence   MA     61,210       946,028             (235,000 )     61,210       711,028       (302,187 )     1965       1993     40 years
SunBridge Care/Rehab-Worcester
     (c )      (2 )   Worchester   MA     92,512       1,374,636             (1,374,636 )     92,512                         1993     40 years
Countryside Community
     (a )      (2 )   South Haven   MI     221,000       4,239,161       12,959             221,000       4,252,120       (705,011 )     1975       2005     40 years
Pepin Manor
     (a )      (2 )   Pepin   WI     318,000       1,569,959       (12,959 )           318,000       1,557,000       (263,494 )     1978       2005     40 years
Highland Health Care Center
     (a )      (2 )   Highland   IL     189,921       1,723,523                   189,921       1,723,523       (306,689 )     1963       2005     40 years
Nebraska Skilled Nursing/Rehab
     (a )      (2 )   Omaha   NE     211,000       6,694,584             (1,510 )     209,490       6,694,584       (1,258,022 )     1971       2005     40 years
Casa Real
     (a )      (2 )   Santa Fe   NM     1,029,800       2,692,295       213,902             1,029,800       2,906,197       (574,086 )     1985       2005     40 years
Clayton Nursing and Rehab
     (a )      (2 )   Clayton   NM     41,000       790,476                   41,000       790,476       (193,131 )     1960       2005     40 years
Country Cottage Care/Rehab Center
     (a )      (2 )   Hobbs   NM     9,000       671,536                   9,000       671,536       (191,863 )     1963       2005     40 years
Bloomfield Nursing/Rehab Center
     (a )      (2 )   Bloomfield   NM     343,800       4,736,296                   343,800       4,736,296       (807,094 )     1985       2005     40 years
Espanola Valley Center
     (a )      (2 )   Espanola   NM     216,000       4,143,364                   216,000       4,143,364       (779,524 )     1984       2005     40 years
Sunshine Haven Lordsburg
     (a )      (2 )   Lordsburg   NM     57,041       1,881,927                   57,041       1,881,927       (296,396 )     1972       2005     40 years
Silver City Care Center
     (a )      (2 )   Silver City   NM     305,000       5,843,505                   305,000       5,843,505       (967,107 )     1984       2005     40 years
Raton Nursing and Rehab Center
     (a )      (2 )   Raton   NM     128,000       1,509,456                   128,000       1,509,456       (355,369 )     1985       2005     40 years
Red Rocks Care Center
     (a )      (2 )   Gallup   NM     329,000       3,952,779                   329,000       3,952,779       (711,360 )     1978       2005     40 years
Heritage Villa Nursing/Rehab
     (a )      (2 )   Dayton   TX     18,000       435,568       9,400             18,000       444,968       (91,614 )     1964       2005     40 years
Wellington Oaks Nursing/Rehab
     (a )      (2 )   Ft. Worth   TX     137,000       1,147,400       (9,400 )           137,000       1,138,000       (245,095 )     1963       2005     40 years
Seven Oaks Nursing and Rehab
     (a )      (2 )   Bonham   TX     63,000       2,583,389                   63,000       2,583,389       (460,092 )     1970       2005     40 years
Birchwood Nursing and Rehab
     (a )      (2 )   Cooper   TX     96,000       2,726,580       8,304             96,000       2,734,884       (475,340 )     1966       2005     40 years
Smith Nursing and Rehab
     (a )      (2 )   Wolfe City   TX     49,000       1,010,304       (8,304 )           49,000       1,002,000       (191,906 )     1946       2005     40 years
Blanco Villa Nursing and Rehab
     (a )      (2 )   San Antonio   TX     341,847       1,931,216       951,592             341,847       2,882,808       (443,687 )     1969       2005     40 years
Forest Hill Nursing Center
     (a )           Ft. Worth   TX     87,904       1,764,129             (1,852,033 )                       1971       2005     40 years
Garland Nursing and Rehab
     (a )      (2 )   Garland   TX     56,509       1,058,409       191,111             56,509       1,249,520       (225,703 )     1964       2005     40 years
Hillcrest Nursing and Rehab
     (a )      (2 )   Wylie   TX     209,992       2,683,768       5,438             209,992       2,689,206       (476,581 )     1975       2005     40 years
Mansfield Nursing and Rehab
     (a )      (2 )   Mansfield   TX     486,958       2,142,550       (17,723 )           486,958       2,124,827       (404,319 )     1964       2005     40 years
Westridge Nursing and Rehab
     (a )      (2 )   Lancaster   TX     625,790       1,847,633       (15,270 )           625,790       1,832,363       (410,108 )     1973       2005     40 years
Clifton Nursing and Rehab
     (a )      (2 )   Clifton   TX     125,000       2,974,643                   125,000       2,974,643       (567,727 )     1995       2005     40 years
Brownwood Nursing and Rehab
     (a )      (2 )   Brownwood   TX     140,000       3,463,711       10,284             140,000       3,473,995       (599,581 )     1968       2005     40 years
Irving Nursing and Rehab
     (a )      (2 )   Irving   TX     137,000       1,248,284       (10,284 )           137,000       1,238,000       (247,394 )     1972       2005     40 years
Stanton Nursing and Rehab
     (a )      (2 )   Stanton   TX     261,000       1,017,599       11,707             261,000       1,029,306       (197,262 )     1972       2005     40 years
Valley Mills Nursing and Rehab
     (a )      (2 )   Valley Mills   TX     34,000       1,091,210       (8,977 )           34,000       1,082,233       (200,522 )     1971       2005     40 years
Hometown Care Center
     (a )           Moody   TX     13,000       328,263             (341,263 )                       1960       2005     40 years
Shuksan Healthcare Center
     (a )      (2 )   Bellingham   WA     61,000       491,085       1,983,432             61,000       2,474,517       (190,602 )     1965       2005     40 years
Orange Villa Nursing and Rehab
     (a )      (2 )   Orange   TX     97,500       1,948,490       17,468             97,500       1,965,958       (360,449 )     1973       2005     40 years
Pinehurst Nursing and Rehab
     (a )      (2 )   Orange   TX     98,500       2,072,051       22,567             98,500       2,094,618       (397,450 )     1955       2005     40 years
Wheeler Nursing and Rehab
     (a )      (2 )   Wheeler   TX     17,000       1,369,290                   17,000       1,369,290       (267,284 )     1982       2005     40 years
North Pointe Nursing and Rehab
     (a )      (2 )   Watauga   TX     1,061,000       3,845,890                   1,061,000       3,845,890       (653,486 )     1999       2005     40 years
ABC Health Center
     (a )      (2 )   Harrisonville   MO     143,500       1,922,391       120,802             143,500       2,043,193       (331,744 )     1970       2005     40 years
Camden Health Center
     (a )      (2 )   Harrisonville   MO     189,000       2,531,961       (20,961 )           189,000       2,511,000       (408,394 )     1977       2005     40 years
Cedar Valley Health Center
     (a )      (2 )   Rayton   MO     252,000       3,375,981       (13,026 )           252,000       3,362,955       (603,031 )     1978       2005     40 years
Monett Healthcare Center
     (a )      (2 )   Monett   MO     259,000       3,469,761       (24,261 )           259,000       3,445,500       (589,519 )     1976       2005     40 years


F-29


Table of Contents

                                                                                                     
                                                                              Life on Which
                                    Costs Capitalized Subsequent
    Gross Amount Carried at
                Depreciation
    Type
                  Initial Cost to Company     to Acquisition     December 31, 2010 (g)                 in Statement
    of
                        Buildings &
          Impairment /
          Buildings &
    Accumulated
    Year of
    Date
    of Operations
Description
  Asset     Encumbrances     City   State   Land     Improvements     Improvements     Dispositions     Land     Improvements     Depreciation     Construction     Acquired     Computed
 
White Ridge Health Center
     (a )      (2 )   Lee’s Summit   MO     292,250       3,914,964       2,174             292,250       3,917,138       (653,116 )     1986       2005     40 years
The Orchards Rehab/Care Center
     (a )      (2 )   Lewiston   ID     201,000       4,319,316       35,324             201,000       4,354,640       (842,587 )     1958       2005     40 years
SunBridge for Payette
     (a )      (2 )   Payette   ID     179,000       3,165,530       (26,331 )           179,000       3,139,199       (471,310 )     1964       2005     40 years
Magic Valley Manor-Assisted Living
     (b )      (2 )   Wendell   ID     177,000       405,331       1,005,334             177,000       1,410,665       (107,671 )     1911       2005     40 years
McCall Rehab and Living Center
     (a )      (2 )   McCall   ID     213,000       675,976       (5,624 )           213,000       670,352       (124,288 )     1965       2005     40 years
Menlo Park Health Care
     (a )      (2 )   Portland   OR     112,000       2,205,297                   112,000       2,205,297       (480,167 )     1959       2005     40 years
Burton Care Center
     (a )      (2 )   Burlington   WA     115,000       1,169,629                   115,000       1,169,629       (198,964 )     1930       2005     40 years
Columbia View Care Center
     (a )      (2 )   Cathlamet   WA     49,200       504,900                   49,200       504,900       (101,682 )     1965       2005     40 years
Pinehurst Park Terrace
     (a )           Seattle   WA           360,236             (360,236 )                       1955       2005     40 years
Grandview Healthcare Center
     (a )      (2 )   Grandview   WA     19,300       1,155,216       163,826             19,300       1,319,041       (274,822 )     1964       2005     40 years
Hillcrest Manor
     (a )      (2 )   Sunnyside   WA     102,000       1,638,826       259,309             102,000       1,898,135       (350,221 )     1970       2005     40 years
Evergreen Foothills Center
     (a )      (2 )   Phoenix   AZ     500,000       4,537,644                   500,000       4,537,644       (991,956 )     1997       2005     40 years
Evergreen Hot Springs Center
     (a )      (2 )   Hot Springs   MT     103,500       1,942,861       19,412             103,500       1,962,273       (330,310 )     1963       2005     40 years
Evergreen Polson Center
     (a )      (2 )   Polson   MT     121,000       2,357,612       (19,412 )           121,000       2,338,200       (423,288 )     1971       2005     40 years
Evergreen Sun City Center
     (a )      (2 )   Sun City   AZ     476,231       5,697,720       60,161             476,231       5,757,881       (1,026,236 )     1985       2005     40 years
Sunset Gardens at Mesa
     (b )      (2 )   Mesa   AZ     123,000       1,640,673       (13,547 )           123,000       1,627,126       (278,318 )     1974       2005     40 years
Evergreen Mesa Christian Center
     (a )      (2 )   Mesa   AZ     466,000       6,231,061       (46,614 )     (615,000 )     466,000       5,569,447       (1,132,671 )     1973       2005     40 years
Evergreen The Dalles Center
     (a )      (2 )   The Dalles   OR     200,000       3,831,789       91,952             200,000       3,923,741       (621,833 )     1964       2005     40 years
Evergreen Vista Health Center
     (a )      (2 )   LaGrande   OR     281,000       4,783,790       248,354             281,000       5,032,144       (754,391 )     1961       2005     40 years
Whitman Health and Rehab Center
     (a )      (2 )   Colfax   WA     231,000       6,271,162       38,289             231,000       6,309,451       (952,131 )     1985       2005     40 years
Fountain Retirement Hotel
     (b )      (2 )   Youngtown   AZ     101,300       1,939,835       60,000             101,300       1,999,835       (364,404 )     1971       2005     40 years
Gilmer Care Center
     (a )      (2 )   Gilmer   TX     257,000       2,992,894       285,320             257,000       3,278,214       (525,138 )     1967       2005     40 years
Columbus Nursing and Rehab Center
     (a )      (2 )   Columbus   WI     352,000       3,476,920                   352,000       3,476,920       (556,076 )     1950       2005     40 years
San Juan Rehab and Care Center
     (a )      (2 )   Anacortes   WA     625,000       1,184,855       2,041,630             625,000       3,226,485       (434,490 )     1965       2005     40 years
Infinia at Faribault
     (a )      (2 )   Faribault   MN     70,000       1,484,598       102,124             70,000       1,586,722       (299,989 )     1958       2005     40 years
Infinia at Owatonna
     (a )      (2 )   Owatonna   MN     125,000       2,321,296       (19,308 )           125,000       2,301,988       (404,188 )     1963       2005     40 years
Infinia at Willmar
     (a )      (2 )   Wilmar   MN     70,000       1,341,155       (11,156 )           70,000       1,329,999       (241,644 )     1998       2005     40 years
Infinia at Florence Heights
     (a )      (2 )   Omaha   NE     413,000       3,516,247       4,353             413,000       3,520,600       (702,614 )     1999       2005     40 years
Infinia at Ogden
     (a )      (2 )   Ogden   UT     233,800       4,478,450       600,306             233,800       5,078,756       (731,670 )     1977       2005     40 years
Prescott Manor Nursing Center
     (a )      (2 )   Prescott   AR     43,500       1,461,860       83,303             43,500       1,545,163       (334,126 )     1965       2005     40 years
Star City Nursing Center
     (a )      (2 )   Star City   AR     28,000       1,068,891       80,123             28,000       1,149,014       (188,464 )     1969       2005     40 years
Westview Manor of Peabody
     (a )      (2 )   Peabody   KS     22,000       502,177                   22,000       502,177       (88,314 )     1963       2005     40 years
Orchard Grove Extended Care Center
     (a )      (2 )   Benton Harbor   MI     166,000       3,185,496       261,000             166,000       3,446,496       (562,899 )     1971       2005     40 years
Marysville Care Center
     (a )           Marysville   CA     281,000       1,319,608             (1,600,608 )                       1965       2005     40 years
Yuba City Care Center
     (a )           Yuba City   CA     177,385       2,129,584             (2,306,969 )                       1964       2005     40 years
Lexington Care Center
     (a )      (2 )   Lexington   MO     151,000       2,943,170       325,142             151,000       3,268,312       (547,569 )     1970       2005     40 years
Twin Falls Care Center
     (a )      (2 )   Twin Falls   ID     448,000       5,144,793                   448,000       5,144,793       (861,945 )     1961       2005     40 years
Gordon Lane Care Center
     (a )      (2 )   Fullerton   CA     2,982,000       3,648,346                   2,982,000       3,648,346       (601,035 )     1966       2005     40 years
Sierra View Care Center
     (a )      (2 )   Baldwin Park   CA     868,400       1,748,141       6,377             868,400       1,754,518       (328,218 )     1938       2005     40 years
Villa Maria Care Center
     (a )           Long Beach   CA     139,600       766,778             (906,378 )                       1951       2005     40 years
High Street Care Center
     (a )      (2 )   Oakland   CA     246,000       684,695       11,776             246,000       696,471       (119,939 )     1961       2005     40 years
MacArthur Care Center
     (a )      (2 )   Oakland   CA     246,000       1,415,776       (11,776 )           246,000       1,404,000       (327,535 )     1960       2005     40 years
Pomona Vista Alzheimer’s Center
     (a )      (2 )   Pomona   CA     403,000       954,853                   403,000       954,853       (183,337 )     1959       2005     40 years
Rose Convalescent Hospital
     (a )      (2 )   Baldwin Park   CA     1,308,000       486,043                   1,308,000       486,043       (108,342 )     1963       2005     40 years
Country Oaks Nursing Center
     (a )      (2 )   Pomona   CA     1,393,000       2,426,180                   1,393,000       2,426,180       (411,755 )     1964       2005     40 years
Evergreen Nursing/Rehab Center
     (a )      (2 )   Effingham   IL     317,388       3,461,794                   317,388       3,461,794       (597,007 )     1974       2005     40 years
Deseret at Hutchinson
     (a )      (2 )   Hutchinson   KS     180,000       2,546,991                   180,000       2,546,991       (444,460 )     1963       2005     40 years
Northridge Healthcare/Rehab
     (a )      (2 )   Little Rock   AR     465,000       3,011,597       55,320             465,000       3,066,917       (739,800 )     1969       2005     40 years
Doctors Nursing and Rehab Center
     (a )      (2 )   Salem   IL     125,000       4,663,792       900,001             125,000       5,563,793       (813,829 )     1972       2005     40 years
Woodland Hills Health/Rehab
     (a )      (2 )   Little Rock   AR     270,000       4,006,007                   270,000       4,006,007       (573,775 )     1979       2005     40 years
North Richland Hills
     (a )           North Richland Hills   TX     980,458             5,067,466       (6,047,924 )                       2007       2005     40 years
Chenal Heights
     (a )      (2 )   Little Rock   AR     1,411,446             7,279,170             1,411,446       7,279,170       (779,257 )     2008       2006     40 years
Willis Nursing and Rehab
     (a )      (2 )   Willis   TX     212,000       2,407,367                   212,000       2,407,367       (318,112 )     1975       2006     40 years
Blanchette Place Care Center
     (a )      (2 )   St. Charles   MO     1,300,000       10,777,312       8,579             1,300,000       10,785,891       (1,262,366 )     1994       2006     40 years
Cathedral Gardens Care Center
     (a )      (2 )   St. Louis   MO     1,600,000       9,524,876       64,333             1,600,000       9,589,209       (1,152,494 )     1979       2006     40 years
Heritage Park Skilled Care
     (a )      (2 )   Rolla   MO     1,200,000       7,840,918       59,900             1,200,000       7,900,818       (900,973 )     1993       2006     40 years
Oak Forest Skilled Care
     (a )      (2 )   Ballwin   MO     550,000       3,995,129       29,766             550,000       4,024,895       (482,989 )     2004       2006     40 years
Richland Care and Rehab
     (a )      (2 )   Olney   IL     350,000       2,484,264                   350,000       2,484,264       (336,295 )     2004       2006     40 years
Bonham Nursing and Rehab
     (a )      (2 )   Bonham   TX     76,000       1,129,849                   76,000       1,129,849       (141,112 )     1969       2006     40 years

F-30


Table of Contents

                                                                                                     
                                                                              Life on Which
                                    Costs Capitalized Subsequent
    Gross Amount Carried at
                Depreciation
    Type
                  Initial Cost to Company     to Acquisition     December 31, 2010 (g)                 in Statement
    of
                        Buildings &
          Impairment /
          Buildings &
    Accumulated
    Year of
    Date
    of Operations
Description
  Asset     Encumbrances     City   State   Land     Improvements     Improvements     Dispositions     Land     Improvements     Depreciation     Construction     Acquired     Computed
 
Columbus Nursing and Rehab
     (a )      (2 )   Columbus   TX     150,000       1,808,552                   150,000       1,808,552       (240,436 )     1974       2006     40 years
Denison Nursing and Rehab
     (a )      (2 )   Denison   TX     178,000       1,945,000                   178,000       1,945,000       (244,184 )     1958       2006     40 years
Falfurrias Nursing and Rehab
     (a )      (2 )   Falfurias   TX     92,000       1,065,000                   92,000       1,065,000       (145,673 )     1974       2006     40 years
Houston Nursing and Rehab
     (a )      (2 )   Houston   TX     228,000       2,451,893                   228,000       2,451,893       (307,071 )     1976       2006     40 years
Kleburg County Nursing/Rehab
     (a )      (2 )   Kingsville   TX     315,000       3,688,676                   315,000       3,688,676       (461,642 )     1947       2006     40 years
Terry Haven Nursing and Rehab
     (a )      (2 )   Mount Vernon   TX     180,000       1,970,861                   180,000       1,970,861       (268,797 )     2004       2006     40 years
Deseret at Mansfield
     (b )      (2 )   Mansfield   OH     146,000       2,689,968       15,748             146,000       2,705,716       (303,991 )     1980       2006     40 years
Clarkston Care Center
     (a )      (2 )   Clarkston   WA     161,633       7,038,367       379,678             161,633       7,418,045       (1,021,418 )     1970       2006     40 years
Highland Terrace Nursing Center
     (a )      (2 )   Camas   WA     592,776       3,921,159       466,188             592,776       4,387,347       (710,452 )     1970       2006     40 years
Richland Rehabilitation Center
     (a )      (2 )   Richland   WA     693,000       9,307,000       145,819             693,000       9,452,819       (1,041,376 )     2004       2006     40 years
Evergreen Milton-Freewater Center
     (a )      (2 )   Milton Freewater   OR     700,000       5,403,570                   700,000       5,403,570       (656,622 )     1965       2006     40 years
Douglas Rehab and Care Center
     (a )      (2 )   Matoon   IL     250,000       2,390,779             (13,246 )     250,000       2,377,533       (288,233 )     1963       2006     40 years
Hillside Living Center
     (a )      (2 )   Yorkville   IL     560,000       3,073,603             (3,168 )     560,000       3,070,436       (397,561 )     1963       2006     40 years
Arbor View Nursing / Rehab Center
     (a )      (2 )   Zion   IL     147,000       5,235,290       142,766       (12,556 )     147,000       5,365,500       (591,422 )     1970       2006     40 years
Ashford Hall
     (a )      (2 )   Irving   TX     1,746,000       11,418,567       113,706       (142,702 )     1,746,000       11,389,571       (1,332,568 )     1964       2006     40 years
Belmont Nursing and Rehab Center
     (a )      (2 )   Madison   WI     480,000       1,861,061       6,207             480,000       1,867,268       (263,247 )     1974       2006     40 years
Blue Ash Nursing and Rehab Center
     (a )      (2 )   Cincinnati   OH     125,000       6,278,450       447,530             125,000       6,725,980       (884,229 )     1969       2006     40 years
West Chester Nursing/Rehab Center
     (a )      (2 )   West Chester   OH     100,000       5,663,460       368,689             100,000       6,032,149       (788,653 )     1965       2006     40 years
Wilmington Nursing/Rehab Center
     (a )      (2 )   Willmington   OH     125,000       6,078,450       472,389             125,000       6,550,839       (855,492 )     1951       2006     40 years
Extended Care Hospital of Riverside
     (a )      (2 )   Riverside   CA     1,091,000       5,646,826             (26,375 )     1,091,000       5,620,451       (986,069 )     1967       2006     40 years
Heritage Manor
     (a )      (2 )   Monterey Park   CA     1,585,508       9,274,154             (23,200 )     1,585,508       9,250,954       (1,438,143 )     1965       2006     40 years
French Park Care Center
     (a )      (2 )   Santa Ana   CA     1,076,447       5,983,614       596,442             1,076,447       6,580,056       (751,009 )     1967       2006     40 years
North Valley Nursing Center
     (a )      (2 )   Tujunga   CA     613,800       5,031,473             (25,382 )     613,800       5,006,091       (694,919 )     1967       2006     40 years
Villa Rancho Bernardo Care Center
     (a )      (2 )   San Diego   CA     1,425,347       9,652,911       65,350       (57,067 )     1,425,347       9,661,194       (1,158,654 )     1994       2006     40 years
Austin Nursing Center
     (a )      (2 )   Austin   TX     1,501,040       4,504,643       (28,091 )           1,501,040       4,476,552       (453,696 )     2007       2007     40 years
Dove Hill Care Center and Villas
     (a )      (2 )   Hamilton   TX     58,397       5,781,296                   58,397       5,781,296       (546,194 )     1998       2007     40 years
Brighten at Medford
     (a )      (2 )   Medford   MA     2,365,610       6,612,915       279,220             2,365,610       6,892,135       (760,794 )     1978       2007     40 years
Brighten at Ambler
     (a )      (2 )   Ambler   PA     370,010       5,111,673       (1,035,832 )             370,010       4,075,841       (440,750 )     1963       2007     40 years
Brighten at Broomall
     (a )      (2 )   Broomall   PA     607,870       3,930,013       590,503             607,870       4,520,516       (486,790 )     1955       2007     40 years
Brighten at Bryn Mawr
     (a )      (2 )   Bryn Mawr   PA     708,300       6,352,474       270,668             708,300       6,623,142       (715,261 )     1972       2007     40 years
Brighten at Julia Ribaudo
     (a )      (2 )   Lake Ariel   PA     369,050       7,559,765       320,189             369,050       7,879,954       (863,484 )     1980       2007     40 years
Good Samaritan Nursing Home
     (a )      (2 )   Avon   OH     393,813       8,856,210       108,495             393,813       8,964,705       (1,021,738 )     1964       2007     40 years
Belleville Illinois
     (a )      (2 )   Belleville   IL     670,481       3,431,286                   670,481       3,431,286       (316,664 )     1978       2007     40 years
Homestead Various Leases (f)
     (a )      (2 )       TX     345,197       4,352,982       5,503             345,197       4,358,485       (426,639 )             2007     40 years
Byrd Haven Nursing Home
     (a )      (2 )   Searcy   AR     772,501       2,413,388       748,914             772,501       3,162,302       (217,762 )     1961       2008     40 years
Evergreen Arvin Healthcare
     (a )      (2 )   Arvin   CA     900,000       4,764,928       758,102             1,020,441       5,402,589       (358,175 )     1984       2008     40 years
Evergreen Bakersfield Healthcare
     (a )      (2 )   Bakersfield   CA     1,000,000       12,154,112       1,760,333             1,133,824       13,780,621       (823,504 )     1987       2008     40 years
Evergreen Lakeport Healthcare
     (a )      (2 )   Lakeport   CA     1,100,000       5,237,033       848,046             1,247,206       5,937,873       (402,652 )     1987       2008     40 years
New Hope Care Center
     (a )      (2 )   Tracy   CA     1,900,000       10,293,920       1,631,837             2,154,265       11,671,491       (710,325 )     1987       2008     40 years
Olive Ridge Care Center
     (a )      (2 )   Oroville   CA     800,000       8,609,470       1,259,211             907,059       9,761,622       (630,582 )     1987       2008     40 years
Twin Oaks Health & Rehab
     (a )      (2 )   Chico   CA     1,300,000       8,397,558       1,297,764             1,473,971       9,521,351       (633,441 )     1988       2008     40 years
Evergreen Health & Rehab
     (a )      (2 )   LaGrande   OR     1,400,000       808,374       295,533             1,587,353       916,554       (77,183 )     1975       2008     40 years
Evergreen Bremerton Health & Rehab
     (a )      (2 )   Bremerton   WA     650,000       1,366,315       269,831             736,985       1,549,160       (102,387 )     1969       2008     40 years
Four Fountains
     (a )      (2 )   Belleville   IL     989,489       5,007,411                   989,489       5,007,411       (306,137 )     1972       2008     40 years
Brookside Health & Rehab
     (a )      (2 )   Little Rock   AR     750,690       4,421,289       1,395,023             750,690       5,816,312       (342,731 )     1969       2008     40 years
Skilcare Nursing Center
     (a )      (2 )   Jonesboro   AR     417,050       7,007,007                   417,050       7,007,007       (464,260 )     1973       2008     40 years
Stoneybrook Health & Rehab Center
     (a )      (2 )   Benton   AR     250,230       3,170,134                   250,230       3,170,134       (225,932 )     1968       2008     40 years
Trumann Health & Rehab
     (a )      (2 )   Trumann   AR     166,820       3,587,185                   166,820       3,587,185       (234,968 )     1971       2008     40 years
Deseret at McPherson
     (a )      (2 )   McPherson   KS     92,000       1,874,921                   92,000       1,874,921       (112,646 )     1970       2008     40 years
Mission Nursing Center
     (a )      (2 )   Riverside   CA     230,000       1,209,977                   230,000       1,209,977       (74,749 )     1957       2008     40 years
New Byrd Haven Nursing Home
     (a )      (2 )   Searcy   AR           10,213,112                         10,213,112       (471,615 )     2009       2009     40 years
Evergreen Health & Rehab of Petaluma
     (a )      (2 )   Petaluma   CA     748,668       2,459,910                   748,668       2,459,910       (165,331 )     1969       2009     40 years
Evergreen Mountain View Health & Rehab
     (a )      (2 )   Carson City   NV     3,454,723       5,942,468                   3,454,723       5,942,468       (287,022 )     1977       2009     40 years
Little Rock Health and Rehab
     (a )      (1 )   Little Rock   AR     471,169       4,778,831       714,336             471,169       5,493,168       (281,236 )     1971       2009     40 years
Hidden Acres Health Care
     (a )           Mount Pleasant   TN     67,413       3,312,587                   67,413       3,312,587       (51,346 )     1979       2010     40 years
Community Care and Rehab
     (a )      (1 )   Riverside   CA     1,648,067       9,851,933                   1,648,067       9,851,933       (54,681 )     1965       2010     40 years
Heritage Gardens of Portageville
     (a )      (2 )   Portageville   MO     223,658       3,088,802                   223,658       3,088,802       (21,731 )     1995       2010     40 years
Heritage Gardens of Greenville
     (a )      (2 )   Greenville   MO     118,925       2,218,775                   118,925       2,218,775       (15,970 )     1990       2010     40 years

F-31


Table of Contents

                                                                                                     
                                                                              Life on Which
                                    Costs Capitalized Subsequent
    Gross Amount Carried at
                Depreciation
    Type
                  Initial Cost to Company     to Acquisition     December 31, 2010 (g)                 in Statement
    of
                        Buildings &
          Impairment /
          Buildings &
    Accumulated
    Year of
    Date
    of Operations
Description
  Asset     Encumbrances     City   State   Land     Improvements     Improvements     Dispositions     Land     Improvements     Depreciation     Construction     Acquired     Computed
 
Heritage Gardens of Senath
     (a )      (2 )   Senath   MO     108,843       2,773,194       159,590             108,843       2,932,785       (20,543 )     1980       2010     40 years
Heritage Gardens of Senath South
     (a )      (2 )   Senath   MO     72,805       1,854,998                   72,805       1,854,998       (13,592 )     1980       2010     40 years
The Carrington
     (a )      (2 )   Lynchburg   VA     705,888       4,294,112                   705,888       4,294,112       (27,603 )     1994       2010     40 years
Arma Care Center
     (a )      (2 )   Arma   KS     57,452       2,897,772                   57,452       2,897,772             1970       2010     40 years
Great Bend Health & Rehab Center
     (a )      (2 )   Great Bend   KS     111,482       4,588,518                   111,482       4,588,518             1965       2010     40 years
Maplewood at Norwalk
     (b )     (2 )   Norwalk   CT     1,589,950       1,010,050       197,189             1,589,950       1,207,239             1983       2010     40 years
Carrizo Springs Nursing & Rehab
     (a )      (2 )   Carrizo Springs   TX     45,317       1,954,683                   45,317       1,954,683             1965       2010     40 years
Maplewood at Orange
     (b )      (2 )   Orange   CT     1,133,533       11,155,287                   1,133,533       11,155,287             1999       2010     40 years
Aviv Asset Management
     (d )           Chicago   IL                 377,544                   377,544       (129,892 )                    
Skagit Aviv
     (e )           Mt. Vernon   WA                 396,702                   396,702                            
                                                                                                     
                            $ 76,935,771     $ 597,669,579     $ 39,341,658     $ (21,674,715 )   $ 76,466,020     $ 615,806,273     $ (75,948,944 )                    
                                                                                                     
 
Assets under direct financing leases
 
                                                                                 
    Type
                          Gross Amount
       
    of
              Initial Cost to
  Accretion/
  Impairment/
  Carried at
  Year of
  Date
Description
  Asset   Encumbrances   City   State   Company   Amortization   Dispositions   December 31, 2010   Construction   Acquired
 
Fountain Lake
     (a )      (2 )     Hot Springs       AR     $ 10,418,738     $ 358,446     $     $ 10,777,184       2007       2008  
                                                                                 
                                    $ 10,418,738     $ 358,446     $     $ 10,777,184                  
                                                                                 
 
 
(a) Skilled Nursing Facilities (SNFs)
 
(b) Assisted Living Facilities (ALFs)
 
(c) Vacant Land
 
(d) Assets relating to corporate office space
 
(e) Developmental asset
 
(f) Includes six properties all located in Texas
 
(g) The aggregate cost for federal income tax purposes of the real estate as of December 31, 2010 is $598,846,000 (unaudited)
 
     
     
Encumbrances:
  (1) Standalone first mortgage
     
    (2) Aviv primary credit facility (GE credit facility)
 

F-32


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
                         
    For the Years Ended December 31,  
    2010     2009     2008  
 
Reconciliation of real estate:
                       
Carrying cost:
                       
Balance at beginning of period
  $ 636,409,268     $ 606,691,800     $ 505,585,195  
Additions during period:
                       
Acquisitions
    63,005,000       17,856,000       103,521,125  
Development of rental properties and capital expenditures
    7,815,209       11,861,468       8,630,503  
Dispositions:
                       
Sale of assets
    (4,084,000 )           (10,138,645 )
Impairment (i)
    (96,000 )           (906,378 )
                         
Balance at end of period
  $ 703,049,477     $ 636,409,268     $ 606,691,800  
                         
Accumulated depreciation:
                       
Balance at beginning of period
  $ 58,673,377     $ 42,091,996     $ 29,961,048  
Additions during period:
                       
Depreciation expense
    17,853,799       17,527,656       14,615,770  
Dispositions:
                       
Sale of assets
    (578,232 )     (946,275 )     (2,459,571 )
Impairment (i)
                (25,251 )
                         
Balance at end of period
  $ 75,948,944     $ 58,673,377     $ 42,091,996  
                         
 
 
(i) Represents the write-down of carrying cost and accumulated depreciation on assets where impairment charges were taken.

F-33


Table of Contents

 
AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
The Board of Directors and the Partners
Aviv Healthcare Properties Limited Partnership and Subsidiaries
 
We have audited the accompanying consolidated balance sheets of Aviv Healthcare Properties Limited Partnership and Subsidiaries (the Partnership) as of December 31, 2010 and 2009, and the related consolidated statements of operations, changes in equity, and cash flows for each of the three years in the period ended December 31, 2010. Our audits also included the financial statement schedule listed in the accompanying index to the financial statements. These financial statements and schedule are the responsibility of the Partnership’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.
 
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Partnership’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Partnership’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Aviv Healthcare Properties Limited Partnership and Subsidiaries at December 31, 2010 and 2009, and the consolidated results of their operations and their cash flows for each of the three years in the period ended December 31, 2010 in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
 
/s/  Ernst & Young LLP
 
Chicago, Illinois
March 15, 2011
except for Note 16 and Schedule III, as to which the date is
April 28, 2011


F-34


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
                 
   
December 31,
 
   
2010
   
2009
 
 
Assets
               
Cash and cash equivalents
    $13,028,474       $15,542,507  
Deferred rent receivable
    30,660,773       27,715,217  
Due from related parties
          15,816  
Tenant receivables
    1,168,842       2,407,737  
Rental properties and financing leases, at cost:
               
Land
    76,466,020       69,844,477  
Buildings and improvements
    615,806,273       555,931,485  
Assets under direct financing leases
    10,777,184       10,633,306  
                 
      703,049,477       636,409,268  
Less accumulated depreciation
    (75,948,944 )     (58,673,377 )
                 
Net rental properties
    627,100,533       577,735,891  
Deferred finance costs, net
    9,957,636       989,658  
Loan receivables
    36,610,638       28,970,129  
Other assets
    12,872,323       11,753,540  
                 
Total assets
    $731,399,219       $665,130,495  
                 
                 
Liabilities and equity                
Accounts payable and accrued expenses
    $6,012,809       $3,241,478  
Tenant security and escrow deposits
    13,658,384       12,314,790  
Other liabilities
    25,996,492       31,936,322  
Mortgage and other notes payable
    440,575,916       480,105,226  
                 
Total liabilities
    486,243,601       527,597,816  
Class E Preferred Units
          62,970,571  
Equity:
               
Partners’ equity
    241,061,186       73,385,093  
Noncontrolling interests
          1,177,015  
Accumulated other comprehensive income
    4,094,432        
                 
Total equity
    245,155,618       74,562,108  
                 
Total liabilities and equity
    $731,399,219       $665,130,495  
                 
 
See accompanying notes to consolidated financial statements.


F-35


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
                         
   
Year Ended December 31,
 
   
2010
   
2009
   
2008
 
 
Revenues
                       
Rental income
    $84,490,144       $82,775,078       $72,142,847  
Tenant recoveries
    6,441,786       6,055,703       4,830,733  
Interest on loans to lessees—capital expenditures
    1,779,620       1,662,107       725,939  
Interest on loans to lessees—working capital and capital lease
    3,446,226       1,830,791       1,133,146  
                         
Total revenues
    96,157,776       92,323,679       78,832,665  
Expenses
                       
Rent and other operating expenses
    574,646       612,185       1,088,220  
General and administrative
    10,725,122       7,741,087       6,808,795  
Offering costs
          6,863,948        
Real estate taxes
    6,475,230       6,231,776       5,116,431  
Depreciation
    17,853,799       17,527,656       14,615,770  
Loss on impairment
    96,000             931,629  
                         
Total expenses
    35,724,797       38,976,652       28,560,845  
                         
Operating income
    60,432,979       53,347,027       50,271,820  
Other income and expenses:
                       
Interest and other income
    133,286       466,177       2,012,046  
Interest expense
    (22,722,785 )     (26,570,071 )     (26,272,012 )
Change in fair value of derivatives
    2,931,309       6,987,825       (8,673,771 )
Amortization of deferred financing costs
    (1,008,059 )     (550,327 )     (536,620 )
Gain on sale of assets, net
    511,552              
Loss on extinguishment of debt
    (2,295,562 )            
                         
Total other income and expenses
    (22,450,259 )     (19,666,396 )     (33,470,357 )
                         
Income from continuing operations
    37,982,720       33,680,631       16,801,463  
Discontinued operations
                72,730  
                         
Net income
    37,982,720       33,680,631       16,874,193  
Distributions and accretion on Class E Preferred Units
    (17,371,893 )     (14,569,875 )     (8,842,980 )
Net income allocable to noncontrolling interests
    (241,622 )     (221,154 )     (155,026 )
                         
Net income allocable to common units
    $20,369,205       $18,889,602       $7,876,187  
                         
Net income allocable to common units
    $37,982,720                  
Unrealized gain on derivative instruments
    4,094,432                  
                         
Total comprehensive income allocable to common units
    $42,077,152                  
                         
 
See accompanying notes to consolidated financial statements.


F-36


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
                                 
          Accumulated Other
             
    Partners’
    Comprehensive
    Noncontrolling
    Total
 
   
Equity
   
Income
   
Interests
   
Equity
 
 
Balance at January 1, 2008
    $92,835,547       $—       $1,422,456       $94,258,003  
Net income
    16,719,167             155,026       16,874,193  
Issuance of warrants
    1,349,494                   1,349,494  
Non-cash stock-based compensation
    406,000                   406,000  
Distributions to partners and accretion on Class E Preferred Units and other
    (34,394,877 )           (621,621 )     (35,016,498 )
                                 
Balance at December 31, 2008
    76,915,331             955,861       77,871,192  
Net income
    33,459,477             221,154       33,680,631  
Issuance of warrants
    8,399,117                   8,399,117  
Non-cash stock-based compensation
    406,000                   406,000  
Distributions to partners and accretion on Class E Preferred Units and other
    (45,794,832 )                 (45,794,832 )
                                 
Balance at December 31, 2009
    73,385,093             1,177,015       74,562,108  
Net income
    37,741,098             241,622       37,982,720  
Non-cash stock-based compensation
    1,631,998                   1,631,998  
Distributions to partners and accretion on Class E Preferred Units
    (79,980,308 )                 (79,980,308 )
Redemption of warrants
    (17,001,453 )                 (17,001,453 )
Capital contributions
    223,597,219             268,902       223,866,121  
Unrealized gain on derivative instruments
          4,094,432             4,094,432  
Capital contributions of noncontrolling interests
    1,687,539             (1,687,539 )      
                                 
Balance at December 31, 2010
    $241,061,186       $4,094,432       $—       $245,155,618  
                                 
 
See accompanying notes to consolidated financial statements.


F-37


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
                         
   
Year Ended December 31,
 
   
2010
   
2009
   
2008
 
 
Operating activities
                       
Net income
    $37,982,720       $33,680,631       $16,874,193  
Adjustments to reconcile net income to net cash provided by operating activities:
                       
Depreciation
    17,853,799       17,527,656       14,661,586  
Amortization
    1,008,059       550,327       536,620  
Change in fair value of derivatives
    (2,931,309 )     (6,987,825 )     8,673,771  
Deferred rental income
    (3,056,430 )     (6,388,600 )     (5,531,005 )
Rental income from intangible amortization, net
    (3,681,109 )     (2,097,655 )     (2,518,376 )
Non-cash stock-based compensation
    1,631,998       406,000       406,000  
Loss on impairment of assets
    96,000             931,629  
Non-cash loss on extinguishment of debt
    1,437,233              
Gain on sale of assets, net
    (511,552 )            
Loss on disposal of assets, net
                183,903  
Reserve for uncollectible loans
    750,000              
Changes in assets and liabilities:
                       
Due from related parties
    15,816       10,000       642,662  
Tenant receivables
    (317,123 )     (365,523 )     (2,087,939 )
Other assets
    177,666       3,022,578       (2,439,953 )
Accounts payable and accrued expenses
    3,357,961       145,652       1,634,170  
Tenant security deposits and other liabilities
    866,527       1,141,304       978,499  
Due to related parties
          (602,253 )     (897,456 )
                         
Net cash provided by operating activities
    54,680,256       40,042,292       32,048,304  
Investing activities
                       
Sales of rental properties
    4,085,825             3,071,177  
Purchase of rental properties
    (54,884,043 )     (16,375,694 )     (94,392,262 )
Capital improvements and other developments
    (7,883,130 )     (13,507,673 )     (1,833,252 )
Payment of earn-out provision for previously acquired rental properties
    (9,600,731 )            
Loan receivables funded to related parties
                 
Proceeds of collections on loan receivables to related parties
                32,000,000  
Loan receivables funded to others, net
    (6,834,568 )     (8,609,528 )     (17,440,989 )
Funding of direct financing leases, net
                (10,479,323 )
                         
Net cash used in investing activities
    (75,116,647 )     (38,492,895 )     (89,074,649 )
Financing activities
                       
Borrowings of debt
    442,789,570       35,651,073       80,915,249  
Repayment of debt
    (482,522,690 )     (19,091,756 )     (4,218,338 )
Payment of financing costs
    (10,567,931 )     (102,803 )      
Payment for swap termination
    (3,380,160 )            
Capital contributions
    223,866,121              
Redemption of Class E Preferred Units and warrants
    (92,001,451 )            
Redemption of Class F Units
    (23,602,649 )            
Proceeds from issuance of warrants
          8,399,117       1,349,494  
Net proceeds from issuance of Class E Preferred Units
          17,898,975       1,813,836  
Cash distributions to partners
    (36,658,452 )     (38,122,989 )     (29,849,750 )
                         
Net cash provided by financing activities
    17,922,358       4,631,617       50,010,491  
                         
Net (decrease) increase in cash and cash equivalents
    (2,514,033 )     6,181,014       (7,015,854 )
Cash and cash equivalents:
                       
Beginning of year
    15,542,507       9,361,493       16,377,347  
                         
End of year
    $13,028,474       $15,542,507       $9,361,493  
                         
Supplemental cash flow information
                       
Cash paid for interest
    $20,983,000       $27,771,260       $25,447,062  
Supplemental disclosure of noncash activity
                       
Accrued distributions payable to partners
    $11,339,775       $3,650,000       $395,046  
Write-off of deferred rent receivable
    $3,367,164       $—       $—  
Write-off of in-place lease intangibles, net
    $1,392,034       $—       $—  
Write-off of deferred finance costs, net
    $1,235,969       $—       $—  
Write-off of debt discount
    $202,307       $—       $—  
Mortgage and other notes payable assumed
    $—       $—       $5,350,939  
 
See accompanying notes to consolidated financial statements.


F-38


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements
 
1.   Description of Operations and Formation
 
Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership, and Subsidiaries, (the Partnership) was formed in 2005 and directly or indirectly owned or leased 181 and 169 properties, principally skilled nursing facilities, across the United States at December 31, 2010 and 2009, respectively. The Partnership generates the majority of its revenues by entering into long-term triple-net leases with qualified local, regional, and national operators. In addition to the base rent, leases provide for tenants to pay the Partnership an ongoing escrow for real estate taxes. Furthermore, all operating and maintenance costs of the buildings are the responsibility of the tenants. Substantially all depreciation expense reflected in the consolidated statements of operations relates to the ownership of senior living properties. The Partnership manages its business as a single business segment as defined in Accounting Standards Codification (ASC) 280, Segment Reporting.
 
The Partnership is the general partner and 99.245% owner of Aviv Healthcare Properties Operating Partnership I, L.P. (the Operating Partnership), a Delaware limited partnership at December 31, 2010. A fractional interest in the Operating Partnership was owned by a related party, Aviv Healthcare LLC, and was shown as a component of noncontrolling interest through the Merger date, at which time the interest was contributed by the related party to the Partnership. The Operating Partnership has six wholly owned subsidiaries: Aviv Development JV, LLC (Aviv Development), a Delaware limited liability company; Aviv Financing I, LLC (Aviv Financing I), a Delaware limited liability company; Aviv Financing II, LLC (Aviv Financing II), a Delaware limited liability company; Aviv Financing III, LLC (Aviv Financing III), a Delaware limited liability company; Aviv Financing IV, LLC (Aviv Financing IV), a Delaware limited liability company; and Aviv Financing V, LLC (Aviv Financing V), a Delaware limited liability company.
 
On September 17, 2010, the Partnership entered into an agreement (the Merger Agreement), by and among Aviv REIT, Inc., a Maryland corporation (the Company), Aviv Healthcare Merger Sub LP, a Delaware limited partnership of which the Company is the general partner (Merger Sub), Aviv Healthcare Merger Sub Partner LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, and the Partnership. Effective on such date, the Company is the sole general partner of the Partnership. Pursuant to the Merger Agreement, the Partnership merged (the Merger) with and into Merger Sub, with Merger Sub continuing as the surviving entity with the identical name (the Surviving Partnership). Following the Merger, the Company remains as the sole general partner of the Surviving Partnership and the Surviving Partnership, as the successor to the Partnership, became the general partner of the Operating Partnership. All of the business, assets and operations will continue to be held by the Operating Partnership and its subsidiaries. The Company’s equity interest in the Surviving Partnership will be linked to future investments in the Company, such that future equity issuances by the Company (pursuant to the Stockholders Agreement, the Company’s management incentive plan or otherwise as agreed between the parties) will result in a corresponding increase in the Company’s equity interest in the Surviving Partnership. The Company is authorized to issue 2 million shares of common stock (par value ($0.01) and 1,000 shares of preferred stock (par value $1,000). At December 31, 2010, there are 227,002 shares of common stock and 125 shares of preferred stock outstanding.
 
As a result of the common control of the Company (which was newly formed) and the Partnership, the Merger, for accounting purposes, did not result in any adjustment to the historical carrying value of the assets or liabilities of the Partnership. The Company was funded in September 2010 with approximately $235 million from its stockholders and such amount, net of costs, was contributed to the Partnership in September 2010 in exchange for Class G Units in the Partnership. At December 31, 2010, the Company owns 53.4% of the economic interests of the Partnership.


F-39


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
2.   Summary of Significant Accounting Policies
 
Estimates
 
The preparation of the financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
 
Noncontrolling Interests
 
In December 2007, the Financial Accounting Standards Board (FASB) issued ASC 810, Consolidations (ASC 810) to improve the relevance, comparability, and transparency of the financial information that a reporting entity provides in its consolidated financial statements by establishing accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. ASC 810 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008.
 
Effective January 1, 2009, the Partnership retrospectively adopted the provisions of ASC 810, which requires a noncontrolling interest in a subsidiary to be reported as equity and the amount of consolidated net income specifically attributable to the noncontrolling interest to be included within consolidated net income.
 
ASC 810 also requires consistency in the manner of reporting changes in the parent’s ownership interest and requires fair value measurement of any noncontrolling equity investment retained in a deconsolidation. Further, as a result of the adoption of ASC 810, net income attributable to noncontrolling interests is now excluded from the determination of consolidated net income.
 
Principles of Consolidation
 
The accompanying consolidated financial statements include the accounts of the Partnership, the Surviving Partnership, the Operating Partnership, and all controlled subsidiaries and joint ventures. The Partnership considers itself to control an entity if it is the majority owner of and has voting control over such entity. The portion of the net income or loss attributed to third parties is reported as net income allocable to noncontrolling interests on the consolidated statements of operations, and such parties’ portion of the net equity in such subsidiaries is reported on the consolidated balance sheets as noncontrolling interests. All significant intercompany balances and transactions have been eliminated in consolidation.
 
Cash and Cash Equivalents
 
Cash and cash equivalents consist of cash and highly liquid short-term investments with original maturities of three months or less. The Partnership maintains cash and cash equivalents in United States banking institutions that exceed amounts insured by the Federal Deposit Insurance Corporation. The Partnership believes the risk of loss from exceeding this insured level is minimal.
 
Rental Properties
 
The Partnership periodically assesses the carrying value of rental properties and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and


F-40


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the rental properties will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the rental properties and related intangibles to their estimated fair value. The estimated fair value of the Partnership’s rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis. As part of the impairment evaluation during 2010, a building in Hometown, Texas was impaired for $96,000 to reflect the difference between the book value and estimated selling price less costs to dispose. The property was sold on December 31, 2010, with an immaterial gain subsequent to the impairment of $96,000 previously taken. As part of the impairment evaluation during 2008, the Partnership recorded a loss on the anticipated sale of a building of approximately $932,000.
 
Buildings and building improvements have been assigned estimated 40-year lives and are depreciated on the straight-line method. Personal property, furniture, and equipment have been assigned estimated lives ranging from 7 to 10 years and are depreciated on the straight-line method.
 
The Partnership may advance monies to its lessees for the purchase, generally, of furniture, fixtures, or equipment or other purposes. Required minimum lease payments due from the lessee increase to provide for the repayment of such amounts over a stated term. These advances in the instance where the depreciable life of the newly purchased asset is less than the remaining lease term are reflected as loan receivables on the consolidated balance sheets, and the incremental lease payments are bifurcated between principal and interest over the stated term. In the instance where the depreciable life of the newly purchased assets is longer than the remaining lease term, the purchase is recorded as property. In other instances, explicit loans are made to lessees for working capital and other funding needs and provide for monthly principal and interest payments generally ranging from 5 to 10 years. Such advances, net of repayments, equaled $36,610,638 and $28,970,129 at December 31, 2010 and 2009, respectively.
 
Purchase Accounting
 
In determining the allocation of the purchase price of partnerships and facilities between net tangible and identified intangible assets acquired and liabilities assumed, the Partnership makes estimates of the fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of preacquisition due diligence, marketing, leasing activities of the Partnership’s diverse operator base, industry surveys of critical valuation metrics such as capitalization rates, discount rates and leasing rates and appraisals obtained as a requirement of the Mortgage. The Partnership allocates the purchase price of facilities to net tangible and identified intangible assets acquired based on their fair values in accordance with the provisions of ASC 805, Business Combinations (ASC 805). The determination of fair value involves the use of significant judgment and estimation.
 
The Partnership determines fair values as follows:
 
  •     Other assets acquired and other liabilities assumed are valued at stated amounts, which approximate fair value.
 
  •     Rental properties are valued using discounted cash flow projections that assume certain future revenue and costs and consider capitalization and discount rates using current market conditions. The Partnership allocates the purchase price of facilities to net tangible and identified intangible assets acquired and liabilities assumed based on their fair values.


F-41


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
  •     Assumed debt balances are valued at fair value, with the computed discount/premium amortized over the remaining term of the obligation.
 
The Partnership determines the value of land either based on real estate tax assessed values in relation to the total value of the asset, internal analyses of recently acquired and existing comparable properties within the Partnership’s portfolio, or third party appraisals. The fair value of in-place leases, if any, reflects: (i) above- and below-market leases, if any, determined by discounting the difference between the estimated current market rent and the in-place rentals, the resulting intangible asset or liability of which is amortized to rental revenue over the remaining life of the associated lease plus any fixed rate renewal periods if applicable; (ii) the estimated value of the cost to obtain tenants, including tenant allowances, tenant improvements, and leasing commissions, which is amortized over the remaining life of the associated lease; and (iii) an estimated value of the absorption period to reflect the value of the rents and recovery costs foregone during a reasonable lease-up period as if the acquired space was vacant, which is amortized over the remaining life of the associated lease. The Partnership also estimates the value of tenant or other customer relationships acquired by considering the nature and extent of existing business relationships with the tenant, growth prospects for developing new business with such tenant, such tenant’s credit quality, expectations of lease renewals with such tenant, and the potential for significant, additional future leasing arrangements with such tenant. The Partnership amortizes such value, if any, over the expected term of the associated arrangements or leases, which would include the remaining lives of the related leases. The amortization is included in the consolidated statements of operations in rental income.
 
Prior to the Merger on September 17, 2010, Aviv Asset Management, L.L.C. (AAM) was a non-consolidated management company to the Partnership based on the application of appropriate accounting guidance (as discussed in Footnote 11). Upon the Merger, AAM became a consolidated entity of the Partnership and is presented as such for all periods included herein with all periods shown at historical cost (carryover basis with no adjustments to fair value). This treatment is in accordance with ASC 805 due to the fact that AAM was under common control prior and subsequent to the Merger.
 
Revenue Recognition
 
Rental income is recognized on a straight-line basis over the term of the lease when collectibility is reasonably assumed. Differences between rental income earned and amounts due under the lease are charged or credited, as applicable, to deferred rent receivable. Income recognized from this policy is titled deferred rental revenue. Additional rents from expense reimbursements for insurance, real estate taxes, and certain other expenses are recognized in the period in which the related expenses are incurred and are reflected as tenant recoveries on the consolidated statements of operations.
 
Below is a summary of the components of rental income for the years ended December 31, 2010, 2009, and 2008:
 
                         
   
2010
   
2009
   
2008
 
 
Rental income
    $77,752,605       $74,288,823       $64,093,466  
Deferred rental revenue
    3,056,430       6,388,600       5,531,005  
Rental income from intangible amortization
    3,681,109       2,097,655       2,518,376  
                         
Total rental income
    $84,490,144       $82,775,078       $72,142,847  
                         


F-42


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
During the year ended December 31, 2010, deferred rental revenue includes an off-setting write-off (expense) of deferred rent receivable of $3,367,164 due to the terminations of leases and replacement of operators.
 
Lease Accounting
 
The Partnership, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statement of operations as rental income for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators. Assets subject to operating leases are reported as rental properties in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to the Partnership’s net initial investment is established on the balance sheet titled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a financing lease. Such accretion was $143,878, $153,983, and $95,793 for the years ended December 31, 2010, 2009, and 2008, respectively.
 
All of the Partnership’s leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.
 
Deferred Finance Costs
 
Deferred finance costs are being amortized using the straight-line method, which approximates the interest method, over the term of the respective underlying debt agreement.
 
Loan Receivables
 
Loan receivables consist of capital improvement loans to tenants and working capital loans to operators. Loan receivables are carried at their principal amount outstanding. Management, periodically evaluates outstanding loans and notes receivable for collectability. When management identifies potential loan impairment indicators, such as nonpayment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator, or other circumstances that may impair full execution of the loan documents, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan, the loan is written down to the present value of the expected future cash flows. As of December 31, 2010, loan receivable reserves amounted to $750,000. No other circumstances exist that would suggest that additional reserves are necessary at the balance sheet date. As of December 31, 2009, loan receivable reserves are immaterial.
 
Stock-Based Compensation
 
The Partnership follows ASC 718, Stock Compensation (ASC 718), which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated statements of operations based on their grant date fair values. On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction. As recipients of the awards under the Plan are employed by or associated with the Partnership, the Partnership records the compensation


F-43


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
expense for all awards granted under the Plan. The non-cash stock-based compensation expense recognized by the Partnership since the Merger date, under the Plan, through December 31, 2010 is summarized in Footnote 9.
 
Fair Value of Financial Instruments
 
ASC 820, Fair Value Measurements and Disclosures, (ASC 820) establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels are defined as follows:
 
  •     Level 1—Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or;
 
  •     Level 2—Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and
 
  •     Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
 
The Partnership’s interest rate swaps are valued using models developed internally by the respective counterparty that use as their basis readily observable market parameters and are classified within Level 2 of the valuation hierarchy.
 
Cash and cash equivalents, cash and escrow deposits—restricted, and derivative financial instruments are reflected in the accompanying consolidated balance sheets at amounts considered by management to reasonably approximate fair value. Management estimates the fair value of its long-term debt using a discounted cash flow analysis based upon the Partnership’s current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Partnership had outstanding mortgage and other notes payable obligations with a carrying value of approximately $440.6 million and $480.1 million as of December 31, 2010 and 2009, respectively. The estimated fair value of debt (Level 2) as of December 31, 2010 approximated its carrying value based upon interest rates available to the Partnership on similar borrowings, and was $458.4 million as of December 31, 2009.
 
Derivative Instruments
 
The Partnership has implemented ASC 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. Changes in the fair market values of the Partnership’s derivative instruments are recorded in the consolidated statements of operations if the derivative does not qualify for or the Partnership does not elect to apply hedge accounting. If the derivative is deemed to be eligible for hedge accounting, such changes are reported in accumulated other comprehensive income within the consolidated statements of changes in equity, exclusive of ineffectiveness amounts, which are recognized as adjustments to net income.


F-44


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
Initial Public Offering Costs
 
During 2009, the Partnership pursued an initial public offering (the IPO) of common stock. Costs related to the IPO incurred by the Partnership were capitalized on the consolidated balance sheets in other assets as they were incurred.
 
On November 2, 2009, the Partnership abandoned its IPO effort. As a result, the Partnership wrote off the IPO costs incurred to date to the consolidated statement of operations. In the year ended December 31, 2009, approximately $6.9 million of IPO-related costs were expensed.
 
Income Taxes
 
As a limited partnership, the consolidated operating results are included in the income tax returns of the individual partners. Accordingly, the Partnership does not provide for federal income taxes. State income taxes were not significant in any of the periods presented. No uncertain income tax positions exist as of December 31, 2010, and December 31, 2009, respectively.
 
Risks and Uncertainties
 
The Partnership is subject to certain risks and uncertainties affecting the healthcare industry as a result of healthcare legislation and continuing regulation by federal, state, and local governments. Additionally, the Partnership is subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the growth in cost of healthcare services.
 
Reclassifications
 
Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Partnership’s consolidated financial position or results of operations.
 
3.   Rental Property Activity
 
The Partnership had the following rental property activity during 2010 as described below:
 
  •     In March 2010, Aviv Financing III recognized an additional $8,121,000 addition to the purchase price for the August 2008 acquisitions of eight properties in California and Oregon from an unrelated third party as per the guidance within ASC 805. The addition is related to the earn-out provision defined at closing. Such $8,121,000 additions along with $1,480,000 previously accrued amounts at December 31, 2009 related to the acquisitions of two properties in April 2009 in California and Nevada under Aviv Financing I, were paid out in the amount of approximately $9,601,000.
 
  •     In June 2010, Aviv Financing III acquired a property in Tennessee from an unrelated third party for a purchase price of approximately $3,380,000. The Partnership financed this purchase through cash.
 
  •     In July 2010, Aviv Financing I disposed of two properties in California to an unrelated third party for a total selling price of approximately $3,988,000, which resulted in a gain on disposal


F-45


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
  of approximately $582,000. The proceeds from the sale were primarily used to pay down a portion of the existing Credit Facility (see Footnote 7) by approximately $3,883,000.
 
  •     In September 2010, Aviv Financing I acquired a property in Virginia from an unrelated third party for a purchase price of approximately $5,000,000. The Partnership financed this purchase through borrowings of approximately $3,162,000 under the Revolver (See Footnote 7).
 
  •     In October 2010, Aviv Financing I acquired four properties in Missouri from various unrelated third parties for a purchase price of approximately $10,460,000. The Partnership financed this purchase through borrowings of approximately $7,718,000 under the Revolver (see Footnote 7).
 
  •     In November 2010, Aviv Financing III acquired a property in California from an unrelated third party for a purchase price of approximately $11,500,000. The Partnership financed this purchase through borrowings of approximately $7,800,000 under an acquisition loan.
 
  •     In December 2010, Aviv Financing III acquired a property in Connecticut from an unrelated third party for a purchase price of approximately $2,600,000. The Partnership financed this purchase through cash.
 
  •     In December 2010, Aviv Financing I acquired four properties in Kansas, Texas and Connecticut, from unrelated third parties for a purchase price of approximately $21,944,000. The Partnership financed this purchase through borrowings of approximately $15,666,000 under the Revolver (see Footnote 7).
 
  •     In December 2010, Aviv Financing I sold a property located in Texas to an unrelated third party for a sales price of approximately $96,000.
 
In accordance with ASC 805, the Partnership allocated the approximate net purchase price of these properties acquired in 2010 as follows:
 
         
Land
    $7,094,000  
Buildings and improvements
    55,911,000  
         
Borrowings and available cash
    $63,005,000  
         
 
The Partnership had the following rental property activity during 2009 as described below:
 
  •     In January 2009, Aviv Financing III acquired a property in Arkansas from an unrelated third party for a purchase price of approximately $5,250,000. The Partnership financed this purchase through borrowings of approximately $2,625,000 via an acquisition loan, which was subsequently paid in full in August 2009.
 
  •     In April 2009, Aviv Financing III acquired two properties in California and Nevada from an unrelated third party for a purchase price of approximately $12,606,000. The Partnership financed this purchase through borrowings of approximately $8,625,000 via an acquisition loan.


F-46


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
In accordance with ASC 805, the Partnership allocated the approximate net purchase price of these properties acquired in 2009 as follows:
 
         
Land
    $4,675,000  
Buildings and improvements
    13,181,000  
         
Borrowings and available cash
    $17,856,000  
         
 
The Partnership acquired additional rental properties during 2008 as described below:
 
  •     In April 2008, Aviv Financing I acquired vacant land in Arkansas from an unrelated third party for a purchase price of approximately $625,000 to be used for construction of a replacement facility and acquired two properties in Arkansas from an unrelated third party for a purchase price of approximately $12,800,000. The Partnership financed this purchase through borrowings of approximately $9,785,000 under the Credit Facility and from proceeds from the issuance of Class E Units.
 
  •     In August 2008, Aviv Financing I acquired eight properties in California and Oregon from an unrelated third party for a purchase price of approximately $60,600,000. The Partnership financed this purchase through borrowings of approximately $47,400,000 under the Credit Facility.
 
  •     In September 2008, Aviv Financing I acquired a property in Illinois from an unrelated third party for a purchase price of approximately $6,200,000. The Partnership financed this purchase through borrowings of approximately $5,571,000 via the assumption of HUD debt.
 
  •     In November 2008, Aviv Financing I acquired four properties in Arkansas from an unrelated third party for a purchase price of approximately $19,617,500. The Partnership financed this purchase through borrowings of approximately $15,694,000 under the Credit Facility.
 
  •     In December 2008, Aviv Financing I acquired two properties, in two separate transactions, in Kansas and California from an unrelated third party for a purchase price of approximately $3,350,000. The Partnership financed this purchase through borrowings of approximately $2,680,000 under the Credit Facility.
 
In accordance with ASC 805, the Partnership allocated the approximate net purchase price plus any related closing costs of these properties acquired in 2008 as follows:
 
         
Land
    $12,719,000  
Buildings and improvements
    80,325,000  
Assets under direct financing leases
    10,390,000  
Mortgage and other notes payable assumed
    (5,571,000 )
         
Borrowings and issuances of Class E Units
    $97,863,000  
         
 
The Partnership considers renewals on below-market leases when ascribing value to the in-place lease intangible liabilities at the date of a property acquisition. In those instances where the renewal lease rate pursuant to the terms of the lease does not adjust to a current market rent, the Partnership evaluates whether the stated renewal rate is below current market rates and considers the past and current operations of the


F-47


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
property, the current rent coverage ratio of the tenant, and the number of years until potential renewal option exercise. If renewal is considered probable based on these factors, an additional lease intangible liability is recorded at acquisition and amortized over the renewal period.
 
4.   Deferred Finance Costs
 
The following summarizes the Partnership’s deferred finance costs at December 31, 2010 and 2009:
 
                 
   
2010
   
2009
 
 
Gross amount
    $10,567,931       $2,620,295  
Accumulated amortization
    (610,295 )     (1,630,637 )
                 
Net
    $9,957,636       $989,658  
                 
 
Amortization of deferred financing costs is reported in the amortization expense line item in the consolidated statements of operations.
 
The estimated annual amortization of the deferred finance costs for each of the five succeeding years is as follows:
 
         
2011
    $2,116,711  
2012
    2,116,711  
2013
    2,116,021  
2014
    2,108,699  
2015
    1,499,494  
         
Total
    $9,957,636  
         
 
5.   Loan Receivables
 
The following summarizes the Partnership’s loan receivables at December 31, 2010 and 2009:
 
                 
   
2010
   
2009
 
 
Beginning balance
    $28,970,129       $20,360,601  
New capital improvement loans issued
    1,415,579       2,816,733  
Working capital and other loans issued
    14,705,259       7,963,189  
Reserve for uncollectible loans
    (750,000 )      
Loan amortization and repayments
    (7,730,329 )     (2,170,394 )
                 
      $36,610,638       $28,970,129  
                 
 
During 2010 and 2009, the Partnership funded loans for both working capital and capital improvement purposes to various operators and tenants. All loans held by the Partnership accrue interest. The payments received from the operator or tenant cover both interest accrued as well as amortization of the principle balance due. Any payments received from the tenant or operator made outside of the normal loan amortization schedule are considered principal prepayments and reduce the outstanding loan receivables balance.


F-48


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
Interest income earned on loan receivables for the years ended December 31, 2010, 2009, and 2008, was $3,823,223, $2,117,461, and $909,645, respectively.
 
6.   In-Place Lease Intangibles
 
The following summarizes the Partnership’s in-place lease intangibles classified as part of other assets or other liabilities at December 31, 2010 and 2009:
 
                                 
   
2010
   
2009
 
   
Assets
   
Liabilities
   
Assets
   
Liabilities
 
 
Gross amount
    $8,393,488       $25,798,147       $11,336,489       $34,275,494  
Accumulated amortization
    (3,049,093 )     (14,049,691 )     (3,836,456 )     (16,690,291 )
                                 
Net
    $5,344,395       $11,748,456       $7,500,033       $17,585,203  
                                 
 
The estimated annual amortization expense of the identified intangibles for each of the five succeeding years is as follows:
 
                 
   
Assets
   
Liabilities
 
 
2011
    $644,570       $2,065,305  
2012
    644,570       1,953,351  
2013
    636,847       1,838,732  
2014
    461,961       923,735  
2015
    402,147       678,961  
Thereafter
    2,554,300       4,288,372  
                 
      $5,344,395       $11,748,456  
                 
 
Amortization expense for the in-place lease intangible assets for the years ended December 31, 2010, 2009, and 2008 was $743,890, $986,871, and $1,020,315, respectively. Accretion for the in-place lease intangible liabilities for the years ended December 31, 2010, 2009, and 2008 was $2,468,500, $3,084,525, and $3,538,691, respectively.
 
During 2010, the Partnership wrote-off in-place lease intangible assets of $2,943,001 with accumulated amortization of $1,531,253, and in-place lease intangible liabilities of $8,477,347 with accumulated accretion of $5,109,101, for a net recognition of $1,956,498 in rental income from intangible amortization, respectively.


F-49


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
7.   Mortgage and Other Notes Payable
 
The Partnership’s mortgage and other notes payable consisted of the following:
 
                 
   
December 31,
 
   
2010
   
2009
 
 
Mortgage (interest rate of 5.75% on December 31, 2010)
    $402,794,111       $—  
Revolver (interest rate of 5.75% on December 31, 2010)
    28,677,230        
Construction loan (interest rate of 5.95% on December 31, 2010)
    1,312,339        
Acquisition loans (interest rate of 6.00% on December 31, 2010)
    7,792,236        
Term A loans (interest rates of 3.25% on December 31, 2009)
          7,000,000  
Term A loan (interest rate of 2.73% on December 31, 2009)
          150,000,000  
Term A loan (interest rate of 2.73% on December 31, 2009)
          50,000,000  
Term B loans (interest rates of 3.25% on December 31, 2009)
          11,062,192  
Term B loan (interest of 2.73% on December 31, 2009)
          200,000,000  
Construction loan (interest rates of 3.25% on December 31, 2009)
          5,188,837  
Construction loan (interest rate of 5.00% on December 31, 2009)
          7,187,276  
HUD-related debt (interest rates ranging from 5.23% to 7.25% on eight HUD properties)
          29,154,033  
Other loan (interest rates of 3.75% on December 31, 2009)
          12,000,000  
Acquisition loan (interest rate of 4.50% on December 31, 2009)
          8,512,888  
                 
Total
    $440,575,916       $480,105,226  
                 
 
In conjunction with the Merger, Aviv Financing I refinanced its debt by paying off all existing mortgages on September 17, 2010 in the amount of $471,064,380 (outstanding balances at the Merger), and entering into a five-year credit agreement (the Credit Agreement) that provided a $405 million mortgage term loan facility (the Mortgage) and a $100 million revolver (the Revolver).
 
The Mortgage
 
Principal payments on the Mortgage are payable in monthly installments beginning on November 1, 2010. The payment schedule for the Mortgage is based upon a 25-year mortgage style amortization as defined in the Credit Agreement. Interest rates, at the Partnership’s option, are based upon the base rate or Eurodollar base rate (0.29% at December 31, 2010 with a 1.25% floor) plus 4.5%. The base rate, as defined in the Credit Agreement, is the rate announced from time to time by the Base Rate Bank as its “prime rate”. The Base Rate Bank is Bank of America, N.A. The balance outstanding on the Term Loan as of December 31, 2010 was $402.8 million. This loan matures in September 2015 and has two one-year extensions.


F-50


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
The Revolver
 
Under the Credit Agreement, the Partnership also has a $100 million Revolver. On each payment date, the Partnership shall pay interest only in arrears on any outstanding principal balance of the Revolver. Interest rates, at the Partnership’s option, are based upon the base rate or Eurodollar base rate (0.29% at December 31, 2010 with a 1.25% floor) plus 4.5%. The base rate, as defined in the GE Credit Agreement, is the rate announced from time to time by the Base Rate Bank as its “prime rate”. The Base Rate Bank is Bank of America, N.A. Additionally, an unused fee equal to 1% per annum of the daily unused balance on the Revolver is due monthly.
 
As of December 31, 2010, approximately $28.7 million had been drawn on The Revolver. The ability to draw on the Revolver terminates in September 2013 at which time principal and interest are payable until the Revolver maturity date in September 2015.
 
Other Loans
 
On November 1, 2010, a subsidiary of Aviv Financing III entered into two acquisition loan agreements of the same terms that provided for borrowings of $7.8 million. Principal and interest payments are due monthly beginning on December 1, 2010 through the maturity date of December 1, 2015. Interest is a fixed rate of 6.00%. These loans are collateralized by a skilled nursing facility controlled by Aviv Financing III. The balance outstanding on these loans at December 31, 2010 was approximately $7.8 million.
 
On November 12, 2010, a subsidiary of Aviv Financing III entered into a construction loan agreement that provides for borrowings up to $6.4 million. Interest-only payments at the prime rate (3.25% at December 31, 2010) plus 0.38%, or a minimum of 5.95%, are due monthly from December 1, 2010 through April 1, 2012. From May 1, 2012 through the maturity date of December 1, 2013, monthly payments of principal and interest are due based on a 20-year amortization schedule. This loan is collateralized by a skilled nursing facility controlled by Aviv Financing III. The balance outstanding on this loan at December 31, 2010 was approximately $1.3 million.
 
Future annual maturities of all debt obligations for five fiscal years subsequent to December 31, 2010, are as follows:
 
         
2011
    $7,321,285  
2012
    7,717,628  
2013
    9,650,608  
2014
    9,227,220  
2015
    406,659,175  
         
      $440,575,916  
         
 
8.   Partners’ Equity and Incentive Program
 
In conjunction with the formation of the Partnership, the Partnership issued 10,323,213 Class A Units and 3,294,733 Class B Units in exchange for all ownership interests of the Roll-up contributed to the Partnership in 2005. The Partnership issued an additional 3,144,010 Class A Units and 1,228,372 Class B Units in 2006. The Class A Units issued as a result of the formation of the Partnership have a par value of $10.00 per unit, while Class A Units issued on December 29, 2006, as a result of the addition of additional properties have a par value of $11.49 per unit. Operating distributions accrue at the rate of 10% per year for


F-51


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
Class A Units. The Class A Units have distribution preference, which decreases ratably after the full return of capital to the Class A Unitholders through distributions, and also have a liquidation preference and a profit interest in the event of sale, disposition, or refinancing as defined in the Agreement of Limited Partnership (the Partnership Agreement).
 
Also in connection with the formation of the Partnership, the Partnership awarded Class C Unit profit interests. These Class C Units do not have a par value, and no capital was contributed in consideration for their issuance. These Class C Units were issued to the General Partner of the Partnership, which is owned by two parties that have significant ownership holdings in the Partnership. When operating distributions are paid in full to the Class A Units as described above, the Class B and Class C Units receive all excess distributions, with 40% to Class B Unitholders and 60% to the Class C Unitholders until the Class B Units receive $3 million in any partnership year to the extent that all Class B Units have been issued per the Partnership Agreement. After reaching this threshold, the remaining distributions are allocated 100% to the Class C Unitholders.
 
The Class D Units represent profit interests in the Partnership, which may be granted periodically to employees of AAM. A total of 10,000 Class D Units have been authorized. A total of 8,050 and 7,800 Class D Units are outstanding at December 31, 2010 and 2009, respectively. The Class D Units are not entitled to any distributions of the Partnership, except in the event of sale, disposition, or refinancing as defined. Class C Units also have an interest in these proceeds. The terms of the Class D Units were amended at the Merger. Part of the Class D Units are defined as performance-based awards under ASC 718 and require employment of the recipient on the date of sale, disposition, or refinancing (Liquidity Event). If the employee is no longer employed on such date, the award is forfeited. For accounting purposes, the grant date fair value will be recognized as an expense when a Liquidity Event becomes imminent and such fair value on the grant date was determined to be $0.9 million. The remainder of the Class D Units are time-based awards under ACS 718 and such fair value determined on the grant date is recognized over the vesting period. During 2010, 3,220 of the time-based D Units vested, resulting in the recognition of $888,400 in expense. No expense relating to these awards was recognized in 2009.
 
Distributions to the Partnership partners are summarized as follows for the years ended December 31:
 
                                                         
   
Class A
 
Class B
 
Class C
 
Class D
 
Class E
 
Class F
 
Class G
 
2010
    $13,594,547       $2,894,457       $12,683,113       $—       $5,342,466       $3,792,881       $6,092,935  
2009
    $13,562,740       $2,894,457       $10,339,900       $—       $6,898,235       $4,430,085       $—  
2008
    $13,562,740       $2,774,081       $4,161,121       $—       $4,692,899       $5,223,778       $—  
 
Weighted-average Units outstanding are summarized as follows for the respective years ended December 31:
 
                                                         
   
Class A
 
Class B
 
Class C
 
Class D
 
Class E
 
Class F
 
Class G
 
2010
    13,467,223       4,523,145       2       7,386       5,342,489       4,597,432       65,338  
2009
    13,467,223       4,523,145       2       8,033       6,901,950       5,369,800        
2008
    13,467,223       4,523,145       2       9,006       4,693,784       5,369,800        
 
The Partnership had established an officer incentive program linked to its future value. Awards vest annually over a five-year period assuming continuing employment by the recipient. The awards can be settled in Class C Units or cash at the Partnership’s discretion at the settlement date of December 31, 2012. For accounting purposes, expense recognition under the program commenced in 2008, and the related expense for the year ended December 31, 2010, 2009, and 2008 was approximately $406,000, $406,000, and $406,000, respectively.


F-52


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
As a result of the Merger on September 17, 2010, such incentive program was modified such that 40% of the previously granted award settled immediately on the Merger date with another 20% vesting and settling on December 31, 2010. The remaining 40% will vest equally on December 31, 2011 and December 31, 2012, and will settle in 2018, subject to the terms and conditions of the amended incentive program agreement. In accordance with ASC 718, Compensation—Stock Compensation (ASC 718), such incentive program will continue to be expensed through general and administrative expenses as non-cash compensation on the statements of operations through the ultimate vesting date of December 31, 2012.
 
The Partership’s equity balance that is projected on the consolidated balance sheets is split between the general partner and limited partners in the amount of $221,578,430 and $19,482,756 at December 31, 2010, respectively.
 
9.   Option Awards
 
On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction. As recipients of the awards under the Plan are employed by or associated with the Partnership, the Partnership records the compensation expense for all awards granted under the Plan.
 
In connection with the Merger, 64,168 options were granted to certain members of management and advisory board members on September 17, 2010 with an exercise price of $1,000 per option. Two thirds of the options granted, or 42,778 shares, are performance based awards whose criteria for vesting is tied to a future liquidity event (as defined) and also contingent upon meeting certain return thresholds (as defined). At this time, the Partnership does not believe it is probable that these options will vest and therefore has not recorded any expense in the December 31, 2010 financial statements in accordance with ASC 718. The grant date fair value associated with all performance based award options aggregates approximately $4.0 million as of December 31, 2010. One third, or 21,390 shares, of the options granted were time based awards and the service period for these options is four years with shares vesting at a rate of 25% on September 17, 2010, 2011, 2012, and 2013.
 
An additional 1,425 options were granted to certain members of management and advisory board members on September 30, 2010 with an exercise price of $1,084 per option. Two thirds of the options granted, or 949 shares, are performance based awards (as defined above). One third, or 476 shares, of the options granted were time based awards (as defined above). The grant date fair value of each time based award is charged to non-cash compensation expense on a graded basis over the vesting period. No option awards were granted prior to September 17, 2010. The following table represents the time based option awards activity for the year ended December 31, 2010.
 
         
    December 31,
 
   
2010
 
 
Outstanding at beginning of period
     
Granted
    21,866  
Exercised
     
Cancelled/Forfeited
     
         
Outstanding at end of period
    21,866  
Options exercisable at end of period
     
         
Weighted average fair value of options granted
    $108.55  
         
Weighted average remaining contractual life
    9.72  
         


F-53


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
The following table represents the time based option awards outstanding for the year ended December 31, 2010 as well as other Plan data:
 
                         
        Remaining
  Weighted
        Contractual Life
  Average
Range of Exercise Prices
 
Outstanding
 
(Years)
 
Exercise Price
 
$1,000—$1,084
    21,866       9.72       $1,002  
 
The Black-Scholes option pricing model has been used to estimate the grant date fair value of the options. The following table includes the assumptions that were made in estimating the grant date fair value for options awarded in 2010.
 
         
   
2010 Grants
 
Dividend yield
    10.28 %
Risk-free interest rate
    2.1 %
Expected life
    7.0 years  
Estimated volatility
    38.00 %
Weighted average exercise price
    $1,001.83  
Weighted average fair value of options granted (per option)
    $108.55  
 
The Partnership recorded non-cash compensation expenses of $337,598 for the year ended December 31, 2010, related to the time based stock options accounted for as equity awards, as a component of general and administrative expenses in the consolidated statements of operations.
 
At December 31, 2010, the total compensation cost related to outstanding, non-vested time based equity option awards that are expected to be recognized as compensation cost in the future aggregates approximately $2,036,000.
 
         
For the Year Ended December 31,
     
 
2011
    $1,056,730  
2012
    572,691  
2013
    298,647  
2014
    107,809  
         
Total
    $2,035,877  
         
 
Dividend equivalent rights associated with the Plan, amounted to $586,630 for the year ended December 31, 2010, which were incurred during the fourth quarter of 2010, and are included in general and administrative expense in the consolidated statements of operations. These dividend rights will be paid in four installments as the option vests.
 
10.   Minimum Future Rentals
 
The Partnership’s rental properties are leased under noncancelable triple-net operating leases. Under the provisions of the leases, the Partnership receives fixed minimum monthly rentals, generally with annual increases, and the tenants are responsible for the repayment of all operating expenses, including repairs and maintenance, insurance, and real estate taxes of the property throughout the term of the leases.


F-54


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
At December 31, 2010, future minimum annual rentals to be received under the noncancelable lease terms are as follows:
 
         
2011
    $84,992,545  
2012
    88,174,683  
2013
    90,498,508  
2014
    88,768,851  
2015
    88,841,343  
Thereafter
    473,832,636  
         
      $915,108,566  
         
 
11.   Related Parties
 
Related party receivables and payables represent amounts due from/to various affiliates of the Partnership, including advances to members of the Partnership, amounts due to certain acquired companies and limited liability companies for transactions occurring prior to the formation of the Partnership, and various advances to entities controlled by affiliates of the Partnership’s management.
 
The Partnership had entered into a management agreement, as amended, effective April 1, 2005, with AAM, an entity affiliated by common ownership. Under the management agreement, AAM had been granted the exclusive right to oversee the portfolio of the Partnership, providing, among other administrative services, accounting and all required financial services; legal administration and regulatory compliance; investor, tenant, and lender relationship services; and transactional support to the Partnership. Except as otherwise provided in the Partnership Agreement, all management powers of the business and affairs of the Partnership are exclusively vested in the General Partner. The annual fee for such services equals six-tenths of one percent (0.6%) of the aggregate fair market value of the properties as determined by the Partnership and AAM annually. This fee arrangement was amended as discussed below. In addition, the Partnership reimbursed AAM for all reasonable and necessary out-of-pocket expenses incurred in AAM’s conduct of its business, including, but not limited to, travel, legal, appraisal, and brokerage fees, fees and expenses incurred in connection with the acquisition, disposition, or refinancing of any property, and reimbursement of compensation and benefits of the officers and employees of AAM. This agreement was terminated on September 17, 2010 when the Merger occurred, effectively consolidating AAM into the Partnership, and eliminating the necessity for reimbursement.
 
On October 16, 2007, the Partnership legally acquired AAM through a Manager Contribution and Exchange Agreement dated October 16, 2007 (the Contribution Agreement). As stipulated in the Contribution Agreement and the Second Amended and Restated Agreement of Limited Partnership on October 16, 2007 (Partnership Agreement), the Partnership issued a new class of Partnership Unit, Class F Units, as consideration to the contributing members of AAM. The contributing members of AAM served as the general partner of the Partnership. The Class F Units have subordinated payment and liquidity preference to the Class E Units but are senior in payment and liquidity preference, where applicable, to the Class A, B, C, and D Units of the Partnership. The Class F Units paid in quarterly installments an annual dividend of 8.25% of the preliminary face amount of $53,698,000. The preliminary pricing was based upon trading multiples of comparably sized publicly traded healthcare REITs. The ultimate Class F Unit valuation was subject to a true-up formula at the time of a Liquidity Event, as defined in the Partnership Agreement.
 
For accounting purposes, prior to the Merger, AAM had not been consolidated by the Partnership, nor had any value been ascribed to the Class F Units issued due to the ability of the Class E Unitholders to


F-55


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
unwind the acquisition as described above. Such action was outside the control of the Partnership, and accordingly, the acquisition is not viewed as having been consummated. The dividends earned by the Class F Unitholders were reflected as a component of management fees as described above. Subsequent to October 16, 2007, the fee for management services to the Partnership are equal to the dividend earned on the Class F Unit and was reported as management fee expense.
 
Under certain circumstances, the Partnership Agreement did permit the Class E Unitholders to unwind this transaction and required the Partnership to redeem the Class F Units by returning to the affiliates all membership interests in AAM. On September 17, 2010, the Partnership settled the investment with JER Aviv Acquisition, LLC (JER). For accounting purposes, this treatment triggered the retroactive consolidation of AAM by the Partnership. The original and follow-on investments of Class E Unitholders were made subject to the Unit Purchase Agreement and related documents (UPA) between the Partnership and JER dated May 26, 2006.
 
The UPA did not give either party the right to settle the investment prior to May 26, 2011. However, the UPA did have an economic arrangement as to how either party could settle the arrangement on or after that date. This economic construct guided the discussions and negotiations of settlement. The UPA allowed the Partnership to call the E Units and warrants anytime after May 26, 2011 as long as it provided JER with a 15% IRR from date of inception. The IRR would be calculated factoring interim distributions as well as exit payments. The units were settled for $92,001,451 contemporaneous with the Merger. A portion of the settlement related to outstanding warrants held by JER and originally issued in connection with the E Units issuance.
 
Coincident with the Merger, 50% of the Class F Unit was purchased and settled by the Partnership for $23,602,649 and is reported as a component of distributions to partners and accretion on Class E Preferred Units in the consolidated statements of changes in equity. The remaining Class F Units will pay in quarterly installments an annual dividend of 9.38% of the face amount of $23,602,649.
 
12.   Derivatives
 
During the periods presented, the Partnership was party to various interest rate swaps, which were purchased to fix the variable interest rate on the denoted notional amount under the original debt agreements.
 
At December 31, 2009, the Partnership was party to the following interest rate swaps, which were purchased to fix the variable interest rate on the denoted notional amount under the Original and Amended Credit Agreements and on the acquisition loan, which was obtained in April 2009:
 
     
Total notional amount
  $289,976,000
Fixed interest rates range
  1.54%—5.20%
Effective date range
  April 18, 2005—July 17, 2009
Termination date range
  February 26, 2010—September 16, 2011
Asset balance at December 31, 2009 (included in other assets)
  $—
Liability balance at December 31, 2009 (included in other liabilities)
  $6,311,470
 
On September 17, 2010 in connection with the extinguishment of the original credit facility, the Partnership settled all related interest rate swaps at a fair value of $3,380,160.


F-56


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
At December 31, 2010, the Partnership is party to two interest rate swaps, with identical terms for $100 million each. They were purchased to fix the variable interest rate on the denoted notional amount under the Mortgage which was obtained in September, 2010, and qualify for hedge accounting. For presentational purposes they are shown as one derivative due to the identical nature of their economic terms.
 
     
Total notional amount
  $200,000,000
Fixed rates
  6.49% (1.99% effective swap base rate plus 4.5% spread per credit agreement)
Floor rate
  1.25%
Effective date
  November 9, 2010
Termination date
  September 17, 2015
Asset balance at December 31, 2010 (included in other assets)
  $4,094,432
Liability balance at December 31, 2010 (included in other liabilities)
  $—
 
The fair value of each interest rate swap agreement may increase or decrease due to changes in market conditions but will ultimately decrease to zero over the term of each respective agreement.
 
For the years ended December 31, 2010, 2009, and 2008, the Partnership recognized approximately $2.9 million and $7.0 million of net income, and recognized approximately $8.7 million of next expense, respectively, in the consolidated statements of operations related to the change in the fair value of interest rate swap agreements where the Partnership did not elect to apply hedge accounting.
 
The following table provides the Partnership’s derivative assets and liabilities carried at fair value as measured on a recurring basis as of December 31, 2010 (dollars in thousands):
 
                                 
                Significant
       
    Total Carrying
    Quoted Prices
    Other
    Significant
 
    Value at
    in Active
    Observable
    Unobservable
 
    December 31,
    Markets
    Inputs
    Inputs
 
   
2010
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
 
Derivative assets
    $4,094       $       $4,094       $  
Derivative liabilities
                       
                                 
      $4,094       $       $4,094       $  
                                 
 
The Partnership’s derivative assets and liabilities include interest rate swaps that effectively convert a portion of the Partnership’s variable rate debt to fixed rate debt. The derivative positions are valued using models developed internally by the respective counterparty that use as their basis readily observable market parameters (such as forward yield curves) and are classified within Level 2 of the valuation hierarchy. The Partnership considers its own credit risk as well as the credit risk of its counterparties when evaluating the fair value of its derivatives.
 
13.   Commitments and Contingencies
 
The Partnership has a contractual arrangement with a tenant to reimburse quality assurance fees levied by the California Department of Health Care Services from August 1, 2005 through July 31, 2008. The Partnership is obligated to reimburse the fees to the tenant if and when the state withholds these fees from the tenant’s Medi-Cal reimbursements associated with 5 facilities that were formerly leased to Trinity Health


F-57


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
Systems. The total possible obligation for these fees is $1,655,286, of which approximately $1.0M has been paid to date. For the year ended December 31, 2010, the Partnership’s indemnity expense for these fees was $1,003,000 which equaled the actual amount paid during the period.
 
Judicial proceedings seeking declaratory relief for these fees are in process which if successful would provide for recovery of such amounts from the State of California. The Partnership has certain rights to seek relief against Trinity Health Systems for monies paid out under the indemnity claim; however, it is uncertain whether the Partnership will be successful in receiving any amounts from Trinity.
 
In the normal course of business, the Partnership is involved in legal actions arising from the ownership of its property. In management’s opinion, the liabilities, if any, that may ultimately result from such legal actions are not expected to have a material adverse effect on the financial position, operations, or liquidity of the Partnership.
 
14.   Concentration of Credit Risk
 
As of December 31, 2010, the Partnership’s portfolio of investments consisted of 181 healthcare facilities, located in 24 states and operated by 32 third party operators. At December 31, 2010, approximately 50.7% (measured as a percentage of total assets) were leased by five private operators: Evergreen Healthcare (13.6%), Daybreak Healthcare (12.4%), Sun Mar Healthcare (9.0%), HiCare (8.1%), and Convacare (7.6%). No other operator represents more than 6.3% of our total assets. The five states in which the Partnership had its highest concentration of total assets were California (19.3%), Texas (16.3%), Missouri (9.6%), Arkansas (8.0%), and Pennsylvania (6.1%) at December 31, 2010.
 
For the year ended December 31, 2010, the Partnership’s rental income from operations totaled approximately $84.5 million, of which approximately $11.6 million was from Evergreen Healthcare (13.7%), $9.1 million from Daybreak Healthcare (10.7%), and $9.1 million was from Sun Mar Healthcare (10.7%). No other operator generated more than 8.3% of the Partnership’s rental income from operations for the year ended December 31, 2010.
 
Below is a summary of unaudited financial information as of and for the year ended December 31, 2009 for the two lessees (operators) of our properties whose total assets, in the aggregate, exceeds 10% of the Partnership’s total assets at December 31, 2010. Financial performance under the terms of lease agreements with these lessees is, by agreement, guaranteed by the entities whose financial data is as follows:
 
                 
    Evergreen
   
Financial Position
 
Healthcare
 
Daybreak
 
Current assets
    $50,975,393       $14,723,053  
Noncurrent assets
    41,653,895       37,043,192  
Current liabilities
    60,991,351       42,847,531  
Noncurrent liabilities
    115,053,022       57,073,485  
(Deficit) equity
    (83,415,085 )     (48,154,771 )
Results of operations
               
Revenues
    $260,280,330       $248,922,846  
Gross profit
    21,988,553       19,982,130  
Income from continuing operations
    5,773,223       9,143,933  
Net income
    7,757,958       8,802,933  


F-58


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
15.   Subsequent Events
 
On January 4, 2011, Aviv Financing I acquired a property in Kansas from an unrelated third party for a purchase price of $3,045,000. The Partnership financed this purchase through borrowings of $2,131,000 under the Mortgage (as described in Footnote 7).
 
On February 4, 2011, the Partnership issued $200 million in Senior Notes at 7.75%. The proceeds from this bond issuance were used to pay down $194 million of the Mortgage.
 
On March 1, 2011, the Partnership replaced an operator of three buildings in Pennsylvania and one in Massachusetts from the operator Brighten to the operator Saber. The Partnership anticipates that it will recognize a charge to write-off a deferred rent receivable of approximately $2.4 million in the first quarter of 2011.
 
The Partnership has evaluated events subsequent to December 31, 2010 through March 15, 2011, and determined that no events other than those noted above would require additional disclosure.
 
16.   Condensed Consolidating Information
 
We and certain of our direct and indirect wholly owned subsidiaries (the “Wholly Owned Subsidiary Guarantors”) fully and unconditionally guaranteed, on a joint and several basis, the obligation to pay principal and interest with respect to our Senior Notes issued in February 2011. These Senior Notes were issued by Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation. Separate financial statements of the guarantors are not provided as the consolidating financial information contained herein provides a more meaningful disclosure to allow investors to determine the nature of the assets held by and the operations of the respective guarantor and non-guarantor subsidiaries. Other wholly owned subsidiaries (“Non-Guarantor Subsidiaries”) that were not included among the Guarantors were not obligated with respect to the Senior Notes. The Non-Guarantor Subsidiaries are subject to mortgages. The following summarizes our condensed consolidating information as of December 31, 2010 and 2009 and for the years ended December 31, 2010, 2009, and 2008:


F-59


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
 
CONDENSED CONSOLIDATING BALANCE SHEET
As of December 31, 2010
 
                                         
          Subsidiary
    Non-Guarantor
             
   
Issuers
   
Guarantors
   
Subsidiaries
   
Eliminations
   
Consolidated
 
 
Assets
                                       
Cash and cash equivalents
    $12,126,776       $908,612       $(6,914 )     $—       $13,028,474  
Net rental properties
          609,972,113       17,128,420             627,100,533  
Deferred financing costs, net
    100,000       9,834,291       23,345             9,957,636  
Other
    13,380,055       67,896,040       36,481             81,312,576  
Investment in and due from related parties, net
    232,906,755       (42,847,014 )     (6,964,810 )     (183,094,931 )      
                                         
Total assets
    $258,513,586       $645,764,042       $10,216,522       $(183,094,931 )     $731,399,219  
                                         
Liabilities and equity
                                       
Mortgage and other notes payable
    $—       $431,471,341       $9,104,575       $—       $440,575,916  
Due to related parties
    6,092,936                         6,092,936  
Tenant security and escrow deposits
          13,422,705       235,679             13,658,384  
Accounts payable and accrued expenses
    1,431,564       4,102,506       478,739             6,012,809  
Other liabilities
    5,833,468       14,070,088                   19,903,556  
                                         
Total liabilities
    13,357,968       463,066,640       9,818,993             486,243,601  
Total equity
    245,155,618       182,697,402       397,529       (183,094,931 )     245,155,618  
                                         
Total liabilities and equity
    $258,513,586       $645,764,042       $10,216,522       $(183,094,931 )     $731,399,219  
                                         


F-60


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING BALANCE SHEET
As of December 31, 2009
 
                                         
          Subsidiary
    Non-Guarantor
             
   
Issuers
   
Guarantors
   
Subsidiaries
   
Eliminations
   
Consolidated
 
 
Assets
                                       
Cash and cash equivalents
    $256,598       $15,285,909       $—       $—       $15,542,507  
Net rental properties
          572,626,869       5,109,022             577,735,891  
Deferred financing costs, net
          989,658                   989,658  
Other
    10,240,463       60,376,547       229,613             70,846,623  
Investment in and due from related parties, net
    144,389,145       665,364       (4,833,054 )     (140,205,639 )     15,816  
                                         
Total assets
    $154,886,206       $649,944,347       $505,581       $(140,205,639 )     $665,130,495  
                                         
Liabilities and equity
                                       
Mortgage and other notes payable
    $12,000,000       $468,105,226       $—       $—       $480,105,226  
Due to related parties
          392,954               (392,954 )      
Tenant security and escrow deposits
          12,184,527       130,263             12,314,790  
Accounts payable and accrued expenses
    1,703,527       1,537,951                   3,241,478  
Other liabilities
    3,650,000       28,286,322                     31,936,322  
                                         
Total liabilities
    17,353,527       510,506,980       130,263       (392,954 )     527,597,816  
Class E Preferred Units
    62,970,571                         62,970,571  
Total equity
    74,562,108       139,437,367       375,318       (139,812,685 )     74,562,108  
                                         
Total liabilities and equity
    $154,886,206       $649,944,347       $505,581       $(140,205,639 )     $665,130,495  
                                         


F-61


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Year Ended December 31, 2010
 
                                         
          Subsidiary
    Non-Guarantor
             
   
Issuers
   
Guarantors
   
Subsidiaries
   
Eliminations
   
Consolidated
 
 
Revenues
                                       
Rental income
    $—       $84,164,837       $325,307       $—       $84,490,144  
Tenant recoveries
          6,361,304       80,482             6,441,786  
Interest on loans to lessees
    1,384,731       3,841,115                   5,225,846  
                                         
Total revenues
    1,384,731       94,367,256       405,789             96,157,776  
Expenses
                                       
Rent and other operating expenses
    31,142       543,504                   574,646  
General and administrative
    3,645,948       7,050,071       29,103             10,725,122  
Real estate taxes
          6,394,748       80,482             6,475,230  
Depreciation
          17,658,861       194,938             17,853,799  
Loss on impairment
          96,000                   96,000  
                                         
Total expenses
    3,677,090       31,743,184       304,523             35,724,797  
                                         
Operating income
    (2,292,359 )     62,624,072       101,266             60,432,979  
                                         
Total other income and expenses
    (300,317 )     (22,070,890 )     (79,052 )           (22,450,259 )
                                         
Net income
    (2,592,676 )     40,553,182       22,214             37,982,720  
                                         
Distributions and accretion on Class E Preferred units
    (17,371,893 )                       (17,371,893 )
Net income attributable to noncontrolling interests
    (241,622 )                       (241,622 )
Equity in income (loss) of subsidiaries
    40,575,396                   (40,575,396 )      
                                         
Net income allocable to common units
    $20,369,205       $40,553,182       $22,214       $(40,575,396 )     $20,369,205  
                                         


F-62


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Year Ended December 31, 2009
 
                                         
          Subsidiary
    Non-Guarantor
             
   
Issuers
   
Guarantors
   
Subsidiaries
   
Eliminations
   
Consolidated
 
 
Revenues
                                       
Rental income
    $—       $82,139,906       $635,172       $—       $82,775,078  
Tenant recoveries
          5,977,940       77,763             6,055,703  
Interest on loans to lessees
    355,037       3,137,861                   3,492,898  
                                         
Total revenues
    355,037       91,255,707       712,935             92,323,679  
Expenses
                                       
Rent and other operating expenses
          612,185                   612,185  
General and administrative
    1,977,321       5,696,708       67,058             7,741,087  
Offering costs
    6,863,948                         6,863,948  
Real estate taxes
          6,154,013       77,763             6,231,776  
Depreciation
          17,386,677       140,979             17,527,656  
                                         
Total expenses
    8,841,269       29,849,583       285,800             38,976,652  
                                         
Operating income
    (8,486,232 )     61,406,124       427,135             53,347,027  
                                         
Total other income and expenses
    (459,317 )     (19,155,259 )     (51,820 )             (19,666,396 )
                                         
Net income
    (8,945,549 )     42,250,865       375,315             33,680,631  
                                         
Distributions and accretion on Class E Preferred units
    (14,569,875 )                         (14,569,875 )
Net income attributable to noncontrolling interests
    (221,154 )                         (221,154 )
Equity in income (loss) of subsidiaries
    42,626,180                   (42,626,180 )      
                                         
Net income allocable to common units
    $18,889,602       $42,250,865       $375,315       $(42,626,180 )     $18,889,602  
                                         


F-63


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Year Ended December 31, 2008
 
                                         
          Subsidiary
    Non-Guarantor
             
   
Issuers
   
Guarantors
   
Subsidiaries
   
Eliminations
   
Consolidated
 
 
Revenues
                                       
Rental income
    $—       $72,142,847       $—       $—       $72,142,847  
Tenant recoveries
            4,830,733                   4,830,733  
Interest on loans to lessees
    182,037       1,677,048                   1,859,085  
                                         
Total revenues
    182,037       78,650,628                   78,832,665  
Expenses
                                       
Rent and other operating expenses
    3,538       1,084,682                   1,088,220  
General and administrative
    1,839,623       4,969,172                   6,808,795  
Real estate taxes
          5,116,431                   5,116,431  
Depreciation
          14,615,770                   14,615,770  
Loss on impairment
          931,629                   931,629  
                                         
Total expenses
    1,843,161       26,717,684                   28,560,845  
                                         
Operating income
    (1,661,124 )     51,932,944                   50,271,820  
                                         
Total other income and expenses
    (2,381,631 )     (31,088,726 )                 (33,470,357 )
                                         
Income from continuing operations
    (4,042,755 )     20,844,218                   16,801,463  
Discontinued operations
          72,730                   72,730  
                                         
Net income
    (4,042,755 )     20,916,948                   16,874,193  
                                         
Distributions and accretion on Class E Preferred units
    (8,842,980 )                       (8,842,980 )
Net income attributable to noncontrolling interests
    (155,026 )                       (155,026 )
Equity in income (loss) of subsidiaries
    20,916,948                     (20,916,948 )      
                                         
Net income allocable to common units
    $7,876,187       $20,916,948       $—       $(20,916,948 )     $7,876,187  
                                         


F-64


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2010
 
                                         
          Subsidiary
    Non-Guarantor
             
   
Issuers
   
Guarantors
   
Subsidiaries
   
Eliminations
   
Consolidated
 
 
Net cash (used in) provided by operating activities
    $(70,625,627 )     $122,178,599       $3,127,284       $—       $54,680,256  
Net cash used in investing activities
    (2,734,426 )     (60,167,884 )     (12,214,337 )           (75,116,647 )
Financing activities
                                     
Borrowings of debt
          433,677,230       9,112,340             442,789,570  
Repayment of debt
    (12,000,000 )     (470,514,925 )     (7,765 )           (482,522,690 )
Payment of financing costs
    (100,000 )     (10,443,495 )     (24,436 )           (10,567,931 )
Payment for swap termination
          (3,380,160 )                 (3,380,160 )
Capital contributions
    223,866,121                         223,866,121  
Redemption of Class E Preferred Units and warrants
    (92,001,451 )                       (92,001,451 )
Redemption of Class F units
          (23,602,649 )                 (23,602,649 )
Cash distributions to partners
    (34,534,439 )     (2,124,013 )                 (36,658,452 )
                                         
Net cash provided by (used in) financing activities
    85,230,231       (76,388,012 )     9,080,139             17,922,358  
                                         
Net increase (decrease) in cash and cash equivalents
    11,870,178       (14,377,297 )     (6,914 )           (2,514,033 )
Cash and cash equivalents:
                                       
Beginning of year
    256,598       15,285,909                   15,542,507  
                                         
End of year
    $12,126,776       $908,612       $(6,914 )     $—       $13,028,474  
                                         


F-65


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2009
 
                                         
          Subsidiary
    Non-Guarantor
             
   
Issuers
   
Guarantors
   
Subsidiaries
   
Eliminations
   
Consolidated
 
 
Net cash provided by operating activities
    $16,614,404       $18,177,888       $5,250,000       $—       $40,042,292  
Net cash used in investing activities
    (7,160,265 )     (26,082,630 )     (5,250,000 )           (38,492,895 )
Financing activities
                                       
Borrowings of debt
          33,026,073       2,625,000             35,651,073  
Repayment of debt
    (1,500,000 )     (14,966,756 )     (2,625,000 )           (19,091,756 )
Payment of financing costs
          (102,803 )                 (102,803 )
Proceeds from issuance of warrants
    8,399,117                         8,399,117  
Net proceeds from issuance of Class E Preferred Units
    17,898,975                         17,898,975  
Cash distributions to partners
    (33,695,587 )     (4,427,402 )                 (38,122,989 )
                                         
Net cash (used in) provided by financing activities
    (8,897,495 )     13,529,112                   4,631,617  
                                         
Net increase in cash and cash equivalents
    556,644       5,624,370                   6,181,014  
Cash and cash equivalents:
                                       
Beginning of year
    (300,046 )     9,661,539                   9,361,493  
                                         
End of year
    $256,598       $15,285,909       $—       $—       $15,542,507  
                                         


F-66


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2008
 
                                         
          Subsidiary
    Non-Guarantor
             
   
Issuers
   
Guarantors
   
Subsidiaries
   
Eliminations
   
Consolidated
 
 
Net cash provided by operating activities
    $22,563,622       $9,484,682       $—       $—       $32,048,304  
Net cash used in investing activities
          (89,074,649 )                 (89,074,649 )
Financing activities
                                     
Borrowings of debt
          80,915,249                   80,915,249  
Repayment of debt
    (1,500,000 )     (2,718,338 )                 (4,218,338 )
Proceeds from issuance of warrants
    1,349,494                         1,349,494  
Net proceeds from issuance of Class E Preferred Units
    1,813,836                         1,813,836  
Cash distributions to partners
    (24,625,972 )     (5,223,778 )                 (29,849,750 )
                                         
Net cash (used in) provided by financing activities
    (22,962,642 )     72,973,133                   50,010,491  
                                         
Net decrease in cash and cash equivalents
    (399,020 )     (6,616,834 )                 (7,015,854 )
Cash and cash equivalents:
                                       
Beginning of year
    98,974       16,278,373                   16,377,347  
                                         
End of year
    $(300,046 )     $9,661,539       $—       $—       $9,361,493  
                                         


F-67


Table of Contents

 
AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
                                                                                                     
                                                                              Life on Which
                                    Costs Capitalized Subsequent
    Gross Amount Carried at
                Depreciation
    Type
                  Initial Cost to Company     to Acquisition     December 31, 2010 (g)                 in Statement
    of
                        Buildings &
          Impairment /
          Buildings &
    Accumulated
    Year of
    Date
    of Operations
Description
  Asset     Encumbrances     City   State   Land     Improvements     Improvements     Dispositions     Land     Improvements     Depreciation     Construction     Acquired     Computed
 
SunBridge Care/Rehab-Broadway
     (a )      (2 )   Methuen   MA   $ 31,469     $ 495,552     $     $ (130,000 )   $ 31,469     $ 365,552     $ (155,360 )     1910       1993     40 years
SunBridge—Colonial Heights
     (a )      (2 )   Lawrence   MA     63,160       958,681             (225,000 )     63,160       733,681       (311,815 )     1963       1993     40 years
SunBridge—Fall River
     (c )      (2 )   Fall River   MA     90,707       1,308,677             (1,308,677 )     90,707                         1993     40 years
SunBridge Care Center—Glenwood
     (a )      (2 )   Lowell   MA     82,483       1,210,652             (252,500 )     82,483       958,152       (407,210 )     1964       1993     40 years
SunBridge—Hammond House
     (a )      (2 )   Worchester   MA     42,062       663,598       488,598       (663,598 )     42,062       488,598       (207,654 )     1965       1993     40 years
SunBridge for North Reading
     (a )      (2 )   North Reading   MA     113,195       1,567,397             (252,500 )     113,195       1,314,897       (558,831 )     1966       1993     40 years
Robbin House Nursing and Rehab
     (c )      (2 )   Quincy   MA     66,000       1,051,668             (1,051,668 )     66,000                         1993     40 years
SunBridge Care Center—Rosewood
     (a )      (2 )   Fall River   MA     31,893       512,984             (142,500 )     31,893       370,484       (157,455 )     1882       1993     40 years
SunBridge Care/Rehab-Sandalwood
     (a )      (2 )   Oxford   MA     64,435       940,982       497,782       (192,500 )     64,435       1,246,264       (345,474 )     1966       1993     40 years
SunBridge—Spring Valley
     (a )      (2 )   Worchester   MA     71,084       1,030,725             (205,000 )     71,084       825,725       (350,933 )     1960       1993     40 years
SunBridge Care/Rehab-Town Manor
     (c )      (2 )   Lawrence   MA     89,790       1,305,518             (1,305,518 )     89,790                         1993     40 years
SunBridge Care/Rehab-Woodmill
     (a )      (2 )   Lawrence   MA     61,210       946,028             (235,000 )     61,210       711,028       (302,187 )     1965       1993     40 years
SunBridge Care/Rehab-Worcester
     (c )      (2 )   Worchester   MA     92,512       1,374,636             (1,374,636 )     92,512                         1993     40 years
Countryside Community
     (a )      (2 )   South Haven   MI     221,000       4,239,161       12,959             221,000       4,252,120       (705,011 )     1975       2005     40 years
Pepin Manor
     (a )      (2 )   Pepin   WI     318,000       1,569,959       (12,959 )           318,000       1,557,000       (263,494 )     1978       2005     40 years
Highland Health Care Center
     (a )      (2 )   Highland   IL     189,921       1,723,523                   189,921       1,723,523       (306,689 )     1963       2005     40 years
Nebraska Skilled Nursing/Rehab
     (a )      (2 )   Omaha   NE     211,000       6,694,584             (1,510 )     209,490       6,694,584       (1,258,022 )     1971       2005     40 years
Casa Real
     (a )      (2 )   Santa Fe   NM     1,029,800       2,692,295       213,902             1,029,800       2,906,197       (574,086 )     1985       2005     40 years
Clayton Nursing and Rehab
     (a )      (2 )   Clayton   NM     41,000       790,476                   41,000       790,476       (193,131 )     1960       2005     40 years
Country Cottage Care/Rehab Center
     (a )      (2 )   Hobbs   NM     9,000       671,536                   9,000       671,536       (191,863 )     1963       2005     40 years
Bloomfield Nursing/Rehab Center
     (a )      (2 )   Bloomfield   NM     343,800       4,736,296                   343,800       4,736,296       (807,094 )     1985       2005     40 years
Espanola Valley Center
     (a )      (2 )   Espanola   NM     216,000       4,143,364                   216,000       4,143,364       (779,524 )     1984       2005     40 years
Sunshine Haven Lordsburg
     (a )      (2 )   Lordsburg   NM     57,041       1,881,927                   57,041       1,881,927       (296,396 )     1972       2005     40 years
Silver City Care Center
     (a )      (2 )   Silver City   NM     305,000       5,843,505                   305,000       5,843,505       (967,107 )     1984       2005     40 years
Raton Nursing and Rehab Center
     (a )      (2 )   Raton   NM     128,000       1,509,456                   128,000       1,509,456       (355,369 )     1985       2005     40 years
Red Rocks Care Center
     (a )      (2 )   Gallup   NM     329,000       3,952,779                   329,000       3,952,779       (711,360 )     1978       2005     40 years
Heritage Villa Nursing/Rehab
     (a )      (2 )   Dayton   TX     18,000       435,568       9,400             18,000       444,968       (91,614 )     1964       2005     40 years
Wellington Oaks Nursing/Rehab
     (a )      (2 )   Ft. Worth   TX     137,000       1,147,400       (9,400 )           137,000       1,138,000       (245,095 )     1963       2005     40 years
Seven Oaks Nursing and Rehab
     (a )      (2 )   Bonham   TX     63,000       2,583,389                   63,000       2,583,389       (460,092 )     1970       2005     40 years
Birchwood Nursing and Rehab
     (a )      (2 )   Cooper   TX     96,000       2,726,580       8,304             96,000       2,734,884       (475,340 )     1966       2005     40 years
Smith Nursing and Rehab
     (a )      (2 )   Wolfe City   TX     49,000       1,010,304       (8,304 )           49,000       1,002,000       (191,906 )     1946       2005     40 years
Blanco Villa Nursing and Rehab
     (a )      (2 )   San Antonio   TX     341,847       1,931,216       951,592             341,847       2,882,808       (443,687 )     1969       2005     40 years
Forest Hill Nursing Center
     (a )           Ft. Worth   TX     87,904       1,764,129             (1,852,033 )                       1971       2005     40 years
Garland Nursing and Rehab
     (a )      (2 )   Garland   TX     56,509       1,058,409       191,111             56,509       1,249,520       (225,703 )     1964       2005     40 years
Hillcrest Nursing and Rehab
     (a )      (2 )   Wylie   TX     209,992       2,683,768       5,438             209,992       2,689,206       (476,581 )     1975       2005     40 years
Mansfield Nursing and Rehab
     (a )      (2 )   Mansfield   TX     486,958       2,142,550       (17,723 )           486,958       2,124,827       (404,319 )     1964       2005     40 years
Westridge Nursing and Rehab
     (a )      (2 )   Lancaster   TX     625,790       1,847,633       (15,270 )           625,790       1,832,363       (410,108 )     1973       2005     40 years
Clifton Nursing and Rehab
     (a )      (2 )   Clifton   TX     125,000       2,974,643                   125,000       2,974,643       (567,727 )     1995       2005     40 years
Brownwood Nursing and Rehab
     (a )      (2 )   Brownwood   TX     140,000       3,463,711       10,284             140,000       3,473,995       (599,581 )     1968       2005     40 years
Irving Nursing and Rehab
     (a )      (2 )   Irving   TX     137,000       1,248,284       (10,284 )           137,000       1,238,000       (247,394 )     1972       2005     40 years
Stanton Nursing and Rehab
     (a )      (2 )   Stanton   TX     261,000       1,017,599       11,707             261,000       1,029,306       (197,262 )     1972       2005     40 years
Valley Mills Nursing and Rehab
     (a )      (2 )   Valley Mills   TX     34,000       1,091,210       (8,977 )           34,000       1,082,233       (200,522 )     1971       2005     40 years
Hometown Care Center
     (a )           Moody   TX     13,000       328,263             (341,263 )                       1960       2005     40 years
Shuksan Healthcare Center
     (a )      (2 )   Bellingham   WA     61,000       491,085       1,983,432             61,000       2,474,517       (190,602 )     1965       2005     40 years
Orange Villa Nursing and Rehab
     (a )      (2 )   Orange   TX     97,500       1,948,490       17,468             97,500       1,965,958       (360,449 )     1973       2005     40 years
Pinehurst Nursing and Rehab
     (a )      (2 )   Orange   TX     98,500       2,072,051       22,567             98,500       2,094,618       (397,450 )     1955       2005     40 years
Wheeler Nursing and Rehab
     (a )      (2 )   Wheeler   TX     17,000       1,369,290                   17,000       1,369,290       (267,284 )     1982       2005     40 years
North Pointe Nursing and Rehab
     (a )      (2 )   Watauga   TX     1,061,000       3,845,890                   1,061,000       3,845,890       (653,486 )     1999       2005     40 years
ABC Health Center
     (a )      (2 )   Harrisonville   MO     143,500       1,922,391       120,802             143,500       2,043,193       (331,744 )     1970       2005     40 years
Camden Health Center
     (a )      (2 )   Harrisonville   MO     189,000       2,531,961       (20,961 )           189,000       2,511,000       (408,394 )     1977       2005     40 years
Cedar Valley Health Center
     (a )      (2 )   Rayton   MO     252,000       3,375,981       (13,026 )           252,000       3,362,955       (603,031 )     1978       2005     40 years
Monett Healthcare Center
     (a )      (2 )   Monett   MO     259,000       3,469,761       (24,261 )           259,000       3,445,500       (589,519 )     1976       2005     40 years


F-68


Table of Contents

                                                                                                     
                                                                              Life on Which
                                    Costs Capitalized Subsequent
    Gross Amount Carried at
                Depreciation
    Type
                  Initial Cost to Company     to Acquisition     December 31, 2010 (g)                 in Statement
    of
                        Buildings &
          Impairment /
          Buildings &
    Accumulated
    Year of
    Date
    of Operations
Description
  Asset     Encumbrances     City   State   Land     Improvements     Improvements     Dispositions     Land     Improvements     Depreciation     Construction     Acquired     Computed
 
White Ridge Health Center
     (a )      (2 )   Lee’s Summit   MO     292,250       3,914,964       2,174             292,250       3,917,138       (653,116 )     1986       2005     40 years
The Orchards Rehab/Care Center
     (a )      (2 )   Lewiston   ID     201,000       4,319,316       35,324             201,000       4,354,640       (842,587 )     1958       2005     40 years
SunBridge for Payette
     (a )      (2 )   Payette   ID     179,000       3,165,530       (26,331 )           179,000       3,139,199       (471,310 )     1964       2005     40 years
Magic Valley Manor-Assisted Living
     (b )      (2 )   Wendell   ID     177,000       405,331       1,005,334             177,000       1,410,665       (107,671 )     1911       2005     40 years
McCall Rehab and Living Center
     (a )      (2 )   McCall   ID     213,000       675,976       (5,624 )           213,000       670,352       (124,288 )     1965       2005     40 years
Menlo Park Health Care
     (a )      (2 )   Portland   OR     112,000       2,205,297                   112,000       2,205,297       (480,167 )     1959       2005     40 years
Burton Care Center
     (a )      (2 )   Burlington   WA     115,000       1,169,629                   115,000       1,169,629       (198,964 )     1930       2005     40 years
Columbia View Care Center
     (a )      (2 )   Cathlamet   WA     49,200       504,900                   49,200       504,900       (101,682 )     1965       2005     40 years
Pinehurst Park Terrace
     (a )           Seattle   WA           360,236             (360,236 )                       1955       2005     40 years
Grandview Healthcare Center
     (a )      (2 )   Grandview   WA     19,300       1,155,216       163,826             19,300       1,319,041       (274,822 )     1964       2005     40 years
Hillcrest Manor
     (a )      (2 )   Sunnyside   WA     102,000       1,638,826       259,309             102,000       1,898,135       (350,221 )     1970       2005     40 years
Evergreen Foothills Center
     (a )      (2 )   Phoenix   AZ     500,000       4,537,644                   500,000       4,537,644       (991,956 )     1997       2005     40 years
Evergreen Hot Springs Center
     (a )      (2 )   Hot Springs   MT     103,500       1,942,861       19,412             103,500       1,962,273       (330,310 )     1963       2005     40 years
Evergreen Polson Center
     (a )      (2 )   Polson   MT     121,000       2,357,612       (19,412 )           121,000       2,338,200       (423,288 )     1971       2005     40 years
Evergreen Sun City Center
     (a )      (2 )   Sun City   AZ     476,231       5,697,720       60,161             476,231       5,757,881       (1,026,236 )     1985       2005     40 years
Sunset Gardens at Mesa
     (b )      (2 )   Mesa   AZ     123,000       1,640,673       (13,547 )           123,000       1,627,126       (278,318 )     1974       2005     40 years
Evergreen Mesa Christian Center
     (a )      (2 )   Mesa   AZ     466,000       6,231,061       (46,614 )     (615,000 )     466,000       5,569,447       (1,132,671 )     1973       2005     40 years
Evergreen The Dalles Center
     (a )      (2 )   The Dalles   OR     200,000       3,831,789       91,952             200,000       3,923,741       (621,833 )     1964       2005     40 years
Evergreen Vista Health Center
     (a )      (2 )   LaGrande   OR     281,000       4,783,790       248,354             281,000       5,032,144       (754,391 )     1961       2005     40 years
Whitman Health and Rehab Center
     (a )      (2 )   Colfax   WA     231,000       6,271,162       38,289             231,000       6,309,451       (952,131 )     1985       2005     40 years
Fountain Retirement Hotel
     (b )      (2 )   Youngtown   AZ     101,300       1,939,835       60,000             101,300       1,999,835       (364,404 )     1971       2005     40 years
Gilmer Care Center
     (a )      (2 )   Gilmer   TX     257,000       2,992,894       285,320             257,000       3,278,214       (525,138 )     1967       2005     40 years
Columbus Nursing and Rehab Center
     (a )      (2 )   Columbus   WI     352,000       3,476,920                   352,000       3,476,920       (556,076 )     1950       2005     40 years
San Juan Rehab and Care Center
     (a )      (2 )   Anacortes   WA     625,000       1,184,855       2,041,630             625,000       3,226,485       (434,490 )     1965       2005     40 years
Infinia at Faribault
     (a )      (2 )   Faribault   MN     70,000       1,484,598       102,124             70,000       1,586,722       (299,989 )     1958       2005     40 years
Infinia at Owatonna
     (a )      (2 )   Owatonna   MN     125,000       2,321,296       (19,308 )           125,000       2,301,988       (404,188 )     1963       2005     40 years
Infinia at Willmar
     (a )      (2 )   Wilmar   MN     70,000       1,341,155       (11,156 )           70,000       1,329,999       (241,644 )     1998       2005     40 years
Infinia at Florence Heights
     (a )      (2 )   Omaha   NE     413,000       3,516,247       4,353             413,000       3,520,600       (702,614 )     1999       2005     40 years
Infinia at Ogden
     (a )      (2 )   Ogden   UT     233,800       4,478,450       600,306             233,800       5,078,756       (731,670 )     1977       2005     40 years
Prescott Manor Nursing Center
     (a )      (2 )   Prescott   AR     43,500       1,461,860       83,303             43,500       1,545,163       (334,126 )     1965       2005     40 years
Star City Nursing Center
     (a )      (2 )   Star City   AR     28,000       1,068,891       80,123             28,000       1,149,014       (188,464 )     1969       2005     40 years
Westview Manor of Peabody
     (a )      (2 )   Peabody   KS     22,000       502,177                   22,000       502,177       (88,314 )     1963       2005     40 years
Orchard Grove Extended Care Center
     (a )      (2 )   Benton Harbor   MI     166,000       3,185,496       261,000             166,000       3,446,496       (562,899 )     1971       2005     40 years
Marysville Care Center
     (a )           Marysville   CA     281,000       1,319,608             (1,600,608 )                       1965       2005     40 years
Yuba City Care Center
     (a )           Yuba City   CA     177,385       2,129,584             (2,306,969 )                       1964       2005     40 years
Lexington Care Center
     (a )      (2 )   Lexington   MO     151,000       2,943,170       325,142             151,000       3,268,312       (547,569 )     1970       2005     40 years
Twin Falls Care Center
     (a )      (2 )   Twin Falls   ID     448,000       5,144,793                   448,000       5,144,793       (861,945 )     1961       2005     40 years
Gordon Lane Care Center
     (a )      (2 )   Fullerton   CA     2,982,000       3,648,346                   2,982,000       3,648,346       (601,035 )     1966       2005     40 years
Sierra View Care Center
     (a )      (2 )   Baldwin Park   CA     868,400       1,748,141       6,377             868,400       1,754,518       (328,218 )     1938       2005     40 years
Villa Maria Care Center
     (a )           Long Beach   CA     139,600       766,778             (906,378 )                       1951       2005     40 years
High Street Care Center
     (a )      (2 )   Oakland   CA     246,000       684,695       11,776             246,000       696,471       (119,939 )     1961       2005     40 years
MacArthur Care Center
     (a )      (2 )   Oakland   CA     246,000       1,415,776       (11,776 )           246,000       1,404,000       (327,535 )     1960       2005     40 years
Pomona Vista Alzheimer’s Center
     (a )      (2 )   Pomona   CA     403,000       954,853                   403,000       954,853       (183,337 )     1959       2005     40 years
Rose Convalescent Hospital
     (a )      (2 )   Baldwin Park   CA     1,308,000       486,043                   1,308,000       486,043       (108,342 )     1963       2005     40 years
Country Oaks Nursing Center
     (a )      (2 )   Pomona   CA     1,393,000       2,426,180                   1,393,000       2,426,180       (411,755 )     1964       2005     40 years
Evergreen Nursing/Rehab Center
     (a )      (2 )   Effingham   IL     317,388       3,461,794                   317,388       3,461,794       (597,007 )     1974       2005     40 years
Deseret at Hutchinson
     (a )      (2 )   Hutchinson   KS     180,000       2,546,991                   180,000       2,546,991       (444,460 )     1963       2005     40 years
Northridge Healthcare/Rehab
     (a )      (2 )   Little Rock   AR     465,000       3,011,597       55,320             465,000       3,066,917       (739,800 )     1969       2005     40 years
Doctors Nursing and Rehab Center
     (a )      (2 )   Salem   IL     125,000       4,663,792       900,001             125,000       5,563,793       (813,829 )     1972       2005     40 years
Woodland Hills Health/Rehab
     (a )      (2 )   Little Rock   AR     270,000       4,006,007                   270,000       4,006,007       (573,775 )     1979       2005     40 years
North Richland Hills
     (a )           North Richland Hills   TX     980,458             5,067,466       (6,047,924 )                       2007       2005     40 years
Chenal Heights
     (a )      (2 )   Little Rock   AR     1,411,446             7,279,170             1,411,446       7,279,170       (779,257 )     2008       2006     40 years
Willis Nursing and Rehab
     (a )      (2 )   Willis   TX     212,000       2,407,367                   212,000       2,407,367       (318,112 )     1975       2006     40 years
Blanchette Place Care Center
     (a )      (2 )   St. Charles   MO     1,300,000       10,777,312       8,579             1,300,000       10,785,891       (1,262,366 )     1994       2006     40 years
Cathedral Gardens Care Center
     (a )      (2 )   St. Louis   MO     1,600,000       9,524,876       64,333             1,600,000       9,589,209       (1,152,494 )     1979       2006     40 years
Heritage Park Skilled Care
     (a )      (2 )   Rolla   MO     1,200,000       7,840,918       59,900             1,200,000       7,900,818       (900,973 )     1993       2006     40 years
Oak Forest Skilled Care
     (a )      (2 )   Ballwin   MO     550,000       3,995,129       29,766             550,000       4,024,895       (482,989 )     2004       2006     40 years
Richland Care and Rehab
     (a )      (2 )   Olney   IL     350,000       2,484,264                   350,000       2,484,264       (336,295 )     2004       2006     40 years
Bonham Nursing and Rehab
     (a )      (2 )   Bonham   TX     76,000       1,129,849                   76,000       1,129,849       (141,112 )     1969       2006     40 years

F-69


Table of Contents

                                                                                                     
                                                                              Life on Which
                                    Costs Capitalized Subsequent
    Gross Amount Carried at
                Depreciation
    Type
                  Initial Cost to Company     to Acquisition     December 31, 2010 (g)                 in Statement
    of
                        Buildings &
          Impairment /
          Buildings &
    Accumulated
    Year of
    Date
    of Operations
Description
  Asset     Encumbrances     City   State   Land     Improvements     Improvements     Dispositions     Land     Improvements     Depreciation     Construction     Acquired     Computed
 
Columbus Nursing and Rehab
     (a )      (2 )   Columbus   TX     150,000       1,808,552                   150,000       1,808,552       (240,436 )     1974       2006     40 years
Denison Nursing and Rehab
     (a )      (2 )   Denison   TX     178,000       1,945,000                   178,000       1,945,000       (244,184 )     1958       2006     40 years
Falfurrias Nursing and Rehab
     (a )      (2 )   Falfurias   TX     92,000       1,065,000                   92,000       1,065,000       (145,673 )     1974       2006     40 years
Houston Nursing and Rehab
     (a )      (2 )   Houston   TX     228,000       2,451,893                   228,000       2,451,893       (307,071 )     1976       2006     40 years
Kleburg County Nursing/Rehab
     (a )      (2 )   Kingsville   TX     315,000       3,688,676                   315,000       3,688,676       (461,642 )     1947       2006     40 years
Terry Haven Nursing and Rehab
     (a )      (2 )   Mount Vernon   TX     180,000       1,970,861                   180,000       1,970,861       (268,797 )     2004       2006     40 years
Deseret at Mansfield
     (b )      (2 )   Mansfield   OH     146,000       2,689,968       15,748             146,000       2,705,716       (303,991 )     1980       2006     40 years
Clarkston Care Center
     (a )      (2 )   Clarkston   WA     161,633       7,038,367       379,678             161,633       7,418,045       (1,021,418 )     1970       2006     40 years
Highland Terrace Nursing Center
     (a )      (2 )   Camas   WA     592,776       3,921,159       466,188             592,776       4,387,347       (710,452 )     1970       2006     40 years
Richland Rehabilitation Center
     (a )      (2 )   Richland   WA     693,000       9,307,000       145,819             693,000       9,452,819       (1,041,376 )     2004       2006     40 years
Evergreen Milton-Freewater Center
     (a )      (2 )   Milton Freewater   OR     700,000       5,403,570                   700,000       5,403,570       (656,622 )     1965       2006     40 years
Douglas Rehab and Care Center
     (a )      (2 )   Matoon   IL     250,000       2,390,779             (13,246 )     250,000       2,377,533       (288,233 )     1963       2006     40 years
Hillside Living Center
     (a )      (2 )   Yorkville   IL     560,000       3,073,603             (3,168 )     560,000       3,070,436       (397,561 )     1963       2006     40 years
Arbor View Nursing / Rehab Center
     (a )      (2 )   Zion   IL     147,000       5,235,290       142,766       (12,556 )     147,000       5,365,500       (591,422 )     1970       2006     40 years
Ashford Hall
     (a )      (2 )   Irving   TX     1,746,000       11,418,567       113,706       (142,702 )     1,746,000       11,389,571       (1,332,568 )     1964       2006     40 years
Belmont Nursing and Rehab Center
     (a )      (2 )   Madison   WI     480,000       1,861,061       6,207             480,000       1,867,268       (263,247 )     1974       2006     40 years
Blue Ash Nursing and Rehab Center
     (a )      (2 )   Cincinnati   OH     125,000       6,278,450       447,530             125,000       6,725,980       (884,229 )     1969       2006     40 years
West Chester Nursing/Rehab Center
     (a )      (2 )   West Chester   OH     100,000       5,663,460       368,689             100,000       6,032,149       (788,653 )     1965       2006     40 years
Wilmington Nursing/Rehab Center
     (a )      (2 )   Willmington   OH     125,000       6,078,450       472,389             125,000       6,550,839       (855,492 )     1951       2006     40 years
Extended Care Hospital of Riverside
     (a )      (2 )   Riverside   CA     1,091,000       5,646,826             (26,375 )     1,091,000       5,620,451       (986,069 )     1967       2006     40 years
Heritage Manor
     (a )      (2 )   Monterey Park   CA     1,585,508       9,274,154             (23,200 )     1,585,508       9,250,954       (1,438,143 )     1965       2006     40 years
French Park Care Center
     (a )      (2 )   Santa Ana   CA     1,076,447       5,983,614       596,442             1,076,447       6,580,056       (751,009 )     1967       2006     40 years
North Valley Nursing Center
     (a )      (2 )   Tujunga   CA     613,800       5,031,473             (25,382 )     613,800       5,006,091       (694,919 )     1967       2006     40 years
Villa Rancho Bernardo Care Center
     (a )      (2 )   San Diego   CA     1,425,347       9,652,911       65,350       (57,067 )     1,425,347       9,661,194       (1,158,654 )     1994       2006     40 years
Austin Nursing Center
     (a )      (2 )   Austin   TX     1,501,040       4,504,643       (28,091 )           1,501,040       4,476,552       (453,696 )     2007       2007     40 years
Dove Hill Care Center and Villas
     (a )      (2 )   Hamilton   TX     58,397       5,781,296                   58,397       5,781,296       (546,194 )     1998       2007     40 years
Brighten at Medford
     (a )      (2 )   Medford   MA     2,365,610       6,612,915       279,220             2,365,610       6,892,135       (760,794 )     1978       2007     40 years
Brighten at Ambler
     (a )      (2 )   Ambler   PA     370,010       5,111,673       (1,035,832 )             370,010       4,075,841       (440,750 )     1963       2007     40 years
Brighten at Broomall
     (a )      (2 )   Broomall   PA     607,870       3,930,013       590,503             607,870       4,520,516       (486,790 )     1955       2007     40 years
Brighten at Bryn Mawr
     (a )      (2 )   Bryn Mawr   PA     708,300       6,352,474       270,668             708,300       6,623,142       (715,261 )     1972       2007     40 years
Brighten at Julia Ribaudo
     (a )      (2 )   Lake Ariel   PA     369,050       7,559,765       320,189             369,050       7,879,954       (863,484 )     1980       2007     40 years
Good Samaritan Nursing Home
     (a )      (2 )   Avon   OH     393,813       8,856,210       108,495             393,813       8,964,705       (1,021,738 )     1964       2007     40 years
Belleville Illinois
     (a )      (2 )   Belleville   IL     670,481       3,431,286                   670,481       3,431,286       (316,664 )     1978       2007     40 years
Homestead Various Leases (f)
     (a )      (2 )       TX     345,197       4,352,982       5,503             345,197       4,358,485       (426,639 )             2007     40 years
Byrd Haven Nursing Home
     (a )      (2 )   Searcy   AR     772,501       2,413,388       748,914             772,501       3,162,302       (217,762 )     1961       2008     40 years
Evergreen Arvin Healthcare
     (a )      (2 )   Arvin   CA     900,000       4,764,928       758,102             1,020,441       5,402,589       (358,175 )     1984       2008     40 years
Evergreen Bakersfield Healthcare
     (a )      (2 )   Bakersfield   CA     1,000,000       12,154,112       1,760,333             1,133,824       13,780,621       (823,504 )     1987       2008     40 years
Evergreen Lakeport Healthcare
     (a )      (2 )   Lakeport   CA     1,100,000       5,237,033       848,046             1,247,206       5,937,873       (402,652 )     1987       2008     40 years
New Hope Care Center
     (a )      (2 )   Tracy   CA     1,900,000       10,293,920       1,631,837             2,154,265       11,671,491       (710,325 )     1987       2008     40 years
Olive Ridge Care Center
     (a )      (2 )   Oroville   CA     800,000       8,609,470       1,259,211             907,059       9,761,622       (630,582 )     1987       2008     40 years
Twin Oaks Health & Rehab
     (a )      (2 )   Chico   CA     1,300,000       8,397,558       1,297,764             1,473,971       9,521,351       (633,441 )     1988       2008     40 years
Evergreen Health & Rehab
     (a )      (2 )   LaGrande   OR     1,400,000       808,374       295,533             1,587,353       916,554       (77,183 )     1975       2008     40 years
Evergreen Bremerton Health & Rehab
     (a )      (2 )   Bremerton   WA     650,000       1,366,315       269,831             736,985       1,549,160       (102,387 )     1969       2008     40 years
Four Fountains
     (a )      (2 )   Belleville   IL     989,489       5,007,411                   989,489       5,007,411       (306,137 )     1972       2008     40 years
Brookside Health & Rehab
     (a )      (2 )   Little Rock   AR     750,690       4,421,289       1,395,023             750,690       5,816,312       (342,731 )     1969       2008     40 years
Skilcare Nursing Center
     (a )      (2 )   Jonesboro   AR     417,050       7,007,007                   417,050       7,007,007       (464,260 )     1973       2008     40 years
Stoneybrook Health & Rehab Center
     (a )      (2 )   Benton   AR     250,230       3,170,134                   250,230       3,170,134       (225,932 )     1968       2008     40 years
Trumann Health & Rehab
     (a )      (2 )   Trumann   AR     166,820       3,587,185                   166,820       3,587,185       (234,968 )     1971       2008     40 years
Deseret at McPherson
     (a )      (2 )   McPherson   KS     92,000       1,874,921                   92,000       1,874,921       (112,646 )     1970       2008     40 years
Mission Nursing Center
     (a )      (2 )   Riverside   CA     230,000       1,209,977                   230,000       1,209,977       (74,749 )     1957       2008     40 years
New Byrd Haven Nursing Home
     (a )      (2 )   Searcy   AR           10,213,112                         10,213,112       (471,615 )     2009       2009     40 years
Evergreen Health & Rehab of Petaluma
     (a )      (2 )   Petaluma   CA     748,668       2,459,910                   748,668       2,459,910       (165,331 )     1969       2009     40 years
Evergreen Mountain View Health & Rehab
     (a )      (2 )   Carson City   NV     3,454,723       5,942,468                   3,454,723       5,942,468       (287,022 )     1977       2009     40 years
Little Rock Health and Rehab
     (a )      (1 )   Little Rock   AR     471,169       4,778,831       714,336             471,169       5,493,168       (281,236 )     1971       2009     40 years
Hidden Acres Health Care
     (a )           Mount Pleasant   TN     67,413       3,312,587                   67,413       3,312,587       (51,346 )     1979       2010     40 years
Community Care and Rehab
     (a )      (1 )   Riverside   CA     1,648,067       9,851,933                   1,648,067       9,851,933       (54,681 )     1965       2010     40 years
Heritage Gardens of Portageville
     (a )      (2 )   Portageville   MO     223,658       3,088,802                   223,658       3,088,802       (21,731 )     1995       2010     40 years
Heritage Gardens of Greenville
     (a )      (2 )   Greenville   MO     118,925       2,218,775                   118,925       2,218,775       (15,970 )     1990       2010     40 years

F-70


Table of Contents

                                                                                                     
                                                                              Life on Which
                                    Costs Capitalized Subsequent
    Gross Amount Carried at
                Depreciation
    Type
                  Initial Cost to Company     to Acquisition     December 31, 2010 (g)                 in Statement
    of
                        Buildings &
          Impairment /
          Buildings &
    Accumulated
    Year of
    Date
    of Operations
Description
  Asset     Encumbrances     City   State   Land     Improvements     Improvements     Dispositions     Land     Improvements     Depreciation     Construction     Acquired     Computed
 
Heritage Gardens of Senath
     (a )      (2 )   Senath   MO     108,843       2,773,194       159,590             108,843       2,932,785       (20,543 )     1980       2010     40 years
Heritage Gardens of Senath South
     (a )      (2 )   Senath   MO     72,805       1,854,998                   72,805       1,854,998       (13,592 )     1980       2010     40 years
The Carrington
     (a )      (2 )   Lynchburg   VA     705,888       4,294,112                   705,888       4,294,112       (27,603 )     1994       2010     40 years
Arma Care Center
     (a )      (2 )   Arma   KS     57,452       2,897,772                   57,452       2,897,772             1970       2010     40 years
Great Bend Health & Rehab Center
     (a )      (2 )   Great Bend   KS     111,482       4,588,518                   111,482       4,588,518             1965       2010     40 years
Maplewood at Norwalk
     (b )     (2 )   Norwalk   CT     1,589,950       1,010,050       197,189             1,589,950       1,207,239             1983       2010     40 years
Carrizo Springs Nursing & Rehab
     (a )      (2 )   Carrizo Springs   TX     45,317       1,954,683                   45,317       1,954,683             1965       2010     40 years
Maplewood at Orange
     (b )      (2 )   Orange   CT     1,133,533       11,155,287                   1,133,533       11,155,287             1999       2010     40 years
Aviv Asset Management
     (d )           Chicago   IL                 377,544                   377,544       (129,892 )                    
Skagit Aviv
     (e )           Mt. Vernon   WA                 396,702                   396,702                            
                                                                                                     
                            $ 76,935,771     $ 597,669,579     $ 39,341,658     $ (21,674,715 )   $ 76,466,020     $ 615,806,273     $ (75,948,944 )                    
                                                                                                     
 
Assets under direct financing leases
 
                                                                                 
    Type
                          Gross Amount
       
    of
              Initial Cost to
  Accretion/
  Impairment/
  Carried at
  Year of
  Date
Description
  Asset   Encumbrances   City   State   Company   Amortization   Dispositions   December 31, 2010   Construction   Acquired
 
Fountain Lake
     (a )      (2 )     Hot Springs       AR     $ 10,418,738     $ 358,446     $     $ 10,777,184       2007       2008  
                                                                                 
                                    $ 10,418,738     $ 358,446     $     $ 10,777,184                  
                                                                                 
 
 
(a) Skilled Nursing Facilities (SNFs)
 
(b) Assisted Living Facilities (ALFs)
 
(c) Vacant Land
 
(d) Assets relating to corporate office space
 
(e) Developmental asset
 
(f) Includes six properties all located in Texas
 
(g) The aggregate cost for federal income tax purposes of the real estate as of December 31, 2010 is $598,846,000 (unaudited)
 
     
     
Encumbrances:
  (1) Standalone first mortgage
     
    (2) Aviv primary credit facility (GE credit facility)

F-71


Table of Contents

 
AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
                         
    For the Years Ended December 31,  
    2010     2009     2008  
 
Reconciliation of real estate:
                       
Carrying cost:
                       
Balance at beginning of period
  $ 636,409,268     $ 606,691,800     $ 505,585,195  
Additions during period:
                       
Acquisitions
    63,005,000       17,856,000       103,521,125  
Development of rental properties and capital expenditures
    7,815,209       11,861,468       8,630,503  
Dispositions:
                       
Sale of assets
    (4,084,000 )           (10,138,645 )
Impairment (i)
    (96,000 )           (906,378 )
                         
Balance at end of period
  $ 703,049,477     $ 636,409,268     $ 606,691,800  
                         
Accumulated depreciation:
                       
Balance at beginning of period
  $ 58,673,377     $ 42,091,996     $ 29,961,048  
Additions during period:
                       
Depreciation expense
    17,853,799       17,527,656       14,615,770  
Dispositions:
                       
Sale of assets
    (578,232 )     (946,275 )     (2,459,571 )
Impairment (i)
                (25,251 )
                         
Balance at end of period
  $ 75,948,944     $ 58,673,377     $ 42,091,996  
                         
 
 
(i) Represents the write-down of carrying cost and accumulated depreciation on assets where impairment charges were taken.


F-72


Table of Contents

 
AVIV REIT, INC. AND SUBSIDIARIES
 
 
                 
    March 31,
    December 31,
 
   
2011
   
2010
 
    (unaudited)        
 
Assets
               
Cash and cash equivalents
    $11,091,932       $13,029,474  
Deferred rent receivable
    29,427,858       30,660,773  
Tenant receivables, net
    1,699,085       1,168,842  
Rental properties and financing leases, at cost:
               
Land
    78,754,371       76,466,020  
Buildings and improvements
    641,556,663       615,806,273  
Assets under direct financing leases
    10,814,648       10,777,184  
                 
      731,125,682       703,049,477  
Less accumulated depreciation
    (80,747,512 )     (75,948,944 )
                 
Net rental properties
    650,378,170       627,100,533  
Deferred finance costs, net
    13,057,896       9,957,636  
Loan receivables, net
    30,726,794       36,610,638  
Other assets
    11,196,114       12,872,323  
                 
Total assets
    $747,577,849       $731,400,219  
                 
Liabilities and equity
               
Accounts payable and accrued expenses
    $7,047,687       $6,012,809  
Tenant security and escrow deposits
    14,132,190       13,658,384  
Other liabilities
    24,752,208       25,996,492  
Mortgage and other notes payable
    454,623,647       440,575,916  
                 
Total liabilities
    500,555,732       486,243,601  
Equity:
               
Stockholders’ equity
               
Common stock (par value $0.01; 235,897 and 227,002 shares outstanding, respectively)
    2,359       2,270  
Additional paid-in-capital
    234,138,378       223,838,999  
Accumulated deficit
    (7,284,941 )     (2,261,839 )
Accumulated other comprehensive income
    2,464,837       2,188,155  
                 
Stockholders’ equity
    229,320,633       223,767,585  
Noncontrolling interests
    17,701,484       21,389,033  
                 
Total equity
    247,022,117       245,156,618  
                 
Total liabilities and equity
    $747,577,849       $731,400,219  
                 
 
See accompanying notes to consolidated financial statements


F-73


Table of Contents

 
AVIV REIT, INC. AND SUBSIDIARIES
 
 
                 
   
Three Months Ended March 31,
 
   
2011
   
2010
 
    (unaudited)  
 
Revenues
               
Rental income
    $19,690,091       $21,150,335  
Tenant recoveries
    1,688,996       1,529,054  
Interest on loans to lessees—capital expenditures
    406,697       450,668  
Interest on loans to lessees—working capital and capital lease
    925,412       680,530  
                 
Total revenues
    22,711,196       23,810,587  
Expenses
               
Rent and other operating expenses
    201,664       169,330  
General and administrative
    3,468,576       1,424,248  
Real estate taxes
    1,689,094       1,605,430  
Depreciation
    4,798,568       4,361,901  
                 
Total expenses
    10,157,902       7,560,909  
                 
Operating income
    12,553,294       16,249,678  
Other income and expenses:
               
Interest and other income
    5,615       63,298  
Interest expense
    (7,556,185 )     (5,865,316 )
Change in fair value of derivatives
          1,320,721  
Amortization of deferred financing costs
    (678,995 )     (139,295 )
Loss on extinguishment of debt
    (3,143,008 )      
                 
Total other income and expenses
    (11,372,573 )     (4,620,592 )
                 
Net income
    1,180,721       11,629,086  
Distributions and accretion on Class E Preferred Units
          (3,998,770 )
Net income allocable to common units of Partnership/noncontrolling interests
    (538,442 )     (7,630,316 )
                 
Net income allocable to stockholders
    $642,279       $—  
                 
Net income
    $1,180,721          
Unrealized gain on derivative instrument
    508,634          
                 
Total comprehensive income
    $1,689,355          
                 
Net income allocable to stockholders
    $642,279          
Unrealized gain on derivative instrument, net of noncontrolling interest portion of $231,952
    276,682          
                 
Total comprehensive income allocable to stockholders
    $918,961          
                 


F-74


Table of Contents

 
AVIV REIT, INC. AND SUBSIDIARIES
 
Three Months Ended March 31, 2011 (unaudited)
 
                                                                 
   
Stockholders’ Equity
             
                            Accumulated
                   
                Additional
          Other
    Total
             
   
Common Stock
    Paid-In-
    Accumulated
    Comprehensive
    Stockholders’
    Noncontrolling
    Total
 
   
Shares
   
Amount
   
Capital
   
Deficit
   
Income
   
Equity
   
Interests
   
Equity
 
 
Balance at January 1, 2011
    227,002       $2,270       $223,838,999       $(2,261,839 )     $2,188,155       $223,767,585       $21,389,033       $245,156,618  
Non-cash stock (unit)-based compensation
                299,468                   299,468       286,977       586,445  
Distributions to partners
                                        (4,744,920 )     (4,744,920 )
Capital contributions
    8,895       89       9,999,911                   10,000,000             10,000,000  
Unrealized gain on derivative instruments
                            276,682       276,682       231,952       508,634  
Dividends to stockholders
                      (5,665,381 )           (5,665,381 )           (5,665,381 )
Net income
                      642,279             642,279       538,442       1,180,721  
                                                                 
Balance at March 31, 2011
    235,897       $2,359       $234,138,378       $(7,284,941 )     $2,464,837       $229,320,633       $17,701,484       $247,022,117  
                                                                 
 
See accompanying notes to consolidated financial statements


F-75


Table of Contents

 
AVIV REIT, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows
 
                 
   
Three Months Ended March 31,
 
   
2011
   
2010
 
    (unaudited)  
 
Operating activities
               
Net income
    $1,180,721       $11,629,086  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation
    4,798,568       4,361,901  
Amortization
    678,995       139,295  
Change in fair value of derivatives
          (1,320,721 )
Deferred rental expense (income), net
    1,165,922       (95,393 )
Rental income from intangible amortization, net
    (362,196 )     (1,770,665 )
Non-cash stock (unit)-based compensation
    586,445       101,500  
Non-cash loss on extinguishment of debt
    3,143,008        
Reserve for uncollectible loan receivables
    157,317        
Changes in assets and liabilities:
               
Tenant receivables
    (530,243 )     (709,641 )
Other assets
    2,023,699       (99,672 )
Accounts payable and accrued expenses
    669,320       353,846  
Tenant security deposits and other liabilities
    744,836       1,424,730  
                 
Net cash provided by operating activities
    14,256,392       14,014,266  
Investing activities
               
Purchase of rental properties
    (24,825,776 )      
Capital improvements and other developments
    (3,250,430 )     (2,151,823 )
Loan receivables received from (funded to) others, net
    5,726,527       (5,604,469 )
                 
Net cash used in investing activities
    (22,349,679 )     (7,756,292 )
Financing activities
               
Borrowings of debt
    210,200,000        
Repayment of debt
    (196,152,269 )     (2,563,125 )
Payment of financing costs
    (6,556,704 )      
Capital contributions
    10,000,000        
Cash distributions to partners
    (5,246,840 )     (11,075,273 )
Cash dividends to stockholders
    (6,088,442 )      
                 
Net cash provided by (used in) financing activities
    6,155,745       (13,638,398 )
                 
Net decrease in cash and cash equivalents
    (1,937,542 )     (7,380,424 )
Cash and cash equivalents:
               
Beginning of period
    13,029,474       15,542,507  
                 
End of period
    $11,091,932       $8,162,083  
                 
Supplemental cash flow information
               
Cash paid for interest
    $6,093,599       $5,967,777  
Supplemental disclosure of noncash activity
               
Accrued dividends payable to stockholders
    $5,665,381       $—  
Accrued distributions payable to partners
    $4,744,920       $5,124,590  
Earn-out accrual and addition to rental properties
    $—       $8,120,656  
Write-off of deferred rent receivable
    $3,026,968       $2,233,768  
Write-off of in-place lease intangibles, net
    $—       $1,224,594  
Write-off of deferred financing costs, net
    $3,143,008       $—  
 
See accompanying notes to consolidated financial statements


F-76


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
 
1.   Description of Operations and Formation
 
Aviv REIT, Inc., a Maryland corporation, and Subsidiaries (the REIT) is the sole general partner of Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership, and Subsidiaries (the Partnership). The Partnership is a majority owned subsidiary that owns all of the real estate properties. In these footnotes, the Company refers generically to Aviv REIT, Inc., the Partnership, and their subsidiaries. The Partnership was formed in 2005 and directly or indirectly owned or leased 187 properties, principally skilled nursing facilities, across the United States at March 31, 2011. The Company generates the majority of its revenues by entering into long-term triple-net leases with qualified local, regional, and national operators. In addition to the base rent, leases provide for tenants to pay the Company an ongoing escrow for real estate taxes. Furthermore, all operating and maintenance costs of the buildings are the responsibility of the tenants. Substantially all depreciation expense reflected in the consolidated statements of operations relates to the ownership of senior living properties. The Company manages its business as a single business segment as defined in Accounting Standards Codification (ASC) 280, Segment Reporting.
 
The Partnership is the general partner of Aviv Healthcare Properties Operating Partnership I, L.P. (the Operating Partnership), a Delaware limited partnership. The Operating Partnership has five wholly owned subsidiaries: Aviv Financing I, LLC (Aviv Financing I), a Delaware limited liability company; Aviv Financing II, LLC (Aviv Financing II), a Delaware limited liability company; Aviv Financing III, LLC (Aviv Financing III), a Delaware limited liability company; Aviv Financing IV, LLC (Aviv Financing IV), a Delaware limited liability company; and Aviv Financing V, LLC (Aviv Financing V), a Delaware limited liability company.
 
On September 17, 2010, the Partnership entered into an agreement (the Merger Agreement), by and among the REIT, Aviv Healthcare Merger Sub LP, a Delaware limited partnership of which the REIT is the general partner (Merger Sub), Aviv Healthcare Merger Sub Partner LLC, a Delaware limited liability company and a wholly owned subsidiary of the REIT, and the Partnership. Pursuant to the Merger Agreement, the Partnership merged (the Merger) with and into Merger Sub, with Merger Sub continuing as the surviving entity with the identical name (the Surviving Partnership). Following the Merger, the REIT remains as the sole general partner of the Surviving Partnership and the Surviving Partnership, as the successor to the Partnership, became the general partner of the Operating Partnership. All of the business, assets and operations will continue to be held by the Operating Partnership and its subsidiaries. The REIT’s equity interest in the Surviving Partnership will be linked to future investments in the REIT, such that future equity issuances by the REIT (pursuant to the Stockholders Agreement, the REIT’s management incentive plan or otherwise as agreed between the parties) will result in a corresponding increase in the REIT’s equity interest in the Surviving Partnership. The REIT is authorized to issue 2 million shares of common stock (par value ($0.01) and 1,000 shares of preferred stock (par value $1,000)). At March 31, 2011, there are 235,897 shares of common stock and 125 shares of preferred stock outstanding. Dividends on each outstanding share of preferred stock accrue on a daily basis at the rate of 12.5% per annum of the sum of $1,000 plus all accumulated and unpaid dividends thereon which are in arrears. The REIT makes annual distributions on the shares in the aggregate amount of $15,625 per year. With respect to the payment of dividends or other distributions and the distribution of the REIT’s assets upon dissolution, liquidation, or winding up, the preferred stock will be senior to all other classes and series of stock of the REIT. The preferred stock has not been shown separately in the consolidated balance sheets, is immaterial, and included in additional paid-in-capital.


F-77


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
As a result of the common control of the REIT (which was newly formed) and the Partnership, the Merger, for accounting purposes, did not result in any adjustment to the historical carrying value of the assets or liabilities of the Partnership. The REIT was funded in September 2010 with approximately $235 million from its stockholders. The REIT contributed the net proceeds of its capital raise to the Partnership in exchange for Class G Units in the Partnership. Periods prior to September 17, 2010 represent the results of operations and financial condition of the Partnership, as predecessor to the Company. An additional $10 million was contributed by the REIT’s stockholders on January 25, 2011.
 
The operating results of the Surviving Partnership are allocated based upon the respective economic interests therein. For the period ended March 31, 2011, the REIT owned 54.4% of the Surviving Partnership.
 
2.   Summary of Significant Accounting Policies
 
Estimates
 
The preparation of the financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
 
Principles of Consolidation
 
The accompanying consolidated financial statements include the accounts of the REIT, the Surviving Partnership, the Operating Partnership, and all controlled subsidiaries and joint ventures. The Company considers itself to control an entity if it is the majority owner of and has voting control over such entity or the power to control a variable interest entity. The portion of the net income or loss attributed to third parties is reported as net income allocable to noncontrolling interests on the consolidated statements of operations, and such parties’ portion of the net equity in such subsidiaries is reported on the consolidated balance sheets as noncontrolling interests. All significant intercompany balances and transactions have been eliminated in consolidation.
 
Quarterly Reporting
 
The accompanying unaudited financial statements and notes of the Company as of March 31, 2011 and for the three months ended March 31, 2011 and 2010 have been prepared in accordance with GAAP for interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared under GAAP have been condensed or omitted pursuant to such rules. In the opinion of management, all adjustments considered necessary for a fair presentation of the Company’s balance sheets, statements of operations, statement of changes in equity, and statements of cash flows have been included and are of a normal and recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for the Company for the years ended December 31, 2010, 2009, and 2008. The consolidated statements of operations and cash flows for the three months ended March 31, 2011 and 2010 are not necessarily indicative of full year results.


F-78


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
Rental Properties
 
The Company periodically assesses the carrying value of rental properties and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the rental properties will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the rental properties and related intangibles to their estimated fair value. The estimated fair value of the Company’s rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis.
 
Revenue Recognition
 
Rental income is recognized on a straight-line basis over the term of the lease when collectibility is reasonably assumed. Differences between rental income earned and amounts due under the lease are charged or credited, as applicable, to deferred rent receivable. Income recognized from this policy is titled deferred rental income. Additional rents from expense reimbursements for insurance, real estate taxes, and certain other expenses are recognized in the period in which the related expenses are incurred and are reflected as tenant recoveries on the consolidated statements of operations.
 
Below is a summary of the components of rental income for the respective periods:
 
                 
   
Three Months Ended March 31,
 
   
2011
   
2010
 
 
Rental income
    $20,493,817       $19,284,277  
Deferred rental (expense) income, net
    (1,165,922 )     95,393  
Rental income from intangible amortization
    362,196       1,770,665  
                 
Total rental income
    $19,690,091       $21,150,335  
                 
 
During the three months ended March 31, 2011 and 2010, deferred rental revenue includes a write-off (expense) of deferred rent receivable of $3,026,968 and $2,233,768, respectively, due to the early termination of leases and replacement of operators.
 
Lease Accounting
 
The Company, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statement of operations as rental income for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators. Assets subject to operating leases are reported as rental properties in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to the Company’s net initial investment is established on the balance sheet titled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a


F-79


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
financing lease. Such accretion was $37,465 and $38,540 for the three months ended March 31, 2011 and 2010, respectively.
 
All of the Company’s leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.
 
Loan Receivables
 
Loan receivables consist of capital improvement loans to tenants and working capital loans to operators. Loan receivables are carried at their principal amount outstanding. Management periodically evaluates outstanding loans and notes receivable for collectability. When management identifies potential loan impairment indicators, such as nonpayment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator, or other circumstances that may impair full execution of the loan documents, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan, the loan is written down to the present value of the expected future cash flows. As of March 31, 2011 and December 31, 2010, loan receivable reserves amounted to $907,317 and $750,000, respectively. No other circumstances exist that would suggest that additional reserves are necessary at the balance sheet dates.
 
Stock-Based Compensation
 
The Company follows ASC 718, Stock Compensation (ASC 718), which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated statements of operations based on their grant date fair values. On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction. A pro-rata allocation of non-cash stock-based compensation expense is made to the Company and noncontrolling interests for awards granted under the Plan. The Plan’s non-cash stock-based compensation expense by the Company through March 31, 2011 is summarized in Footnote 9.
 
Fair Value of Financial Instruments
 
ASC 820, Fair Value Measurements and Disclosures (ASC 820), establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels are defined as follows:
 
  •     Level 1—Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or;
 
  •     Level 2—Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and
 
  •     Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.


F-80


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
The Company’s interest rate swaps are valued using models developed internally by the respective counterparty that use as their basis readily observable market parameters and are classified within Level 2 of the valuation hierarchy.
 
Cash and cash equivalents and derivative financial instruments are reflected in the accompanying consolidated balance sheets at amounts considered by management to reasonably approximate fair value. Management estimates the fair value of its long-term debt using a discounted cash flow analysis based upon the Company’s current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Company had outstanding mortgage and other notes payable obligations with a carrying value of approximately $454.6 million and $440.6 million as of March 31, 2011 and December 31, 2010, respectively. The fair values of debt as of March 31, 2011 and December 31, 2010 approximate carrying value based upon interest rates available to the Company on similar borrowings.
 
Derivative Instruments
 
The Company has implemented ASC 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. Changes in the fair market values of the Company’s derivative instruments are recorded in the consolidated statements of operations if the derivative does not qualify for or the Company does not elect to apply hedge accounting. If the derivative is deemed to be eligible for hedge accounting, such changes are reported in accumulated other comprehensive income within the consolidated statement of changes in equity, exclusive of ineffectiveness amounts, which are recognized as adjustments to net income.
 
Income Taxes
 
For federal income tax purposes, the Company intends to elect, with the filing of its initial 1120 REIT, U.S. Income Tax Return for Real Estate Investment Trusts, to be taxed as a Real Estate Investment Trust (REIT) effective at the time of the Merger. To qualify as a REIT, the Company must meet certain organizational, income, asset and distribution tests. The Company currently intends to comply with these requirements and maintain REIT status. If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes at regular corporate rates (including any applicable alternative minimum tax) and may not elect REIT status for four subsequent years. However, the Company may still be subject to federal excise tax. In addition, the Company may be subject to certain state and local income and franchise taxes. Historically, the Company and its predecessor have generally only incurred certain state and local income and franchise taxes, but these amounts were immaterial in each of the periods presented. Prior to the Merger, the Partnership was a limited partnership and the consolidated operating results were included in the income tax returns of the individual partners. No uncertain income tax positions exist as of March 31, 2011 or December 31, 2010.
 
The rental properties of the Company have an income tax basis of approximately $627,663,049 as of March 31, 2011.


F-81


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
Business Combinations
 
The Company applies ASC 805, Business Combinations (ASC 805), in determining how to account for and identify business combinations while allocating fair value to tangible and identified intangible assets acquired and liabilities assumed. Prior to the Merger on September 17, 2010, Aviv Asset Management, L.L.C. (AAM) was a non-consolidated management company to the Partnership based on the application of appropriate accounting guidance (as discussed in Footnote 10). Upon the Merger, AAM became a consolidated entity of the Company and is presented as such for all periods included herein with all periods shown at historical cost (carryover basis with no adjustments to fair value). This treatment is in accordance with ASC 805 due to the fact that AAM was under common control prior and subsequent to the Merger.
 
Reclassifications
 
Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Company’s consolidated financial position or results of operations.
 
3.   Rental Property Activity
 
The Company had the following rental property activity during the three months ended March 31, 2011 as described below:
 
  •     In January 2011, Aviv Financing I acquired a property in Kansas from an unrelated third party for a purchase price of $3,045,000. The Company financed this purchase through cash and borrowings of $2,131,000 under the Mortgage (see Footnote 7).
 
  •     In March 2011, Aviv Financing II acquired a property in Pennsylvania from an unrelated third party for a purchase price of approximately $2,200,000. The Company financed this purchase through cash.
 
  •     In March 2011, Aviv Financing II acquired a property in Ohio from an unrelated third party for a purchase price of approximately $9,581,000. The Company financed this purchase through cash.
 
  •     In March 2011, Aviv Financing II acquired a property in Florida from an unrelated third party for a purchase price of approximately $10,000,000. The Company financed this purchase through borrowings of $10,200,000 under the Revolver (see Footnote 7).
 
The Company considers renewals on below-market leases when ascribing value to the in-place lease intangible liabilities at the date of a property acquisition. In those instances where the renewal lease rate pursuant to the terms of the lease does not adjust to a current market rent, the Company evaluates whether the stated renewal rate is below current market rates and considers the past and current operations of the property, the current rent coverage ratio of the tenant, and the number of years until potential renewal option exercise. If renewal is considered probable based on these factors, an additional lease intangible liability is recorded at acquisition and amortized over the renewal period.


F-82


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
4.   Loan Receivables
 
The following summarizes the Company’s loan receivables at:
 
                 
    March 31,
    December 31,
 
   
2011
   
2010
 
 
Beginning balance, January 1, 2011 and 2010, respectively
    $36,610,638       $28,970,129  
New capital improvement loans issued
    66,338       1,415,579  
Working capital and other loans issued
    613,858       14,705,259  
Reserve for uncollectible loans
    (157,317 )     (750,000 )
Loan amortization and repayments
    (6,406,723 )     (7,730,329 )
                 
      $30,726,794       $36,610,638  
                 
 
The Company’s reserve for uncollectible loan receivables balances at March 31, 2011 and December 31, 2010 was $907,317 and $750,000, respectively. The activity for the three months ended March 31, 2011 consisted of additional reserves of $157,317.
 
During 2011 and 2010, the Company funded loans for both working capital and capital improvement purposes to various operators and tenants. All loans held by the Company accrue interest. The payments received from the operator or tenant cover both interest accrued as well as amortization of the principal balance due. Any payments received from the tenant or operator made outside of the normal loan amortization schedule are considered principal prepayments and reduce the outstanding loan receivables balance.
 
Interest income earned on loan receivables for the three months ended March 31, 2011 and 2010 was $978,514 and $782,306, respectively.
 
5.   Deferred Finance Costs
 
The following summarizes the Company’s deferred finance costs at:
 
                 
    March 31,
    December 31,
 
   
2011
   
2010
 
 
Gross amount
    $13,965,324       $10,567,931  
Accumulated amortization
    (907,428 )     (610,295 )
                 
Net
    $13,057,896       $9,957,636  
                 
 
Amortization of deferred financing costs is reported in the amortization expense line item in the consolidated statements of operations.
 
During the three months ended March 31, 2011, the Company wrote-off deferred financing costs of $3,524,869 with $381,861 accumulated amortization associated with the Mortgage (see Footnote 7) pay down for a net recognition as loss on extinguishment of debt of $3,143,008.


F-83


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
6.   In-Place Lease Intangibles
 
The following summarizes the Company’s in-place lease intangibles classified as part of other assets or other liabilities at:
 
                                 
   
March 31, 2011
   
December 31, 2010
 
   
Assets
   
Liabilities
   
Assets
   
Liabilities
 
 
Gross amount
    $8,393,488       $25,798,147       $8,393,488       $25,798,147  
Accumulated amortization
    (3,210,236 )     (14,573,030 )     (3,049,093 )     (14,049,691 )
                                 
Net
    $5,183,252       $11,225,117       $5,344,395       $11,748,456  
                                 
 
Amortization expense for the in-place lease intangible assets for the three months ended March 31, 2011 and 2010 was $161,143 and $243,721, respectively. Accretion for the in-place lease intangible liabilities for the three months ended March 31, 2011 and 2010 was $523,339 and $789,792, respectively.
 
As of March 31, 2010, the Company wrote-off in-place lease intangible assets of $2,678,000 with accumulated amortization of $1,316,232, and in-place lease intangible liabilities of $4,660,000 with accumulated accretion of $2,073,638, for a net recognition of $1,224,594 in rental income from intangible amortization. These write-offs were in connection with properties that had been transitioned to new operators.
 
7.   Mortgage and Other Notes Payable
 
The Company’s mortgage and other notes payable consisted of the following:
 
                 
    March 31,
    December 31,
 
   
2011
   
2010
 
 
Mortgage (interest rates of 5.75% on March 31, 2011 and December 31, 2010, respectively)
    $235,350,523       $402,794,111  
Acquisition Credit Line (interest rates of 5.75% on March 31, 2011 and December 31, 2010, respectively)
          28,677,230  
Revolver (interest rate of 6.25% on March 31, 2011)
    10,200,000        
Construction loan (interest rates of 5.95% on March 31, 2011 and December 31, 2010, respectively)
    1,312,339       1,312,339  
Acquisition loans (interest rates of 6.00% on March 31, 2011 and December 31, 2010, respectively)
    7,760,785       7,792,236  
Senior Notes (interest rate of 7.75%, on March 31, 2011
    200,000,000        
                 
Total
    $454,623,647       $440,575,916  
                 
 
Senior Notes
 
On February 4, 2011, Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation (the Issuers) issued $200 million of Senior Notes (the Senior Notes). The Company


F-84


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
is a guarantor of the Issuers Senior Notes. The Senior Notes are unsecured senior obligations of the Issuers and will mature on February 15, 2019. The Senior Notes bear interest at a rate of 7.750% per annum, payable semiannually to holders of record at the close of business on the February 1 or the August 1 immediately preceding the interest payment date on February 15 and August 15 of each year, commencing August 15, 2011. The Company used the proceeds, amongst other things, to pay down approximately $165.9 million on the Mortgage and the balance of $28.7 million on the Acquisition Credit Line.
 
Revolver
 
In conjunction with the Senior Notes issuance on February 4, 2011, the Company, under Aviv Financing IV, LLC, acquired a $25 million revolver with Bank of America (the Revolver). On each payment date, the Company shall pay interest only in arrears on any outstanding principal balance of the Revolver. Interest rates are based upon the base rate (3.25% at March 31, 2011) plus the applicable percentage based on the consolidated leverage ratio (3.00% at March 31, 2011). The base rate is the rate announced by Bank of America as the “prime rate”. Additionally, an unused fee equal to 0.5% per annum of the daily unused balance on the Revolver is due monthly. The Revolver commitment terminates in February 2014.
 
8.   Partnership Equity and Incentive Program
 
Distributions to the Partnership’s partners are summarized as follows for the three months ended March 31:
 
                                                     
   
Class A
 
Class B
 
Class C
 
Class D
 
Class E
 
Class F
 
Class G
 
2011
    $2,066,628       $849,812       $1,274,719     $—     $—       $553,761       $5,665,381  
2010
    $3,390,685       $1,897,169       2,845,753     $—     $1,849,315       $1,092,350       $—  
 
Weighted-average Units outstanding are summarized as follows for the three months ended March 31:
 
                                                         
   
Class A
 
Class B
 
Class C
 
Class D
 
Class E
 
Class F
 
Class G
 
2011
    13,467,223       4,523,145       2       8,050             2,684,900       233,551  
2010
    13,467,223       4,523,145       2       7,714       7,500,000       5,369,800        
 
The Partnership had established an officer incentive program linked to its future value. Awards vest annually over a five-year period assuming continuing employment by the recipient. The awards can be settled in Class C Units or cash at the Company’s discretion at the settlement date of December 31, 2012. For accounting purposes, expense recognition under the program commenced in 2008, and the related expense for the three months ended March 31, 2011 and 2010 was approximately $101,500 and $101,500, respectively.
 
As a result of the Merger on September 17, 2010, such incentive program was modified such that 40% of the previously granted award settled immediately on the Merger date with another 20% vesting and settling on December 31, 2010. The remaining 40% will vest equally on December 31, 2011 and December 31, 2012, and will settle in 2018, subject to the terms and conditions of the amended incentive program agreement. In accordance with ASC 718, Compensation—Stock Compensation (ASC 718), such incentive program will continue to be expensed through general and administrative expenses


F-85


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
as non-cash compensation on the statements of operations through the ultimate vesting date of December 31, 2012.
 
9.   Option Awards
 
On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction.
 
The following table represents the time based option awards activity for the three months ended March 31, 2011.
 
         
   
March 31, 2011
 
 
Outstanding at beginning of period
    21,866  
Granted
    456  
Exercised
     
Cancelled/Forfeited
     
         
Outstanding at end of period
    22,322  
Options exercisable at end of period
     
         
Weighted average fair value of options granted
    $149.09  
         
Weighted average remaining contractual life
    9.48  
         
 
The following table represents the time based option awards outstanding at March 31, 2011 as well as other Plan data:
 
                         
        Remaining
  Weighted
        Contractual Life
  Average
Range of Exercise Prices
 
Outstanding
 
(Years)
 
Exercise Price
 
$1,000—$1,124
    22,322       9.48       $1,004  
 
The Company has used the Black-Scholes option pricing model to estimate the grant date fair value of the options. The following table includes the assumptions that were made in estimating the grant date fair value for options awarded in 2011.
 
         
   
2011 Grants
 
Dividend yield
    9.16 %
Risk-free interest rate
    2.72 %
Expected life
    7.0 years  
Estimated volatility
    38.00 %
Weighted average exercise price
    $1,124.22  
Weighted average fair value of options granted (per option)
    $149.09  
 
The Company recorded non-cash compensation expenses of $299,468 for the three months ended March 31, 2011, related to the time based stock options accounted for as equity awards, as a component of general and administrative expenses in the consolidated statements of operations.


F-86


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
At March 31, 2011, the total compensation cost related to outstanding, non-vested time based equity option awards that are expected to be recognized as compensation cost in the future aggregates to approximately $1,804,000.
 
         
For the Period Ended December 31,
 
Options
 
 
2011
    $791,093  
2012
    591,886  
2013
    309,028  
2014
    112,338  
2015
    48  
         
Total
    $1,804,393  
         
 
Dividend equivalent rights associated with the Plan amounted to $535,728 for the three months ended March 31, 2011, and are included in general and administrative expense in the consolidated statements of operations. These dividend rights will be paid in four installments as the option vests.
 
10.   Related Parties
 
Related party receivables and payables represent amounts due from/to various affiliates of the Company, including advances to members of the Company, amounts due to certain acquired companies and limited liability companies for transactions occurring prior to the formation of the Company, and various advances to entities controlled by affiliates of the Company’s management. An officer of the Company received a loan and such loan had a balance of $311,748 at March 31, 2011, which was paid off in full subsequent to that date.
 
The Partnership had entered into a management agreement, as amended, effective April 1, 2005, with AAM, an entity affiliated by common ownership. Under the management agreement, AAM had been granted the exclusive right to oversee the portfolio of the Partnership, providing, among other administrative services, accounting and all required financial services; legal administration and regulatory compliance; investor, tenant, and lender relationship services; and transactional support to the Partnership. Except as otherwise provided in the Partnership Agreement, all management powers of the business and affairs of the Partnership are exclusively vested in the General Partner. The annual fee for such services equals six-tenths of one percent (0.6%) of the aggregate fair market value of the properties as determined by the Partnership and AAM annually. This fee arrangement was amended as discussed below. In addition, the Partnership reimbursed AAM for all reasonable and necessary out-of-pocket expenses incurred in AAM’s conduct of its business, including, but not limited to, travel, legal, appraisal, and brokerage fees, fees and expenses incurred in connection with the acquisition, disposition, or refinancing of any property, and reimbursement of compensation and benefits of the officers and employees of AAM. This agreement was terminated on September 17, 2010 when the Merger occurred, effectively consolidating AAM into the Company, and eliminating the necessity for reimbursement.
 
On October 16, 2007, the Company legally acquired AAM through a Manager Contribution and Exchange Agreement dated October 16, 2007 (the Contribution Agreement). As stipulated in the Contribution Agreement and the Second Amended and Restated Agreement of Limited Partnership on October 16, 2007 (Partnership Agreement), the Company issued a new class of Company Unit, Class F Units, as consideration to the contributing members of AAM. The contributing members of AAM served as the general partner of the Partnership. The Class F Units have subordinated payment and liquidity preference to the Class E Units but are senior in payment and liquidity preference, where applicable, to


F-87


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
the Class A, B, C, and D Units of the Partnership. The Class F Units paid in quarterly installments an annual dividend of 8.25% of the preliminary face amount of $53,698,000. The preliminary pricing was based upon trading multiples of comparably sized publicly traded healthcare REITs. The ultimate Class F Unit valuation was subject to a true-up formula at the time of a Liquidity Event, as defined in the Partnership Agreement.
 
For accounting purposes, prior to the Merger, AAM had not been consolidated by the Company, nor had any value been ascribed to the Class F Units issued due to the ability of the Class E Unitholders to unwind the acquisition as described above. Such action was outside the control of the Company, and accordingly, the acquisition is not viewed as having been consummated. The dividends earned by the Class F Unitholders were reflected as a component of management fees as described above. Prior to the Merger, the fee for management services to the Company are equal to the dividend earned on the Class F Unit.
 
Under certain circumstances, the Partnership Agreement did permit the Class E Unitholders to unwind this transaction and requires the Company to redeem the Class F Units by returning to the affiliates all membership interests in AAM. On September 17, 2010, the Company settled the investment with JER Aviv Acquisition, LLC (JER). For accounting purposes, this treatment triggered the retroactive consolidation of AAM by the Company. The original and follow-on investments of Class E unitholders were made subject to the Unit Purchase Agreement and related documents (UPA) between the Company and JER dated May 26, 2006.
 
The UPA did not give either party the right to settle the investment prior to May 26, 2011. However, the UPA did have an economic arrangement as to how either party could settle the arrangement on or after that date. This economic construct guided the discussions and negotiations of settlement. The UPA allowed the Company to call the E Units and warrants anytime after May 26, 2011 as long as it provided JER with a 15% IRR from date of inception. The IRR would be calculated factoring interim distributions as well as exit payments. The units were settled for $92,001,451 contemporaneous with the Merger. A portion of the settlement related to outstanding warrants held by JER and originally issued in connection with the E units issuance.
 
Coincident with the Merger, 50% of the Class F Unit was purchased and settled by the Company for $23,602,649 and is reported as a component of distributions to partners and accretion on Class E Preferred Units in the consolidated statements of changes in equity. The remaining Class F Units will pay in quarterly installments an annual dividend of 9.38% of the face amount of $23,602,649.
 
11.   Derivatives
 
During the periods presented, the Company was party to various interest rate swaps, which were purchased to fix the variable interest rate on the denoted notional amount under the original debt agreements.
 
At March 31, 2011, the Company is party to two interest rate swaps, with identical terms for $100 million each. They were purchased to fix the variable interest rate on the denoted notional amount under the Mortgage which was obtained in September, 2010, and qualify for hedge accounting. For presentational purposes they are shown as one derivative due to the identical nature of their economic terms.
 


F-88


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
     
Total notional amount
  $200,000,000
Fixed rates
  6.49% (1.99% effective swap base rate plus 4.5% spread per credit agreement)
Floor rate
  1.25%
Effective date
  November 9, 2010
Termination date
  September 17, 2015
Asset balance at March 31, 2011 (included in other assets)
  $4,603,066
Liability balance at March 31, 2011 (included in other liabilities)
  $—
 
The fair value of each interest rate swap agreement may increase or decrease due to changes in market conditions but will ultimately decrease to zero over the term of each respective agreement.
 
For the three months ended March 31, 2011 and 2010, the Company recognized $0 and $1,320,721 of net income, respectively, in the consolidated statements of operations related to the change in the fair value of these interest rate swap agreements, where the Company did not elect to apply hedge accounting. Such instruments that did not elect to apply hedge accounting were settled at the Merger date.
 
The following table provides the Company’s derivative assets and liabilities carried at fair value as measured on a recurring basis as of March 31, 2011 (dollars in thousands):
 
                                 
                Significant
       
    Total Carrying
    Quoted Prices
    Other
    Significant
 
    Value at
    in Active
    Observable
    Unobservable
 
    March 31,
    Markets
    Inputs
    Inputs
 
   
2011
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
 
Derivative assets
    $4,603       $       $4,603       $  
Derivative liabilities
                       
                                 
      $4,603       $       $4,603       $  
                                 
 
The Company’s derivative assets and liabilities include interest rate swaps that effectively convert a portion of the Company’s variable rate debt to fixed rate debt. The derivative positions are valued using models developed by the respective counterparty that use as their basis readily observable market parameters (such as forward yield curves) and are classified within Level 2 of the valuation hierarchy. The Company considers its own credit risk as well as the credit risk of its counterparties when evaluating the fair value of its derivatives.
 
12.   Commitments and Contingencies
 
The Company has a contractual arrangement with a tenant to reimburse quality assurance fees levied by the California Department of Health Care Services from August 1, 2005 through July 31, 2008. The Company is obligated to reimburse the fees to the tenant if and when the state withholds these fees from the tenant’s Medi-Cal reimbursements associated with 5 facilities that were formerly leased to Trinity Health Systems. The total possible obligation for these fees is $1,655,286, of which approximately $1.0M has been paid to date. For the three months ended March 31, 2011, and 2010, the Company’s indemnity expense for these fees was $0 and $183,000, respectively, which equaled the actual amount paid during the period.

F-89


Table of Contents

AVIV REIT, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
Judicial proceedings seeking declaratory relief for these fees are in process which if successful would provide for recovery of such amounts from the State of California. The Company has certain rights to seek relief against Trinity Health Systems for monies paid out under the indemnity claim; however, it is uncertain whether the Company will be successful in receiving any amounts from Trinity.
 
In the normal course of business, the Company is involved in legal actions arising from the ownership of its property. In management’s opinion, the liabilities, if any, that may ultimately result from such legal actions are not expected to have a material adverse effect on the financial position, operations, or liquidity of the Company.
 
13.   Concentration of Credit Risk
 
As of March 31, 2011, the Company’s portfolio of investments consisted of 187 healthcare facilities, located in 25 states and operated by 31 third party operators. At March 31, 2011, approximately 50.7% (measured as a percentage of total assets) were leased by five private operators: Evergreen Healthcare (13.6%), Daybreak Healthcare (12.4%), Sun Mar Healthcare (9.1%), Hi-Care Management (8.0%), and Convacare Management (7.6%). No other operator represents more than 6.3% of our total assets. The five states in which the Company had its highest concentration of total assets were California (19.4%), Texas (16.3%), Missouri (9.5%), Arkansas (8.1%), and New Mexico (5.9%) at March 31, 2011.
 
For the three months ended March 31, 2011, the Company’s rental income from operations totaled approximately $19.7 million, of which approximately $3.0 million was from Evergreen Healthcare (15.1%), $2.4 million was from Sun Mar Healthcare (12.1%), $2.3 million was from Daybreak Venture (11.8%), $1.7 million was from Cathedral Rock Corporation (8.9%), and $1.6 million was from ConvaCare Management (8.3%). No other operator generated more than 6.0% of the Company’s rental income from operations for the three months ended March 31, 2011.
 
14.   Subsequent Events
 
On April 5, 2011, the Company issued $100 million in Senior Notes at 7.75%. The proceeds from this bond issuance were used to pay down $35.7 million of the Mortgage and the remaining proceeds were received as cash.
 
On April 28, 2011 Aviv Financing II acquired three properties in Ohio from an unrelated third party for a purchase price of $9,250,000. The Company financed this purchase with cash.
 
On April 29, 2011 Aviv Financing II acquired six properties in Texas, Kansas, and Missouri from unrelated third parties for a purchase price of $17,570,000. The Company financed this purchase with cash.
 
On May 2, 2011, Aviv Financing II acquired three properties in Kansas from an unrelated third party for a purchase price of approximately $2,273,000. The Company financed this purchase with cash.
 
On May 3, 2011, Aviv Financing II acquired a property in Connecticut from an unrelated third party for a purchase price of $12,000,000. The Company financed this purchase with cash.
 
The Company has evaluated events subsequent to March 31, 2011 through May 18, 2011, and determined that no events other than those noted above would require changes to the consolidated financial statements or additional disclosure.


F-90


Table of Contents

 
AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
                 
    March 31,
    December 31,
 
   
2011
   
2010
 
    (unaudited)        
 
Assets
               
Cash and cash equivalents
    $10,504,302       $13,028,474  
Deferred rent receivable
    29,427,858       30,660,773  
Tenant receivables, net
    1,699,085       1,168,842  
Rental properties and financing leases, at cost:
               
Land
    78,754,371       76,466,020  
Buildings and improvements
    641,556,663       615,806,273  
Assets under direct financing leases
    10,814,648       10,777,184  
                 
      731,125,682       703,049,477  
Less accumulated depreciation
    (80,747,512 )     (75,948,944 )
                 
Net rental properties
    650,378,170       627,100,533  
Deferred finance costs, net
    13,057,896       9,957,636  
Loan receivables, net
    30,726,794       36,610,638  
Other assets
    11,196,114       12,872,323  
                 
Total assets
    $746,990,219       $731,399,219  
                 
Liabilities and equity
               
Accounts payable and accrued expenses
    $7,047,687       $6,012,809  
Tenant security and escrow deposits
    14,132,190       13,658,384  
Other liabilities
    24,165,578       25,996,492  
Mortgage and other notes payable
    454,623,647       440,575,916  
                 
Total liabilities
    499,969,102       486,243,601  
Equity:
               
Partners’ equity
    242,418,051       241,061,186  
Accumulated other comprehensive income
    4,603,066       4,094,432  
                 
Total equity
    247,021,117       245,155,618  
                 
Total liabilities and equity
    $746,990,219       $731,399,219  
                 
 
See accompanying notes to consolidated financial statements


F-91


Table of Contents

 
AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
                 
   
Three Months Ended March 31,
 
   
2011
   
2010
 
    (unaudited)  
 
Revenues
               
Rental income
    $19,690,091       $21,150,335  
Tenant recoveries
    1,688,996       1,529,054  
Interest on loans to lessees—capital expenditures
    406,697       450,668  
Interest on loans to lessees—working capital and capital lease
    925,412       680,530  
                 
Total revenues
    22,711,196       23,810,587  
Expenses
               
Rent and other operating expenses
    201,664       169,330  
General and administrative
    3,468,576       1,424,248  
Real estate taxes
    1,689,094       1,605,430  
Depreciation
    4,798,568       4,361,901  
                 
Total expenses
    10,157,902       7,560,909  
                 
Operating income
    12,553,294       16,249,678  
Other income and expenses:
               
Interest and other income
    5,615       63,298  
Interest expense
    (7,556,185 )     (5,865,316 )
Change in fair value of derivatives
          1,320,721  
Amortization of deferred financing costs
    (678,995 )     (139,295 )
Loss on extinguishment of debt
    (3,143,008 )      
                 
Total other income and expenses
    (11,372,573 )     (4,620,592 )
                 
Net income
    1,180,721       11,629,086  
Distributions and accretion on Class E Preferred Units
          (3,998,770 )
Net income allocable to noncontrolling interests
          (79,617 )
                 
Net income allocable to common units
    $1,180,721       $7,550,699  
                 
Net income allocable to common units
    $1,180,721          
Unrealized gain on derivative instruments
    508,634          
                 
Total comprehensive income allocable to common units
    $1,689,355          
                 
 
See accompanying notes to consolidated financial statements


F-92


Table of Contents

 
AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
                         
          Accumulated
       
          Other
       
    Partners’
    Comprehensive
    Total
 
   
Equity
   
Income
   
Equity
 
 
Balance at January 1, 2011
    $241,061,186       $4,094,432       $245,155,618  
Non-cash stock-based compensation
    586,445             586,445  
Distributions to partners
    (10,410,301 )           (10,410,301 )
Capital contributions
    10,000,000             10,000,000  
Unrealized gain on derivative instruments
          508,634       508,634  
Net income
    1,180,721             1,180,721  
                         
Balance at March 31, 2011
    $242,418,051       $4,603,066       $247,021,117  
                         
 
See accompanying notes to consolidated financial statements


F-93


Table of Contents

 
AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
 
                 
   
Three Months Ended March 31,
 
   
2011
   
2010
 
    (unaudited)  
 
Operating activities
               
Net income
    $1,180,721       $11,629,086  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation
    4,798,568       4,361,901  
Amortization
    678,995       139,295  
Change in fair value of derivatives
          (1,320,721 )
Deferred rental expense (income), net
    1,165,922       (95,393 )
Rental income from intangible amortization, net
    (362,196 )     (1,770,665 )
Non-cash stock-based compensation
    586,445       101,500  
Non-cash loss on extinguishment of debt
    3,143,008        
Reserve for uncollectible loan receivables
    157,317        
Changes in assets and liabilities:
               
Tenant receivables
    (530,243 )     (709,641 )
Other assets
    2,023,699       (99,672 )
Accounts payable and accrued expenses
    669,320       353,346  
Tenant security deposits and other liabilities
    158,206       1,424,730  
                 
Net cash provided by operating activities
    13,669,762       14,013,766  
Investing activities
               
Purchase of rental properties
    (24,825,776 )      
Capital improvements and other developments
    (3,250,430 )     (2,151,823 )
Loan receivables received from (funded to) others, net
    5,726,527       (5,604,469 )
                 
Net cash used in investing activities
    (22,349,679 )     (7,756,292 )
Financing activities
               
Borrowings of debt
    210,200,000        
Repayment of debt
    (196,152,269 )     (2,563,125 )
Payment of financing costs
    (6,556,704 )      
Capital contributions
    10,000,000        
Cash distributions to partners
    (11,335,282 )     (11,075,273 )
                 
Net cash provided by (used in) financing activities
    6,155,745       (13,638,398 )
                 
Net decrease in cash and cash equivalents
    (2,524,172 )     (7,380,924 )
Cash and cash equivalents:
               
Beginning of period
    13,028,474       15,542,507  
                 
End of period
    $10,504,302       $8,161,583  
                 
Supplemental cash flow information
               
Cash paid for interest
    $6,093,599       $5,967,777  
Supplemental disclosure of noncash activity
               
Accrued distributions payable to partners
    $10,410,301       $5,124,590  
Earn-out accrual and addition to rental properties
    $—       $8,120,656  
Write-off of deferred rent receivable
    $3,026,968       $2,233,768  
Write-off of in-place lease intangibles, net
    $—       $1,224,594  
Write-off of deferred finance costs, net
    $3,143,008       $—  
 
See accompanying notes to consolidated financial statements


F-94


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Three Months Ended March 31, 2011 and 2010
 
1.   Description of Operations and Formation
 
Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership, and Subsidiaries (the Partnership) was formed in 2005 and directly or indirectly owned or leased 187 properties, principally skilled nursing facilities, across the United States at March 31, 2011. The Partnership generates the majority of its revenues by entering into long-term triple-net leases with qualified local, regional, and national operators. In addition to the base rent, leases provide for tenants to pay the Partnership an ongoing escrow for real estate taxes. Furthermore, all operating and maintenance costs of the buildings are the responsibility of the tenants. Substantially all depreciation expense reflected in the consolidated statements of operations relates to the ownership of senior living properties. The Partnership manages its business as a single business segment as defined in Accounting Standards Codification (ASC) 280, Segment Reporting.
 
The Partnership is the general partner of Aviv Healthcare Properties Operating Partnership I, L.P. (the Operating Partnership), a Delaware limited partnership. The Operating Partnership has five wholly owned subsidiaries: Aviv Financing I, LLC (Aviv Financing I), a Delaware limited liability company; Aviv Financing II, LLC (Aviv Financing II), a Delaware limited liability company; Aviv Financing III, LLC (Aviv Financing III), a Delaware limited liability company; Aviv Financing IV, LLC (Aviv Financing IV), a Delaware limited liability company; and Aviv Financing V, LLC (Aviv Financing V), a Delaware limited liability company.
 
On September 17, 2010, the Partnership entered into an agreement (the Merger Agreement), by and among Aviv REIT, Inc. (the Company), a Maryland corporation, Aviv Healthcare Merger Sub LP (Merger Sub), a Delaware limited partnership of which the Company is the general partner, Aviv Healthcare Merger Sub Partner LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, and the Partnership. Effective on such date, the Company is the sole general partner of the Partnership. Pursuant to the Merger Agreement, the Partnership merged with and into the Merger Sub (the Merger), with Merger Sub continuing as the surviving entity with the identical name (the Surviving Partnership). Following the Merger, the Company remains as the sole general partner of the Surviving Partnership and the Surviving Partnership, as the successor to the Partnership, became the general partner of the Operating Partnership.
 
All of the business, assets and operations will continue to be held by the Operating Partnership and its subsidiaries. The Company’s equity interest in the Surviving Partnership will be linked to future investments in the Company, such that future equity issuances by the Company (pursuant to the Stockholders Agreement, the Company’s management incentive plan or otherwise as agreed between the parties) will result in a corresponding increase in the Company’s equity interest in the Surviving Partnership. The Company is authorized to issue two million shares of common stock (par value ($0.01) and 1,000 shares of preferred stock (par value $1,000). At March 31, 2011, there are 235,897 shares of common stock and 125 shares of preferred stock outstanding.
 
As a result of the common control of the Company (which was newly formed) and the Partnership, the Merger, for accounting purposes, did not result in any adjustment to the historical carrying value of the assets or liabilities of the Partnership. The Company was funded in September 2010 with approximately $235 million from its stockholders, and such amounts, net of costs, was contributed to the Partnership in September 2010 in exchange for Class G Units in the Partnership. An additional $10 million was contributed by the Company’s stockholders on January 25, 2011. For the period ended March 31, 2011, the Company owned 54.4% of the Partnership.


F-95


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
2.   Summary of Significant Accounting Policies
 
Estimates
 
The preparation of the financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
 
Principles of Consolidation
 
The accompanying consolidated financial statements include the accounts of the Partnership, the Surviving Partnership, the Operating Partnership, and all controlled subsidiaries and joint ventures. The Partnership considers itself to control an entity if it is the majority owner of and has voting control over such entity or the power to control a variable interest entity. The portion of the net income or loss attributed to third parties is reported as net income allocable to noncontrolling interests on the consolidated statements of operations, and such parties’ portion of the net equity in such subsidiaries is reported on the consolidated balance sheets as noncontrolling interests. All significant intercompany balances and transactions have been eliminated in consolidation.
 
Quarterly Reporting
 
The accompanying unaudited financial statements and notes of the Partnership as of March 31, 2011 and for the three months ended March 31, 2011 and 2010 have been prepared in accordance with GAAP for interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared under GAAP have been condensed or omitted pursuant to such rules. In the opinion of management, all adjustments considered necessary for a fair presentation of the Partnership’s balance sheets, statements of operations, statement of changes in equity, and statements of cash flows have been included and are of a normal and recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for the Partnership for the years ended December 31, 2010, 2009, and 2008. The consolidated statements of operations and cash flows for the three months ended March 31, 2011 and 2010 are not necessarily indicative of full year results.
 
Rental Properties
 
The Partnership periodically assesses the carrying value of rental properties and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the rental properties will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the rental properties and related intangibles to their estimated fair value. The estimated fair value of the Partnership’s rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis.


F-96


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
Revenue Recognition
 
Rental income is recognized on a straight-line basis over the term of the lease when collectibility is reasonably assumed. Differences between rental income earned and amounts due under the lease are charged or credited, as applicable, to deferred rent receivable. Income recognized from this policy is titled deferred rental income. Additional rents from expense reimbursements for insurance, real estate taxes, and certain other expenses are recognized in the period in which the related expenses are incurred and are reflected as tenant recoveries on the consolidated statements of operations.
 
Below is a summary of the components of rental income for the respective periods:
 
                 
   
Three Months Ended March 31,
 
   
2011
   
2010
 
 
Rental income
    $20,493,817       $19,284,277  
Deferred rental (expense) income, net
    (1,165,922 )     95,393  
Rental income from intangible amortization
    362,196       1,770,665  
                 
Total rental income
    $19,690,091       $21,150,335  
                 
 
During the three months ended March 31, 2011 and 2010, deferred rental revenue includes a write-off (expense) of deferred rent receivable of $3,026,968 and $2,233,768, respectively, due to the early termination of leases and replacement of operators.
 
Lease Accounting
 
The Partnership, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statement of operations as rental income for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators. Assets subject to operating leases are reported as rental properties in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to the Partnership’s net initial investment is established on the balance sheet titled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a financing lease. Such accretion was $37,465 and $38,540 for the three months ended March 31, 2011 and 2010, respectively.
 
All of the Partnership’s leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.
 
Loan Receivables
 
Loan receivables consist of capital improvement loans to tenants and working capital loans to operators. Loan receivables are carried at their principal amount outstanding. Management periodically evaluates outstanding loans and notes receivable for collectability. When management identifies potential


F-97


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
loan impairment indicators, such as nonpayment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator, or other circumstances that may impair full execution of the loan documents, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan, the loan is written down to the present value of the expected future cash flows. As of March 31, 2011 and December 31, 2010, loan receivable reserves amounted to $907,317 and $750,000, respectively. No other circumstances exist that would suggest that additional reserves are necessary at the balance sheet dates.
 
Stock-Based Compensation
 
The Partnership follows ASC 718, Stock Compensation (ASC 718), which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated statements of operations based on their grant date fair values. On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction. A pro-rata allocation of non-cash stock-based compensation expense is made to the Partnership for awards granted under the Plan. The Plan’s non-cash stock-based compensation expense by the Partnership through March 31, 2011 is summarized in Footnote 9.
 
Fair Value of Financial Instruments
 
ASC 820, Fair Value Measurements and Disclosures (ASC 820), establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels are defined as follows:
 
  •     Level 1—Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or;
 
  •     Level 2—Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and
 
  •     Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
 
The Partnership’s interest rate swaps are valued using models developed internally by the respective counterparty that use as their basis readily observable market parameters and are classified within Level 2 of the valuation hierarchy.
 
Cash and cash equivalents and derivative financial instruments are reflected in the accompanying consolidated balance sheets at amounts considered by management to reasonably approximate fair value. Management estimates the fair value of its long-term debt using a discounted cash flow analysis based upon the Partnership’s current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Partnership had outstanding mortgage and other notes payable obligations with a carrying value of approximately $454.6 million and $440.6 million as of March 31, 2011 and December 31, 2010, respectively. The fair values of debt as of March 31, 2011 and December 31, 2010 approximate carrying value based upon interest rates available to the Partnership on similar borrowings.


F-98


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
Derivative Instruments
 
The Partnership has implemented ASC 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. Changes in the fair market values of the Partnership’s derivative instruments are recorded in the consolidated statements of operations if the derivative does not qualify for or the Partnership does not elect to apply hedge accounting. If the derivative is deemed to be eligible for hedge accounting, such changes are reported in accumulated other comprehensive income within the consolidated statement of changes in equity, exclusive of ineffectiveness amounts, which are recognized as adjustments to net income.
 
Income Taxes
 
As a limited partnership, the consolidated operating results are included in the income tax returns of the individual partners. Accordingly, the Partnership does not provide for federal income taxes. State income taxes were not significant in any of the periods presented. No uncertain income tax positions exist as of March 31, 2011 or December 31, 2010.
 
Business Combinations
 
The Partnership applies ASC 805, Business Combinations (ASC 805), in determining how to account for and identify business combinations while allocating fair value to tangible and identified intangible assets acquired and liabilities assumed. Prior to the Merger on September 17, 2010, Aviv Asset Management, L.L.C. (AAM) was a non-consolidated management company to the Partnership based on the application of appropriate accounting guidance (as discussed in Footnote 10). Upon the Merger, AAM became a consolidated entity of the Partnership and is presented as such for all periods included herein with all periods shown at historical cost (carryover basis with no adjustments to fair value). This treatment is in accordance with ASC 805 due to the fact that AAM was under common control prior and subsequent to the Merger.
 
Reclassifications
 
Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Partnership’s consolidated financial position or results of operations.
 
3.   Rental Property Activity
 
The Partnership had the following rental property activity during the three months ended March 31, 2011 as described below:
 
  •     In January 2011, Aviv Financing I acquired a property in Kansas from an unrelated third party for a purchase price of $3,045,000. The Partnership financed this purchase through cash and borrowings of $2,131,000 under the Mortgage (see Footnote 7).


F-99


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
  •     In March 2011, Aviv Financing II acquired a property in Pennsylvania from an unrelated third party for a purchase price of approximately $2,200,000. The Partnership financed this purchase through cash.
 
  •     In March 2011, Aviv Financing II acquired a property in Ohio from an unrelated third party for a purchase price of approximately $9,581,000. The Partnership financed this purchase through cash.
 
  •     In March 2011, Aviv Financing II acquired a property in Florida from an unrelated third party for a purchase price of approximately $10,000,000. The Partnership financed this purchase through borrowings of $10,200,000 under the Revolver (see Footnote 7).
 
The Partnership considers renewals on below-market leases when ascribing value to the in-place lease intangible liabilities at the date of a property acquisition. In those instances where the renewal lease rate pursuant to the terms of the lease does not adjust to a current market rent, the Partnership evaluates whether the stated renewal rate is below current market rates and considers the past and current operations of the property, the current rent coverage ratio of the tenant, and the number of years until potential renewal option exercise. If renewal is considered probable based on these factors, an additional lease intangible liability is recorded at acquisition and amortized over the renewal period.
 
4.   Loan Receivables
 
The following summarizes the Partnership’s loan receivables at:
 
                 
   
March 31, 2011
   
December 31, 2010
 
 
Beginning balance, January 1, 2011 and 2010, respectively
    $36,610,638       $28,970,129  
New capital improvement loans issued
    66,338       1,415,579  
Working capital and other loans issued
    613,858       14,705,259  
Reserve for uncollectible loans
    (157,317 )     (750,000 )
Loan amortization and repayments
    (6,406,723 )     (7,730,329 )
                 
      $30,726,794       $36,610,638  
                 
 
The Partnership’s reserve for uncollectible loan receivables balances at March 31, 2011 and December 31, 2010 was $907,317 and $750,000, respectively. The activity for the three months ended March 31, 2011 consisted of additional reserves of $157,317.
 
During 2011 and 2010, the Partnership funded loans for both working capital and capital improvement purposes to various operators and tenants. All loans held by the Partnership accrue interest. The payments received from the operator or tenant cover both interest accrued as well as amortization of the principal balance due. Any payments received from the tenant or operator made outside of the normal loan amortization schedule are considered principal prepayments and reduce the outstanding loan receivables balance.
 
Interest income earned on loan receivables for the three months ended March 31, 2011 and 2010 was $978,514 and $782,306, respectively.


F-100


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
5.   Deferred Finance Costs
 
The following summarizes the Partnership’s deferred finance costs at:
 
                 
   
March 31, 2011
   
December 31, 2010
 
 
Gross amount
    $13,965,324       $10,567,931  
Accumulated amortization
    (907,428 )     (610,295 )
                 
Net
    $13,057,896       $9,957,636  
                 
 
Amortization of deferred financing costs is reported in the amortization expense line item in the consolidated statements of operations.
 
During the three months ended March 31, 2011, the Partnership wrote-off deferred financing costs of $3,524,869 with $381,861 accumulated amortization associated with the Mortgage (see Footnote 7) pay down for a net recognition as loss on extinguishment of debt of $3,143,008.
 
6.   In-Place Lease Intangibles
 
The following summarizes the Partnership’s in-place lease intangibles classified as part of other assets or other liabilities at:
 
                                 
   
March 31, 2011
   
December 31, 2010
 
   
Assets
   
Liabilities
   
Assets
   
Liabilities
 
 
Gross amount
    $8,393,488       $25,798,147       $8,393,488       $25,798,147  
Accumulated amortization
    (3,210,236 )     (14,573,030 )     (3,049,093 )     (14,049,691 )
                                 
Net
    $5,183,252       $11,225,117       $5,344,395       $11,748,456  
                                 
 
Amortization expense for the in-place lease intangible assets for the three months ended March 31, 2011 and 2010 was $161,143 and $243,721, respectively. Accretion for the in-place lease intangible liabilities for the three months ended March 31, 2011 and 2010 was $523,339 and $789,792, respectively.
 
As of March 31, 2010, the Partnership wrote-off in-place lease intangible assets of $2,678,000 with accumulated amortization of $1,316,232, and in-place lease intangible liabilities of $4,660,000 with accumulated accretion of $2,073,638, for a net recognition of $1,224,594 in rental income from intangible amortization. These write-offs were in connection with properties that had been transitioned to new operators.


F-101


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
7.   Mortgage and Other Notes Payable
 
The Partnership’s mortgage and other notes payable consisted of the following:
 
                 
    March 31,
    December 31,
 
   
2011
   
2010
 
 
Mortgage (interest rates of 5.75% on March 31, 2011 and December 31, 2010, respectively)
    $235,350,523       $402,794,111  
Acquisition Credit Line (interest rates of 5.75% on March 31, 2011 and December 31, 2010, respectively)
          28,677,230  
Revolver (interest rate of 6.25% on March 31, 2011)
    10,200,000        
Construction loan (interest rates of 5.95% on March 31, 2011 and December 31, 2010, respectively)
    1,312,339       1,312,339  
Acquisition loans (interest rates of 6.00% on March 31, 2011 and December 31, 2010, respectively)
    7,760,785       7,792,236  
Senior Notes (interest rate of 7.75%, on March 31, 2011
    200,000,000        
                 
Total
    $454,623,647       $440,575,916  
                 
 
Senior Notes
 
On February 4, 2011, Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation (the Issuers) issued $200 million of Senior Notes (the Senior Notes). The Company is a guarantor of the Issuers Senior Notes. The Senior Notes are unsecured senior obligations of the Issuers and will mature on February 15, 2019. The Senior Notes bear interest at a rate of 7.750% per annum, payable semiannually to holders of record at the close of business on the February 1 or the August 1 immediately preceding the interest payment date on February 15 and August 15 of each year, commencing August 15, 2011. The Partnership used the proceeds, amongst other things, to pay down approximately $165.9 million on the Mortgage and the balance of $28.7 million on the Acquisition Credit Line.
 
Revolver
 
In conjunction with the Senior Notes issuance on February 4, 2011, the Partnership, under Aviv Financing IV, LLC, acquired a $25 million revolver with Bank of America (the Revolver). On each payment date, the Partnership shall pay interest only in arrears on any outstanding principal balance of the Revolver. Interest rates are based upon the base rate (3.25% at March 31, 2011) plus the applicable percentage based on the consolidated leverage ratio (3.00% at March 31, 2011). The base rate is the rate announced by Bank of America as the “prime rate”. Additionally, an unused fee equal to 0.5% per annum of the daily unused balance on the Revolver is due monthly. The Revolver commitment terminates in February 2014.


F-102


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
8.   Partnership Equity and Incentive Program
 
Distributions to the Partnership’s partners are summarized as follows for the three months ended March 31:
 
                                                         
   
Class A
   
Class B
   
Class C
   
Class D
   
Class E
   
Class F
   
Class G
 
 
2011
    $2,066,628       $849,812       $1,274,719       $—       $—       $553,761       $5,665,381  
2010
    $3,390,685       $1,897,169       $2,845,753       $—       $1,849,315       $1,092,350       $—  
 
Weighted-average Units outstanding are summarized as follows for the three months ended March 31:
 
                                                         
   
Class A
   
Class B
   
Class C
   
Class D
   
Class E
   
Class F
   
Class G
 
 
2011
    13,467,223       4,523,145       2       8,050             2,684,900       233,551  
2010
    13,467,223       4,523,145       2       7,714       7,500,000       5,369,800        
 
The Partnership had established an officer incentive program linked to its future value. Awards vest annually over a five-year period assuming continuing employment by the recipient. The awards can be settled in Class C Units or cash at the Partnership’s discretion at the settlement date of December 31, 2012. For accounting purposes, expense recognition under the program commenced in 2008, and the related expense for the three months ended March 31, 2011 and 2010 was approximately $101,500 and $101,500, respectively.
 
As a result of the Merger on September 17, 2010, such incentive program was modified such that 40% of the previously granted award settled immediately on the Merger date with another 20% vesting and settling on December 31, 2010. The remaining 40% will vest equally on December 31, 2011 and December 31, 2012, and will settle in 2018, subject to the terms and conditions of the amended incentive program agreement. In accordance with ASC 718, Compensation—Stock Compensation (ASC 718), such incentive program will continue to be expensed through general and administrative expenses as non-cash compensation on the statements of operations through the ultimate vesting date of December 31, 2012.
 
The Partnership’s equity balance that is presented on the consolidated balance sheets is split between the general partner and limited partners in the amounts of $226,854,796 and $15,563,255 at March 31, 2011, respectively. The Partnership’s equity balance that is presented on the consolidated balance sheets is split between the general partner and limited partners in the amounts of $221,578,430 and $19,482,756 at December 31, 2010, respectively.
 
9.   Option Awards
 
On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction.


F-103


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
The following table represents the time based option awards activity for the three months ended March 31, 2011.
 
         
    March 31,
 
   
2011
 
 
Outstanding at beginning of period
    21,866  
Granted
    456  
Exercised
     
Cancelled/Forfeited
     
         
Outstanding at end of period
    22,322  
Options exercisable at end of period
     
         
Weighted average fair value of options granted
    $149.09  
         
Weighted average remaining contractual life
    9.48  
         
 
The following table represents the time based option awards outstanding for at March 31, 2011 as well as other Plan data:
 
                         
        Remaining
  Weighted
        Contractual Life
  Average
Range of Exercise Prices
 
Outstanding
 
(Years)
 
Exercise Price
 
$1,000—$1,124
    22,322       9.48       $1,004  
 
The Partnership has used the Black-Scholes option pricing model to estimate the grant date fair value of the options. The following table includes the assumptions that were made in estimating the grant date fair value for options awarded in 2011.
 
         
   
2011 Grants
 
Dividend yield
    9.16 %
Risk-free interest rate
    2.72 %
Expected life
    7.0 years  
Estimated volatility
    38.00 %
Weighted average exercise price
    $1,124.22  
Weighted average fair value of options granted (per option)
    $149.09  
 
The Partnership recorded non-cash compensation expenses of $299,468 for the three months ended March 31, 2011, related to the time based stock options accounted for as equity awards, as a component of general and administrative expenses in the consolidated statements of operations.
 
At March 31, 2011, the total compensation cost related to outstanding, non-vested time based equity option awards that are expected to be recognized as compensation cost in the future aggregates to approximately $1,804,000.
 


F-104


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
         
For the Period Ended December 31,
 
Options
 
 
2011
    $791,093  
2012
    591,886  
2013
    309,028  
2014
    112,338  
2015
    48  
         
Total
    $1,804,393  
         
 
Dividend equivalent rights associated with the Plan amounted to $535,728 for the three months ended March 31, 2011, and are included in general and administrative expense in the consolidated statements of operations. These dividend rights will be paid in four installments as the option vests.
 
10.   Related Parties
 
Related party receivables and payables represent amounts due from/to various affiliates of the Partnership, including advances to members of the Partnership, amounts due to certain acquired companies and limited liability companies for transactions occurring prior to the formation of the Partnership, and various advances to entities controlled by affiliates of the Partnership’s management. An officer of the Company received a loan and such loan had a balance of $311,748 at March 31, 2011, which was paid off in full subsequent to that date.
 
The Partnership had entered into a management agreement, as amended, effective April 1, 2005, with AAM, an entity affiliated by common ownership. Under the management agreement, AAM had been granted the exclusive right to oversee the portfolio of the Partnership, providing, among other administrative services, accounting and all required financial services; legal administration and regulatory compliance; investor, tenant, and lender relationship services; and transactional support to the Partnership. Except as otherwise provided in the Partnership Agreement, all management powers of the business and affairs of the Partnership are exclusively vested in the General Partner. The annual fee for such services equals six-tenths of one percent (0.6%) of the aggregate fair market value of the properties as determined by the Partnership and AAM annually. This fee arrangement was amended as discussed below. In addition, the Partnership reimbursed AAM for all reasonable and necessary out-of-pocket expenses incurred in AAM’s conduct of its business, including, but not limited to, travel, legal, appraisal, and brokerage fees, fees and expenses incurred in connection with the acquisition, disposition, or refinancing of any property, and reimbursement of compensation and benefits of the officers and employees of AAM. This agreement was terminated on September 17, 2010 when the Merger occurred, effectively consolidating AAM into the Partnership, and eliminating the necessity for reimbursement.
 
On October 16, 2007, the Partnership legally acquired AAM through a Manager Contribution and Exchange Agreement dated October 16, 2007 (the Contribution Agreement). As stipulated in the Contribution Agreement and the Second Amended and Restated Agreement of Limited Partnership on October 16, 2007 (Partnership Agreement), the Partnership issued a new class of Partnership Unit, Class F Units, as consideration to the contributing members of AAM. The contributing members of AAM served as the general partner of the Partnership. The Class F Units have subordinated payment and liquidity preference to the Class E Units but are senior in payment and liquidity preference, where applicable, to the Class A, B, C, and D Units of the Partnership. The Class F Units paid in quarterly installments an annual dividend of 8.25% of the preliminary face amount of $53,698,000. The preliminary pricing was based upon trading multiples of comparably sized publicly traded healthcare

F-105


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
REITs. The ultimate Class F Unit valuation was subject to a true-up formula at the time of a Liquidity Event, as defined in the Partnership Agreement.
 
For accounting purposes, prior to the Merger, AAM had not been consolidated by the Partnership, nor had any value been ascribed to the Class F Units issued due to the ability of the Class E Unitholders to unwind the acquisition as described above. Such action was outside the control of the Partnership, and accordingly, the acquisition is not viewed as having been consummated. The dividends earned by the Class F Unitholders were reflected as a component of management fees as described above. Prior to the Merger, the fee for management services to the Partnership are equal to the dividend earned on the Class F Unit.
 
Under certain circumstances, the Partnership Agreement did permit the Class E Unitholders to unwind this transaction and requires the Partnership to redeem the Class F Units by returning to the affiliates all membership interests in AAM. On September 17, 2010, the Partnership settled the investment with JER Aviv Acquisition, LLC (JER). For accounting purposes, this treatment triggered the retroactive consolidation of AAM by the Partnership. The original and follow-on investments of Class E unitholders were made subject to the Unit Purchase Agreement and related documents (UPA) between the Partnership and JER dated May 26, 2006.
 
The UPA did not give either party the right to settle the investment prior to May 26, 2011. However, the UPA did have an economic arrangement as to how either party could settle the arrangement on or after that date. This economic construct guided the discussions and negotiations of settlement. The UPA allowed the Partnership to call the E Units and warrants anytime after May 26, 2011 as long as it provided JER with a 15% IRR from date of inception. The IRR would be calculated factoring interim distributions as well as exit payments. The units were settled for $92,001,451 contemporaneous with the Merger. A portion of the settlement related to outstanding warrants held by JER and originally issued in connection with the E units issuance.
 
Coincident with the Merger, 50% of the Class F Unit was purchased and settled by the Partnership for $23,602,649 and is reported as a component of distributions to partners and accretion on Class E Preferred Units in the consolidated statements of changes in equity. The remaining Class F Units will pay in quarterly installments an annual dividend of 9.38% of the face amount of $23,602,649.
 
As of March 31, 2011 and December 31, 2010, the Partnership has a due to related party payable to the Company for distributions to be made by the Company to the stockholders of $5,669,876 and $6,092,936, respectively.
 
11.   Derivatives
 
During the periods presented, the Partnership was party to various interest rate swaps, which were purchased to fix the variable interest rate on the denoted notional amount under the original debt agreements.
 
At March 31, 2011, the Partnership is party to two interest rate swaps, with identical terms for $100 million each. They were purchased to fix the variable interest rate on the denoted notional amount under the Mortgage which was obtained in September, 2010, and qualify for hedge accounting. For presentational purposes they are shown as one derivative due to the identical nature of their economic terms.
 


F-106


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
     
Total notional amount
  $200,000,000
Fixed rates
  6.49% (1.99% effective swap base rate plus 4.5% spread per credit agreement)
Floor rate
  1.25%
Effective date
  November 9, 2010
Termination date
  September 17, 2015
Asset balance at March 31, 2011 (included in other assets)
  $4,603,066
Liability balance at March 31, 2011 (included in other liabilities)
  $—
 
The fair value of each interest rate swap agreement may increase or decrease due to changes in market conditions but will ultimately decrease to zero over the term of each respective agreement.
 
For the three months ended March 31, 2011 and 2010, the Partnership recognized $0 and $1,320,721 of net income, respectively, in the consolidated statements of operations related to the change in the fair value of these interest rate swap agreements, where the Partnership did not elect to apply hedge accounting. Such instruments that did not elect to apply hedge accounting were settled at the Merger date.
 
The following table provides the Partnership’s derivative assets and liabilities carried at fair value as measured on a recurring basis as of March 31, 2011 (dollars in thousands):
 
                                 
                Significant
       
    Total Carrying
    Quoted Prices
    Other
    Significant
 
    Value at
    in Active
    Observable
    Unobservable
 
    March 31,
    Markets
    Inputs
    Inputs
 
   
2011
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
 
Derivative assets
    $4,603       $       $4,603       $  
Derivative liabilities
                       
                                 
      $4,603       $       $4,603       $  
                                 
 
The Partnership’s derivative assets and liabilities include interest rate swaps that effectively convert a portion of the Partnership’s variable rate debt to fixed rate debt. The derivative positions are valued using models developed by the respective counterparty that use as their basis readily observable market parameters (such as forward yield curves) and are classified within Level 2 of the valuation hierarchy. The Partnership considers its own credit risk as well as the credit risk of its counterparties when evaluating the fair value of its derivatives.
 
12.   Commitments and Contingencies
 
The Partnership has a contractual arrangement with a tenant to reimburse quality assurance fees levied by the California Department of Health Care Services from August 1, 2005 through July 31, 2008. The Partnership is obligated to reimburse the fees to the tenant if and when the state withholds these fees from the tenant’s Medi-Cal reimbursements associated with 5 facilities that were formerly leased to Trinity Health Systems. The total possible obligation for these fees is $1,655,286, of which approximately $1.0M has been paid to date. For the three months ended March 31, 2011, and 2010, the Partnership’s indemnity expense for these fees was $0 and $183,000, respectively, which equaled the actual amount paid during the period.

F-107


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
Judicial proceedings seeking declaratory relief for these fees are in process which if successful would provide for recovery of such amounts from the State of California. The Partnership has certain rights to seek relief against Trinity Health Systems for monies paid out under the indemnity claim; however, it is uncertain whether the Partnership will be successful in receiving any amounts from Trinity.
 
In the normal course of business, the Partnership is involved in legal actions arising from the ownership of its property. In management’s opinion, the liabilities, if any, that may ultimately result from such legal actions are not expected to have a material adverse effect on the financial position, operations, or liquidity of the Partnership.
 
13.   Concentration of Credit Risk
 
As of March 31, 2011, the Partnership’s portfolio of investments consisted of 187 healthcare facilities, located in 25 states and operated by 31 third party operators. At March 31, 2011, approximately 50.7% (measured as a percentage of total assets) were leased by five private operators: Evergreen Healthcare (13.6%), Daybreak Healthcare (12.4%), Sun Mar Healthcare (9.1%), Hi-Care Management (8.0%), and Convacare Management (7.6%). No other operator represents more than 6.3% of our total assets. The five states in which the Partnership had its highest concentration of total assets were California (19.4%), Texas (16.3%), Missouri (9.5%), Arkansas (8.1%), and New Mexico (5.9%) at March 31, 2011.
 
For the three months ended March 31, 2011, the Partnership’s rental income from operations totaled approximately $19.7 million, of which approximately $3.0 million was from Evergreen Healthcare (15.1%), $2.4 million was from Sun Mar Healthcare (12.1%), $2.3 million was from Daybreak Venture (11.8%), $1.7 million was from Cathedral Rock Corporation (8.9%), and $1.6 million was from ConvaCare Management (8.3%). No other operator generated more than 6.0% of the Partnership’s rental income from operations for the three months ended March 31, 2011.
 
14.   Subsequent Events
 
On April 5, 2011, the Partnership issued $100 million in Senior Notes at 7.75%. The proceeds from this bond issuance were used to pay down $35.7 million of the Mortgage and the remaining proceeds were received as cash.
 
On April 28, 2011 Aviv Financing II acquired three properties in Ohio from an unrelated third party for a purchase price of $9,250,000. The Partnership financed this purchase with cash.
 
On April 29, 2011 Aviv Financing II acquired six properties in Texas, Kansas, and Missouri from unrelated third parties for a purchase price of $17,570,000. The Partnership financed this purchase with cash.
 
On May 2, 2011, Aviv Financing II acquired three properties in Kansas from an unrelated third party for a purchase price of approximately $2,273,000. The Partnership financed this purchase with cash.
 
On May 3, 2011, Aviv Financing II acquired a property in Connecticut from an unrelated third party for a purchase price of $12,000,000. The Partnership financed this purchase with cash.


F-108


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements (unaudited)—(Continued)
 
 
The Partnership has evaluated events subsequent to March 31, 2011 through May 18, 2011, and determined that no events other than those noted above would require changes to the consolidated financial statements or additional disclosure.
 
15.   Condensed Consolidating Information
 
We and certain of our direct and indirect wholly owned subsidiaries (the “Wholly Owned Subsidiary Guarantors”) fully and unconditionally guaranteed, on a joint and several basis, the obligation to pay principal and interest with respect to our Senior Notes issued in February 2011. Separate financial statements of the guarantors are not provided as the consolidating financial information contained herein provides a more meaningful disclosure to allow investors to determine the nature of the assets held by and the operations of the respective guarantor and non-guarantor subsidiaries. Other wholly owned subsidiaries (“Non-Guarantor Subsidiaries”) that were not included among the Guarantors were not obligated with respect to the Senior Notes. The Non-Guarantor Subsidiaries are subject to mortgages. The following summarizes our condensed consolidating information as of March 31, 2011 and December 31, 2010 and for the three months ended March 31, 2011 and 2010:


F-109


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to the Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING BALANCE SHEET
As of March 31, 2011
 
                                         
                Non-
             
          Subsidiary
    Guarantor
             
    Issuers     Guarantors     Subsidiaries     Eliminations     Consolidated  
 
Assets
                                       
Cash and cash equivalents
  $ 10,424,243     $ 126,974     $ (46,915 )   $     $ 10,504,302  
Net rental properties
          632,540,085       17,838,085             650,378,170  
Deferred financing costs, net
    6,028,981       7,007,572       21,343             13,057,896  
Other
    9,594,582       63,401,908       53,361             73,049,851  
Investment in and due from related parties, net
    435,594,673       (239,351,384 )     (7,390,102 )     (188,853,187 )      
                                         
Total assets
  $ 461,642,479     $ 463,725,155     $ 10,475,772     $ (188,853,187 )   $ 746,990,219  
                                         
Liabilities and equity
                                       
Mortgage and other notes payable
  $ 200,000,000     $ 245,550,522     $ 9,073,125     $     $ 454,623,647  
Due to related parties
    5,669,876                         5,669,876  
Tenant security and escrow deposits
    25,000       13,870,961       236,229             14,132,190  
Accounts payable and accrued expenses
    3,643,808       2,745,298       658,581             7,047,687  
Other liabilities
    5,282,678       13,213,024                   18,495,702  
                                         
Total liabilities
    214,621,362       275,379,805       9,967,935             499,969,102  
Total equity
    247,021,117       188,345,350       507,837       (188,853,187 )     247,021,117  
                                         
Total liabilities and equity
  $ 461,642,479     $ 463,725,155     $ 10,475,772     $ (188,853,187 )   $ 746,990,219  
                                         


F-110


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to the Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING BALANCE SHEET
As of December 31, 2010
 
                                         
                Non-
             
          Subsidiary
    Guarantor
             
    Issuers     Guarantors     Subsidiaries     Eliminations     Consolidated  
 
Assets
                                       
Cash and cash equivalents
  $ 12,126,776     $ 908,612     $ (6,914 )   $     $ 13,028,474  
Net rental properties
          609,972,113       17,128,420             627,100,533  
Deferred financing costs, net
    100,000       9,834,291       23,345             9,957,636  
Other
    13,380,055       67,896,040       36,481             81,312,576  
Investment in and due from related parties, net
    232,906,755       (42,847,014 )     (6,964,810 )     (183,094,931 )      
                                         
Total assets
  $ 258,513,586     $ 645,764,042     $ 10,216,522     $ (183,094,931 )   $ 731,399,219  
                                         
Liabilities and equity
                                       
Mortgage and other notes payable
  $     $ 431,471,341     $ 9,104,575     $     $ 440,575,916  
Due to related parties
    6,092,936                         6,092,936  
Tenant security and escrow deposits
          13,422,705       235,679             13,658,384  
Accounts payable and accrued expenses
    1,431,564       4,102,506       478,739             6,012,809  
Other liabilities
    5,833,468       14,070,088                   19,903,556  
                                         
Total liabilities
    13,357,968       463,066,640       9,818,993             486,243,601  
Total equity
    245,155,618       182,697,402       397,529       (183,094,931 )     245,155,618  
                                         
Total liabilities and equity
  $ 258,513,586     $ 645,764,042     $ 10,216,522     $ (183,094,931 )   $ 731,399,219  
                                         


F-111


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to the Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended March 31, 2011
 
                                         
                Non-
             
          Subsidiary
    Guarantor
             
    Issuers     Guarantors     Subsidiaries     Eliminations     Consolidated  
 
Revenues
                                       
Rental income
  $     $ 19,343,806     $ 346,285     $     $ 19,690,091  
Tenant recoveries
          1,658,925       30,071             1,688,996  
Interest on loans to lessees
    361,144       970,965                   1,332,109  
                                         
Total revenues
    361,144       21,973,696       376,356             22,711,196  
Expenses
                                       
Rent and other operating expenses
    39,137       162,527                   201,664  
General and administrative
    1,711,598       1,756,828       150             3,468,576  
Real estate taxes
          1,659,023       30,071             1,689,094  
Depreciation
          4,681,392       117,176             4,798,568  
                                         
Total expenses
    1,750,735       8,259,770       147,397             10,157,902  
                                         
Operating income
    (1,389,591 )     13,713,926       228,959             12,553,294  
                                         
Total other income and expenses
    (2,516,408 )     (8,737,512 )     (118,653 )           (11,372,573 )
                                         
Net income
    (3,905,999 )     4,976,414       110,306             1,180,721  
                                         
Equity in income (loss) of subsidiaries
    5,086,720                   (5,086,720 )      
                                         
Net income allocable to common units
  $ 1,180,721     $ 4,976,414     $ 110,306     $ (5,086,720 )   $ 1,180,721  
                                         


F-112


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to the Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended March 31, 2010
 
                                         
                Non-
             
          Subsidiary
    Guarantor
             
    Issuers     Guarantors     Subsidiaries     Eliminations     Consolidated  
 
Revenues
                                       
Rental income
  $     $ 20,990,600     $ 159,735     $     $ 21,150,335  
Tenant recoveries
          1,509,613       19,441             1,529,054  
Interest on loans to lessees
    272,052       859,146                   1,131,198  
                                         
Total revenues
    272,052       23,359,359       179,176             23,810,587  
Expenses
                                       
Rent and other operating expenses
          169,330                   169,330  
General and administrative
    436,011       987,837       400             1,424,248  
Real estate taxes
          1,585,989       19,441             1,605,430  
Depreciation
          4,327,108       34,793             4,361,901  
                                         
Total expenses
    436,011       7,070,264       54,634             7,560,909  
                                         
Operating income
    (163,959 )     16,289,095       124,542             16,249,678  
                                         
Total other income and expenses
    (96,711 )     (4,523,881 )                   (4,620,592 )
                                         
Net income
    (260,670 )     11,765,214       124,542             11,629,086  
                                         
Distributions and accretion on Class E Preferred units
    (3,998,770 )                       (3,998,770 )
Net income attributable to noncontrolling interests
    (79,617 )                       (79,617 )
Equity in income (loss) of subsidiaries
    11,889,756                   (11,889,756 )      
                                         
Net income allocable to common units
  $ 7,550,699     $ 11,765,214     $ 124,542     $ (11,889,756 )   $ 7,550,699  
                                         


F-113


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to the Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Three Months Ended March 31, 2011
 
                                         
                Non-
             
          Subsidiary
    Guarantor
             
    Issuers     Guarantors     Subsidiaries     Eliminations     Consolidated  
 
Net cash (used in) provided by operating activities
  $ (199,908,610 )   $ 212,760,082     $ 818,290     $     $ 13,669,762  
Net cash provide by (used in) investing activities
    4,945,998       (26,468,836 )     (826,841 )           (22,349,679 )
Financing activities
                                       
Borrowings of debt
    200,000,000       10,200,000                   210,200,000  
Repayment of debt
          (196,120,819 )     (31,450 )           (196,152,269 )
Payment of financing costs
    (5,704,107 )     (852,597 )                 (6,556,704 )
Capital contributions
    10,000,000                           10,000,000  
Cost of raising capital
    299,468       (299,468 )                  
Cash distributions to partners
    (11,335,282 )                       (11,335,282 )
                                         
Net cash provided by (used in) financing activities
    193,260,079       (187,072,884 )     (31,450 )           6,155,745  
                                         
Net decrease in cash and cash equivalents
    (1,702,533 )     (781,638 )     (40,001 )           (2,524,172 )
Cash and cash equivalents:
                                       
Beginning of period
    12,126,776       908,612       (6,914 )           13,028,474  
                                         
End of period
  $ 10,424,243     $ 126,974     $ (46,915 )   $     $ 10,504,302  
                                         


F-114


Table of Contents

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES
 
Notes to the Consolidated Financial Statements—(Continued)
 
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Three Months Ended March 31, 2010
 
                                         
                Non-
             
          Subsidiary
    Guarantor
             
    Issuers     Guarantors     Subsidiaries     Eliminations     Consolidated  
 
Net cash provided by (used in) operating activities
  $ 9,930,733     $ 4,083,433     $ (400 )   $     $ 14,013,766  
Net cash used in investing activities
    (1,467,921 )     (6,288,371 )                 (7,756,292 )
Financing activities
                                       
Repayment of debt
    (750,000 )     (1,813,125 )                 (2,563,125 )
Cash distributions to partners
    (9,982,923 )     (1,092,350 )                 (11,075,273 )
                                         
Net cash used in financing activities
    (10,732,923 )     (2,905,475 )                 (13,638,398 )
                                         
Net decrease in cash and cash equivalents
    (2,270,111 )     (5,110,413 )     (400 )           (7,380,924 )
Cash and cash equivalents:
                                       
Beginning of period
    256,598       15,285,909                   15,542,507  
                                         
End of period
  $ (2,013,513 )   $ 10,175,496     $ (400 )   $     $ 8,161,583  
                                         


F-115


Table of Contents

 
$300,000,000
 
(AVIV HEALTHCARE  LOGO)
 
Aviv Healthcare Properties Limited Partnership
Aviv Healthcare Capital Corporation
 
Exchange Offer for
7  3/4% Senior Notes due 2019
 
 
PROSPECTUS
 
 
July 21, 2011
 
 
Until October 19, 2011, all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.
 
 

GRAPHIC 2 c64208b3c64208100.gif GRAPHIC begin 644 c64208b3c64208100.gif M1TE&.#EAB``W`.9_`/GZ_&E]LA$QAKW&W:FUTV5YL(24P&%VKJ6QT;.]V.'E M\(Z=Q4EBHMG>[.;J\BU)E):DRH*&NS\+*X`,D?M_C[JVXU?'S^)VJS6R`M-+8Z+K$W.#D M[];ERGB*NC]9G0XNA-3:Z76(N'N- MO`DJ@I^LSEQRK)FGR[_(WB`^C8PG*%MPSO]HN;Q(R;Q!LZB\;-XC10EV=\L>CK\_/T M^6Z"M>_Q]VM^L^7I\EMRK-SA[6Q_M,7-X8:6P(B8J+C(V"7F!^?D)YCI:7F)F:FXLTDI)% M=9RCI*6FCAZ??AH.IZZOL)J>GZ&QMK>X@VHLDB5$N<#!IVL9-J+""GW*R\S- MSL_/'37"U*1\JMB?`BH/*B5'V>'8!8<*-!6&('E+T'U+#2"'83CLS4LP\?3M MR@,R?U`=VG7($\^0ESW0KH4;HH)#FA-OKI`0D\(;.''8'C0YE,-/FE^$`"S` MZ*<''Q2'5A@1$&Y!F#]L>I#TPZ'!GS@LQ?VH@M)0'A9#LKE1B&W("2)\.ESI MP`,+##XD()1)<9$DF$-K[)2L@FB&3%5)_#$B`><3AA6&$G#`!@:'(2-?_S\! MZ;EH1DX+"?X0E33DP9D`!4Z4$!!``IH**228`<#&3=5P3!`<6O))`MU",[#Q ML#2+SC%#)BQ\LC`&T8&@GV!8NA#4AR"B?6F\L9$"3A,=8I9@J)(':I439(H\ MZ*%%7)E#*`Q\2B$Y)1U5!5XV*N#G1X=$(]9*8H5HPP-5'"E0``V(9[86:*!"9,H&(JHB+#`PF-)/5QQR!C??<(%=FY\PL$3C33P@1\' MR(&==JNT@D@%<5U`02,#L-3"(`H-`1@#`?!1``T=%`!$#`!#&+)%\THH1,3BB2W?\GW"$21H&2D-#(%T/TL`:( M?@S!``,J[-`!%0(H`28;01"PQ!4BV`!'`5*088`$4SB'X'!&-D8D$D-. M?IP1`2,'^,&`31,R:2$B-/`)Q@:+`"#3`07I)2@"<4#@PVD!,%``&&^84`4- M9""0A@5(H'$F%F2PX=\G#T1Q2`)^,&$'`Y^4X=8A9DBAB@&+V/!=&XLLN=VA MA\!`H1\A+(($2QN!:$4<<3#`QQ8,V.%#'&(D(:($8@3@0P$'B!`#&P+PH((: M9A3P@B0B'.)`H"PXX,,G/9B02`NJE/%G(D7X48*42E+89")Z\'F`6(B4!8=T MKTD;1P4PN%>%`&1@<(#_!!`44``+#)!1P00#&-#%"@.X@,0%.*80PR$D2))G M"$Q\(@(`B)B1BER)[.)'`(P&;.@B'<3\":&3L31#I'K%H4`'+1P`SA!@`%'! M$@<4P&T!50R0Q`=@A(#'"@7T\003.*J`U1=^P%$:!7$L1T`B5:@"Q@V(F"#) MRL$*3"PB$J#FQQ=>(%)`E1L2PL<0$H%P``/1V@&$"4GT@)\1#P#AK11;R%#" M%$(\D0*.%KAF"!0I0#C($ZHL&,A($!`4PZ#F*'! M_R<77(?(2$P63D@")?@A>NW#-L*`WPM<)H@!+!'M;`!]M$"M'F10`!1L4``Q M<.$('+"`$J30`S1XP`(8>``2!O`YPAQ"#6405"$0H(K-(*(#4+(`W@CQG`NX MBA'"JE`C6B`:25A`?8-8BQ!H5H@0;,,)<`29$1)B#Y(X@PGX0$M:MB$.W[ M1`RD

XN$1B(2QJ.$026W,H0>PG'`T"`S3`08%WBL`!7 M#)$!200@$3V2!#D0,0?J?&('@@B`'R[0Q&+:[IC)E$2SUF(91`04&UJP0`VP MZ84)(#0<%_C,(%`0MPOLZQ`1.,$GX`"P0[#S$Q^``1'*&(0U^BQ^EL`"GW2) M`)D@P*ALQ$A*5]J%EKX4&P+_F,`A&G"!52A");M*A`(B\0D$Q$T`ZH2?"BW1 M@-SY00UW^D'@3$J2J;+4I>(HP1X.00!_Y45)JOC`%0D!!%5PH'U2V%X]C6F) M`_")`2P)PBX!6E>5WO6JJO!`L1ZT!4;D00+T0D,B;D!65;QOL1]U1!3DB0T% M*.*DJK!K5?&:C1]$LA"H^X$2&A$W)D&3$+W]A`J:90E[9@(HJM"`)RDK5`KE^<`/"Z-I&C:M M@T";'QJ,B3&4114!N%(FNNH'8KZVL@8F<2^@0`@9Y!,;%O#`APX!@!FD(:38 M2($4;&"()_Q`!=-PA`%8\`"_J4(`0DC#/XTD``]<-Q%]J*6:U;P`"F`3`#G` M@)H-L%M"K,`)/%@S']+CI!_JN98&:$-I#*&!AUHB!GG^I2F_K4J/ZS"_Z0C'VX^M6PCK6L M9TWK6CO#M9W.M:YWS>M>^_K7P`XV+AH0!#XT4A$9V`$&9JEPAT38P`"#'40# M$C"`$#CAGL+F1`C@,$X^*((,(I!"$,S'5RH0UQ`$V$$*-!"'FV:[%'U@`0*" M\,=$9.`+`UC$`+Z0@46P``GO?@49+O``"0P:$340P1"`E8A]]UL1_PZX*T)0 MAA.PP'Z%R``6$)#)0SC